Compositions and methods

ABSTRACT

Provided are defined bacterial compositions for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for populating the gastrointestinal tract of a subject. Provided also are bacterial formulations for oral or gastric administration to a mammalian subject in an effective amount for prevention or treatment of a gastrointestinal disease, disorder or condition.

RELATED APPLICATIONS

This application is a divisional of U.S. application Ser. No. 14/765,812having a 371(c) date of Aug. 4, 2015, which is a National Stage Entry ofInternational Application No. PCT/US2014/014747 filed Feb. 4, 2014,which claims priority to U.S. Provisional Application No. 61/760,584,filed on Feb. 4, 2013, and to U.S. Provisional Application No.61/760,585, filed on Feb. 4, 2013, and to U.S. Provisional ApplicationNo. 61/760,574, filed on Feb. 4, 2013, and to U.S. ProvisionalApplication No. 61/760,606, filed on Feb. 4, 2013, and to U.S.Provisional Application No. 61/798,606, filed on Mar. 15, 2013, and toU.S. Provisional Application No. 61/926,918, filed on Jan. 13, 2014,each of which is incorporated herein by reference in its entirety forall purposes.

REFERENCE TO A SEQUENCE LISTING

This application includes a Sequence Listing submitted electronically asa text file named 4268_0260007_Seqlisting_ST25.txt, created on Apr. 9,2021, with a size of 4,180,262 bytes. The sequence listing isincorporated by reference.

BACKGROUND

Mammals are colonized by microbes in the gastrointestinal (GI) tract, onthe skin, and in other epithelial and tissue niches such as the oralcavity, eye surface and vagina. The gastrointestinal tract harbors anabundant and diverse microbial community. It is a complex system,providing an environment or niche for a community of many differentspecies or organisms, including diverse strains of bacteria. Hundreds ofdifferent species may form a commensal community in the GI tract in ahealthy person, and this complement of organisms evolves from the timeof birth to ultimately form a functionally mature microbial populationby about 3 years of age. Interactions between microbial strains in thesepopulations and between microbes and the host, e.g. the host immunesystem, shape the community structure, with availability of andcompetition for resources affecting the distribution of microbes. Suchresources may be food, location and the availability of space to grow ora physical structure to which the microbe may attach. For example, hostdiet is involved in shaping the GI tract flora.

A healthy microbiota provides the host with multiple benefits, includingcolonization resistance to a broad spectrum of pathogens, essentialnutrient biosynthesis and absorption, and immune stimulation thatmaintains a healthy gut epithelium and an appropriately controlledsystemic immunity. In settings of ‘dysbiosis’ or disrupted symbiosis,microbiota functions can be lost or deranged, resulting in increasedsusceptibility to pathogens, altered metabolic profiles, or induction ofproinflammatory signals that can result in local or systemicinflammation or autoimmunity. Thus, the intestinal microbiota plays asignificant role in the pathogenesis of many diseases and disorders,including a variety of pathogenic infections of the gut. For instance,subjects become more susceptible to pathogenic infections when thenormal intestinal microbiota has been disturbed due to use ofbroad-spectrum antibiotics. Many of these diseases and disorders arechronic conditions that significantly decrease a subject's quality oflife and can be ultimately fatal.

Manufacturers of probiotics have asserted that their preparations ofbacteria promote mammalian health by preserving the natural microflorain the GI tract and reinforcing the normal controls on aberrant immuneresponses. See, e.g., U.S. Pat. No. 8,034,601. Probiotics, however, havebeen limited to a very narrow group of genera and a correspondinglylimited number of species; as such, they do not adequately replace themissing natural microflora of the GI tract in many situations.

Thus, there is a need for a method of populating a subject'sgastrointestinal tract with a diverse and useful selection of microbiotain order to alter a dysbiosis. In response to the need for durable,efficient, and effective compositions and methods for treatment of GIdiseases by way of restoring or enhancing microbiota functions,Applicants address these and other shortcomings of the art by providingcompositions and methods for treating subjects.

SUMMARY OF THE INVENTION

Disclosed herein are therapeutic compositions comprising a bacterialpopulation comprising at least three but fewer than nine bacterialstrains selected from the group consisting of Escherichia coli,Enterococcus faecalis, Clostridium innocuum, Clostridium ramosum,Clostridium bifermentans, Bacteroides ovatus, Bacteroides vulgatus,Bacteroides thetaiotaomicron, and Blautia producta, wherein thecomposition is formulated for oral or gastric administration to amammalian subject in an effective amount for prevention or treatment ofa gastrointestinal disease, disorder or condition. In some embodiments,the bacterial strains are not a colonic bacterium and/or are notobtained from a fecal culture. In some embodiments, at least oneBacteroides species is detectably present in the mammalian subject priorto administration of the composition or, in other embodiments at leastone Bacteroides species is not detectably present in the mammaliansubject prior to administration of the composition, but is detectablypresent in the mammalian subject at least one hour after administrationof the composition. In some embodiments, the mammalian subject has notreceived at least two doses of vancomycin, metronidazole and/or orsimilar antibiotic compound within one week prior to administration ofthe therapeutic composition. In some embodiments, a singleadministration is substantially effective to reduce C. difficile and/orC. difficile toxin content in a mammalian subject to whom thecomposition is administered. In some embodiments, one strain of E. coliis present in amounts at least 2, 5, 10, 50, 100 or more than 100 timesgreater than any other strain of E. coli present in the composition. Insome embodiments, at least three bacterial strains are not present inthe composition in equal ratios or are present in a ratio equivalent tothe ratio of the bacterial strains in a reference mammalian subject. Insome embodiments, at least one of the bacterial strains is provided in aconcentration of greater than 1×10⁹ viable bacteria per gram ofcomposition or is provided in a concentration of less than 1×10⁸ viablebacteria per gram of composition. In some embodiments, a plurality ofthe bacterial strains is provided in a concentration of less than 1×10⁸viable bacteria per gram of composition. In some embodiments, no morethan nine different bacterial strains are used, wherein at least twostrains are from the group selected from: Escherichia coli, Enterococcusfaecalis, Clostridium innocuum, Clostridium ramosum, Clostridiumbifermentans, Bacteroides ovatus, Bacteroides vulgatus, Bacteroidesthetaiotaomicron, and Blautia producta. In some embodiments, thecomposition is formulated for oral administration as a solid,semi-solid, gel, or liquid form; in the form of a pill, tablet, capsule,or lozenge; the bacterial strains are substantially encapsulated in anenteric coating; and/or the bacterial strains are substantially inactiveprior to localization in the gastrointestinal tract of a mammaliansubject to whom the composition is administered. In some embodiments, nomore than two of the bacterial strains are strains whose growth issubstantially inhibited by an equivalent amount of C. difficilebacteria.

Also disclosed is a method of treating a mammalian subject sufferingfrom or at risk of developing a gastrointestinal disease, disorder orcondition, comprising the step of administering to the mammalian subjecta therapeutic composition comprising a bacterial population as describedherein, wherein the composition is formulated for oral or gastricadministration. In some embodiments, the gastrointestinal disease,disorder or condition is selected from the group consisting of relapsingdiarrhea caused by C. difficile, ulcerative colitis, colitis, Crohn'sdisease, and irritable bowel disease. In some embodiments, the mammaliansubject is an agricultural mammal. In some embodiments, the bacterialpopulation comprises at least six bacterial strains or comprises atleast six but fewer than ten bacterial strains. In some embodiments, thetherapeutic composition is administered only once prior to improvementof the disease, disorder or condition; wherein the therapeuticcomposition is administered at intervals greater than two days; themammalian subject has not received at least two doses of vancomycin,metronidazole and/or or similar antibiotic compound within one weekprior to administration of the therapeutic composition; the mammaliansubject is not suffering from relapsing diarrhea caused by C. difficile;and/or the mammalian subject has not previously received an antibioticcompound in the one month prior to administration of the therapeuticcomposition.

Also disclosed is a method of treating a mammalian subject sufferingfrom or at risk of developing a gastrointestinal disease, disorder orcondition, comprising the step of administering to the mammalian subjectany therapeutic composition disclosed herein.

Also disclosed is a method of treating a mammalian subject sufferingfrom or at risk of developing a gastrointestinal disease, disorder orcondition, or a metabolic disease, disorder or condition selected fromthe group consisting of diabetes and autism, comprising the step ofadministering to the mammalian subject a therapeutic compositioncomprising a bacterial population comprising at least three bacterialstrains, wherein no greater than nine of the bacterial strains aremembers of a bacterial species selected from the group consisting ofEscherichia coli, Enterococcus faecalis, Clostridium innocuum,Clostridium ramosum, Clostridium bifermentans, Bacteroides ovatus,Bacteroides vulgatus, Bacteroides thetaiotaomicron, and Blautiaproducta, wherein the composition is formulated for oral or gastricadministration. In some embodiments, the method further comprises thestep of detecting one or more of the administered bacterial strains inthe mammalian subject subsequent to administration, for example,detecting a 16S nucleic acid sequence in at least one administeredbacterial strain.

Also disclosed is a therapeutic composition comprising a bacterialpopulation comprising at least three but fewer than nine bacterialstrains, wherein the bacterial strains comprise 16S nucleic acidsequences at least 97% identical to reference 16S nucleic acid sequencesin bacterial strains selected from the group consisting of Escherichiacoli, Enterococcus faecalis, Clostridium innocuum, Clostridium ramosum,Clostridium bifermentans, Bacteroides ovatus, Bacteroides vulgatus,Bacteroides thetaiotaomicron, and Blautia producta, wherein thecomposition is formulated for oral or gastric administration to amammalian subject in an effective amount for prevention or treatment ofa gastrointestinal disease, disorder or condition.

Also disclosed is a therapeutic composition comprising a bacterialpopulation comprising at least three but fewer than nine bacterialstrains, wherein the bacterial strains comprise Clostridium innocuum,Clostridium ramosum, and Clostridium bifermentans, wherein thecomposition is formulated for oral or gastric administration to amammalian subject in an effective amount for prevention or treatment ofa gastrointestinal disease, disorder or condition.

Also disclosed is a therapeutic composition comprising a bacterialpopulation comprising at least three but fewer than nine bacterialstrains, wherein the bacterial strains do not comprise detectableamounts of Bacteroides ovatus, Bacteroides vulgatus, or Bacteroidesthetaiotaomicron, wherein the composition is formulated for oral orgastric administration to a mammalian subject in an effective amount forprevention or treatment of a gastrointestinal disease, disorder orcondition.

Also disclosed is a method of increasing diversity of a gastrointestinalmicrobiota in a mammalian subject in need thereof, comprisingadministering to the mammalian subject a therapeutic compositioncomprising a bacterial population comprising at least three but fewerthan nine bacterial strains, wherein the bacterial strains comprise 16Snucleic acid sequences at least 97% identical to reference 16S nucleicacid sequences in bacterial strains selected from the group consistingof Escherichia coli, Enterococcus faecalis, Clostridium innocuum,Clostridium ramosum, Clostridium bifermentans, Bacteroides ovatus,Bacteroides vulgatus, Bacteroides thetaiotaomicron, and Blautiaproducta, wherein the composition is formulated for oral or gastricadministration to a mammalian subject in an effective amount forincreasing the diversity of the gastrointestinal microbiota of themammalian subject subsequent to administration. In some embodiments, thediversity is increased for at least 1 day after administration or for atleast 4 days after administration or for at least 7 days afteradministration or for at least 14 days after administration or for atleast 21 days after administration. In some embodiments, wherein themammalian subject is suffering from or at risk of developing a disease,disorder or condition other than a gastrointestinal disease, disorder orcondition.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1A provides a schematic of 16S rRNA gene and denotes thecoordinates of hypervariable regions 1-9 (V1-V9). Coordinates of V1-V9are 69-99, 137-242, 433-497, 576-682, 822-879, 986-1043, 1117-1173,1243-1294, and 1435-1465 respectively, based on numbering using E. colisystem of nomenclature defined by Brosius et al., Complete nucleotidesequence of a 16S ribosomal RNA gene (16S rRNA) from Escherichia coli,PNAS 75(10):4801-4805 (1978).

FIG. 1B highlights in bold the nucleotide sequences for eachhypervariable region in the exemplary reference E. coli 16S sequence(SEQ ID NO: 2043) described by Brosius et al.

FIG. 2 shows a photograph of a CsCl gradient demonstrating the sporeseparation from other residual habitat material.

FIG. 3 shows three phase contrast image demonstrating the progressiveenrichment of spores from a fecal suspension; ethanol treated, CsClpurified spore preparation; and an ethanol treated, CsCl purified,sucrose purified spore preparation.

FIG. 4 shows a set of survival curves demonstrating efficacy of thespore population in a hamster prophylaxis model of C. difficile.

FIG. 5 provides a set of survival curves demonstrating efficacy of thespore population in a hamster relapse prevention model of C. difficile.

FIG. 6 shows the strong correlation and linear correspondence betweenthe measurement of DPA concentration by a coupled fluorescence assay andthe viable spore colony forming units.

The figures depict various embodiments of the present invention forpurposes of illustration only. One skilled in the art will readilyrecognize from the following discussion that alternative embodiments ofthe structures and methods illustrated herein may be employed withoutdeparting from the principles of the invention described herein.

DETAILED DESCRIPTION Definitions

“Microbiota” refers to the community of microorganisms that occur(sustainably or transiently) in and on an animal subject, typically amammal such as a human, including eukaryotes, archaea, bacteria, andviruses (including bacterial viruses i.e., phage).

“Microbiome” refers to the genetic content of the communities ofmicrobes that live in and on the human body, both sustainably andtransiently, including eukaryotes, archaea, bacteria, and viruses(including bacterial viruses (i.e., phage)), wherein “genetic content”includes genomic DNA, RNA such as ribosomal RNA, the epigenome,plasmids, and all other types of genetic information.

“Microbial Carriage” or simply “Carriage” refers to the population ofmicrobes inhabiting a niche within or on humans. Carriage is oftendefined in terms of relative abundance. For example, OTU1 comprises 60%of the total microbial carriage, meaning that OTU1 has a relativeabundance of 60% compared to the other OTUs in the sample from which themeasurement was made. Carriage is most often based on genomic sequencingdata where the relative abundance or carriage of a single OTU or groupof OTUs is defined by the number of sequencing reads that are assignedto that OTU/s relative to the total number of sequencing reads for thesample.

“Microbial Augmentation” or simply “augmentation” refers to theestablishment or significant increase of a population of microbes thatare (i) absent or undetectable (as determined by the use of standardgenomic and microbiological techniques) from the administeredtherapeutic microbial composition, (ii) absent, undetectable, or presentat low frequencies in the host niche (as example: gastrointestinaltract, skin, anterior-nares, or vagina) before the delivery of themicrobial composition, and (iii) are found after the administration ofthe microbial composition or significantly increase, for instance2-fold, 5-fold, 1×10², 1×10³, 1×10⁴, 1×10⁵, 1×10⁶, 1×10⁷, or greaterthan 1×10⁸, in cases where they were present at low frequencies. Themicrobes that comprise an augmented ecology can be derived fromexogenous sources such as food and the environment, or grow out frommicro-niches within the host where they reside at low frequency.

The administration of the therapeutic microbial composition induces anenvironmental shift in the target niche that promotes favorableconditions for the growth of these commensal microbes. In the absence oftreatment with a therapeutic microbial composition, the host can beconstantly exposed to these microbes; however, sustained growth and thepositive health effects associated with the stable population ofincreased levels of the microbes comprising the augmented ecology arenot observed.

“Microbial Engraftment” or simply “engraftment” refers to theestablishment of OTUs comprising a therapeutic microbial composition ina target niche that are absent in the treated host prior to treatment.The microbes that comprise the engrafted ecology are found in thetherapeutic microbial composition and establish as constituents of thehost microbial ecology upon treatment. Engrafted OTUs can establish fora transient period of time, or demonstrate long-term stability in themicrobial ecology that populates the host post treatment with atherapeutic microbial composition. The engrafted ecology can induce anenvironmental shift in the target niche that promotes favorableconditions for the growth of commensal microbes capable of catalyzing ashift from a dysbiotic ecology to one representative of a health state.

“Ecological Niche” or simply “Niche” refers to the ecological space inwhich a an organism or group of organisms occupies. Niche describes howan organism or population or organisms responds to the distribution ofresources, physical parameters (e.g., host tissue space) and competitors(e.g., by growing when resources are abundant, and when predators,parasites and pathogens are scarce) and how it in turn alters those samefactors (e.g., limiting access to resources by other organisms, actingas a food source for predators and a consumer of prey).

“Dysbiosis” refers to a state of the microbiota of the gut or other bodyarea in a subject, including mucosal or skin surfaces in which thenormal diversity and/or function of the ecological network is disrupted.This unhealthy state can be due to a decrease in diversity, theovergrowth of one or more pathogens or pathobionts, symbiotic organismsable to cause disease only when certain genetic and/or environmentalconditions are present in a subject, or the shift to an ecologicalmicrobial network that no longer provides an essential function to thehost subject, and therefore no longer promotes health.

“Pathobionts” or “Opportunistic Pathogens” refers to symbiotic organismsable to cause disease only when certain genetic and/or environmentalconditions are present in a subject.

“Phylogenetic tree” refers to a graphical representation of theevolutionary relationships of one genetic sequence to another that isgenerated using a defined set of phylogenetic reconstruction algorithms(e.g. parsimony, maximum likelihood, or Bayesian). Nodes in the treerepresent distinct ancestral sequences and the confidence of any node isprovided by a bootstrap or Bayesian posterior probability, whichmeasures branch uncertainty.

“Operational taxonomic units,” “OTU” (or plural, “OTUs”) refer to aterminal leaf in a phylogenetic tree and is defined by a nucleic acidsequence, e.g., the entire genome, or a specific genetic sequence, andall sequences that share sequence identity to this nucleic acid sequenceat the level of species. In some embodiments the specific geneticsequence may be the 16S sequence or a portion of the 16S sequence. Inother embodiments, the entire genomes of two entities are sequenced andcompared. In another embodiment, select regions such as multilocussequence tags (MLST), specific genes, or sets of genes may begenetically compared. In 16S embodiments, OTUs that share ≥97% averagenucleotide identity across the entire 16S or some variable region of the16S are considered the same OTU (see e.g. Claesson M J, Wang Q,O'Sullivan O, Greene-Diniz R, Cole J R, Ross R P, and O'Toole P W. 2010.Comparison of two next-generation sequencing technologies for resolvinghighly complex microbiota composition using tandem variable 16S rRNAgene regions. Nucleic Acids Res 38: e200. Konstantinidis K T, Ramette A,and Tiedje J M. 2006. The bacterial species definition in the genomicera. Philos Trans R Soc Lond B Biol Sci 361: 1929-1940.). In embodimentsinvolving the complete genome, MLSTs, specific genes, or sets of genesOTUs that share ≥95% average nucleotide identity are considered the sameOTU (see e.g. Achtman M, and Wagner M. 2008. Microbial diversity and thegenetic nature of microbial species. Nat. Rev. Microbiol. 6: 431-440.Konstantinidis K T, Ramette A, and Tiedje J M. 2006. The bacterialspecies definition in the genomic era. Philos Trans R Soc Lond B BiolSci 361: 1929-1940.). OTUs are frequently defined by comparing sequencesbetween organisms. Generally, sequences with less than 95% sequenceidentity are not considered to form part of the same OTU. OTUs may alsobe characterized by any combination of nucleotide markers or genes, inparticular highly conserved genes (e.g., “house-keeping” genes), or acombination thereof. Such characterization employs, e.g., WGS data or awhole genome sequence.

Table 1 below shows a List of Operational Taxonomic Units (OTU) withtaxonomic assignments made to Genus, Species, and Phylogenetic Clade.Clade membership of bacterial OTUs is based on 16S sequence data. Cladesare defined based on the topology of a phylogenetic tree that isconstructed from full-length 16S sequences using maximum likelihoodmethods familiar to individuals with ordinary skill in the art ofphylogenetics. Clades are constructed to ensure that all OTUs in a givenclade are: (i) within a specified number of bootstrap supported nodesfrom one another, and (ii) within 5% genetic similarity. OTUs that arewithin the same clade can be distinguished as genetically andphylogenetically distinct from OTUs in a different clade based on 16S-V4sequence data, while OTUs falling within the same clade are closelyrelated. OTUs falling within the same clade are evolutionarily closelyrelated and may or may not be distinguishable from one another using16S-V4 sequence data. Members of the same clade, due to theirevolutionary relatedness, play similar functional roles in a microbialecology such as that found in the human gut. Compositions substitutingone species with another from the same clade are likely to haveconserved ecological function and therefore are useful in the presentinvention. All OTUs are denoted as to their putative capacity to formspores and whether they are a Pathogen or Pathobiont (see Definitionsfor description of “Pathobiont”). NIAID Priority Pathogens are denotedas ‘Category-A’, ‘Category-B’, or ‘Category-C’, and OpportunisticPathogens are denoted as ‘OP’. OTUs that are not pathogenic or for whichtheir ability to exist as a pathogen is unknown are denoted as ‘N’. The‘SEQ ID Number’ denotes the identifier of the OTU in the SequenceListing File and ‘Public DB Accession’ denotes the identifier of the OTUin a public sequence repository.

“Residual habitat products” refers to material derived from the habitatfor microbiota within or on a human or animal. For example, microbiotalive in feces in the gastrointestinal tract, on the skin itself, insaliva, mucus of the respiratory tract, or secretions of thegenitourinary tract (i.e., biological matter associated with themicrobial community). Substantially free of residual habitat productsmeans that the bacterial composition no longer contains the biologicalmatter associated with the microbial environment on or in the human oranimal subject and is 100% free, 99% free, 98% free, 97% free, 96% free,or 95% free of any contaminating biological matter associated with themicrobial community. Residual habitat products can include abioticmaterials (including undigested food) or it can include unwantedmicroorganisms. Substantially free of residual habitat products may alsomean that the bacterial composition contains no detectable cells from ahuman or animal and that only microbial cells are detectable. In oneembodiment, substantially free of residual habitat products may alsomean that the bacterial composition contains no detectable viral(including bacterial viruses (i.e., phage)), fungal, mycoplasmalcontaminants. In another embodiment, it means that fewer than 1×10⁻²%,1×10⁻³%, 1×10⁻⁴%, 1×10⁻⁵%, 1×10⁻⁶%, 1×10⁻⁷%, 1×10⁻⁸ of the viable cellsin the bacterial composition are human or animal, as compared tomicrobial cells. There are multiple ways to accomplish this degree ofpurity, none of which are limiting. Thus, contamination may be reducedby isolating desired constituents through multiple steps of streaking tosingle colonies on solid media until replicate (such as, but not limitedto, two) streaks from serial single colonies have shown only a singlecolony morphology. Alternatively, reduction of contamination can beaccomplished by multiple rounds of serial dilutions to single desiredcells (e.g., a dilution of 10⁻⁸ or 10⁻⁹), such as through multiple10-fold serial dilutions. This can further be confirmed by showing thatmultiple isolated colonies have similar cell shapes and Gram stainingbehavior. Other methods for confirming adequate purity include geneticanalysis (e.g. PCR, DNA sequencing), serology and antigen analysis,enzymatic and metabolic analysis, and methods using instrumentation suchas flow cytometry with reagents that distinguish desired constituentsfrom contaminants.

“Clade” refers to the OTUs or members of a phylogenetic tree that aredownstream of a statistically valid node in a phylogenetic tree. Theclade comprises a set of terminal leaves in the phylogenetic tree thatis a distinct monophyletic evolutionary unit and that share some extentof sequence similarity.

16s Sequencing, 16s, 16s-rRNA, 16s-NGS: In microbiology, “16Ssequencing” or “16S-rRNA” or “16S” refers to sequence derived bycharacterizing the nucleotides that comprise the 16S ribosomal RNAgene(s). The bacterial 16S rDNA is approximately 1500 nucleotides inlength and is used in reconstructing the evolutionary relationships andsequence similarity of one bacterial isolate to another usingphylogenetic approaches. 16S sequences are used for phylogeneticreconstruction as they are in general highly conserved, but containspecific hypervariable regions that harbor sufficient nucleotidediversity to differentiate genera and species of most bacteria.

The “V1-V9 regions” of the 16S rRNA refers to the first through ninthhypervariable regions of the 16S rRNA gene that are used for genetictyping of bacterial samples. These regions in bacteria are defined bynucleotides 69-99, 137-242, 433-497, 576-682, 822-879, 986-1043,1117-1173, 1243-1294 and 1435-1465 respectively using numbering based onthe E. coli system of nomenclature. Brosius et al., Complete nucleotidesequence of a 16S ribosomal RNA gene from Escherichia coli, PNAS75(10):4801-4805 (1978). In some embodiments, at least one of the V1,V2, V3, V4, V5, V6, V7, V8, and V9 regions are used to characterize anOTU. In one embodiment, the V1, V2, and V3 regions are used tocharacterize an OTU. In another embodiment, the V3, V4, and V5 regionsare used to characterize an OTU. In another embodiment, the V4 region isused to characterize an OTU. A person of ordinary skill in the art canidentify the specific hypervariable regions of a candidate 16S rRNA bycomparing the candidate sequence in question to a reference sequence andidentifying the hypervariable regions based on similarity to thereference hypervariable regions, or alternatively, one can employ WholeGenome Shotgun (WGS) sequence characterization of microbes or amicrobial community.

The term “subject” refers to any animal subject including humans,laboratory animals (e.g., primates, rats, mice), livestock (e.g., cows,sheep, goats, pigs, turkeys, and chickens), and household pets (e.g.,dogs, cats, and rodents). The subject may be suffering from a dysbiosis,including, but not limited to, an infection due to a gastrointestinalpathogen or may be at risk of developing or transmitting to others aninfection due to a gastrointestinal pathogen.

The term “phenotype” refers to a set of observable characteristics of anindividual entity. As example an individual subject may have a phenotypeof “health” or “disease”. Phenotypes describe the state of an entity andall entities within a phenotype share the same set of characteristicsthat describe the phenotype. The phenotype of an individual results inpart, or in whole, from the interaction of the entities genome and/ormicrobiome with the environment.

The term “Network Ecology” refers to a consortium of OTUs that co-occurin some number of subjects. As used herein, a “network” is definedmathematically by a graph delineating how specific nodes (i.e. OTUs) andedges (connections between specific OTUs) relate to one another todefine the structural ecology of a consortium of OTUs. Any given NetworkEcology will possess inherent phylogenetic diversity and functionalproperties. A Network Ecology can also be defined in terms of functionwhere for example the nodes would be comprised of elements such as, butnot limited to, enzymes, clusters of orthologous groups (COGS;www.ncbi.nlm.nih.gov/books/NBK21090/), or KEGG pathways(www.genome.jp/kegg/).

Network Class, Core Network, Core Network Ecology: The terms “NetworkClass”, “Core Network” and “Core Network Ecology” refer to a group ofnetwork ecologies that in general are computationally determined tocomprise ecologies with similar phylogenetic and/or functionalcharacteristics. A Core Network therefore contains important biologicalfeatures, defined either phylogenetically or functionally, of a group(i.e., a cluster) of related network ecologies. One representation of aCore Network Ecology is a designed consortium of microbes, typicallynon-pathogenic bacteria, that represents core features of a set ofphylogenetically or functionally related network ecologies seen in manydifferent subjects. In many occurrences, a Core Network, while designedas described herein, exists as a Network Ecology observed in one or moresubjects. Core Network ecologies are useful for reversing or reducing adysbiosis in subjects where the underlying, related Network Ecology hasbeen disrupted.

The term “Keystone OTU” refers to one or more OTUs that are common tomany network ecologies and are members of networks ecologies that occurin many subjects (i.e. are pervasive). Due to the ubiquitous nature ofKeystone OTUs, they are central to the function of network ecologies inhealthy subjects and are often missing or at reduced levels in subjectswith disease. Keystone OTUs may exist in low, moderate, or highabundance in subjects.

The term “non-Keystone OTU” refers to an OTU that is observed in aNetwork Ecology and is not a keystone OTU.

The term “Phylogenetic Diversity” refers to the biodiversity present ina given Network Ecology or Core Network Ecology based on the OTUs thatcomprise the network. Phylogenetic diversity is a relative term, meaningthat a Network Ecology or Core Network that is comparatively morephylogenetically diverse than another network contains a greater numberof unique species, genera, and taxonomic families. Uniqueness of aspecies, genera, or taxonomic family is generally defined using aphylogenetic tree that represents the genetic diversity all species,genera, or taxonomic families relative to one another. In anotherembodiment phylogenetic diversity may be measured using the total branchlength or average branch length of a phylogenetic tree.

“Spore” or “endospore” refers to an entity, particularly a bacterialentity, which is in a dormant, non-vegetative and non-reproductivestage. Spores are generally resistant to environmental stress such asradiation, desiccation, enzymatic treatment, temperature variation,nutrient deprivation, and chemical disinfectants.

A “spore population” refers to a plurality of spores present in acomposition. Synonymous terms used herein include spore composition,spore preparation, ethanol treated spore fraction and spore ecology. Aspore population may be purified from a fecal donation, e.g. via ethanolor heat treatment, or a density gradient separation or any combinationof methods described herein to increase the purity, potency and/orconcentration of spores in a sample. Alternatively, a spore populationmay be derived through culture methods starting from isolated sporeformer species or spore former OTUs or from a mixture of such species,either in vegetative or spore form.

In one embodiment, the spore preparation comprises spore forming specieswherein residual non-spore forming species have been inactivated bychemical or physical treatments including ethanol, detergent, heat,sonication, and the like; or wherein the non-spore forming species havebeen removed from the spore preparation by various separations stepsincluding density gradients, centrifugation, filtration and/orchromatography; or wherein inactivation and separation methods arecombined to make the spore preparation. In yet another embodiment, thespore preparation comprises spore forming species that are enriched overviable non-spore formers or vegetative forms of spore formers. In thisembodiment, spores are enriched by 2-fold, 5-fold, 10-fold, 50-fold,100-fold, 1000-fold, 10,000-fold or greater than 10,000-fold compared toall vegetative forms of bacteria. In yet another embodiment, the sporesin the spore preparation undergo partial germination during processingand formulation such that the final composition comprises spores andvegetative bacteria derived from spore forming species.

A “germinant” is a material or composition or physical-chemical processcapable of inducing vegetative growth of a bacterium that is in adormant spore form, or group of bacteria in the spore form, eitherdirectly or indirectly in a host organism and/or in vitro.

A “sporulation induction agent” is a material or physical-chemicalprocess that is capable of inducing sporulation in a bacterium, eitherdirectly or indirectly, in a host organism and/or in vitro.

To “increase production of bacterial spores” includes an activity or asporulation induction agent. “Production” includes conversion ofvegetative bacterial cells into spores and augmentation of the rate ofsuch conversion, as well as decreasing the germination of bacteria inspore form, decreasing the rate of spore decay in vivo, or ex vivo, orto increasing the total output of spores (e.g. via an increase involumetric output of fecal material).

The “colonization” of a host organism includes the non-transitoryresidence of a bacterium or other microscopic organism. As used herein,“reducing colonization” of a host subject's gastrointestinal tract (orany other microbiotal niche) by a pathogenic bacterium includes areduction in the residence time of the pathogen in the gastrointestinaltract as well as a reduction in the number (or concentration) of thepathogen in the gastrointestinal tract or adhered to the luminal surfaceof the gastrointestinal tract. Measuring reductions of adherentpathogens may be demonstrated, e.g., by a biopsy sample, or reductionsmay be measured indirectly, e.g., by measuring the pathogenic burden inthe stool of a mammalian host.

A “combination” of two or more bacteria includes the physicalco-existence of the two bacteria, either in the same material or productor in physically connected products, as well as the temporalco-administration or co-localization of the two bacteria.

A “cytotoxic” activity or bacterium includes the ability to kill abacterial cell, such as a pathogenic bacterial cell. A “cytostatic”activity or bacterium includes the ability to inhibit, partially orfully, growth, metabolism, and/or proliferation of a bacterial cell,such as a pathogenic bacterial cell.

To be free of “non-comestible products” means that a bacterialcomposition or other material provided herein does not have asubstantial amount of a non-comestible product, e.g., a product ormaterial that is inedible, harmful or otherwise undesired in a productsuitable for administration, e.g., oral administration, to a humansubject. Non-comestible products are often found in preparations ofbacteria from the prior art.

As used herein the term “vitamin” is understood to include any ofvarious fat-soluble or water-soluble organic substances (non-limitingexamples include vitamin A, Vitamin B1 (thiamine), Vitamin B2(riboflavin), Vitamin B3 (niacin or niacinamide), Vitamin B5(pantothenic acid), Vitamin B6 (pyridoxine, pyridoxal, or pyridoxamine,or pyridoxine hydrochloride), Vitamin B7 (biotin), Vitamin B9 (folicacid), and Vitamin B12 (various cobalamins; commonly cyanocobalamin invitamin supplements), vitamin C, vitamin D, vitamin E, vitamin K, K1 andK2 (i.e. MK-4, MK-7), folic acid and biotin) essential in minute amountsfor normal growth and activity of the body and obtained naturally fromplant and animal foods or synthetically made, pro-vitamins, derivatives,analogs.

As used herein, the term “minerals” is understood to include boron,calcium, chromium, copper, iodine, iron, magnesium, manganese,molybdenum, nickel, phosphorus, potassium, selenium, silicon, tin,vanadium, zinc, or combinations thereof.

As used herein, the term “antioxidant” is understood to include any oneor more of various substances such as beta-carotene (a vitamin Aprecursor), vitamin C, vitamin E, and selenium) that inhibit oxidationor reactions promoted by Reactive Oxygen Species (“ROS”) and otherradical and non-radical species. Additionally, antioxidants aremolecules capable of slowing or preventing the oxidation of othermolecules. Non-limiting examples of antioxidants include astaxanthin,carotenoids, coenzyme Q10 (“CoQ10”), flavonoids, glutathione, Goji(wolfberry), hesperidin, lactowolfberry, lignan, lutein, lycopene,polyphenols, selenium, vitamin A, vitamin C, vitamin E, zeaxanthin, orcombinations thereof.

Compositions of the Invention

Bacterial Compositions

We have identified combinations of commensal bacteria of the human gutmicrobiota with the capacity to meaningfully provide functions of ahealthy microbiota when administered to mammalian hosts. Without beinglimited to a specific mechanism, it is thought that such compositionsinhibit the growth of a pathogen such as C. difficile, Salmonella spp.,enteropathogenic E. coli, and vancomycin-resistant Enterococcus spp. andother pathobionts, so that a healthy, diverse and protective microbiotacan be maintained or, in the case of pathogenic bacterial infectionssuch as recurrent C. difficile infection, repopulate the intestinallumen to reestablish ecological control over potential pathogens.Furthermore, the bacterial compositions have the ability to shift thestate of the gut microbiota toward a healthy state allowing foraugmentation of the microbiota with commensal bacteria found in healthymicrobiomes. The bacterial compositions may also engraft in the hostthemselves and remain present in the gut for 1 day, 1 week, 1 month, 1year, or longer than 1 year.

Preferred bacterial species include Escherichia coli, Streptococcusfaecalis, Clostridium innocuum, Clostridium ramosum, Clostridiumbifermentans, Bacteroides ovatus, Bacteroides vulgatus, Bacteroidesthetaiotaomicron, and Blautia producta. As used herein, a “type” or morethan one “types” of bacteria may be differentiated at the genus level,the species, level, the sub-species level, the strain level or by anyother taxonomic method, as described herein and otherwise known in theart. Preferred bacterial species also include species that share 97%homology in the 16s rDNA region to the species of Escherichia coli,Streptococcus faecalis, Clostridium innocuum, Clostridium ramosum,Clostridium bifermentans, Bacteroides ovatus, Bacteroides vulgatus,Bacteroides thetaiotaomicron, and Blautia producta as defined by theprovided 16s sequences (See Table 1).

Bacterial compositions may consist essentially of no greater than anumber of types of these preferred bacteria. For instance, a bacterialcomposition may comprise no more than 2, no more than 3, no more than 4,no more than 5, no more than 6, no more than 7, no more than 8, no morethan 9, no more than 10, no more than 11, no more than 12, no more than13, no more than 14, no more than 15, no more than 16, no more than 17,no more than 18, no more than 19, or no more than 20 types of bacteria,as defined by above species or operational taxonomic unit (OTU)encompassing such species.

Bacterial compositions may consist essentially of a range of numbers ofspecies of these preferred bacteria, but the precise number of speciesin a given composition is not known. For instance, a bacterialcomposition may consist essentially of between 2 and 10, 3 and 10, 4 and10, 5 and 10, 6 and 10, 7 and 10, 8 and 10, or 9 and 10; or 2 and 9, 3and 9, 4 and 9, 5 and 9, 6 and 9, 7 and 8 or 8 and 9; or 2 and 8, 3 and8, 4 and 8, 5 and 8, 6 and 8 or 7 and 8; or 2 and 7, 3 and 7, 4 and 7, 5and 7, or 6 and 7; or 2 and 6, 3 and 6, 4 and 6 or 5 and 6; or 2 and 5,3 and 5 or 4 and 5; or 2 and 4 or 3 and 4; or 2 and 3, as defined byabove species or operational taxonomic unit (OTU) encompassing suchspecies.

Bacterial compositions containing a plurality of species may be providedsuch that the relative concentration of a given species in thecomposition to any other species in the composition is known or unknown.Such relative concentrations of any two species, or OTUs, may beexpressed as a ratio, where the ratio of a first species or OTU to asecond species or OTU is 1:1 or any ratio other than 1:1, such as 1:2,1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10, 1:15, 1:20, 1:25; 1:50; 1:75,1:100, 1:200, 1:500; 1:1000, 1:10,000, 1:100,000 or greater than1:100,000. The ratio of bacterial strains present in a bacterialcomposition may be determined by the ratio of the bacterial strains in areference mammalian subject, e.g., a healthy human not suffering from orat known risk of developing a dysbiosis.

Bacterial compositions comprising a plurality of species may be providedsuch that the concentration of a given strain, or the aggregate of allstrains, is between 1×10⁴ and 1×10¹⁵ viable bacteria per gram ofcomposition or per administered dose. For example the concentration of agiven strain, or the aggregate of all strains, is e.g., 1×10⁴, 1×10⁵,1×10⁶, 1×10⁷, 1×10⁸, 1×10⁹, 1×10¹⁰, 1×10¹¹, 1×10¹², 1×10¹³, 1×10¹⁴,1×10¹⁵, or greater than 1×10¹⁵ viable bacteria per gram of compositionor per administered dose. Alternatively, the concentration of a givenstrain, or the aggregate of all strains, is below a given concentratione.g., below 1×10⁴, 1×10⁵, 1×10⁶, 1×10⁷, 1×10⁸, 1×10⁹, 1×10¹⁰, 1×10¹¹,1×10¹², 1×10¹³, 1×10¹⁴, 1×10¹⁵, or below 1×10¹⁵ viable bacteria per gramof composition or per administered dose.

In certain embodiments, the bacterial compositions comprise a pluralityof strains of the same species of bacteria. In certain embodiments, thestrain of bacteria is present in amounts at least 2, 5, 10, 50, 100 ormore than 100 times greater than any other strain of that speciespresent in the composition. For example, provided are compositionscontaining one strain of E. coli, where this strain is present inamounts at least 2, 5, 10, 50, 100 or more than 100 times greater thanany other strain of E. coli present in the composition.

Because pathogenic bacteria such as C. difficile bacteria may inhibitgrowth of the bacterial strains present in the composition, it isgenerally beneficial such that no more than two of the bacterial strainsin the bacterial composition are strains whose growth is substantiallyinhibited, e.g., in vitro, by an equivalent amount of C. difficilebacteria.

In one embodiment, the bacterial composition comprises at least one andpreferably more than one of the following species or a species that is97% identical based on the 16s rDNA: Barnesiella intestinihominis;Lactobacillus reuteri; a species characterized as one of Enterococcushirae, Enterococcus faecium, or Enterococcus durans; a speciescharacterized as one of Anaerostipes caccae or Clostridium indolis; aspecies characterized as one of Staphylococcus warneri or Staphylococcuspasteuri; and Adlercreutzia equolifaciens. In an alternative embodiment,at least one of the preceding species is not substantially present inthe bacterial composition.

In one embodiment, the bacterial composition comprises at least one andpreferably more than one of the following species or a species that is97% identical based on the 16s rDNA: Clostridium absonum, Clostridiumargentinense, Clostridium baratii, Clostridium bifermentans, Clostridiumbotulinum, Clostridium butyricum, Clostridium cadaveris, Clostridiumcamis, Clostridium celatum, Clostridium chauvoei, Clostridiumclostridioforme, Clostridium cochlearium, Clostridium difficile,Clostridium fallax, Clostridium felsineum, Clostridium ghonii,Clostridium glycolicum, Clostridium haemolyticum, Clostridiumhastiforme, Clostridium histolyticum, Clostridium indolis, Clostridiuminnocuum, Clostridium irregulare, Clostridium limosum, Clostridiummalenominatum, Clostridium novyi, Clostridium oroticum, Clostridiumparaputrificum, Clostridium perfringens, Clostridium piliforme,Clostridium putrefaciens, Clostridium putrificum, Clostridium ramosum,Clostridium sardiniense, Clostridium sartagoforme, Clostridium scindens,Clostridium septicum, Clostridium sordellii, Clostridium sphenoides,Clostridium spiroforme, Clostridium sporogenes, Clostridiumsubterminale, Clostridium symbiosum, Clostridium tertium, Clostridiumtetani, Clostridium welchii, and Clostridium villosum. In an alternativeembodiment, at least one of the preceding species is not substantiallypresent in the bacterial composition.

In one embodiment, the bacterial composition comprises at least one andpreferably more than one of the following species or a species that is97% identical based on the 16s rDNA: Clostridium innocuum, Clostridiumbifermentans, Clostridium butyricum, Bacteroides fragilis, Bacteroidesthetaiotaomicron, Bacteroides uniformis, three strains of Escherichiacoli, and Lactobacillus sp. In an alternative embodiment, at least oneof the preceding species is not substantially present in the bacterialcomposition.

In one embodiment, the bacterial composition comprises at least one andpreferably more than one of the following species or a species that is97% identical based on the 16s rDNA: Clostridium bifermentans,Clostridium innocuum, Clostridium butyricum, three strains ofEscherichia coli, three strains of Bacteroides, and Blautia producta. Inan alternative embodiment, at least one of the preceding species is notsubstantially present in the bacterial composition.

In one embodiment, the bacterial composition comprises at least one andpreferably more than one of the following species or a species that is97% identical based on the 16s rDNA: Bacteroides sp., Escherichia coli,and non pathogenic Clostridia, including Clostridium innocuum,Clostridium bifermentans and Clostridium ramosum. In an alternativeembodiment, at least one of the preceding species is not substantiallypresent in the bacterial composition.

In one embodiment, the bacterial composition comprises at least one andpreferably more than one of the following species or a species that is97% identical based on the 16s rDNA: Bacteroides species, Escherichiacoli and non-pathogenic Clostridia, such as Clostridium butyricum,Clostridium bifermentans and Clostridium innocuum. In an alternativeembodiment, at least one of the preceding species is not substantiallypresent in the bacterial composition.

In one embodiment, the bacterial composition comprises at least one andpreferably more than one of the following species or a species that is97% identical based on the 16s rDNA: Bacteroides caccae, Bacteroidescapillosus, Bacteroides coagulans, Bacteroides distasonis, Bacteroideseggerthii, Bacteroides forsythus, Bacteroides fragilis, Bacteroidesfragilis-ryhm, Bacteroides gracilis, Bacteroides levii, Bacteroidesmacacae, Bacteroides merdae, Bacteroides ovatus, Bacteroidespneumosintes, Bacteroides putredinis, Bacteroides pyogenes, Bacteroidessplanchnicus, Bacteroides stercoris, Bacteroides tectum, Bacteroidesthetaiotaomicron, Bacteroides uniformis, Bacteroides ureolyticus, andBacteroides vulgatus. In an alternative embodiment, at least one of thepreceding species is not substantially present in the bacterialcomposition.

In one embodiment, the bacterial composition comprises at least one andpreferably more than one of the following species or a species that is97% identical based on the 16s rDNA: Bacteroides, Eubacteria,Fusobacteria, Propionibacteria, Lactobacilli, anaerobic cocci,Ruminococcus, Escherichia coli, Gemmiger, Desulfomonas, andPeptostreptococcus. In an alternative embodiment, at least one of thepreceding species is not substantially present in the bacterialcomposition.

In one embodiment, the bacterial composition comprises at least one andpreferably more than one of the following species or a species that is97% identical based on the 16s rDNA: Bacteroides fragilis ss. Vulgatus,Eubacterium aerofaciens, Bacteroides fragilis ss. Thetaiotaomicron,Blautia producta (previously known as Peptostreptococcus productus II),Bacteroides fragilis ss. Distasonis, Fusobacterium prausnitzii,Coprococcus eutactus, Eubacterium aerofaciens III, Blautia producta(previously known as Peptostreptococcus productus I), Ruminococcusbronii, Bifidobacterium adolescentis, Gemmiger formicilis,Bifidobacterium longum, Eubacterium siraeum, Ruminococcus torques,Eubacterium rectale III-H, Eubacterium rectale IV, Eubacterium eligens,Bacteroides eggerthii, Clostridium leptum, Bacteroides fragilis ss. A,Eubacterium biforme, Bifidobacterium infantis, Eubacterium rectaleIII-F, Coprococcus comes, Bacteroides capillosus, Ruminococcus albus,Eubacterium formicigenerans, Eubacterium hallii, Eubacterium ventriosumI, Fusobacterium russii, Ruminococcus obeum, Eubacterium rectale II,Clostridium ramosum I, Lactobacillus leichmanii, Ruminococcus cailidus,Butyrivibrio crossotus, Acidaminococcus fermentans, Eubacteriumventriosum, Bacteroides fragilis ss. fragilis, Bacteroides AR,Coprococcus catus, Eubacterium hadrum, Eubacterium cylindroides,Eubacterium ruminantium, Eubacterium CH-1, Staphylococcus epidermidis,Peptostreptococcus BL, Eubacterium limosum, Bacteroides praeacutus,Bacteroides L, Fusobacterium mortiferum I, Fusobacterium naviforme,Clostridium innocuum, Clostridium ramosum, Propionibacterium acnes,Ruminococcus flavefaciens, Ruminococcus AT, Peptococcus AU-1,Eubacterium AG, -AK, -AL, -AL-1, -AN; Bacteroides fragilis ss. ovatus,-ss. d, -ss. f; Bacteroides L-1, L-5; Fusobacterium nucleatum,Fusobacterium mortiferum, Escherichia coli, Streptococcus morbiliorum,Peptococcus magnus, Peptococcus G, AU-2; Streptococcus intermedius,Ruminococcus lactaris, Ruminococcus CO Gemmiger X, Coprococcus BH, -CC;Eubacterium tenue, Eubacterium ramulus, Eubacterium AE, -AG-H, -AG-M,-AJ, -BN-1; Bacteroides clostridiiformis ss. clostridliformis,Bacteroides coagulans, Bacteroides orails, Bacteroides ruminicola ss.brevis, -ss. ruminicola, Bacteroides splanchnicus, Desuifomonas pigra,Bacteroides L-4, -N-i; Fusobacterium H, Lactobacillus G, andSuccinivibrio A. In an alternative embodiment, at least one of thepreceding species is not substantially present in the bacterialcomposition.

Bacterial Compositions Described by Operational Taxonomic Unit (OTUs)

Bacterial compositions may be prepared comprising at least two types ofisolated bacteria, chosen from the species in Table 1.

A bacterial composition may be prepared comprising at least two types ofisolated bacteria, wherein a first type is a first OTU comprising aspecies of E. coli, S. faecalis, Cl. innocuum, Cl. ramosum, Cl.bifermentans, Bact. ovatus, Bact. vulgatus, Bact. thetaiotaomicron, orBlautia producta and the type is a second OTU is characterized by, i.e.,at least 95%, 96%, 97%, 98%, 99% or including 100% sequence identity to,the first OTU. In some embodiments, two types of bacteria are providedin a composition, and the first bacteria and the second bacteria are notthe same OTU.

OTUs can be defined either by full 16S sequencing of the rRNA gene(Table 1), by sequencing of a specific hypervariable region of this gene(i.e. V1, V2, V3, V4, V5, V6, V7, V8, or V9), or by sequencing of anycombination of hypervariable regions from this gene (e.g. V1-3 or V3-5).The bacterial 16S rDNA is approximately 1500 nucleotides in length andis used in reconstructing the evolutionary relationships and sequencesimilarity of one bacterial isolate to another using phylogeneticapproaches. 16S sequences are used for phylogenetic reconstruction asthey are in general highly conserved, but contain specific hypervariableregions that harbor sufficient nucleotide diversity to differentiategenera and species of most microbes.

Using well known techniques, in order to determine the full 16S sequenceor the sequence of any hypervariable region of the 16S sequence, genomicDNA is extracted from a bacterial sample, the 16S rDNA (full region orspecific hypervariable regions) amplified using polymerase chainreaction (PCR), the PCR products cleaned, and nucleotide sequencesdelineated to determine the genetic composition of 16S gene or subdomainof the gene. If full 16S sequencing is performed, the sequencing methodused may be, but is not limited to, Sanger sequencing. If one or morehypervariable regions are used, such as the V4 region, the sequencingcan be, but is not limited to being, performed using the Sanger methodor using a next-generation sequencing method, such as an IIlumina(sequencing by synthesis) method using barcoded primers allowing formultiplex reactions.

OTUs can be defined by a combination of nucleotide markers or genes, inparticular highly conserved genes (e.g., “house-keeping” genes), or acombination thereof, full-genome sequence, or partial genome sequencegenerated using amplified genetic products, or whole genome sequence(WGS). Using well defined methods DNA extracted from a bacterial samplewill have specific genomic regions amplified using PCR and sequenced todetermine the nucleotide sequence of the amplified products. In thewhole genome shotgun (WGS) method, extracted DNA will be directlysequenced without amplification. Sequence data can be generated usingany sequencing technology including, but not limited to Sanger,IIlumina, 454 Life Sciences, Ion Torrent, ABI, Pacific Biosciences,and/or Oxford Nanopore.

In one embodiment, the OTUs can be characterized by one or more of thevariable regions of the 16S sequence (V1-V9). These regions in bacteriaare defined by nucleotides 69-99, 137-242, 433-497, 576-682, 822-879,986-1043, 1117-1173, 1243-1294 and 1435-1465 respectively usingnumbering based on the E. coli system of nomenclature. (See, e.g.,Brosius et al., Complete nucleotide sequence of a 16S ribosomal RNA genefrom Escherichia coli, PNAS 75(10):4801-4805 (1978)). In someembodiments, at least one of the V1, V2, V3, V4, V5, V6, V7, V8, and V9regions are used to characterize an OTU. In one embodiment, the V1, V2,and V3 regions are used to characterize an OTU. In another embodiment,the V3, V4, and V5 regions are used to characterize an OTU. In anotherembodiment, the V4 region is used to characterize an OTU.

Inhibition of Bacterial Pathogens

In some embodiments, the bacterial composition provides a protective ortherapeutic effect against infection by one or more GI pathogens ofinterest. A list of exemplary bacterial pathogens and pathobionts isprovided in Table 1.

In some embodiments, the pathogenic bacterium is selected from the groupconsisting of Yersinia, Vibrio, Treponema, Streptococcus,Staphylococcus, Shigella, Salmonella, Rickettsia, Orientia, Pseudomonas,Neisseria, Mycoplasma, Mycobacterium, Listeria, Leptospira, Legionella,Klebsiella, Helicobacter, Haemophilus, Francisella, Escherichia,Ehrlichia, Enterococcus, Coxiella, Corynebacterium, Clostridium,Chlamydia, Chlamydophila, Campylobacter, Burkholderia, Brucella,Borrelia, Bordetella, Bifidobacterium, Bacillus, multi-drug resistantbacteria, extended spectrum beta-lactam resistant Enterococci (ESBL),Carbapenem-resistant Enterobacteriaceae (CRE), and vancomycin-resistantEnterococci (VRE).

In some embodiments, these pathogens include, but are not limited to,Aeromonas hydrophila, Campylobacter fetus, Plesiomonas shigelloides,Bacillus cereus, Campylobacter jejuni, Clostridium botulinum,Clostridium difficile, Clostridium perfringens, enteroaggregativeEscherichia coli, enterohemorrhagic Escherichia coli, enteroinvasiveEscherichia coli, enterotoxigenic Escherichia coli (such as, but notlimited to, LT and/or ST), Escherichia coli 0157:H7, Helicobacterpylori, Klebsiella pneumonia, Listeria monocytogenes, Plesiomonasshigelloides, Salmonella spp., Salmonella typhi, Salmonella paratyphi,Shigella spp., Staphylococcus spp., Staphylococcus aureus,vancomycin-resistant Enterococcus spp., Vibrio spp., Vibrio cholerae,Vibrio parahaemolyticus, Vibrio vulnificus, and Yersinia enterocolitica.

In one embodiment, the pathogen of interest is at least one pathogenchosen from Clostridium difficile, Salmonella spp., pathogenicEscherichia coli, vancomycin-resistant Enterococcus spp., and extendedspectrum beta-lactam resistant Enterococci (ESBL).

Generation and Formulation of Bacterial Compositions

The bacterial compositions are generally formulated for oral or gastricadministration, typically to a mammalian subject. Preferably, suchformulations contain or are coated by an enteric coating to protect thebacteria through the stomach and small intestine. In particularembodiments, the composition is formulated for oral administration as asolid, semi-solid, powder, gel, or liquid form, such as in the form of apill, tablet, capsule, or lozenge.

The bacterial strains may, individually or together, be substantiallyinactive prior to localization in the gastrointestinal tract of themammalian subject to whom the composition is administered. The bacterialstrains may be lyophilized or otherwise acted upon to increase long-termstorage viability.

Preferential species include E. coli, S. faecalis, Cl. innocuum, Cl.ramosum, Cl. bifermentans, Bact. ovatus, Bact. vulgatus, Bact.thetaiotaomicron, and Blautia producta, or species 97% identical to the16s rDNA sequences of these species and are generally provided inbacterial compositions containing at least three strains. In certainembodiments, at least one of the bacterial strains is not a colonicbacterium. In another embodiment, at least one of the bacterial strainsis not obtained from a fecal culture, e.g., the bacterial strain isobtained from culturing a non-fecal biological material from a subject,from an environmental source, or from repeatedly streaking and purifyingstrains from any source. Alternatively, at least one bacterial strain isgenetically engineered. In another embodiment, at least one species ispresent in the composition in spore form. In an alternative embodiment,all of the species are present as vegetative forms, substantially freeof spores.

The bacterial compositions may be formulated to be effective in a givenmammalian subject in a single administration or over multipleadministrations. For example, a single administration is substantiallyeffective to reduce C. difficile and/or C. difficile toxin content in amammalian subject to whom the composition is administered.Alternatively, a single administration is substantially effective toreduce vancomycin resistant Enterococci, carbapenem resistant bacteria,or another pathobiont in a mammalian subject to whom the composition isadministered (See Table 1). Substantially effective means that C.difficile and/or C. difficile toxin and/or pathobiont content in thesubject is reduced by at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%,90%, 95%, 98%, 99% or greater than 99% following administration of thecomposition.

In some embodiments, the bacterial compositions comprise purified sporepopulations. Purified spore populations comprise one or more commensalbacteria of the human gut microbiota present in the form of a spore.Without being limited to a specific mechanism, it is thought that suchcompositions inhibit the growth of a pathogen such as C. difficile,Salmonella spp., enteropathogenic E. coli, and vancomycin-resistantEnterococcus spp., so that a healthy, diverse and protective microbiotacan be maintained or, in the case of pathogenic bacterial infectionssuch as C. difficile infection, repopulate the intestinal lumen toreestablish ecological control over potential pathogens.

In some embodiments, spore-forming bacteria are identified by thepresence of nucleic acid sequences that modulate sporulation. Inparticular, signature sporulation genes are highly conserved acrossmembers of distantly related genera including Clostridium and Bacillus.Traditional approaches of forward genetics have identified many, if notall, genes that are essential for sporulation (spo). The developmentalprogram of sporulation is governed in part by the successive action offour compartment-specific sigma factors (appearing in the order σF, σE,σG and σK), whose activities are confined to the forespore (σF and σG)or the mother cell (σE and σK).

Provided are bacterial compositions comprising more than one type ofspore forming bacterium. As used herein, a “type” or more than one“types” of bacteria may be differentiated at the genus level, thespecies, level, the sub-species level, the strain level or by any othertaxonomic method, as described herein and otherwise known in the art.

Pharmaceutical Compositions and Formulations of the Invention

Provided are formulations for administration to humans and othersubjects in need thereof. Generally the bacterial compositions arecombined with additional active and/or inactive materials in order toproduce a final product, which may be in single dosage unit or in amulti-dose format.

In some embodiments, the composition comprises at least onecarbohydrate. A “carbohydrate” refers to a sugar or polymer of sugars.The terms “saccharide,” “polysaccharide,” “carbohydrate,” and“oligosaccharide” may be used interchangeably. Most carbohydrates arealdehydes or ketones with many hydroxyl groups, usually one on eachcarbon atom of the molecule. Carbohydrates generally have the molecularformula C_(n)H_(2n)O_(n). A carbohydrate can be a monosaccharide, adisaccharide, trisaccharide, oligosaccharide, or polysaccharide. Themost basic carbohydrate is a monosaccharide, such as glucose, sucrose,galactose, mannose, ribose, arabinose, xylose, and fructose.Disaccharides are two joined monosaccharides. Exemplary disaccharidesinclude sucrose, maltose, cellobiose, and lactose. Typically, anoligosaccharide includes between three and six monosaccharide units(e.g., raffinose, stachyose), and polysaccharides include six or moremonosaccharide units. Exemplary polysaccharides include starch,glycogen, and cellulose. Carbohydrates can contain modified saccharideunits, such as 2′-deoxyribose wherein a hydroxyl group is removed,2′-fluororibose wherein a hydroxyl group is replace with a fluorine, orN-acetylglucosamine, a nitrogen-containing form of glucose (e.g.,2′-fluororibose, deoxyribose, and hexose). Carbohydrates can exist inmany different forms, for example, conformers, cyclic forms, acyclicforms, stereoisomers, tautomers, anomers, and isomers.

In some embodiments, the composition comprises at least one lipid. Asused herein, a “lipid” includes fats, oils, triglycerides, cholesterol,phospholipids, fatty acids in any form including free fatty acids. Fats,oils and fatty acids can be saturated, unsaturated (cis or trans) orpartially unsaturated (cis or trans). In some embodiments, the lipidcomprises at least one fatty acid selected from lauric acid (12:0),myristic acid (14:0), palmitic acid (16:0), palmitoleic acid (16:1),margaric acid (17:0), heptadecenoic acid (17:1), stearic acid (18:0),oleic acid (18:1), linoleic acid (18:2), linolenic acid (18:3),octadecatetraenoic acid (18:4), arachidic acid (20:0), eicosenoic acid(20:1), eicosadienoic acid (20:2), eicosatetraenoic acid (20:4),eicosapentaenoic acid (20:5) (EPA), docosanoic acid (22:0), docosenoicacid (22:1), docosapentaenoic acid (22:5), docosahexaenoic acid (22:6)(DHA), and tetracosanoic acid (24:0). In other embodiments, thecomposition comprises at least one modified lipid, for example, a lipidthat has been modified by cooking.

In some embodiments, the composition comprises at least one supplementalmineral or mineral source. Examples of minerals include, withoutlimitation: chloride, sodium, calcium, iron, chromium, copper, iodine,zinc, magnesium, manganese, molybdenum, phosphorus, potassium, andselenium. Suitable forms of any of the foregoing minerals includesoluble mineral salts, slightly soluble mineral salts, insoluble mineralsalts, chelated minerals, mineral complexes, non-reactive minerals suchas carbonyl minerals, and reduced minerals, and combinations thereof.

In certain embodiments, the composition comprises at least onesupplemental vitamin. In one embodiment, at least one vitamin can befat-soluble or water soluble vitamins. Suitable vitamins include but arenot limited to vitamin C, vitamin A, vitamin E, vitamin B12, vitamin K,riboflavin, niacin, vitamin D, vitamin B6, folic acid, pyridoxine,thiamine, pantothenic acid, and biotin. Suitable forms of any of theforegoing are salts of the vitamin, derivatives of the vitamin,compounds having the same or similar activity of the vitamin, andmetabolites of the vitamin.

In other embodiments, the composition comprises an excipient.Non-limiting examples of suitable excipients include a buffering agent,a preservative, a stabilizer, a binder, a compaction agent, a lubricant,a dispersion enhancer, a disintegration agent, a flavoring agent, asweetener, and a coloring agent.

In another embodiment, the excipient is a buffering agent. Non-limitingexamples of suitable buffering agents include sodium citrate, magnesiumcarbonate, magnesium bicarbonate, calcium carbonate, and calciumbicarbonate.

In some embodiments, the excipient comprises a preservative.Non-limiting examples of suitable preservatives include antioxidants,such as alpha-tocopherol and ascorbate, and antimicrobials, such asparabens, chlorobutanol, and phenol.

In other embodiments, the composition comprises a binder as anexcipient. Non-limiting examples of suitable binders include starches,pregelatinized starches, gelatin, polyvinylpyrrolidone, cellulose,methylcellulose, sodium carboxymethylcellulose, ethylcellulose,polyacrylamides, polyvinyloxoazolidone, polyvinylalcohols, C₁₂-C₁₈ fattyacid alcohol, polyethylene glycol, polyols, saccharides,oligosaccharides, and combinations thereof.

In another embodiment, the composition comprises a lubricant as anexcipient. Non-limiting examples of suitable lubricants includemagnesium stearate, calcium stearate, zinc stearate, hydrogenatedvegetable oils, sterotex, polyoxyethylene monostearate, talc,polyethyleneglycol, sodium benzoate, sodium lauryl sulfate, magnesiumlauryl sulfate, and light mineral oil.

In other embodiments, the composition comprises a dispersion enhancer asan excipient. Non-limiting examples of suitable dispersants includestarch, alginic acid, polyvinylpyrrolidones, guar gum, kaolin,bentonite, purified wood cellulose, sodium starch glycolate,isoamorphous silicate, and microcrystalline cellulose as high HLBemulsifier surfactants.

In some embodiments, the composition comprises a disintegrant as anexcipient. In other embodiments, the disintegrant is a non-effervescentdisintegrant. Non-limiting examples of suitable non-effervescentdisintegrants include starches such as corn starch, potato starch,pregelatinized and modified starches thereof, sweeteners, clays, such asbentonite, micro-crystalline cellulose, alginates, sodium starchglycolate, gums such as agar, guar, locust bean, karaya, pectin, andtragacanth. In another embodiment, the disintegrant is an effervescentdisintegrant. Non-limiting examples of suitable effervescentdisintegrants include sodium bicarbonate in combination with citricacid, and sodium bicarbonate in combination with tartaric acid.

In another embodiment, the excipient comprises a flavoring agent.Flavoring agents can be chosen from synthetic flavor oils and flavoringaromatics; natural oils; extracts from plants, leaves, flowers, andfruits; and combinations thereof. In some embodiments the flavoringagent is selected from cinnamon oils; oil of wintergreen; peppermintoils; clover oil; hay oil; anise oil; eucalyptus; vanilla; citrus oilsuch as lemon oil, orange oil, grape and grapefruit oil; and fruitessences including apple, peach, pear, strawberry, raspberry, cherry,plum, pineapple, and apricot.

In other embodiments, the excipient comprises a sweetener. Non-limitingexamples of suitable sweeteners include glucose (corn syrup), dextrose,invert sugar, fructose, and mixtures thereof (when not used as acarrier); saccharin and its various salts such as the sodium salt;dipeptide sweeteners such as aspartame; dihydrochalcone compounds,glycyrrhizin; Stevia rebaudiana (Stevioside); chloro derivatives ofsucrose such as sucralose; and sugar alcohols such as sorbitol,mannitol, sylitol, and the like. Also contemplated are hydrogenatedstarch hydrolysates and the synthetic sweetener3,6-dihydro-6-methyl-1,2,3-oxathiazin-4-one-2,2-dioxide, particularlythe potassium salt (acesulfame-K), and sodium and calcium salts thereof.

In yet other embodiments, the composition comprises a coloring agent.Non-limiting examples of suitable color agents include food, drug andcosmetic colors (FD&C), drug and cosmetic colors (D&C), and externaldrug and cosmetic colors (Ext. D&C). The coloring agents can be used asdyes or their corresponding lakes.

The weight fraction of the excipient or combination of excipients in theformulation is usually about 99% or less, such as about 95% or less,about 90% or less, about 85% or less, about 80% or less, about 75% orless, about 70% or less, about 65% or less, about 60% or less, about 55%or less, 50% or less, about 45% or less, about 40% or less, about 35% orless, about 30% or less, about 25% or less, about 20% or less, about 15%or less, about 10% or less, about 5% or less, about 2% or less, or about1% or less of the total weight of the composition.

The bacterial compositions disclosed herein can be formulated into avariety of forms and administered by a number of different means. Thecompositions can be administered orally, rectally, or parenterally, informulations containing conventionally acceptable carriers, adjuvants,and vehicles as desired. The term “parenteral” as used herein includessubcutaneous, intravenous, intramuscular, or intrasternal injection andinfusion techniques. In an exemplary embodiment, the bacterialcomposition is administered orally.

Solid dosage forms for oral administration include capsules, tablets,caplets, pills, troches, lozenges, powders, and granules. A capsuletypically comprises a core material comprising a bacterial compositionand a shell wall that encapsulates the core material. In someembodiments, the core material comprises at least one of a solid, aliquid, and an emulsion. In other embodiments, the shell wall materialcomprises at least one of a soft gelatin, a hard gelatin, and a polymer.Suitable polymers include, but are not limited to: cellulosic polymerssuch as hydroxypropyl cellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose (HPMC), methyl cellulose, ethyl cellulose, celluloseacetate, cellulose acetate phthalate, cellulose acetate trimellitate,hydroxypropylmethyl cellulose phthalate, hydroxypropylmethyl cellulosesuccinate and carboxymethylcellulose sodium; acrylic acid polymers andcopolymers, such as those formed from acrylic acid, methacrylic acid,methyl acrylate, ammonio methylacrylate, ethyl acrylate, methylmethacrylate and/or ethyl methacrylate (e.g., those copolymers soldunder the trade name “Eudragit”); vinyl polymers and copolymers such aspolyvinyl pyrrolidone, polyvinyl acetate, polyvinylacetate phthalate,vinylacetate crotonic acid copolymer, and ethylene-vinyl acetatecopolymers; and shellac (purified lac). In yet other embodiments, atleast one polymer functions as taste-masking agents.

Tablets, pills, and the like can be compressed, multiply compressed,multiply layered, and/or coated. The coating can be single or multiple.In one embodiment, the coating material comprises at least one of asaccharide, a polysaccharide, and glycoproteins extracted from at leastone of a plant, a fungus, and a microbe. Non-limiting examples includecorn starch, wheat starch, potato starch, tapioca starch, cellulose,hemicellulose, dextrans, maltodextrin, cyclodextrins, inulins, pectin,mannans, gum arabic, locust bean gum, mesquite gum, guar gum, gumkaraya, gum ghatti, tragacanth gum, funori, carrageenans, agar,alginates, chitosans, or gellan gum. In some embodiments the coatingmaterial comprises a protein. In another embodiment, the coatingmaterial comprises at least one of a fat and an oil. In otherembodiments, the at least one of a fat and an oil is high temperaturemelting. In yet another embodiment, the at least one of a fat and an oilis hydrogenated or partially hydrogenated. In one embodiment, the atleast one of a fat and an oil is derived from a plant. In otherembodiments, the at least one of a fat and an oil comprises at least oneof glycerides, free fatty acids, and fatty acid esters. In someembodiments, the coating material comprises at least one edible wax. Theedible wax can be derived from animals, insects, or plants. Non-limitingexamples include beeswax, lanolin, bayberry wax, carnauba wax, and ricebran wax. Tablets and pills can additionally be prepared with entericcoatings.

Alternatively, powders or granules embodying the bacterial compositionsdisclosed herein can be incorporated into a food product. In someembodiments, the food product is a drink for oral administration.Non-limiting examples of a suitable drink include fruit juice, a fruitdrink, an artificially flavored drink, an artificially sweetened drink,a carbonated beverage, a sports drink, a liquid diary product, a shake,an alcoholic beverage, a caffeinated beverage, infant formula and soforth. Other suitable means for oral administration include aqueous andnonaqueous solutions, emulsions, suspensions and solutions and/orsuspensions reconstituted from non-effervescent granules, containing atleast one of suitable solvents, preservatives, emulsifying agents,suspending agents, diluents, sweeteners, coloring agents, and flavoringagents.

In some embodiments, the food product can be a solid foodstuff. Suitableexamples of a solid foodstuff include without limitation a food bar, asnack bar, a cookie, a brownie, a muffin, a cracker, an ice cream bar, afrozen yogurt bar, and the like.

In other embodiments, the compositions disclosed herein are incorporatedinto a therapeutic food. In some embodiments, the therapeutic food is aready-to-use food that optionally contains some or all essentialmacronutrients and micronutrients. In another embodiment, thecompositions disclosed herein are incorporated into a supplementary foodthat is designed to be blended into an existing meal. In one embodiment,the supplemental food contains some or all essential macronutrients andmicronutrients. In another embodiment, the bacterial compositionsdisclosed herein are blended with or added to an existing food tofortify the food's protein nutrition. Examples include food staples(grain, salt, sugar, cooking oil, margarine), beverages (coffee, tea,soda, beer, liquor, sports drinks), snacks, sweets and other foods.

In one embodiment, the formulations are filled into gelatin capsules fororal administration. An example of an appropriate capsule is a 250 mggelatin capsule containing from 10 (up to 100 mg) of lyophilized powder(10⁸ to 10¹¹ bacteria), 160 mg microcrystalline cellulose, 77.5 mggelatin, and 2.5 mg magnesium stearate. In an alternative embodiment,from 10⁵ to 10¹² bacteria may be used, 10⁵ to 10⁷, 10⁶ to 10⁷, or 10⁸ to10¹⁰, with attendant adjustments of the excipients if necessary. In analternative embodiment, an enteric-coated capsule or tablet or with abuffering or protective composition can be used.

Methods of the Invention

Administration of Bacterial Compositions

The bacterial compositions of the invention are suitable foradministration to mammals and non-mammalian animals in need thereof. Thebacterial compositions can be administered to animals, including humans,laboratory animals (e.g., primates, rats, mice), livestock (e.g., cows,sheep, goats, pigs, turkeys, chickens), and household pets (e.g., dogs,cats, rodents). In certain embodiments, the mammalian subject is a humansubject who has one or more symptoms of a dysbiosis.

When the mammalian subject is suffering from a disease, disorder orcondition characterized by an aberrant microbiota, the bacterialcompositions described herein are suitable for treatment thereof. Insome embodiments, the mammalian subject has not received antibiotics inadvance of treatment with the bacterial compositions. For example, themammalian subject has not been administered at least two doses ofvancomycin, metronidazole and/or or similar antibiotic compound withinone week prior to administration of the therapeutic composition. Inother embodiments, the mammalian subject has not previously received anantibiotic compound in the one month prior to administration of thetherapeutic composition.

The bacterial compositions are useful in methods of treating a mammaliansubject suffering from or at risk of developing a gastrointestinaldisease, disorder or condition. Therefore, a therapeutic benefit isprovided by orally administering to the mammalian subject a therapeuticcomposition containing a bacterial population comprising at least threebacterial strains, wherein each bacterial strain is a member of abacterial species selected from the group consisting of E. coli, S.faecalis, C. ramosum, C. bifermentans, Bact. ovatus, Bact. vulgatus,Bact. thetaiotaomicron, and Blautia producta, wherein the therapeuticcomposition is formulated for oral administration. In some embodiments,the gastrointestinal disease, disorder or condition is relapsingdiarrhea caused by C. difficile, ulcerative colitis, colitis, Crohn'sdisease, or irritable bowel disease. Beneficially, the therapeuticcomposition is administered only once prior to improvement of thedisease, disorder or condition. In some embodiments the therapeuticcomposition is administered at intervals greater than two days, such asonce every three, four, five or six days, or every week or lessfrequently than every week.

Also provided are methods of treating or preventing a mammalian subjectsuffering from or at risk of developing a metabolic disease, disorder orcondition selected from the group consisting of diabetes, metabolicsyndrome, obesity, and autism using the therapeutic compositionsprovided herein. The bacterial compositions can be administered as acomplementary treatment to antibiotics when a patient is suffering froman acute infection, to reduce the risk of recurrence after an acuteinfection has subsided, or when a patient will be in close proximity toothers with or at risk of serious gastrointestinal infections(physicians, nurses, hospital workers, family members of those who areill or hospitalized).

An In Vivo Assay Establishing that a Bacterial Composition Populates aSubject's Gastrointestinal Tract

In order to determine that the bacterial composition populates thegastrointestinal tract of a subject, an animal model, such as a mousemodel, may be used. The model may begin by evaluating the microbiota ofthe mice. Qualitative assessments may be accomplished using 16Sprofiling of the microbial community in the feces of normal mice. It mayalso be accomplished by full genome sequencing, whole genome shotgunsequencing (WGS), or traditional microbiological techniques.Quantitative assessments may be conducted using quantitative PCR (qPCR),described in section below, or by using traditional microbiologicaltechniques and counting colony formation.

Optionally, the mice may receive an antibiotic treatment to mimic thecondition of dysbiosis. Antibiotic treatment can decrease the taxonomicrichness, diversity, and evenness of the community, including areduction of abundance of a significant number of bacterial taxa.Dethlefsen et al., The pervasive effects of an antibiotic on the humangut microbiota, as revealed by deep 16S rRNA sequencing, PLoS Biology6(11):3280 (2008). At least one antibiotic may be used and antibioticsare well known. Antibiotics may include aminoglycoside antibiotics(amikacin, arbekacin, gentamicin, kanamycin, neomycin, netilmicin,paromomycin, rhodostreptomycin, streptomycin, tobramycin, andapramycin), amoxicillin, ampicillin, Augmentin (anamoxicillin/clavulanate potassium combination), cephalosporin (cefaclor,defadroxil, cefazolin, cefixime, fefoxitin, cefprozil, ceftazimdime,cefuroxime, cephalexin), clavulanate potassium, clindamycin, colistin,gentamycin, kanamycin, metronidazole, or vancomycin. As an individual,nonlimiting specific example, the mice may be provided with drinkingwater containing a mixture of the antibiotics kanamycin, colistin,gentamycin, metronidazole and vancomycin at 40 mg/kg, 4.2 mg/kg, 3.5mg/kg, 21.5 mg/kg, and 4.5 mg/kg (mg per average mouse body weight),respectively, for 7 days. Alternatively, mice may be administeredciprofloxacin at a dose of 15-20 mg/kg (mg per average mouse bodyweight), for 7 days.

If the mice are provided with an antibiotic, a wash out period of fromone day to three days may be provided with no antibiotic treatment andno bacterial composition treatment.

Subsequently, the test bacterial composition is administered to the miceby oral gavage. The test bacterial composition may be administered in avolume of 0.2 ml containing 10⁴ CFUs of each type of bacteria in thebacterial composition. Dose-response may be assessed by using a range ofdoses, including, but not limited to 10², 10³, 10⁴, 10⁵, 10⁶, 10⁷, 10⁸,10⁹, and/or 10¹⁰.

The mice may be evaluated using 16S sequencing, full genome sequencing,whole genome shotgun sequencing (WGS), or traditional microbiologicaltechniques to determine whether the test bacterial composition haspopulated the gastrointestinal tract of the mice. For example only, oneday, three days, one week, two weeks, and one month after administrationof the bacterial composition to the mice, 16S profiling is conducted todetermine whether the test bacterial composition has populated thegastrointestinal tract of the mice. Quantitative assessments, includingqPCR and traditional microbiological techniques such as colony counting,may additionally or alternatively be performed, at the same timeintervals.

Furthermore, the number of sequence counts that correspond exactly tothose in the bacterial composition over time may be assessed todetermine specifically which components of the bacterial compositionreside in the gastrointestinal tract over a particular period of time.In one embodiment, the strains of the bacterial composition persist fora desired period of time; in another embodiment, the components of thebacterial composition persist for a desired period of time while alsoincreasing the ability of other microbes (such as those present in theenvironment, food, etc.) to populate the gastrointestinal tract, furtherincreasing overall diversity, as discussed below.

Ability of Bacterial Compositions to Populate Different Regions of theGastrointestinal Tract

The present bacterial compositions may also be assessed for theirability to populate different regions on the gastrointestinal tract. Inone embodiment, a bacterial composition may be chosen for its ability topopulate one or more than one region of the gastrointestinal tract,including, but not limited to the stomach, the small intestine(duodenum, jejunum, and ileum), the large intestine (the cecum, thecolon (the ascending, transverse, descending, and sigmoid colon), andthe rectum).

An in vivo study may be conducted to determine which regions of thegastrointestinal tract a given bacterial composition will populate. Amouse model similar to the one described above in section II.A may beconducted, except instead of assessing the feces produced by the mice,particular regions of the gastrointestinal tract may be removed andstudied individually. For example, at least one particular region of thegastrointestinal tract may be removed and a qualitative or quantitativedetermination may be performed on the contents of that region of thegastrointestinal tract. In another embodiment, the contents mayoptionally be removed and the qualitative or quantitative determinationmay be conducted on the tissue removed from the mouse.

Methods for Testing Sensitivity of Bacterial Composition

In certain embodiments, methods for testing the sensitivity of bacterialcompositions in order to select for particular desirable characteristicsmay be employed. For example, the constituents in the bacterialcomposition may be tested for pH resistance, bile acid resistance,and/or antibiotic sensitivity, either individually on aconstituent-by-constituent basis or collectively as a bacterialcomposition comprised of multiple bacterial constituents (collectivelyreferred to in this section as bacterial composition).

1. pH Sensitivity Testing

For oral administration of the bacterial compositions, optionallytesting for pH resistance enhances the selection of bacterialcompositions that will survive at the highest yield possible through thevarying pH environments of the distinct regions of the GI tract.Understanding how the bacterial compositions react to the pH of the GItract also assists in formulation, so that the number of bacteria in adosage form can be increased if beneficial and/or so that thecomposition may be administered in an enteric-coated capsule or tabletor with a buffering composition. As the pH of the stomach can drop to apH of 1 to 2 after a high-protein meal for a short time beforephysiological mechanisms adjust it to a pH of 3 to 4 and often residesat a resting pH of 4 to 5, and as the pH of the small intestine canrange from a pH of 6 to 7.4, bacterial compositions can be prepared thatsurvive these varying pH ranges (specifically wherein at least 1%, 5%,10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or as much as100% of the bacteria can survive gut transit times through various pHranges).

This may be tested by exposing the bacterial composition to varying pHranges for the expected gut transit times through those pH ranges.Therefore, as a nonlimiting example only, 18-hour cultures of bacterialcompositions may be grown in standard media, such as gut microbiotamedium (“GMM”, see Goodman et al., Extensive personal human gutmicrobiota culture collections characterized and manipulated ingnotobiotic mice, PNAS 108(15):6252-6257 (2011)) or anotheranimal-products-free medium, with the addition of pH adjusting agentsfor a pH of 1 to 2 for 30 minutes, a pH of 3 to 4 for 1 hour, a pH of 4to 5 for 1 to 2 hours, and a pH of 6 to 7.4 for 2.5 to 3 hours.

Alternatively, bacterial cells may be grown in a standard media, such asthe GMM media described above, and adjusted to pH 2.5 with 1M HCl. Thecells may be incubated anaerobically at 37° C. and their survivalmeasured at intervals of 0, 30, 60, 120, 240, and/or 360 minutes.

A further alternative method for testing stability to acid is describedin U.S. Pat. No. 4,839,281.

Survival of bacteria may be determined by culturing the bacteria andcounting colonies on appropriate selective or non-selective media.

2. Bile Acid Sensitivity Testing

Additionally, in some embodiments, testing for bile-acid resistanceenhances the selection of bacterial compositions that will surviveexposures to bile acid during transit through the GI tract. Bile acidsare secreted into the small intestine and can, like pH, affect thesurvival of bacterial compositions.

This may be tested by exposing the bacterial compositions to bile acidsfor the expected gut exposure time to bile acids. For example, bile acidsolutions may be prepared at desired concentrations using 0.05 mM Trisat pH 9 as the solvent. After the bile acid is dissolved, the pH of thesolution may be adjusted to 7.2 with 10% HCl. Bacterial compositions maybe cultured in 2.2 ml of a bile acid composition mimicking theconcentration and type of bile acids in the subject, 1.0 ml of 10%sterile-filtered feces media and 0.1 ml of an 18-hour culture of thegiven strain of bacteria. Incubations may be conducted for from 2.5 to 3hours or longer. Survival of bacteria may be determined by culturing thebacteria and counting colonies on appropriate selective or non-selectivemedia.

As another alternative, bacterial strains may be streaked onto agarplates supplemented with porcine bile (Sigma) at 0.5%, 1%, and 5% (w/v).Plates may be incubated at 37° C. under anaerobic conditions and thegrowth recorded after 48 hours. Growth may be compared with controlplates by an experienced observer and the growth of colonies scored as:0=no growth, 1=hazy translucent growth (<33% control plates with 0%bile), 2=definite growth but not as good as controls (>33% but <66%),3=growth equivalent to controls (>66%).

A further alternative method for testing stability to bile acid isdescribed in U.S. Pat. No. 4,839,281. Survival of bacteria may bedetermined by culturing the bacteria and counting colonies onappropriate selective or non-selective media.

3. Antibiotic Sensitivity Testing

As a further optional sensitivity test, bacterial compositions may betested for sensitivity to antibiotics. In one embodiment, bacterialcompositions may be chosen so that the bacterial constituents aresensitive to antibiotics such that if necessary they can be eliminatedor substantially reduced from the subject's gastrointestinal tract by atleast one antibiotic targeting the bacterial composition.

4. Adherence to Gastrointestinal Cells

The bacterial compositions may optionally be tested for the ability toadhere to gastrointestinal cells. Without being bound by theory, in someinstances, adherence can enhance the ability to repopulate a subject'sgastrointestinal tract and thus may be used as a criterion in someembodiments. As a first embodiment, this may be conducted in a tissueculture model, where gastrointestinal epithelial cells, such as but notlimited to CACO-2 cells (ATCC HTB-37), are grown in tissue cultureflasks to differentiation in an antibiotic containing media, grown forat least 1, at least 2, at least 3, at least 4, at least 5, at least 6,or at least 7 days in an antibiotic-free medium, incubated withbacterial cells for 30 minutes, 60 minutes, 90 minutes, or 120 minutes,and washed three times. After washing, the number of adherent bacteriamay be assessed by lysing the epithelial cells and enumerating thebacteria using the plate count method or qPCR, as described herein.

As another mode, bacterial adherence may be evaluated using anengineered tissue model of the lining of the gastrointestinal tract.Viney et al., “Co-culture of Intestinal Epithelial and Stromal Cells in3D Collagen-based Environments,” Regen Med 4(3):397-406 (2009). Afterpreparation of the engineered tissue model, the bacterial cells may beincubated, washed, and adherence enumerated, as described above.

Furthermore, bacterial adherence may be evaluated using a tissue explantfrom the gastrointestinal tract of a subject. Gastrointestinal tracttissue may be surgically removed from a healthy donor. Alternatively,gastrointestinal tract tissue may be surgically removed from a donor whohas a gastrointestinal disease, such as from an unused portion of abiopsy. After surgical excision, the bacterial cells may be incubated,washed, and adherence enumerated, as described above.

As an alternative, one technique involves the collection of the effluentfrom a subject with a well functioning ileostomy by saline lavage, asdescribed in U.S. Pat. No. 4,839,281.

Assessment of Microbiota Diversity

Microbiota diversity, as assessed by deep 16S rRNA sequencing ormetagenomic sequencing, may be evaluated at a variety of time points toassess the effect of microbial compositions on restoring microbiotadiversity. Microbial diversity may optionally be assessed beforeadministration of an antibiotic or removal of microbiota by acolon-cleansing preparation. Microbial diversity may also be assessedbefore administration of a microbial composition and afteradministration of a microbial composition at any frequency (e.g., morefrequently than 1 day, 1 day, 3 days, 1 week, 2 weeks, one month, ormore than one month). One may provide for any temporal resolution thathas more or less frequent sampling intervals, and/or samples taken for alonger time period (e.g., at least 1 week, at least 1 month, at leastthree months, at least six months, at least 1, 2, 3, 4, 5, 6, 7, 8, 9,10 or over more than 10 years.

Diversity may be measured according to known sequencing methods,including, but not limited to Dethlefsen et al., The pervasive effectsof an antibiotic on the human gut microbiota, as revealed by deep 16SrRNA sequencing, PLoS Biology 6(11):3280 (2008). Sequence data used fordiversity analysis may comprise 16S rRNA, whole genome sequence, anysubset of a genome as well as whole genome shotgun metagenomic sequence(WGS). Sequence data may be generated using any sequencing technologyincluding, but not limited to Sanger, Illumina, 454 Life Sciences, IonTorrent, ABI, Pacific Biosciences, and/or Oxford Nanopore. Subjects maybe assessed for a variety of diversity metrics, including, but notlimited to, observed taxon richness, Shannon diversity index, Shannonequitability index, alpha diversity, beta diversity, Chao1 index,Simpson diversity index, normalized abundance over time, and/orphylogenetic breadth.

In another embodiment, subjects may be assessed for a variety ofdiversity metrics, including, but not limited to, Simpson diversity orby plotting rarefaction curve comparisons of reference OTUs for subjectsbefore and after treatment with microbial compositions. Phylogeneticdiversity may be plotted against the number of sequence reads (full 16Ssequence or one or any combination of more hypervariable regions of the16S sequence, whole genome sequence, or specific marker loci). Shahinas,et al., Toward an understanding of changes in diversity associated withfecal microbiome transplantation based on 16S rRNA Gene Deep Sequencing,mBio 3(5):e00338-12 (2012).

In another embodiment, diversity may be shown by graphing a bar plot ofabundance at the family level and showing an increase in either thenumber of families or the balance of abundance between families.

In another embodiment, diversity may be shown by plotting heatmaps ofthe abundance of an OTU, species, genus, and/or higher taxonomicassignment showing sets of samples that are enriched or depleted forspecific constituents.

In another embodiment, diversity may be shown by generation of aphylogenetic tree of OTUs, species, genera, and/or higher or lower cladeassignments. In this embodiment genetic distances may be computedbetween all OTUs, and summary statistics including, but not limited toaverage genetic distance and number of unique clades may be computed.

In another embodiment, beta-diversity may be computed using diversitymetrics familiar to those with ordinary skill in the art that includebut are not limited to Bray-Curtis Dissimilarity Indices or JaccardDistances and plotted using Principal Coordinates Analysis.

Beneficial bacterial compositions may result in an increase in diversityafter their administration that is 10%, 20%, 30%, 40%, or 50% higherthan diversity before their administration. In another embodimentbacterial compositions may result in restoration of diversity to atleast 70%, 80%, 90%, 95%, or up to 100% of the diversity either measuredbefore administration of an antibiotic or removal of microbiota by acolon-cleansing preparation, or alternatively, as compared to thediversity of a reference mammalian subject.

Methods for Preparing a Bacterial Composition for Administration to aSubject

Methods for producing bacterial compositions may include three mainprocessing steps, combined with one or more mixing steps. The steps are:organism banking, organism production, and preservation.

For banking, the strains included in the bacterial composition may be(1) isolated directly from a specimen or taken from a banked stock, (2)optionally cultured on a nutrient agar or broth that supports growth togenerate viable biomass, and (3) the biomass optionally preserved inmultiple aliquots in long-term storage.

In embodiments using a culturing step, the agar or broth may containnutrients that provide essential elements and specific factors thatenable growth. An example would be a medium composed of 20 g/L glucose,10 g/L yeast extract, 10 g/L soy peptone, 2 g/L citric acid, 1.5 g/Lsodium phosphate monobasic, 100 mg/L ferric ammonium citrate, 80 mg/Lmagnesium sulfate, 10 mg/L hemin chloride, 2 mg/L calcium chloride, 1mg/L menadione. Medium can be added to the culture at the start, may beadded during the culture, or may be intermittently/continuously flowedthrough the culture. The strains in the bacterial composition may becultivated alone, as a subset of the bacterial composition, or as anentire collection comprising the bacterial composition. As an example, afirst strain may be cultivated together with a second strain in a mixedcontinuous culture, at a dilution rate lower than the maximum growthrate of either cell to prevent the culture from washing out of thecultivation.

The inoculated culture is incubated under favorable conditions for atime sufficient to build biomass. For bacterial compositions for humanuse this is often at 37° C. temperature, pH, and other parameter withvalues similar to the normal human niche. The environment may beactively controlled, passively controlled (e.g., via buffers), orallowed to drift. For example, for anaerobic bacterial compositions(e.g., gut applications), an anoxic/reducing environment may beemployed. This can be accomplished by addition of reducing agents suchas cysteine to the broth, and/or stripping it of oxygen. As an example,a culture of a bacterial composition may be grown at 37° C., pH 7, inthe medium above, pre-reduced with 1 g/L cysteineŸHCl.

When the culture has generated sufficient biomass, it may be preservedfor banking. The organisms may be placed into a chemical milieu thatprotects from freezing (adding ‘cryoprotectants’), drying(‘lyoprotectants’), and/or osmotic shock (‘osmoprotectants’), dispensinginto multiple (optionally identical) containers to create a uniformbank, and then treating the culture for preservation. Containers aregenerally impermeable and have closures that assure isolation from theenvironment. Cryopreservation treatment is accomplished by freezing aliquid at ultra-low temperatures (e.g., at or below −80° C.). Driedpreservation removes water from the culture by evaporation (in the caseof spray drying or ‘cool drying’) or by sublimation (e.g., for freezedrying, spray freeze drying). Removal of water improves long-termbacterial composition storage stability at temperatures elevated abovecryogenic. Bacterial composition banking may be done by culturing andpreserving the strains individually, or by mixing the strains togetherto create a combined bank. As an example of cryopreservation, abacterial composition culture may be harvested by centrifugation topellet the cells from the culture medium, the supernatant decanted andreplaced with fresh culture broth containing 15% glycerol. The culturecan then be aliquoted into 1 mL cryotubes, sealed, and placed at −80° C.for long-term viability retention. This procedure achieves acceptableviability upon recovery from frozen storage.

Organism production may be conducted using similar culture steps tobanking, including medium composition and culture conditions. It may beconducted at larger scales of operation, especially for clinicaldevelopment or commercial production. At larger scales, there may beseveral subcultivations of the bacterial composition prior to the finalcultivation. At the end of cultivation, the culture is harvested toenable further formulation into a dosage form for administration. Thiscan involve concentration, removal of undesirable medium components,and/or introduction into a chemical milieu that preserves the bacterialcomposition and renders it acceptable for administration via the chosenroute. For example, a bacterial composition may be cultivated to aconcentration of 10¹⁰ CFU/mL, then concentrated 20-fold by tangentialflow microfiltration; the spent medium may be exchanged by diafilteringwith a preservative medium consisting of 2% gelatin, 100 mM trehalose,and 10 mM sodium phosphate buffer. The suspension can then befreeze-dried to a powder and titrated. After drying, the powder may beblended to an appropriate potency, and mixed with other cultures and/ora ‘filler’ such as microcrystalline cellulose for consistency and easeof handling, and the bacterial composition filled into gelatin capsulesfor oral administration.

An example of an appropriate capsule is a 250 mg gelatin capsulecontaining from 10 (up to 100 mg) of lyophilized powder (10⁸ to 10¹¹bacteria), 160 mg microcrystalline cellulose, 77.5 mg gelatin, and 2.5mg magnesium stearate. In an alternative embodiment, from 10⁵ to 10¹²bacteria may be used, 10⁵ to 10⁷, 10⁶ to 10⁷, or 10⁸ to 10¹⁰, withattendant adjustments of the excipients if necessary.

In one embodiment, the number of bacteria of each type may be present inthe same amount or in different amounts. For example, in a bacterialcomposition with two types of bacteria, the bacteria may be present infrom a 1:10,000 ratio to a 1:1 ratio, from a 1:10,000 ratio to a 1:1,000ratio, from a 1:1,000 ratio to a 1:100 ratio, from a 1:100 ratio to a1:50 ratio, from a 1:50 ratio to a 1:20 ratio, from a 1:20 ratio to a1:10 ratio, from a 1:10 ratio to a 1:1 ratio. For bacterial compositionscomprising at least three types of bacteria, the ratio of type ofbacteria may be chosen pairwise from ratios for bacterial compositionswith two types of bacteria. For example, in a bacterial compositioncomprising bacteria A, B, and C, at least one of the ratio betweenbacteria A and B, the ratio between bacteria B and C, and the ratiobetween bacteria A and C may be chosen, independently, from the pairwisecombinations above.

Methods of Treating a Subject

A. Overview of Method

The bacterial compositions may be used to populate the gastrointestinaltract of a subject, resulting in one or more of a changed constitutionof a subject's microbiota and improvement or correction of a dysbiosis.Without being bound by theory, bacterial compositions can promotemammalian health by restoring the natural microflora in the GI tract andreinforcing the normal controls on aberrant immune responses.

Bacterial compositions can also improve fiber and protein digestion.Improving fiber and protein digestion is desirable as it promotes thegrowth of microbiota. A probiotic composition with multiple species hasbeen shown to reduce production of toxic metabolites from proteinfermentation. Rehman, Effects of Probiotics and antibiotics onintestinal homeostasis in a computer controlled model of the largeintestine, BMC Microbiology 12:47 (2012). Carbohydrate fermentation is,for the most part, believed to be a beneficial process in the large gut,because the growth of saccharolytic bacteria stimulates theirrequirements for toxic products associated with putrefaction, forincorporation into cellular proteins, thereby protecting the host.However, as digestive materials move along the gut, carbohydrates becomedepleted, which may be linked to the increased prevalence of colonicdisease in the distal bowel. Macfarlane, et al., Bacteria, colonicfermentation, and gastrointestinal health, J AOAC Int. 95(1):50-60(2012). Thus, restoring microbiota, including, but not limited to,restoring microbiota in the distal bowel can provide health benefits.

Fiber digestion may be determined using the method described in Vickerset al., Comparison of fermentation of selected fructooligosaccharidesand other fiber substrates by canine colonic microflora, Am. J. Vet.Res. 61 (4), 609-615 (2001), with the exception that instead ofinoculating using diluted fecal samples each experiment may use thebacterial compositions of interest.

In one embodiment, the pathogen may be Clostridium difficile, Salmonellaspp., pathogenic Escherichia coli, or vancomycin-resistant Enterococcusspp. In yet another embodiment, the pathogen may be Clostridiumdifficile, or other pathogen or pathobiont listed in Table 1.

The present bacterial compositions may be useful in a variety ofclinical situations. For example, the bacterial compositions may beadministered as a complementary treatment to antibiotics when a subjectis suffering from an acute infection, to reduce the risk of recurrenceafter an acute infection has subsided, or when a subject will be inclose proximity to others with or at risk of serious gastrointestinalinfections (physicians, nurses, hospital workers, family members ofthose who are ill or hospitalized).

The present bacterial compositions may be administered to animals,including humans, laboratory animals (e.g., primates, rats, mice),livestock (e.g., cows, sheep, goats, pigs, turkeys, chickens), andhousehold pets (e.g., dogs, cats, rodents).

In the present method, the bacterial composition is administeredenterically, in other words by a route of access to the gastrointestinaltract. This includes oral administration, rectal administration(including enema, suppository, or colonoscopy), by an oral or nasal tube(nasogastric, nasojejunal, oral gastric, or oral jejunal), as detailedmore fully in the section below.

B. Pretreatment Protocols

Prior to administration of the bacterial composition, the subject mayoptionally have a pretreatment protocol to prepare the gastrointestinaltract to receive the bacterial composition. In certain embodiments, thepretreatment protocol is advisable, such as when a subject has an acuteinfection with a highly resilient pathogen or when the microbiotaresident in the subject's gastrointestinal tract is likely to resistcolonization by the bacterial composition. In other embodiments, thepretreatment protocol is entirely optional, such as when the dysbiosisis not associated with a pathogenic infection; when, if an infection ispresent, the pathogen causing the infection is not resilient, or whenthe subject has had an acute infection that has been successfullytreated but where the physician is concerned that the infection mayrecur. In these instances, the pretreatment protocol may enhance theability of the bacterial composition to affect the subject's microbiome.

As one way of preparing the subject for administration of the microbialecosystem, a standard colon-cleansing preparation may be administered tothe subject to substantially empty the contents of the colon, such asused to prepare a subject for a colonoscopy. By “substantially emptyingthe contents of the colon,” this application means removing at least75%, at least 80%, at least 90%, at least 95%, or about 100% of thecontents of the ordinary volume of colon contents.

If a subject has received an antibiotic for treatment of an infection,or if a subject has received an antibiotic as part of a specificpretreatment protocol, in one embodiment the antibiotic should bestopped in sufficient time to allow the antibiotic to be substantiallyreduced in concentration in the gut before the bacterial composition isadministered. In one embodiment, the antibiotic may be discontinued 1,2, or 3 days before the administration of the bacterial composition. Inone embodiment, the antibiotic may be discontinued 3, 4, 5, 6, or 7antibiotic half-lives before administration of the bacterialcomposition. In another embodiment, the antibiotic may be chosen so theconstituents in the bacterial composition have an MIC50 that is higherthan the concentration of the antibiotic in the gut.

MIC50 of a bacterial composition or the elements in the composition maybe determined by methods well known in the art. Reller et al.,Antimicrobial Susceptibility Testing: A Review of General Principles andContemporary Practices, Clinical Infectious Diseases 49(11):1749-1755(2009). In such an embodiment, the additional time between antibioticadministration and administration of the bacterial composition is notnecessary. If the pretreatment protocol is part of treatment of an acuteinfection, the antibiotic may be chosen so that the infection issensitive to the antibiotic, but the constituents in the bacterialcomposition are not sensitive to the antibiotic.

C. Routes of Administration

In the present method, the bacterial composition is administeredenterically, in other words by a route of access to the gastrointestinaltract. This preferentially includes oral administration, or by an oralor nasal tube (including nasogastric, nasojejunal, oral gastric, or oraljejunal). In other embodiments, administration includes rectaladministration (including enema, suppository, or colonoscopy). Thebacterial composition may be administered to at least one region of thegastrointestinal tract, including the mouth, esophagus, stomach, smallintestine, large intestine, and rectum. In some embodiments it isadministered to all regions of the gastrointestinal tract. The bacterialcompositions may be administered orally in the form of medicaments suchas powders, capsules, tablets, gels or liquids. The bacterialcompositions may also be administered in gel or liquid form by the oralroute or through a nasogastric tube, or by the rectal route in a gel orliquid form, by enema or instillation through a colonoscope or by asuppository.

If the composition is administered colonoscopically and, optionally, ifthe bacterial composition is administered by other rectal routes (suchas an enema or suppository) or even if the subject has an oraladministration, the subject may have a colonic-cleansing preparation.The colon-cleansing preparation can facilitate proper use of thecolonoscope or other administration devices, but even when it does notserve a mechanical purpose it can also maximize the proportion of thebacterial composition relative to the other organisms previouslyresiding in the gastrointestinal tract of the subject. Any ordinarilyacceptable colonic-cleansing preparation may be used such as thosetypically provided when a subject undergoes a colonoscopy.

D. Dosages and Schedule for Administration

In one embodiment, from 10⁸ and 10¹¹ microorganisms total may beadministered to the subject in a given dosage form. In one mode, aneffective amount may be provided in from 1 to 500 ml or from 1 to 500grams of the bacterial composition having from 10⁸ to 10¹¹ bacteria perml or per gram, or a capsule, tablet or suppository having from 1 mg to1000 mg lyophilized powder having from 10⁸ to 10¹⁵ bacteria. Thosereceiving acute treatment may receive higher doses than those who arereceiving chronic administration (such as hospital workers or thoseadmitted into long-term care facilities).

Any of the preparations described herein may be administered once on asingle occasion or on multiple occasions, such as once a day for severaldays or more than once a day on the day of administration (includingtwice daily, three times daily, or up to five times daily). Or thepreparation may be administered intermittently according to a setschedule, e.g., once a day, once weekly, or once monthly, or when thesubject relapses from the primary illness. In another embodiment, thepreparation may be administered on a long-term basis to individuals whoare at risk for infection with or who may be carriers of thesepathogens, including individuals who will have an invasive medicalprocedure (such as surgery), who will be hospitalized, who live in along-term care or rehabilitation facility, who are exposed to pathogensby virtue of their profession (livestock and animal processing workers),or who could be carriers of pathogens (including hospital workers suchas physicians, nurses, and other health care professionals).

E. Subject Selection

Particular bacterial compositions may be selected for individualsubjects or for subjects with particular profiles. For example, 16Ssequencing may be performed for a given subject to identify the bacteriapresent in his or her microbiota. The sequencing may either profile thesubject's entire microbiome using 16S sequencing (to the family, genera,or species level), a portion of the subject's microbiome using 16Ssequencing, or it may be used to detect the presence or absence ofspecific candidate bacteria that are biomarkers for health or aparticular disease state. Based on the biomarker data, a particularcomposition may be selected for administration to a subject tosupplement or complement a subject's microbiota in order to restorehealth or treat or prevent disease.

The specification is most thoroughly understood in light of theteachings of the references cited within the specification. Theembodiments within the specification provide an illustration ofembodiments and should not be construed to limit the scope. The skilledartisan readily recognizes that many other embodiments are encompassed.All publications and patents cited in this disclosure are incorporatedby reference in their entirety. To the extent the material incorporatedby reference contradicts or is inconsistent with this specification, thespecification will supersede any such material. The citation of anyreferences herein is not an admission that such references are priorart.

Unless otherwise indicated, all numbers expressing quantities ofingredients, reaction conditions, and so forth used in thespecification, including claims, are to be understood as being modifiedin all instances by the term “about.” Accordingly, unless otherwiseindicated to the contrary, the numerical parameters are approximationsand may vary depending upon the desired properties sought to beobtained. At the very least, and not as an attempt to limit theapplication of the doctrine of equivalents to the scope of the claims,each numerical parameter should be construed in light of the number ofsignificant digits and ordinary rounding approaches.

Unless otherwise indicated, the term “at least” preceding a series ofelements is to be understood to refer to every element in the series.

EXAMPLES

Below are examples of specific embodiments for carrying out the presentinvention. The examples are offered for illustrative purposes only, andare not intended to limit the scope of the present invention in any way.Efforts have been made to ensure accuracy with respect to numbers used(e.g., amounts, temperatures, etc.), but some experimental error anddeviation should, of course, be allowed for.

The practice of the present invention will employ, unless otherwiseindicated, conventional methods of protein chemistry, biochemistry,recombinant DNA techniques and pharmacology, within the skill of theart. Such techniques are explained fully in the literature. See, e.g.,T. E. Creighton, Proteins: Structures and Molecular Properties (W.H.Freeman and Company, 1993); A. L. Lehninger, Biochemistry (WorthPublishers, Inc., current addition); Sambrook, et al., MolecularCloning: A Laboratory Manual (2nd Edition, 1989); Methods In Enzymology(S. Colowick and N. Kaplan eds., Academic Press, Inc.); Remington'sPharmaceutical Sciences, 18th Edition (Easton, Pa.: Mack PublishingCompany, 1990); Carey and Sundberg Advanced Organic Chemistry 3^(rd) Ed.(Plenum Press) Vols A and B (1992).

Example 1 Administration of Bacterial Compositions to Mammalian Subjectshaving C. difficile Infection

An in vivo mouse model was employed to demonstrate the protective effectof the bacterial compositions against C. difficile. In this model (basedon Chen, et al., A mouse model of Clostridium difficile associateddisease, Gastroenterology 135(6):1984-1992 (2008)), mice were madesusceptible to C. difficile by a 7 or 9 day treatment (days −14 or −12until −5 of experiment) with 5 to 7 antibiotics (kanamycin, colistin,gentamycin, metronidazole and vancomycin, and optionally includingampicillin and ciprofloxacin) delivered via their drinking water,followed by a single dose with clindamycin on day −3. The mice were thenchallenged three days later (on day 0) with 10⁴ spores of C. difficilevia oral gavage (i.e., oro-gastric lavage). The outcomes assessed eachday from day 0 to day 6 were weight, clinical signs, mortality andshedding of C. difficile in the feces. Weight, clinical signs andmortality were also evaluated on day −1. Weight loss, clinical signs ofdisease, and C. difficile shedding were typically observed withouttreatment. Vancomycin treatment protects against these outcomes andserves as a positive control when provided by oral gavage on days −1 to4. Clinical signs were subjective, and scored each day by the sameexperienced observer. Mortality includes euthanasia of animals that losegreater than or equal to 25% of their body weight or that display severemorbidity as assessed by clinical signs. Feces were gathered from themouse cages (5 mice per cage) each day, and suspended in 5 mL of PBS byvortexing. The shedding of C. difficile spores is detected in the fecesusing a selective plating assay as described for the in vitro assayabove, after a 1 hour treatment with 50% ethanol at room temperature tokill C. difficile vegetative cells. C. difficile may also be detected inthe mouse fecal suspension via qPCR for the toxin gene as describedherein. The effects of various administrations, including 10% suspensionof human feces in PBS (as a positive control), microbial compositions,or PBS (as a negative vehicle control), were determined by introducingthe bacterial composition in a 0.2 mL volume into the mice via oralgavage on day −1, one day prior to C. difficile challenge. Vancomycin,as discussed above, is given on days −1 to −4 as another positivecontrol. Alternative dosing schedules can be employed, includingmultiple doses of bacterial composition, and 10³ to 10¹⁰ of a givenorganism or composition may be delivered.

Exemplary bacterial compositions as described herein were administeredas follows.

In a first demonstration, the results of which are provided in tabularform as Table 3B, Treatment 1 is the vehicle control of phosphatebuffered saline (PBS), Treatment 2 is a positive control of 10% fecalsuspension in PBS which has total anaerobic cfu/ml of 4.5×10⁹, Treatment3 is a positive control of 10% fecal suspension in PBS which has totalanaerobic cfu/ml of 6.2×10⁸, Treatment 4 is a bacterial compositioncomprising Escherichia coli (family Enterobacteriaceae, ATCC 35320),Enterococcus faecalis (family Enterococcaceae ATCC, 19433), Blautiaproducta (family Lachnospiraceae, DSM 14466), Bacteroides vulgatus(family Bacteroidaceae, ATCC 8482), Bacteroides thetaiotaomicron (familyBacteroidaceae, ATCC 29148), Bacteroides ovatus (family Bacteroidaceae,ATCC 8483), Clostridium bifermentans (family Peptostreptococcaceae, ATCC638), Clostridium ramosum (family Erysipelotrichaceae, ATCC 25582),Clostridium innocuum (family Erysipelotrichaceae, DSM 22910) with atotal anaerobic cfu/ml of 7.1×10⁹. Treatment 5 is a bacterialcomposition comprising Escherichia coli (family Enterobacteriaceae, ATCC35320), Enterococcus faecalis (family Enterococcaceae ATCC, 19433),Blautia producta (family Lachnospiraceae, DSM 14466), Bacteroidesvulgatus (family Bacteroidaceae, ATCC 8482), Bacteroidesthetaiotaomicron (family Bacteroidaceae, ATCC 29148), Bacteroides ovatus(family Bacteroidaceae, ATCC 8483), Clostridium bifermentans (familyPeptostreptococcaceae, ATCC 638), Clostridium ramosum (familyErysipelotrichaceae, ATCC 25582), Clostridium innocuum (familyErysipelotrichaceae, DSM 22910) with a total anaerobic cfu/ml of7.1×10⁸. Treatment 6 is a bacterial composition comprising Escherichiacoli (family Enterobacteriaceae, ATCC 35320), Enterococcus faecalis(family Enterococcaceae ATCC, 19433), Blautia producta (familyLachnospiraceae, DSM 14466), Bacteroides vulgatus (familyBacteroidaceae, ATCC 8482), Bacteroides thetaiotaomicron (familyBacteroidaceae, ATCC 29148), Bacteroides ovatus (family Bacteroidaceae,ATCC 8483), Clostridium bifermentans (family Peptostreptococcaceae, ATCC638), Clostridium ramosum (family Erysipelotrichaceae, ATCC 25582),Clostridium innocuum (family Erysipelotrichaceae, DSM 22910) with atotal anaerobic cfu/ml of 7.1×10⁷. Treatment 7 is a bacterialcomposition comprising Escherichia coli (family Enterobacteriaceae, ATCC35320), Enterococcus faecalis (family Enterococcaceae ATCC, 19433),Blautia producta (family Lachnospiraceae, DSM 14466), Clostridiumbifermentans (family Peptostreptococcaceae, ATCC 638), Clostridiumramosum (family Erysipelotrichaceae, ATCC 25582), Clostridium innocuum(family Erysipelotrichaceae, DSM 22910) with a total anaerobic cfu/ml of3.7×10⁹. Treatment 8 is a bacterial composition comprising Bacteroidesvulgatus (family Bacteroidaceae, ATCC 8482), Bacteroidesthetaiotaomicron (family Bacteroidaceae, ATCC 29148), Bacteroides ovatus(family Bacteroidaceae, ATCC 8483) with a total anaerobic cfu/ml of3.5×10⁹. Treatment 9 is a bacterial composition comprising Enterococcusfaecalis (family Enterococcaceae ATCC, 19433), Bacteroides vulgatus(family Bacteroidaceae, ATCC 8482), Bacteroides thetaiotaomicron (familyBacteroidaceae, ATCC 29148), Bacteroides ovatus (family Bacteroidaceae,ATCC 8483), Clostridium ramosum (family Erysipelotrichaceae, ATCC25582), Clostridium innocuum (family Erysipelotrichaceae, DSM 22910)with a total anaerobic cfu/ml of 6.7×10⁹. Treatment 10 is a bacterialcomposition comprising Clostridium bifermentans (familyPeptostreptococcaceae, ATCC 638), Clostridium ramosum (familyErysipelotrichaceae, ATCC 25582), and Clostridium innocuum (familyErysipelotrichaceae, DSM 22910) with a total anaerobic cfu/ml of1.2×10⁹. Treatment 11 is a bacterial composition comprising Escherichiacoli (family Enterobacteriaceae, ATCC 35320), Enterococcus faecalis(family Enterococcaceae ATCC, 19433), Blautia producta (familyLachnospiraceae, DSM 14466), Bacteroides vulgatus (familyBacteroidaceae, ATCC 8482), Bacteroides thetaiotaomicron (familyBacteroidaceae, ATCC 29148), Bacteroides ovatus (family Bacteroidaceae,ATCC 8483), Clostridium celatum (family Clostridiaceae, SPC21278) with atotal anaerobic cfu/ml of 6.1×10⁹. Treatment 12 is a bacterialcomposition comprising Escherichia coli (family Enterobacteriaceae, ATCC35320), Enterococcus faecalis (family Enterococcaceae ATCC, 19433),Bacteroides vulgatus (family Bacteroidaceae, ATCC 8482), Bacteroidesthetaiotaomicron (family Bacteroidaceae, ATCC 29148), Bacteroides ovatus(family Bacteroidaceae, ATCC 8483), Clostridium bifermentans (familyPeptostreptococcaceae, ATCC 638), Clostridium ramosum (familyErysipelotrichaceae, ATCC 25582), Clostridium innocuum (familyErysipelotrichaceae, DSM 22910) with a total anaerobic cfu/ml of 1×10¹⁰.

In a second demonstration, the results of which are provided in tabularform as Table 2, Treatment 1 is the vehicle control of phosphatebuffered saline (PBS), Treatment 2 is a positive control of 10% fecalsuspension in PBS which has total anaerobic cfu/ml of 5×10⁹, Treatment 3is a positive control of 10% fecal suspension in PBS which has totalanaerobic cfu/ml of 7×10⁸.

Treatment 4 is a bacterial composition comprising Escherichia coli(family Enterobacteriaceae, ATCC 35320), Enterococcus faecalis (familyEnterococcaceae ATCC, 19433), Blautia producta (family Lachnospiraceae,DSM 14466), Bacteroides vulgatus (family Bacteroidaceae, ATCC 8482),Bacteroides thetaiotaomicron (family Bacteroidaceae, ATCC 29148),Bacteroides ovatus (family Bacteroidaceae, ATCC 8483), Clostridiumbifermentans (family Peptostreptococcaceae, ATCC 638), Clostridiumramosum (family Erysipelotrichaceae, ATCC 25582), Clostridium innocuum(family Erysipelotrichaceae, DSM 22910) with a total anaerobic cfu/ml of2.2×10⁹, Treatment 5 is a bacterial composition comprising Escherichiacoli (family Enterobacteriaceae, ATCC 35320), Enterococcus faecalis(family Enterococcaceae ATCC, 19433), Blautia producta (familyLachnospiraceae, DSM 14466), Bacteroides vulgatus (familyBacteroidaceae, ATCC 8482), Bacteroides thetaiotaomicron (familyBacteroidaceae, ATCC 29148), Bacteroides ovatus (family Bacteroidaceae,ATCC 8483), Clostridium bifermentans (family Peptostreptococcaceae, ATCC638), Clostridium ramosum (family Erysipelotrichaceae, ATCC 25582),Clostridium innocuum (family Erysipelotrichaceae, DSM 22910) with atotal anaerobic cfu/ml of 2.2×10⁸. Treatment 6 is a bacterialcomposition comprising Escherichia coli (family Enterobacteriaceae, ATCC35320), Enterococcus faecalis (family Enterococcaceae ATCC, 19433),Blautia producta (family Lachnospiraceae, DSM 14466), Bacteroidesvulgatus (family Bacteroidaceae, ATCC 8482), Bacteroidesthetaiotaomicron (family Bacteroidaceae, ATCC 29148), Bacteroides ovatus(family Bacteroidaceae, ATCC 8483), Clostridium bifermentans (familyPeptostreptococcaceae, ATCC 638), Clostridium ramosum (familyErysipelotrichaceae, ATCC 25582), Clostridium innocuum (familyErysipelotrichaceae, DSM 22910) with a total anaerobic cfu/ml of2.2×10⁷, Treatment 7 is a bacterial composition comprising Escherichiacoli (family Enterobacteriaceae, ATCC 35320), Enterococcus faecalis(family Enterococcaceae ATCC, 19433), Blautia producta (familyLachnospiraceae, DSM 14466), Bacteroides vulgatus (familyBacteroidaceae, ATCC 8482), Bacteroides thetaiotaomicron (familyBacteroidaceae, ATCC 29148), Bacteroides ovatus (family Bacteroidaceae,ATCC 8483), Clostridium innocuum (family Erysipelotrichaceae, DSM 22910)with a total anaerobic cfu/ml of 5×10⁹, Treatment 8 is a bacterialcomposition comprising Escherichia coli (family, Enterobacteriaceae,SPC21221), Escherichia coli (family, Enterobacteriaceae, SPC21248),Enterococcus faecalis (family, Enterococcaceae, SPC21240), Enterococcusfaecalis (family, Enterococcaceae, SPC21252), Blautia producta (family,Lachnospiraceae, SPC2115104), Bacteriodes vulgatus (family,Bacteroidaceae, SPC21122), Bacteriodes vulgatus (family, Bacteroidaceae,SPC21192), Bacteriodes thetaiotaomicron (family Bacteroidaceae,SPC21132), Bacteriodes thetaiotaomicron, (family Bacteroidaceae,SPC21133), Bacteriodes ovatus (family, Bacteroidaceae, SPC21141),Bacteriodes ovatus (family, Bacteroidaceae, SPC21181), Clostridiuminnocuum (family, Erysipelotrichaceae, SPC21112), Clostridiumbifermentans (family Peptostreptococcaceae, ATCC 638), Clostridiumramosum (family Erysipelotrichaceae, ATCC 25582), with a total anaerobiccfu/ml of 1.7×10¹⁰, Treatment 9 is a bacterial composition comprisingEscherichia coli (family, Enterobacteriaceae, SPC21221), Escherichiacoli (family, Enterobacteriaceae, SPC21248), Enterococcus faecalis(family, Enterococcaceae, SPC21240), Enterococcus faecalis (family,Enterococcaceae, SPC21252), Blautia producta (family, Lachnospiraceae,SPC2115104), Bacteriodes vulgatus (family, Bacteroidaceae, SPC21122),Bacteriodes vulgatus (family, Bacteroidaceae, SPC21192), Bacteriodesthetaiotaomicron (family Bacteroidaceae, SPC21132), Bacteriodesthetaiotaomicron, (family Bacteroidaceae, SPC21133), Bacteriodes ovatus(family, Bacteroidaceae, SPC21141), Bacteriodes ovatus (family,Bacteroidaceae, SPC21181), Clostridium innocuum (family,Erysipelotrichaceae, SPC21112), Clostridium bifermentans (familyPeptostreptococcaceae, ATCC 638), Clostridium ramosum (familyErysipelotrichaceae, ATCC 25582), with a total anaerobic cfu/ml of1.7×10⁹, Treatment 10 is a bacterial composition comprising Escherichiacoli (family, Enterobacteriaceae, SPC21221), Escherichia coli (family,Enterobacteriaceae, SPC21248), Enterococcus faecalis (family,Enterococcaceae, SPC21240), Enterococcus faecalis (family,Enterococcaceae, SPC21252), Blautia producta (family, Lachnospiraceae,SPC2115104), Bacteriodes vulgatus (family, Bacteroidaceae, SPC21122),Bacteriodes vulgatus (family, Bacteroidaceae, SPC21192), Bacteriodesthetaiotaomicron (family Bacteroidaceae, SPC21132), Bacteriodesthetaiotaomicron, (family Bacteroidaceae, SPC21133), Bacteriodes ovatus(family, Bacteroidaceae, SPC21141), Bacteriodes ovatus (family,Bacteroidaceae, SPC21181), Clostridium innocuum (family,Erysipelotrichaceae, SPC21112), Clostridium bifermentans (familyPeptostreptococcaceae, ATCC 638), and Clostridium ramosum (familyErysipelotrichaceae, ATCC 25582), with a total anaerobic cfu/ml of1.7×10⁸, Treatment 11 is a bacterial composition comprising Escherichiacoli (family, Enterobacteriaceae, SPC21221), Escherichia coli (family,Enterobacteriaceae, SPC21248), Enterococcus faecalis (family,Enterococcaceae, SPC21240), Enterococcus faecalis (family,Enterococcaceae, SPC21252), Blautia producta (family, Lachnospiraceae,SPC2115104), Bacteriodes vulgatus (family, Bacteroidaceae, SPC21122),Bacteriodes vulgatus (family, Bacteroidaceae, SPC21192), Bacteriodesthetaiotaomicron (family Bacteroidaceae, SPC21132), Bacteriodesthetaiotaomicron, (family Bacteroidaceae, SPC21133), Bacteriodes ovatus(family, Bacteroidaceae, SPC21141), Bacteriodes ovatus (family,Bacteroidaceae, SPC21181), and Clostridium innocuum (family,Erysipelotrichaceae, SPC21112) with a total anaerobic cfu/ml of1.2×10¹⁰, Treatment 12 is a bacterial composition comprising Escherichiacoli (family, Enterobacteriaceae, SPC21221), Escherichia coli (family,Enterobacteriaceae, SPC21248), Enterococcus faecalis (family,Enterococcaceae, SPC21240), Enterococcus faecalis (family,Enterococcaceae, SPC21252), Blautia producta (family, Lachnospiraceae,SPC2115104), Bacteriodes vulgatus (family, Bacteroidaceae, SPC21122),Bacteriodes vulgatus (family, Bacteroidaceae, SPC21192), Bacteriodesthetaiotaomicron (family Bacteroidaceae, SPC21132), Bacteriodesthetaiotaomicron, (family Bacteroidaceae, SPC21133), Bacteriodes ovatus(family, Bacteroidaceae, SPC21141), Bacteriodes ovatus (family,Bacteroidaceae, SPC21181), Clostridium innocuum (family,Erysipelotrichaceae, SPC21112), and Clostridium celatum (familyClostridiaceae, SPC21278) with a total anaerobic cfu/ml of 9×10⁹,Treatment 13 is a bacterial composition comprising Escherichia coli(family Enterobacteriaceae, SPC21221), Enterococcus faecalis (familyEnterococcaceae, SPC21240), Blautia producta (family Lachnospiraceae,SPC2115104), Bacteriodes vulgatus (family Bacteroidaceae, SPC21122),Bacteriodes thetaiotaomicron (family Bacteroidaceae, SPC21132),Bacteriodes ovatus (family Bacteroidaceae, SPC21141), and Clostridiuminnocuum (family Erysipelotrichaceae, SPC21112) with a total anaerobiccfu/ml of 6×10⁹. Treatment 14 is a bacterial composition comprisingEscherichia coli (family Enterobacteriaceae, SPC21248), Enterococcusfaecalis (family Enterococcaceae, SPC21252), Blautia producta (familyLachnospiraceae, SPC2115104), Bacteriodes vulgatus (family,Bacteroidaceae, SPC21192), Bacteriodes thetaiotaomicron (familyBacteroidaceae, SPC21133), Bacteriodes ovatus (family Bacteroidaceae,SPC21181), and Clostridium innocuum (family Erysipelotrichaceae,SPC21112) with a total anaerobic cfu/ml of 5×10⁹.

In a third demonstration, the results of which are provided in tabularform as Table 3A, Treatment 1 is the vehicle control of phosphatebuffered saline (PBS), Treatment 2 is a positive control of 10% fecalsuspension in PBS which has total anaerobic cfu/ml of 2.3×10¹¹,Treatment 3 is a bacterial composition comprising Escherichia coli(family Enterobacteriaceae, SPC21221), Enterococcus faecalis (familyEnterococcaceae, SPC21240), Blautia producta (family Lachnospiraceae,SPC2115104), Bacteroides vulgatus (family Bacteroidaceae, SPC21192),Bacteroides thetaiotaomicron (family Bacteroidaceae, SPC21132),Bacteroides ovatus (family Bacteroidaceae, SPC21141), Clostridiuminnocuum (family Erysipelotrichaceae, SPC21112), and Clostridium celatum(family Clostridiaceae, SPC21278) with a total anaerobic cfu/ml of2.5×10⁹, Treatment 4 is a bacterial composition comprising Escherichiacoli (family Enterobacteriaceae, SPC21221), Enterococcus faecalis(family Enterococcaceae, SPC21240), Blautia producta (familyLachnospiraceae, SPC2115104), Bacteroides vulgatus (familyBacteroidaceae, SPC21192), Bacteroides thetaiotaomicron (familyBacteroidaceae, SPC21132), Bacteroides ovatus (family Bacteroidaceae,SPC21141), Clostridium innocuum (family Erysipelotrichaceae, SPC21112),and Clostridium celatum (family Clostridiaceae, SPC21278) with a totalanaerobic cfu/ml of 2.5×10⁸, Treatment 5 is a bacterial compositioncomprising Escherichia coli (family Enterobacteriaceae, SPC21221),Enterococcus faecalis (family Enterococcaceae, SPC21240), Blautiaproducta (family Lachnospiraceae, SPC2115104), Bacteroides vulgatus(family Bacteroidaceae, SPC21192), Bacteroides thetaiotaomicron (familyBacteroidaceae, SPC21132), Bacteroides ovatus (family Bacteroidaceae,SPC21141), Clostridium innocuum (family Erysipelotrichaceae, SPC21112),and Clostridium celatum (family Clostridiaceae, SPC21278) with a totalanaerobic cfu/ml of 2.5×10⁷, Treatment 6 is a bacterial compositioncomprising Blautia producta (family Lachnospiraceae, SPC2115104),Bacteroides vulgatus (family Bacteroidaceae, SPC21192), Bacteroidesthetaiotaomicron (family Bacteroidaceae, SPC21132), Bacteroides ovatus(family Bacteroidaceae, SPC21141), Clostridium innocuum (familyErysipelotrichaceae, SPC21112), and Clostridium celatum (familyClostridiaceae, SPC21278) with a total anaerobic cfu/ml of 2.8×10⁹,Treatment 7 is a bacterial composition comprising Escherichia coli(family Enterobacteriaceae, SPC21221), Enterococcus faecalis (familyEnterococcaceae, SPC21240), Bacteroides vulgatus (family Bacteroidaceae,SPC21192), Bacteroides thetaiotaomicron (family Bacteroidaceae,SPC21132), Bacteroides ovatus (family Bacteroidaceae, SPC21141),Clostridium innocuum (family Erysipelotrichaceae, SPC21112), andClostridium celatum (family Clostridiaceae, SPC21278) with a totalanaerobic cfu/ml of 6×10⁹, Treatment 8 is a bacterial compositioncomprising Escherichia coli (family Enterobacteriaceae, SPC21221),Enterococcus faecalis (family Enterococcaceae, SPC21240), Blautiaproducta (family Lachnospiraceae, SPC2115104), Clostridium innocuum(family Erysipelotrichaceae, SPC21112), and Clostridium celatum (familyClostridiaceae, SPC21278) with a total anaerobic cfu/ml of 1.8×10⁹,Treatment 9 is a bacterial composition comprising Escherichia coli(family Enterobacteriaceae, SPC21221), Enterococcus faecalis (familyEnterococcaceae, SPC21240), Blautia producta (family Lachnospiraceae,SPC2115104), Bacteroides vulgatus (family Bacteroidaceae, SPC21192),Bacteroides thetaiotaomicron (family Bacteroidaceae, SPC21132), andBacteroides ovatus (family Bacteroidaceae, SPC21141) with a totalanaerobic cfu/ml of 2×10⁹, Treatment 10 is a bacterial compositioncomprising Escherichia coli (family Enterobacteriaceae, SPC21221),Enterococcus faecalis (family Enterococcaceae, SPC21240), Blautiaproducta (family Lachnospiraceae, SPC2115104), Bacteroides vulgatus(family Bacteroidaceae, SPC21192), Bacteroides thetaiotaomicron (familyBacteroidaceae, SPC21132), Bacteroides ovatus (family Bacteroidaceae,SPC21141), Clostridium innocuum (family Erysipelotrichaceae, SPC21112),Clostridium celatum (family Clostridiaceae, SPC21278), Clostridiumbutyricum (family Clostridiaceae, SPC21367), and Clostridium glycolicum(family Peptostreptococcaceae, SPC21349) with a total anaerobic cfu/mlof 8×10⁹, Treatment 11 is a bacterial composition comprising Escherichiacoli (family Enterobacteriaceae, SPC21221), Enterococcus faecalis(family Enterococcaceae, SPC21240), Blautia producta (familyLachnospiraceae, SPC2115104), Bacteroides vulgatus (familyBacteroidaceae, SPC21192), Bacteroides thetaiotaomicron (familyBacteroidaceae, SPC21132), Bacteroides ovatus (family Bacteroidaceae,SPC21141), Clostridium innocuum (family Erysipelotrichaceae, SPC21112),Clostridium celatum (family Clostridiaceae, SPC21278), Clostridiumbutyricum (family Clostridiaceae, SPC21367), Clostridium glycolicum(family Peptostreptococcaceae, SPC21349), Dorea formicigerans (familyLachnospiraceae, SPC21308), Ruminococcus torques (familyRuminococcaceae, SPC21344), Eubacterium tenue (familyPeptostreptococcaceae, SPC21391) and Eubacterium cylindroides (familyErysipelotrichacea, SPC21300) with a total anaerobic cfu/ml of 2.5×10⁹.Treatment 12 is a bacterial composition comprising Blautia producta(family Lachnospiraceae, SPC2115104), Clostridium innocuum (familyErysipelotrichaceae, SPC21112), and Clostridium celatum (familyClostridiaceae, SPC21278), with a total anaerobic cfu/ml of 2.1×10⁷.Treatment 13 is a bacterial composition comprising Blautia producta(family Lachnospiraceae, SPC2115104), Clostridium innocuum (familyErysipelotrichaceae, SPC21112), Clostridium celatum (familyClostridiaceae, SPC21278), Clostridium butyricum (family Clostridiaceae,SPC21367), and Clostridium glycolicum (family Peptostreptococcaceae,SPC21349) with a total anaerobic cfu/ml of 1.4×10⁸. Treatment 14 is abacterial composition comprising Blautia producta (familyLachnospiraceae, SPC2115104), Clostridium innocuum (familyErysipelotrichaceae, SPC21112), Clostridium celatum (familyClostridiaceae, SPC21278), Clostridium butyricum (family Clostridiaceae,SPC21367), Clostridium glycolicum (family Peptostreptococcaceae,SPC21349), Dorea formicigerans (family Lachnospiraceae, SPC21308),Ruminococcus torques (family Ruminococcaceae, SPC21344), Eubacteriumtenue (family Peptostreptococcaceae, SPC21391) and Eubacteriumcylindroides (family Erysipelotrichacea, SPC21300) with a totalanaerobic cfu/ml of 3.1×10⁷. Treatment 15 is a bacterial compositioncomprising Escherichia coli (family Enterobacteriaceae, SPC21221),Enterococcus faecalis (family Enterococcaceae, SPC21240), Blautiaproducta (family Lachnospiraceae, SPC2115104), Bacteroides vulgatus(family Bacteroidaceae, SPC21192), Bacteroides thetaiotaomicron (familyBacteroidaceae, SPC21132), Bacteroides ovatus (family Bacteroidaceae,SPC21141), Clostridium innocuum (family Erysipelotrichaceae, SPC21112),Clostridium celatum (family Clostridiaceae, SPC21278), Clostridiumbutyricum (family Clostridiaceae, SPC21367), Clostridium glycolicum(family Peptostreptococcaceae, SPC21349), Dorea formicigerans (familyLachnospiraceae, SPC21308), Ruminococcus torques (familyRuminococcaceae, SPC21344), Eubacterium tenue (familyPeptostreptococcaceae, SPC21391) and Eubacterium cylindroides (familyErysipelotrichacea, SPC21300) that was treated with 50% EtOH for 1 hourat 37 C, centrifuged to pellet the bacterial cells and resuspended insterile PBS at the equivalent original volume and having a totalanaerobic cfu/ml of 1.3×10⁷.

For each of the three demonstrations, scores for each treatment rangefrom 0 to 9. Scores were calculated as follows. Groups of animals(N=10/group) were scored for % mortality. Mortality was normalized in agiven demonstration by setting the observed mortality of the PBS vehiclecontrol group=3. A treatment group was then scored based on the observedmortality for that group divided by the mortality of the PBS vehiclecontrol times 3. Thus, if the mortality of the PBS vehicle group was 60%(score=3), then a treatment group with mortality of 30% would receive ascore of 1.5. Similarly, mean weight loss on Day 3 was normalized to ascore of 3 for the PBS vehicle control group. A score for each treatmentwas calculated by dividing the actual mean weight loss by the meanweight loss for the PBS vehicle control group and multiplying by 3. Asimilar procedure was used for the clinical scores evaluation. Finally,the individual values for mortality, mean weight loss on Day 3 andclinical scores were summed to give a final value of 0-9 for eachtreatment, with 0 being best (no death, no weight loss, no clinicalsymptoms) and 9 being equivalent to the vehicle control.

Example 2 Species Identification

The identity of the bacterial species which grew up from a complexfraction can be determined in multiple ways. First, individual coloniescan be picked into liquid media in a 96 well format, grown up and savedas 15% glycerol stocks at −80 C. Aliquots of the cultures can be placedinto cell lysis buffer and colony PCR methods can be used to amplify andsequence the 16S rDNA gene (described below in Example 3).Alternatively, colonies may be streaked to purity in several passages onsolid media. Well separated colonies are streaked onto the fresh platesof the same kind and incubated for 48-72 hours at 37 C. The process isrepeated multiple times in order to ensure purity. Pure cultures can beanalyzed by phenotypic- or sequence-based methods, including 16S rDNAamplification and sequencing as described in Examples 3 and 4. Sequencecharacterization of pure isolates or mixed communities e.g. platescrapes and spore fractions can also include whole genome shotgunsequencing. The latter is valuable to determine the presence of genesassociated with sporulation, antibiotic resistance, pathogenicity, andvirulence. Colonies can also be scraped from plates en masse andsequenced using a massively parallel sequencing method as described inExamples 3 & 4 such that individual 16S signatures can be identified ina complex mixture. Optionally, the sample can be sequenced prior togermination (if appropriate DNA isolation procedures are used to lyseand release the DNA from spores) in order to compare the diversity ofgerminable species with the total number of species in a spore sample.As an alternative or complementary approach to 16S analysis,MALDI-TOF-mass spec can also be used for species identification (asreviewed in Anaerobe 22:123).

Example 3 16s Sequencing to Determine Operational Taxonomic Unit (OTU)

Method for Determining 16S Sequence

OTUs may be defined either by full 16S sequencing of the rRNA gene, bysequencing of a specific hypervariable region of this gene (i.e. V1, V2,V3, V4, V5, V6, V7, V8, or V9), or by sequencing of any combination ofhypervariable regions from this gene (e.g. V1-3 or V3-5). The bacterial16S rDNA is approximately 1500 nucleotides in length and is used inreconstructing the evolutionary relationships and sequence similarity ofone bacterial isolate to another using phylogenetic approaches. 16Ssequences are used for phylogenetic reconstruction as they are ingeneral highly conserved, but contain specific hypervariable regionsthat harbor sufficient nucleotide diversity to differentiate genera andspecies of most microbes.

Using well known techniques, in order to determine the full 16S sequenceor the sequence of any hypervariable region of the 16S sequence, genomicDNA is extracted from a bacterial sample, the 16S rDNA (full region orspecific hypervariable regions) amplified using polymerase chainreaction (PCR), the PCR products cleaned, and nucleotide sequencesdelineated to determine the genetic composition of 16S gene or subdomainof the gene. If full 16S sequencing is performed, the sequencing methodused may be, but is not limited to, Sanger sequencing. If one or morehypervariable regions are used, such as the V4 region, the sequencingmay be, but is not limited to being, performed using the Sanger methodor using a next-generation sequencing method, such as an IIlumina(sequencing by synthesis) method using barcoded primers allowing formultiplex reactions.

In addition to the 16S rRNA gene, one may define an OTU by sequencing aselected set of genes that are known to be marker genes for a givenspecies or taxonomic group of OTUs. These genes may alternatively beassayed using a PCR-based screening strategy. As example, variousstrains of pathogenic Escherichia coli can be distinguished using DNAsfrom the genes that encode heat-labile (LTI, LTIIa, and LTIIb) andheat-stable (STI and STII) toxins, verotoxin types 1, 2, and 2e (VT1,VT2, and VT2e, respectively), cytotoxic necrotizing factors (CNF1 andCNF2), attaching and effacing mechanisms (eaeA), enteroaggregativemechanisms (Eagg), and enteroinvasive mechanisms (Einv). The optimalgenes to utilize for taxonomic assignment of OTUs by use of marker geneswill be familiar to one with ordinary skill of the art of sequence basedtaxonomic identification and may include, but will not be limited, tohighly conserved “house-keeping” genes or a combination thereof,full-genome sequence, or partial genome sequence generated usingamplified genetic products, or whole genome sequence (WGS). Using welldefined methods DNA extracted from a bacterial sample will have specificgenomic regions amplified using PCR and sequenced to determine thenucleotide sequence of the amplified products. In the whole genomeshotgun (WGS) method, extracted DNA will be directly sequenced withoutamplification. Sequence data can be generated using any sequencingtechnology including, but not limited to Sanger, IIlumina, 454 LifeSciences, Ion Torrent, ABI, Pacific Biosciences, and/or Oxford Nanopore.

Genomic DNA Extraction

Genomic DNA is extracted from pure microbial cultures using a hotalkaline lysis method. 1 μl of microbial culture is added to 9 μl ofLysis Buffer (25 mM NaOH, 0.2 mM EDTA) and the mixture is incubated at95° C. for 30 minutes. Subsequently, the samples are cooled to 4° C. andneutralized by the addition of 10 μl of Neutralization Buffer (40 mMTris-HCl) and then diluted 10-fold in Elution Buffer (10 mM Tris-HCl).Alternatively, genomic DNA is extracted from pure microbial culturesusing commercially available kits such as the Mo Bio Ultraclean®Microbial DNA Isolation Kit (Mo Bio Laboratories, Carlsbad, Calif.) orby standard methods known to those skilled in the art.

Amplification of 16S Sequences for Downstream Sanger Sequencing

To amplify bacterial 16S rDNA (FIG. 1A), 2 μl of extracted gDNA is addedto a 20 μl final volume PCR reaction. For full-length 16 sequencing thePCR reaction also contains 1× HotMasterMix (5PRIME, Gaithersburg, Md.),250 nM of 27f (AGRGTTTGATCMTGGCTCAG (SEQ ID NO: 2033), IDT, Coralville,Iowa), and 250 nM of 1492r (TACGGYTACCTTGTTAYGACTT(SEQ ID NO: 2034),IDT, Coralville, Iowa), with PCR Water (Mo Bio Laboratories, Carlsbad,Calif.) for the balance of the volume. Alternatively, other universalbacterial primers or thermostable polymerases known to those skilled inthe art are used. For example primers are available to those skilled inthe art for the sequencing of the “V1-V9 regions” of the 16S rRNA (FIG.1A). These regions refer to the first through ninth hypervariableregions of the 16S rRNA gene that are used for genetic typing ofbacterial samples. These regions in bacteria are defined by nucleotides69-99, 137-242, 433-497, 576-682, 822-879, 986-1043, 1117-1173,1243-1294 and 1435-1465 respectively using numbering based on the E.coli system of nomenclature. Brosius et al., Complete nucleotidesequence of a 16S ribosomal RNA gene from Escherichia coli, PNAS75(10):4801-4805 (1978). In some embodiments, at least one of the V1,V2, V3, V4, V5, V6, V7, V8, and V9 regions are used to characterize anOTU. In one embodiment, the V1, V2, and V3 regions are used tocharacterize an OTU. In another embodiment, the V3, V4, and V5 regionsare used to characterize an OTU. In another embodiment, the V4 region isused to characterize an OTU. A person of ordinary skill in the art canidentify the specific hypervariable regions of a candidate 16S rRNA (inFIG. 1A) by comparing the candidate sequence in question to thereference sequence (FIG. 1B) and identifying the hypervariable regionsbased on similarity to the reference hypervariable regions.

The PCR is performed on commercially available thermocyclers such as aBioRad MyCycler™ Thermal Cycler (BioRad, Hercules, Calif.). Thereactions are run at 94° C. for 2 minutes followed by 30 cycles of 94°C. for 30 seconds, 51° C. for 30 seconds, and 68° C. for 1 minute 30seconds, followed by a 7 minute extension at 72° C. and an indefinitehold at 4° C. Following PCR, gel electrophoresis of a portion of thereaction products is used to confirm successful amplification of a ˜1.5kb product.

To remove nucleotides and oligonucleotides from the PCR products, 2 μlof HT ExoSap-IT (Affymetrix, Santa Clara, Calif.) is added to 5 μl ofPCR product followed by a 15 minute incubation at 37° C. and then a 15minute inactivation at 80° C.

Amplification of 16S Sequences for Downstream Characterization byMassively Parallel Sequencing Technologies

Amplification performed for downstream sequencing by short readtechnologies such as Illumina require amplification using primers knownto those skilled in the art that additionally include a sequence-basedbarcoded tag. As example, to amplify the 16s hypervariable region V4region of bacterial 16S rDNA, 2 μl of extracted gDNA is added to a 20 μlfinal volume PCR reaction. The PCR reaction also contains 1×HotMasterMix (5PRIME, Gaithersburg, Md.), 200 nM of V4_515f_adapt(AATGATACGGCGACCACCGAGATCTACACTATGGTAATTGTGTGCCAGCMGCCGCGGTAA (SEQ IDNO: 2035), IDT, Coralville, Iowa), and 200 nM of barcoded 806rbc(CAAGCAGAAGACGGCATACGAGAT_12pGolayBarcode_AGTCAGTCAGCCGGACTACHVGGGTWTCTAAT(SEQ ID NOS: 2036 and 2037, respectively, in order of appearance), IDT,Coralville, Iowa), with PCR Water (Mo Bio Laboratories, Carlsbad,Calif.) for the balance of the volume. These primers incorporatebarcoded adapters for Illumina sequencing by synthesis. Optionally,identical replicate, triplicate, or quadruplicate reactions may beperformed. Alternatively other universal bacterial primers orthermostable polymerases known to those skilled in the art are used toobtain different amplification and sequencing error rates as well asresults on alternative sequencing technologies.

The PCR amplification is performed on commercially availablethermocyclers such as a BioRad MyCycler™ Thermal Cycler (BioRad,Hercules, Calif.). The reactions are run at 94° C. for 3 minutesfollowed by 25 cycles of 94° C. for 45 seconds, 50° C. for 1 minute, and72° C. for 1 minute 30 seconds, followed by a 10 minute extension at 72°C. and a indefinite hold at 4° C. Following PCR, gel electrophoresis ofa portion of the reaction products is used to confirm successfulamplification of a ˜1.5 kb product. PCR cleanup is performed asspecified in the previous example.

Sanger Sequencing of Target Amplicons from Pure Homogeneous Samples

To detect nucleic acids for each sample, two sequencing reactions areperformed to generate a forward and reverse sequencing read. Forfull-length 16s sequencing primers 27f and 1492r are used. 40 ng ofExoSap-IT-cleaned PCR products are mixed with 25 pmol of sequencingprimer and Mo Bio Molecular Biology Grade Water (Mo Bio Laboratories,Carlsbad, Calif.) to 15 μl total volume. This reaction is submitted to acommercial sequencing organization such as Genewiz (South Plainfield,N.J.) for Sanger sequencing.

Massively Parallel Sequencing of Target Amplicons from HeterogeneousSamples

DNA Quantification & Library Construction. The cleaned PCR amplificationproducts are quantified using the Quant-iT™ PicoGreen® dsDNA Assay Kit(Life Technologies, Grand Island, N.Y.) according to the manufacturer'sinstructions. Following quantification, the barcoded cleaned PCRproducts are combined such that each distinct PCR product is at anequimolar ratio to create a prepared Illumina library.

Nucleic Acid Detection. The prepared library is sequenced on IlluminaHiSeq or MiSeq sequencers (Illumina, San Diego, Calif.) with clustergeneration, template hybridization, iso-thermal amplification,linearization, blocking and denaturization and hybridization of thesequencing primers performed according to the manufacturer'sinstructions. 16SV4SeqFw (TATGGTAATTGTGTGCCAGCMGCCGCGGTAA) (SEQ ID NO:2038), 16SV4SeqRev (AGTCAGTCAGCCGGACTACHVGGGTWTCTAAT) (SEQ ID NO: 2037),and 16SV4Index (ATTAGAWACCCBDGTAGTCCGGCTGACTGACT) (SEQ ID NO: 2039))(IDT, Coralville, Iowa) are used for sequencing. Other sequencingtechnologies can be used such as but not limited to 454, PacificBiosciences, Helicos, Ion Torrent, and Nanopore using protocols that arestandard to someone skilled in the art of genomic sequencing.

Example 4 Sequence Read Annotation

Primary Read Annotation

Nucleic acid sequences are analyzed and annotations are to definetaxonomic assignments using sequence similarity and phylogeneticplacement methods or a combination of the two strategies. A similarapproach can be used to annotate protein names, transcription factornames, and any other classification schema for nucleic acid sequences.Sequence similarity based methods include those familiar to individualsskilled in the art including, but not limited to BLAST, BLASTx, tBLASTn,tBLASTx, RDP-classifier, DNAclust, and various implementations of thesealgorithms such as Qiime or Mothur. These methods rely on mapping asequence read to a reference database and selecting the match with thebest score and e-value. Common databases include, but are not limited tothe Human Microbiome Project, NCBI non-redundant database, Greengenes,RDP, and Silva. Phylogenetic methods can be used in combination withsequence similarity methods to improve the calling accuracy of anannotation or taxonomic assignment. Here tree topologies and nodalstructure are used to refine the resolution of the analysis. In thisapproach we analyze nucleic acid sequences using one of numeroussequence similarity approaches and leverage phylogenetic methods thatare well known to those skilled in the art, including but not limited tomaximum likelihood phylogenetic reconstruction (see e.g. Liu K, Linder CR, and Warnow T. 2011. RAxML and FastTree: Comparing Two Methods forLarge-Scale Maximum Likelihood Phylogeny Estimation. PLoS ONE 6: e27731.McGuire G, Denham M C, and Balding D J. 2001. Models of sequenceevolution for DNA sequences containing gaps. Mol. Biol. Evol 18:481-490. Wróbel B. 2008. Statistical measures of uncertainty forbranches in phylogenetic trees inferred from molecular sequences byusing model-based methods. J. Appl. Genet. 49: 49-67.) Sequence readsare placed into a reference phylogeny comprised of appropriate referencesequences. Annotations are made based on the placement of the read inthe phylogenetic tree. The certainty or significance of the OTUannotation is defined based on the OTU's sequence similarity to areference nucleic acid sequence and the proximity of the OTU sequencerelative to one or more reference sequences in the phylogeny. As anexample, the specificity of a taxonomic assignment is defined withconfidence at the the level of Family, Genus, Species, or Strain withthe confidence determined based on the position of bootstrap supportedbranches in the reference phylogenetic tree relative to the placement ofthe OTU sequence being interrogated.

Clade Assignments

The ability of 16S-V4 OTU identification to assign an OTU as a specificspecies depends in part on the resolving power of the 16S-V4 region ofthe 16S gene for a particular species or group of species. Both thedensity of available reference 16S sequences for different regions ofthe tree as well as the inherent variability in the 16S gene betweendifferent species will determine the definitiveness of a taxonomicannotation. Given the topological nature of a phylogenetic tree and thefact that tree represents hierarchical relationships of OTUs to oneanother based on their sequence similarity and an underlyingevolutionary model, taxonomic annotations of a read can be rolled up toa higher level using a clade-based assignment procedure (Table 1). Usingthis approach, clades are defined based on the topology of aphylogenetic tree that is constructed from full-length 16S sequencesusing maximum likelihood or other phylogenetic models familiar toindividuals with ordinary skill in the art of phylogenetics. Clades areconstructed to ensure that all OTUs in a given clade are: (i) within aspecified number of bootstrap supported nodes from one another(generally, 1-5 bootstraps), and (ii) within a 5% genetic similarity.OTUs that are within the same clade can be distinguished as geneticallyand phylogenetically distinct from OTUs in a different clade based on16S-V4 sequence data. OTUs falling within the same clade areevolutionarily closely related and may or may not be distinguishablefrom one another using 16S-V4 sequence data. The power of clade basedanalysis is that members of the same clade, due to their evolutionaryrelatedness, are likely to play similar functional roles in a microbialecology such as that found in the human gut. Compositions substitutingone species with another from the same clade are likely to haveconserved ecological function and therefore are useful in the presentinvention.

Notably, 16S sequences of isolates of a given OTU are phylogeneticallyplaced within their respective clades, sometimes in conflict with themicrobiological-based assignment of species and genus that may havepreceded 16S-based assignment. Discrepancies between taxonomicassignment based on microbiological characteristics versus geneticsequencing are known to exist from the literature.

Example 5 Germinating Spores

Mixtures of bacteria can include species that are in spore form.Germinating a spore fraction increases the number of viable bacteriathat will grow on various media types. To germinate a population ofspores, the sample is moved to the anaerobic chamber, resuspended inprereduced PBS, mixed and incubated for 1 hour at 37 C to allow forgermination. Germinants can include amino-acids (e.g., alanine,glycine), sugars (e.g., fructose), nucleosides (e.g., inosine), bilesalts (e.g., cholate and taurocholate), metal cations (e.g., Mg2+,Ca2+), fatty acids, and long-chain alkyl amines (e.g., dodecylamine,Germination of bacterial spores with alkyl primary amines” J.Bacteriology, 1961.). Mixtures of these or more complex naturalmixtures, such as rumen fluid or Oxgall, can be used to inducegermination. Oxgall is dehydrated bovine bile composed of fatty acids,bile acids, inorganic salts, sulfates, bile pigments, cholesterol,mucin, lecithin, glycuronic acids, porphyrins, and urea. The germinationcan also be performed in a growth medium like prereduced BHIS/oxgallgermination medium, in which BHIS (Brain heart infusion powder (37 g/L),yeast extract (5 g/L), L-cysteine HCl (1 g/L)) provides peptides, aminoacids, inorganic ions and sugars in the complex BHI and yeast extractmixtures and Oxgall provides additional bile acid germinants.

In addition, pressure may be used to germinate spores. The selection ofgerminants can vary with the microbe being sought. Different speciesrequire different germinants and different isolates of the same speciescan require different germinants for optimal germination. Finally, it isimportant to dilute the mixture prior to plating because some germinantsare inhibitory to growth of the vegetative-state microorganisms. Forinstance, it has been shown that alkyl amines must be neutralized withanionic lipophiles in order to promote optimal growth. Bile acids canalso inhibit growth of some organisms despite promoting theirgermination, and must be diluted away prior to plating for viable cells.

For example, BHIS/oxgall solution is used as a germinant and contains0.5× BHIS medium with 0.25% oxgall (dehydrated bovine bile) where 1×BHIS medium contains the following per L of solution: 6 g Brain HeartInfusion from solids, 7 g peptic digest of animal tissue, 14.5 g ofpancreatic digest of casein, 5 g of yeast extract, 5 g sodium chloride,2 g glucose, 2.5 g disodium phosphate, and 1 g cysteine. Additionally,Ca-DPA is a germinant and contains 40 mM CaCl2, and 40 mM dipicolinicacid (DPA). Rumen fluid (Bar Diamond, Inc.) is also a germinant.Simulated gastric fluid (Ricca Chemical) is a germinant and is 0.2%(w/v) Sodium Chloride in 0.7% (v/v) Hydrochloric Acid. Mucin medium is agerminant and prepared by adding the following items to 1 L of distilledsterile water: 0.4 g KH₂PO₄, 0.53 g Na₂HPO₄, 0.3 g NH₄Cl, 0.3 g NaCl,0.1 g MgCl₂×6H₂O, 0.11 g CaCl₂, 1 ml alkaline trace element solution, 1ml acid trace element solution, 1 ml vitamin solution, 0.5 mg resazurin,4 g NaHCO₃, 0.25 g Na₂S×9 H₂O. The trace element and vitamin solutionsprepared as described previously (Stams et al., 1993). All compoundswere autoclaved, except the vitamins, which were filter-sterilized. Thebasal medium was supplemented with 0.7% (v/v) clarified, sterile rumenfluid and 0.25% (v/v) commercial hog gastric mucin (Type III; Sigma),purified by ethanol precipitation as described previously (Miller &Hoskins, 1981). This medium is referred herein as mucin medium.

Fetal Bovine Serum (Gibco) can be used as a germinant and contains 5%FBS heat inactivated, in Phosphate Buffered Saline (PBS, FisherScientific) containing 0.137M Sodium Chloride, 0.0027M PotassiumChloride, 0.0119M Phosphate Buffer. Thioglycollate is a germinant asdescribed previously (Kamiya et al Journal of Medical Microbiology 1989)and contains 0.25M (pH 10) sodium thioglycollate. Dodecylamine solutioncontaining 1 mM dodecylamine in PBS is a germinant. A sugar solution canbe used as a germinant and contains 0.2% fructose, 0.2% glucose, and0.2% mannitol. Amino acid solution can also be used as a germinant andcontains 5 mM alanine, 1 mM arginine, 1 mM histidine, 1 mM lysine, 1 mMproline, 1 mM asparagine, 1 mM aspartic acid, 1 mM phenylalanine. Agerminant mixture referred to herein as Germix 3 can be a germinant andcontains 5 mM alanine, 1 mM arginine, 1 mM histidine, 1 mM lysine, 1 mMproline, 1 mM asparagine, 1 mM aspartic acid, 1 mM phenylalanine, 0.2%taurocholate, 0.2% fructose, 0.2% mannitol, 0.2% glucose, 1 mM inosine,2.5 mM Ca-DPA, and 5 mM KCl. BHIS medium+DPA is a germinant mixture andcontains BHIS medium and 2 mM Ca-DPA. Escherichia coli spent mediumsupernatant referred to herein as EcSN is a germinant and is prepared bygrowing E. coli MG1655 in SweetB/Fos inulin medium anaerobically for 48hr, spinning down cells at 20,000 rcf for 20 minutes, collecting thesupernatant and heating to 60 C for 40 min. Finally, the solution isfilter sterilized and used as a germinant solution.

Example 6 Selection of Media for Growth

It is important to select appropriate media to support growth, includingpreferred carbon sources. For example, some organisms prefer complexsugars such as cellobiose over simple sugars. Examples of media used inthe isolation of sporulating organisms include EYA, BHI, BHIS, and GAM(see below for complete names and references). Multiple dilutions areplated out to ensure that some plates will have well isolated colonieson them for analysis, or alternatively plates with dense colonies mayscraped and suspended in PBS to generate a mixed diverse community.

Plates are incubated anaerobically or aerobically at 37° C. for 48-72 ormore hours, targeting anaerobic or aerobic spore formers, respectively.

Solid plate media include:

-   -   Gifu Anaerobic Medium (GAM, Nissui) without dextrose        supplemented with fructooligosaccharides/inulin (0.4%), mannitol        (0.4%), inulin (0.4%), or fructose (0.4%), or a combination        thereof.    -   Sweet GAM [Gifu Anaerobic Medium (GAM, Nissui)] modified,        supplemented with glucose, cellobiose, maltose, L-arabinose,        fructose, fructooligosaccharides/inulin, mannitol and sodium        lactate)    -   Brucella Blood Agar (BBA, Atlas, Handbook of Microbiological        Media, 4th ed, ASM Press, 2010)    -   PEA sheep blood (Anaerobe Systems; 5% Sheep Blood Agar with        Phenylethyl Alcohol)    -   Egg Yolk Agar (EYA) (Atlas, Handbook of Microbiological Media,        4th ed, ASM Press, 2010)    -   Sulfite polymyxin milk agar (Mevissen-Verhage et al., J. Clin.        Microbiol. 25:285-289 (1987))    -   Mucin agar (Derrien et al., IJSEM 54: 1469-1476 (2004))    -   Polygalacturonate agar (Jensen & Canale-Parola, Appl. Environ.        Microbiol. 52:880-997 (1986))    -   M2GSC (Atlas, Handbook of Microbiological Media, 4th ed, ASM        Press, 2010)    -   M2 agar (Atlas, Handbook of Microbiological Media, 4th ed, ASM        Press, 2010) supplemented with starch (1%), mannitol (0.4%),        lactate (1.5 g/L) or lactose (0.4%)    -   Sweet B-Brain Heart Infusion agar (Atlas, Handbook of        Microbiological Media, 4th ed, ASM Press, 2010) supplemented        with yeast extract (0.5%), hemin, cysteine (0.1%), maltose        (0.1%), cellobiose (0.1%), soluble starch (sigma, 1%), MOPS (50        mM, pH 7).    -   PY-salicin (peptone-yeast extract agar supplemented with        salicin) (Atlas, Handbook of Microbiological Media, 4th ed, ASM        Press, 2010).    -   Modified Brain Heart Infusion (M-BHI) [[sweet and sour]]        contains the following per L: 37.5 g Brain Heart Infusion powder        (Remel), 5 g yeast extract, 2.2 g meat extract, 1.2 g liver        extract, 1 g cysteine HCl, 0.3 g sodium thioglycolate, 10 mg hem        in, 2 g soluble starch, 2 g FOS/Inulin, 1 g cellobiose, 1 g        L-arabinose, 1 g mannitol, 1 Na-lactate, 1 mL TWEEN® 80, 0.6 g        MgSO4×7H2O, 0.6 g CaCl2, 6 g (NH4)2SO4, 3 g KH2PO4, 0.5 g        K2HPO4, 33 mM Acetic acid, 9 mM propionic acid, 1 mM Isobutyric        acid, 1 mM isovaleric acid, 15 g agar, and after autoclaving add        50 mL of 8% NaHCO3 solution and 50 mL 1M MOPS-KOH (pH 7).    -   Noack-Blaut Eubacterium agar (See Noack et al. J. Nutr. (1998)        128:1385-1391)    -   BHIS az1/ge2-BHIS az/ge agar (Reeves et. al. Infect. Immun.        80:3786-3794 (2012)) [Brain Heart Infusion agar (Atlas, Handbook        of Microbiological Media, 4th ed, ASM Press, 2010) supplemented        with yeast extract 0.5%, cysteine 0.1%, 0.1% cellobiose, 0.1%        inulin, 0.1% maltose, aztreonam 1 mg/L, gentamycin 2 mg/L]    -   BHIS CInM az1/ge2-BHIS CInM [Brain Heart Infusion agar (Atlas,        Handbook of Microbiological Media, 4th ed, ASM Press, 2010)        supplemented with yeast extract 0.5%, cysteine 0.1%, 0.1%        cellobiose, 0.1% inulin, 0.1% maltose, aztreonam 1 mg/L,        gentamycin 2 mg/L]

Example 7 The Purification and Isolation of a Spore Forming Fractionfrom Feces

To purify and selectively isolate efficacious spores from fecal materiala donation is first blended with saline using a homogenization device(e.g., laboratory blender) to produce a 20% slurry (w/v). 100% ethanolis added for an inactivation treatment that lasts 10 seconds to 1 hour.The final alcohol concentration can range from 30-90%, preferably50-70%. High speed centrifugation (3200 rcf for 10 min) is performed toremove solvent and the pellet is retained and washed. Subsequently, oncethe washed pellet is resuspended, a low speed centrifugation step (200rcf for 4 min) is performed to remove large particulate vegetativematter and the supernatant containing the spores is retained. High speedcentrifugation (3200 rcf for 10 min) is performed on the supernatant toconcentrate the spore material. The pellet is then washed andresuspended to generate a 20% slurry. This is the ethanol treated sporepreparation. The concentrated slurry is then separated with a densitybased gradient e.g. a CsCl gradient, sucrose gradient or combination ofthe two generating a ethanol treated, gradient-purified sporepreparation. For example, a CsCl gradient is performed by loading a 20%volume of spore suspension on top a 80% volume of a stepwise CsClgradient (w/v) containing the steps of 64%, 50%, 40% CsCl (w/v) andcentrifuging for 20 min at 3200 rcf. The spore fraction is then run on asucrose step gradient with steps of 67%, 50%, 40%, and 30% (w/v). Whencentrifuged in a swinging bucket rotor for 10 min at 3200 rcf. Thespores run roughly in the 30% and 40% sucrose fractions. The lower sporefraction (FIG. 2) is then removed and washed to produce a concentratedethanol treated, gradient-purified spore preparation. Taking advantageof the refractive properties of spores observed by phase contrastmicroscopy (spores are bright and refractive while germinated spores andvegetative cells are dark) one can see an enrichment of the sporefraction from a fecal bacterial cell suspension (FIG. 3, left) comparedto an ethanol treated, CsCl gradient purified, spore preparation (FIG.3, center), and to an ethanol treated, CsCl gradient purified, sucrosegradient purified, spore preparation (FIG. 3, right).

Furthermore, growth of spores after treatment with a germinant can alsobe used to quantify a viable spore population. Briefly, samples wereincubated with a germinant (Oxgall, 0.25% for up to 1 hour), diluted andplated anaerobically on BBA (Brucella Blood Agar) or similar media (e.g.see Examples 5 and 6). Individual colonies were picked and DNA isolatedfor full-length 16S sequencing to identify the species composition (e.g.see Examples 3 and 4). Analysis revealed that 22 species were observedin total (Table 4) with a vast majority present in both the materialpurified with the gradient and without the gradient, indicating no orinconsequential shift in the ecology as a result of gradientpurification. Spore yield calculations demonstrate an efficient recoveryof 38% of the spores from the initial fecal material as measured bygermination and plating of spores on BBA or measuring DPA count in thesample.

Example 8 Bacterial Compositions Prevent C. difficile Infection in aMouse Model

To test the therapeutic potential of the bacterial composition such asbut not limited to a spore population, a prophylactic mouse model of C.difficile infection (model based on Chen, et al., A mouse model ofClostridium difficile associated disease, Gastroenterology135(6):1984-1992) was used. Two cages of five mice each were tested foreach arm of the experiment. All mice received an antibiotic cocktailconsisting of 10% glucose, kanamycin (0.5 mg/ml), gentamicin (0.044mg/ml), colistin (1062.5 U/ml), metronidazole (0.269 mg/ml),ciprofloxacin (0.156 mg/ml), ampicillin (0.1 mg/ml) and Vancomycin(0.056 mg/ml) in their drinking water on days −14 through −5 and a doseof 10 mg/kg Clindamycin by oral gavage on day −3. On day −1, theyreceived either the test article or vehicle control via oral gavage. Onday 0 they were challenged by administration of approximately 4.5 log 10cfu of C. difficile (ATCC 43255) via oral gavage. Optionally a positivecontrol group received vancomycin from day −1 through day 3 in additionto the antibiotic protocol and C. difficile challenge specified above.Feces were collected from the cages for analysis of bacterial carriage,mortality was assessed every day from day 0 to day 6 and the weight andsubsequent weight change of the animal was assessed with weight lossbeing associated with C. difficile infection. Mortality and reducedweight loss of the test article compared to the vehicle were used toassess the success of the test article. Additionally, a C. difficilesymptom scoring was performed each day from day −1 through day 6.Clinical Score was based on a 0-4 scale by combining scores forAppearance (0-2 pts based on normal, hunched, piloerection, orlethargic), and Clinical Signs (0-2 points based on normal, wet tail,cold-to-the-touch, or isolation from other animals).

In a naive control arm, animals were challenged with C. difficile. Inthe vancomycin positive control arm animals were dosed with C. difficileand treated with vancomycin from day −1 through day 3. The negativecontrol was gavaged with PBS alone and no bacteria. The test arms of theexperiment tested 1×, 0.1×, 0.01× dilutions derived from a single donorpreparation of ethanol treated spores (e.g. see Example 7) or the heattreated feces prepared by treating a 20% slurry for 30 min at 80 C.Dosing for CFU counts was determined from the final ethanol treatedspores and dilutions of total spores were administered at 1×, 0.1×,0.01× of the spore mixture for the ethanol treated fraction and a 1×dose for the heat treated fraction.

Weight loss and mortality were assessed on day 3. The negative control,treated with C. difficile only, exhibits 20% mortality and weight losson Day 3, while the positive control of 10% human fecal suspensiondisplays no mortality or weight loss on Day 3 (Table 5). EtOH-treatedfeces prevents mortality and weight loss at three dilutions, while theheat-treated fraction was protective at the only dose tested. These dataindicate that the spore fraction is efficacious in preventing C.difficile infection in the mouse.

Example 9 The Prophylactic and Relapse Prevention Hamster Models

Previous studies with hamsters using toxigenic and nontoxigenic strainsof C. difficile demonstrated the utility of the hamster model inexamining relapse post antibiotic treatment and the effects ofprophylaxis treatments with cecal flora in C. difficile infection(Wilson et al. 1981, Wilson et al. 1983, Borriello et al. 1985) and morebroadly gastrointestinal infectious disease. To demonstrate prophylacticuse of a bacterial composition such as but not limited to a sporepopulation, spore preparation, vegetative cell population, to ameliorateC. difficile infection, the following hamster model is used. In aprophylactic model, Clindamycin (10 mg/kg s.c.) is given on day −5, thebacterial composition or control is administered on day −3, and C.difficile challenge occurs on day 0. In the positive control arm,vancomycin is then administered on day 1-5 (and vehicle control isdelivered on day −3). Feces are collected on day −5, −4, −1, 1, 3, 5, 7,9 and fecal samples are assessed for pathogen carriage and reduction bymicrobiological methods, 16S sequencing approaches or other methodsutilized by one skilled in the art. Mortality is assessed throughout theexperiment through 21 days post C. difficile challenge. The percentagesurvival curves show that ethanol treated spores and ethanol treated,gradient-purified spores better protect the hamsters compared to theVancomycin control, and vehicle control.

FIG. 4 shows prophylaxis model with the ethanol treated sporepreparation and the ethanol treated, gradient-purified sporepreparation.

In the relapse prevention model, hamsters are challenged with toxigenicC. difficile strains on day 0, and treated with clindamycin by oralgavage on day 1, and vancomycin dosing day 2-6. Test or controltreatment was then administered on day 7, 8, and 9. The groups ofhamsters for each arm consist of 8 hamsters per group. Fecal material iscollected on day −1, 1, 3, 5, 7, 10 and 13 and hamster mortality isassessed throughout. Survival curves are used to assess the success ofthe test article e.g. ethanol treated or ethanol treated, gradientpurified spores versus the control treatment in preventing hamsterdeath. The survival curves demonstrate maximum efficacy for the ethanoltreated, gradient-purified spores followed by the ethanol treatedspores. Both treatments improved survival percentage over vancomycintreatment alone.

FIG. 5 shows relapse prevention model with ethanol treated spores andethanol treated, gradient purified spores

Example 10 Clinical Treatment of Recurrent C. difficile in Patients

To assess the efficacy of test articles like bacterial compositionsincluding but not limited to a ethanol treated spore preparations (e.g.see Example 7) to treat recurrent C. difficile in human patients, thefollowing procedure was performed to take feces from a healthy donor,inactivate via the ethanol treated spore preparation protocol describedbelow, and treat recurrent C. difficile in patients presenting with thisindication. Non-related donors were screened for general health historyfor absence of chronic medical conditions (including inflammatory boweldisease; irritable bowel syndrome; Celiac disease; or any history ofgastrointestinal malignancy or polyposis), absence of risk factors fortransmissible infections, antibiotic non-use in the previous 6 months,and negative results in laboratory assays for blood-borne pathogens(HIV, HTLV, HCV, HBV, CMV, HAV and Treponema pallidum) and fecalbacterial pathogens (Salmonella, Shigella, Yersinia, Campylobacter, E.coli 0157), ova and parasites, and other infectious agents (Giardia,Cryptosporidium Cyclospora, Isospora) prior to stool donation.

Donor stool was frozen shortly after donation and sampled for testing.At the time of use, approximately 75 g of donor stool was thawed andresuspended in 500 mL of non-bacteriostatic normal saline and mixed in asingle use glass or plastic blender. The resulting slurry wassequentially passed through sterile, disposable mesh screens that removeparticles of size 600, 300 and 200 microns. The slurry was thencentrifuged briefly (200 rcf for 4 min) to separate fibrous andparticulate materials, and the supernatant (containing bacterial cellsand spores) was transferred to a fresh container. Ethanol was added to afinal concentration of 50% and the resulting ˜1500 ml slurry wasincubated at room temperature for 1 hr with continuous mixing toinactivate vegetative bacterial cells. Midway through inactivation theslurry was transferred to a new bottle to ensure complete contact withthe ethanol. The solid matter was pelleted in a centrifuge and washed 3times with normal saline to remove residual ethanol. The final pelletwas resuspended in 100% sterile, USP glycerol at a minimum volume, andfilled into approximately 30 size 0 delayed release capsules(hypromellose DRcaps, Capsugel, Inc.) at 0.65 mL suspension each. Thecapsules were immediately capped and placed onto an aluminum freezingblock held at −80° C. via dry ice to freeze. The frozen capsules were inturn over-capsulated with size 00 DRcaps to enhance capsule stability,labeled, and placed into <−65° C. storage immediately. The final productwas stored at <−65° C. until the day and time of use. Encapsulatedproduct may be stored for indefinitely at <−65° C. On the day of dosingcapsules were warmed on wet ice for 1 to 2 hours to improvetolerability, and were then dosed with water ad libitum.

Patient 1 is a 45-year old woman with a history of C. difficileinfection and diarrhea for at least 1 year prior to treatment. She hasbeen previously treated with multiple courses of antibiotics followedeach time by recurrence of C. difficile-associated diarrhea.

Patient 2 is an 81-year old female who has experienced recurrent C.difficile infection for 6 months prior to treatment despite adequateantibiotic therapy following each recurrence.

24 hours prior to starting oral treatment, CDAD antibiotic therapy wasdiscontinued. Each patient received a colon preparation procedureintended to reduce the competing microbial burden in thegastrointestinal tract and to facilitate repopulation by the sporeforming organisms in the investigational product.

On the morning of the first treatment day, the patients received a doseof delayed release capsules containing the investigational product withwater ad libitum. Patients were requested to avoid food for 1 hourthereafter. The next day, the patient returned to the clinic to receivean additional dose. Patients were asked to avoid food for 4 hours priorto receiving their second dose and for 1 hour following dosing.

Both patients were followed closely for evidence of relapse or adversesymptoms following treatment. Patients were contacted by phone on Day 2,Day 4, and Weeks 1, 2 and 4 and each was queried about her generalstatus and the condition of her CDAD and related symptoms. Stool sampleswere collected at baseline and Weeks 1, 2, 4 and 8 post-treatment toassess changes in the gut microbiota via 16S sequencing and spore countwith methods explained previously (e.g. see Examples AAAB and AAAC).Through 4 weeks post treatment, each patient has gradually improved withno evidence of C. difficile recurrence.

Six other patients with recurrent C. difficile-associated diarrhea weretreated in a similar fashion, with no CDI recurrence and no requirementfor resumption of antibiotics (total of 8 patients). Additionally, therewere no treatment-related serious adverse events.

The above protocol could be modified to deliver other bacterialcompositions e.g. vegetative cells, spore preparations, combinationsthereof.

Example 11 Enrichment and Purification of Bacteria

To purify individual bacterial strains, dilution plates were selected inwhich the density enables distinct separation of single colonies.Colonies were picked with a sterile implement (either a sterile loop ortoothpick) and re-streaked to BBA or other solid media. Plates wereincubated at 37° C. for 3-7 days. One or more well-isolated singlecolonies of the major morphology type were re-streaked. This process wasrepeated at least three times until a single, stable colony morphologyis observed. The isolated microbe was then cultured anaerobically inliquid media for 24 hours or longer to obtain a pure culture of 10⁶-10¹⁰cfu/ml. Liquid growth medium might include Brain Heart Infusion-basedmedium (Atlas, Handbook of Microbiological Media, 4th ed, ASM Press,2010) supplemented with yeast extract, hemin, cysteine, andcarbohydrates (for example, maltose, cellobiose, soluble starch) orother media described previously (e.g. see example 6). The culture wascentrifuged at 10,000×g for 5 min to pellet the bacteria, the spentculture media was removed, and the bacteria were resuspended in sterilePBS. Sterile 75% glycerol was added to a final concentration of 20%. Analiquot of glycerol stock was titered by serial dilution and plating.The remainder of the stock was frozen on dry ice for 10-15 min and thenplaced at −80 C for long term storage.

Example 12 Cell Bank Preparation

Cell banks (RCBs) of bacterial strains were prepared as follows.Bacterial strains were struck from −80° C. frozen glycerol stocks toBrucella blood agar with Hemin or Vitamin K (Atlas, Handbook ofMicrobiological Media, 4th ed, ASM Press, 2010), M2GSC (Atlas, Handbookof Microbiological Media, 4th ed, ASM Press, 2010) or other solid growthmedia and incubated for 24 to 48 h at 37° C. in an anaerobic chamberwith a gas mixture of H₂:CO₂:N₂ of 10:10:80. Single colonies were thenpicked and used to inoculate 250 ml to 1 L of Wilkins-Chalgren broth,Brain-Heart Infusion broth, M2GSC broth or other growth media, and grownto mid to late exponential phase or into the stationary phase of growth.Alternatively, the single colonies may be used to inoculate a pilotculture of 10 ml, which were then used to inoculate a large volumeculture. The growth media and the growth phase at harvest were selectedto enhance cell titer, sporulation (if desired) and phenotypes thatmight be associated desired in vitro or in vivo. Optionally, Cultureswere grown static or shaking, depending which yielded maximal celltiter. The cultures were then concentrated 10 fold or more bycentrifugation at 5000 rpm for 20 min, and resuspended in sterilephosphate buffered saline (PBS) plus 15% glycerol. 1 ml aliquots weretransferred into 1.8 ml cryovials which were then frozen on dry ice andstored at −80 C. The identity of a given cell bank was confirmed by PCRamplification of the 16S rDNA gene, followed by Sanger direct cyclesequencing, and comparison to a curated rDNA database to determine ataxonomic ID. Each bank was confirmed to yield colonies of a singlemorphology upon streaking to Brucella blood agar or M2GSC agar. Whenmore than one morphology was observed, colonies were confirmed to be theexpected species by PCR and sequencing analysis of the 16S rDNA gene.Variant colony morphologies can be observed within pure cultures, and ina variety of bacteria the mechanisms of varying colony morphologies havebeen well described (van der Woude, Clinical Microbiology Reviews,17:518, 2004), including in Clostridium species (Wadsworth-KTL AnaerobicBacteriology Manual, 6th Ed, Jousimie-Somer, et al 2002). For obligateanaerobes, RCBs were confirmed to lack aerobic colony forming units at alimit of detection of 10 cfu/ml.

Example 13 Titer Determination

The number of viable cells per ml was determined on the freshlyharvested, washed and concentrated culture by plating serial dilutionsof the RCB to Brucella blood agar or other solid media, and varied from106 to 1010 cfu/ml. The impact of freezing on viability was determinedby titering the banks after one or two freeze-thaw cycles on dry ice orat −80° C., followed by thawing in an anaerobic chamber at roomtemperature. Some strains displayed a 1-3 log drop in viable cfu/mlafter the 1st and/or 2nd freeze thaw, while the viability of others wereunaffected.

Example 14 Preparation of Bacterial Compositions

Individual strains were typically thawed on ice and combined in ananaerobic chamber to create mixtures, followed by a second freeze at−80° C. to preserve the mixed samples. When making combinations ofstrains for in vitro or in vivo assays, the cfu in the final mixture wasestimated based on the second freeze-thaw titer of the individualstrains. For experiments in rodents, strains may be combined at equalcounts in order to deliver between 1e4 and 1e10 per strain.Additionally, some bacteria may not grow to sufficient titer to yieldcell banks that allowed the production of compositions where allbacteria were present at 1e10.

Example 15 Provision of Gut Microbiome Sample Material

For sourcing of microbial cultures and for use as a positive control inin vivo studies, fresh gut microbiome samples, e.g. fecal samples, wereobtained from healthy human donors who have been screened for generalgood health and for the absence of infectious diseases, and meetinclusion and exclusion criteria, inclusion criteria include being ingood general health, without significant medical history, physicalexamination findings, or clinical laboratory abnormalities, regularbowel movements with stool appearance typically Type 2, 3, 4, 5 or 6 onthe Bristol Stool Scale, and having a BMI ≥18 kg/m² and ≤25 kg/m².Exclusion criteria generally included significant chronic or acutemedical conditions including renal, hepatic, pulmonary,gastrointestinal, cardiovascular, genitourinary, endocrine, immunologic,metabolic, neurologic or hematological disease, a family history of,inflammatory bowel disease including Crohn's disease and ulcerativecolitis, Irritable bowel syndrome, colon, stomach or othergastrointestinal malignancies, or gastrointestinal polyposis syndromes,or recent use of yogurt or commercial probiotic materials in which anorganism(s) is a primary component. Samples were collected directlyusing a commode specimen collection system, which contains a plasticsupport placed on the toilet seat and a collection container that restson the support. Gut microbiome samples e.g. feces were deposited intothe container, and the lid was then placed on the container and sealedtightly. The sample was then delivered on ice within 1-4 hours forprocessing. Samples were mixed with a sterile disposable tool, and 2-4 galiquots were weighed and placed into tubes and flash frozen in a dryice/ethanol bath. Aliquots are frozen at −80 degrees Celsius until use.

Optionally, the microbiome sample was suspended in a solution, and/orfibrous and/or particulate materials were removed. A frozen aliquotcontaining a known weight of sample was removed from storage at −80degrees Celsius and allowed to thaw at room temperature. Sterile 1× PBSwas added to create a 10% w/v suspension, and vigorous vortexing wasperformed to suspend the sample until the material appeared homogeneous.The sample was then left to sit for 10 minutes at room temperature tosediment fibrous and particulate matter. The suspension above thesediment was then carefully removed into a new tube and contains apurified spore population. Optionally, the suspension was thencentrifuged at a low speed, e.g., 1000×g, for 5 minutes to pelletparticulate matter including fibers. The pellet was discarded and thesupernatant, which contained vegetative organisms and spores, wasremoved into a new tube. The supernatant was then centrifuged at 6000×gfor 10 minutes to pellet the vegetative organisms and spores. The pelletwas then resuspended in 1× PBS with vigorous vortexing until the samplematerial appears homogenous.

Example 16 Quantification of Spore Concentrations Using DPA Assay

Methods to assess spore concentration in complex mixtures typicallyrequire the separation and selection of spores and subsequent growth ofindividual species to determine the colony forming units. The art doesnot teach how to quantitatively germinate all the spores in a complexmixture as there are many species for which appropriate germinants havenot been identified. Furthermore, sporulation is thought to be astochastic process as a result of evolutionary selection, meaning thatnot all spores from a single species germinate with same response togerminant concentration, time and other environmental conditions.Alternatively, a key metabolite of bacterial spores, dipicolinic acid(DPA) has been developed to quantify spores particles in a sample andavoid interference from fecal contaminants. The assay utilizes the factthat DPA chelates Terbium 3+ to form a luminescent complex (Fichtel etal, FEMS Microbiology Ecology, 2007; Kort et al, Applied andEnvironmental Microbiology, 2005; Shafaat and Ponce, Applied andEnvironmental Microbiology, 2006; Yang and Ponce, International Journalof Food Microbiology, 2009; Hindle and Hall, Analyst, 1999). Atime-resolved fluorescence assay detects terbium luminescence in thepresence of DPA giving a quantitative measurement of DPA concentrationin a solution.

To perform the assay 1 mL of the spore standard to be measured wastransferred to a 2 mL microcentrifuge tube. The samples were centrifugedat 13000 RCF for 10 min and the sample is washed in 1 mL steriledeionized H₂O. Wash an additional time by repeating the centrifugation.Transfer the 1 mL solution to hungate tubes and autoclave samples on asteam cycle for 30 min at 250 C. Add 100 uL of 30 uM TbCl₃ solution (400mM sodium acetate, pH 5.0, 30 μM TbCl₃) to the sample. Make serialdilutions of of the autoclaved material and measure the fluorescence ofeach sample by exciting with 275 nm light and measuring the emissionwavelength of 543 nm for an integration time of 1.25 ms and a 0.1 msdelay.

Purified spores are produced as described previously (e.g. seewww.epa.gov/pesticides/methods/MB-28-00.pdf). Serial dilutions ofpurified spores from C. bifermentans, C. sporogenes, and C. butyricumcultures were prepared and measured by plating on BBA media andincubating overnight at 37 C to determine CFU/ml. FIG. 6 shows thelinear correspondence across different spore producing bacteria acrossseveral logs demonstrating the DPA assay as means to assess sporecontent (linear range of DPA assay compared to CFU counts/ml).

The discrepancy for complex spore populations between spore countsmeasured by germinable spore CFU and by DPA has important implicationsfor determining the potency of an ethanol treated spore preparation forclinical use. Table 6 shows spore content data from 3 different ethanoltreated spore preparations used to successfully treat 3 patientssuffering from recurrent C. difficile infection. The spore content ofeach spore preparation is characterized using the two described methods.

What is immediately apparent is that spore content varies greatly per 30capsules. As measured by germinable SCFU, spore content varies bygreater than 10,000-fold. As measured by DPA, spore content varies bygreater than 100-fold. In the absence of the DPA assay, it would bedifficult to set a minimum dose for administration to a patient. Forinstance, without data from the DPA assay, one would conclude that aminimum effective dose of spores is 4×105 or less using the SCFU assay(e.g. Preparation 1, Table 7). If that SCFU dose was used to normalizedosing in a clinical setting, however, then the actual spore doses givento patients would be much lower for other ethanol treated sporepreparations as measured as by the DPA assay (Table 7).

It becomes immediately obvious from the variability of SCFU and DPAcounts across various donations that using SCFU as the measure ofpotency would lead to significant underdosing in certain cases. Forinstance, setting a dose specification of 4×10⁵ SCFU (the apparenteffective dose from donor Preparation 1) for product Preparation 3 wouldlead to a potential underdosing of more than 100-fold. This can berectified only by setting potency specifications based on the DPA assaywhich better reflects total spore counts in an ethanol treated sporepreparation. The unexpected finding of this work is that the DPA assayis uniquely suited to set potency and determine dosing for an ethanoltreated spore preparation.

Example 17 Identification of Keystone OTUs and Functions

The human body is an ecosystem in which the microbiota, and themicrobiome, play a significant role in the basic healthy function ofhuman systems (e.g. metabolic, immunological, and neurological). Themicrobiota and resulting microbiome comprise an ecology ofmicroorganisms that co-exist within single subjects interacting with oneanother and their host (i.e., the mammalian subject) to form a dynamicunit with inherent biodiversity and functional characteristics. Withinthese networks of interacting microbes (i.e. ecologies), particularmembers can contribute more significantly than others; as such thesemembers are also found in many different ecologies, and the loss ofthese microbes from the ecology can have a significant impact on thefunctional capabilities of the specific ecology. Robert Paine coined theconcept “Keystone Species” in 1969 (see Paine R T. 1969. A note ontrophic complexity and community stability. The American Naturalist 103:91-93.) to describe the existence of such lynchpin species that areintegral to a given ecosystem regardless of their abundance in theecological community. Paine originally describe the role of the starfishPisaster ochraceus in marine systems and since the concept has beenexperimentally validated in numerous ecosystems.

Keystone OTUs and/or Functions are computationally-derived by analysisof network ecologies elucidated from a defined set of samples that sharea specific phenotype. Keystone OTUs and/or Functions are defined as allNodes within a defined set of networks that meet two or more of thefollowing criteria. Using Criterion 1, the node is frequently observedin networks, and the networks in which the node is observed are found ina large number of individual subjects; the frequency of occurrence ofthese Nodes in networks and the pervasiveness of the networks inindividuals indicates these Nodes perform an important biologicalfunction in many individuals. Using Criterion 2, the node is frequentlyobserved in networks, and each the networks in which the node isobserved contain a large number of Nodes—these Nodes are thus“super-connectors”, meaning that they form a nucleus of a majority ofnetworks and as such have high biological significance with respect totheir functional contributions to a given ecology. Using Criterion 3,the node is found in networks containing a large number of Nodes (i.e.they are large networks), and the networks in which the node is foundoccur in a large number of subjects; these networks are potentially ofhigh interest as it is unlikely that large networks occurring in manyindividuals would occur by chance alone strongly suggesting biologicalrelevance. Optionally, the required thresholds for the frequency atwhich a node is observed in network ecologies, the frequency at which agiven network is observed across subject samples, and the size of agiven network to be considered a Keystone node are defined by the 50th,70th, 80th, or 90th percentiles of the distribution of these variables.Optionally, the required thresholds are defined by the value for a givenvariable that is significantly different from the mean or median valuefor a given variable using standard parametric or non-parametricmeasures of statistical significance. In another embodiment a Keystonenode is defined as one that occurs in a sample phenotype of interestsuch as but not limited to “health” and simultaneously does not occur ina sample phenotype that is not of interest such as but not limited to“disease.” Optionally, a Keystone Node is defined as one that is shownto be significantly different from what is observed using permuted testdatasets to measure significance.

Example 18 Prophylactic Use and Treatment in a Mouse Model of VancomycinResistant Enterococcus (VRE) Colonization

The emergence and spread of highly antibiotic-resistant bacteriarepresent a major clinical challenge (Snitkin et al ScienceTranslational Medicine, 2012). In recent years, the numbers ofinfections caused by organisms such as methicillin-resistantStaphylococcus aureus, carbapenem-resistant Enterobacteriaceae,vancomycin-resistant Enterococcus (VRE), and Clostridium difficile haveincreased markedly, and many of these strains are acquiring resistanceto the few remaining active antibiotics. Most infections produced byhighly antibiotic-resistant bacteria are acquired duringhospitalizations, and preventing patient-to-patient transmission ofthese pathogens is one of the major challenges confronting hospitals andclinics. Most highly antibiotic-resistant bacterial strains belong togenera that colonize mucosal surfaces, usually at low densities. Thehighly complex microbiota that normally colonizes mucosal surfacesinhibits expansion of and domination by bacteria such asEnterobacteriaceae and Enterococcaceae. Destruction of the normal floraby antibiotic administration, however, disinhibitionantibiotic-resistant members of these bacterial families, leading totheir expansion to very high densities (Ubeda et al Journal of ClinicalInvestigation 2010). High-density colonization by these organisms can becalamitous for the susceptible patient, resulting in bacteremia andsepsis (Taur et al, Clinical Infectious Disease, 2012).

To test prophylactic use and treatment of a bacterial composition testarticle, a VRE infection mouse model is used as previously described(Ubeda et al, Infectious Immunity 2013, Ubeda et al, Journal of clinicalinvestigation, 2010). Briefly, experiments are done with 7-week-oldC57BL/6J female mice purchased from Jackson Laboratory, housed withirradiated food, and provided with acidified water. Mice areindividually housed to avoid contamination between mice due tocoprophagia. For experimental infections with VRE, mice are treated withampicillin (0.5 g/liter) in their drinking water, which is changed every3 days.

In the treatment model, on day 1, mice are infected by means of oralgavage with 108 CFU of the vancomycin-resistant Enterococcus faeciumstrain purchased from ATCC (ATCC 700221). One day after infection (day1), antibiotic treatment is stopped and VRE levels are determined atdifferent time points by plating serial dilutions of fecal pellets onEnterococcosel agar plates (Difco) with vancomycin (8 ug/ml; Sigma). VREcolonies are identified by appearance and confirmed by Gram staining orother methods previously described (e.g. see examples 2, 3 and 4). Inaddition, as previously described (Ubeda et al, Journal of ClinicalInvestigation 2010), PCR of the vanA gene, which confers resistance tovancomycin, confirms the presence of VRE in infected mice. The bacterialcomposition test article such as but not limited to an ethanol treated,gradient purified spore preparation (as described herein), fecalsuspension, or antibiotic treatment is delivered in PBS on days 1-3while the negative control contains only PBS and is also delivered ondays 1-3 by oral gavage. Fresh fecal stool pellets are obtained dailyfor the duration of the experiment from days −7 to day 10. The samplesare immediately frozen and stored at −80° C. DNA was extracted usingstandard techniques and analyzed with 16S or comparable methods (e.g.see example 3 and 4).

In the colonization model, ampicillin is administered as described abovefor day −7 to day 1, treatment with the test article or vehicle controlis administered on day 0-2 and the VRE resistant bacteria at 108 CFU areadministered on day 14. Fecal samples are taken throughout theexperiment daily from −7 to day 21 and submitted for 16S sequencing aspreviously described (e.g. see examples 3 and 4).

In both models titers of VRE in feces are used to evaluate the successof the test article versus the negative control. Furthermore, microbiotacomposition is assessed for the ability of the bacterial compositiontest article to induce a healthy microbiome.

Example 19 Prophylactic Use and Treatment of a Mouse Model of CarbapenemResistant Klebsiella (CRKB) Colonization

The emergence of Klebsiella pneumoniae strains with decreasedsusceptibility to carbapenems is a significant threat to hospitalizedpatients. Resistance to carbapenems in these organisms is mostfrequently mediated by K. pneumoniae carbapenemase (KPC), a class Abeta-lactamase that also confers resistance to broad-spectrumcephalosporins and commercially available beta-lactam/beta-lactamaseinhibitor combinations (Queenan et al, Clinical Microbiology Review,2007). KPC-producing K. pneumoniae (KPC-Kp) strains often harborresistance determinants against several other classes of antimicrobials,including aminoglycosides and fluoroquinolones, resulting in trulymultidrug-resistant (MDR) organisms (Hirsch et al, Journal ofAntimicrobial Chemotherapy, 2009). Considering the limited antimicrobialoptions, infections caused by KPC-Kp pose a tremendous therapeuticchallenge and are associated with poor clinical outcomes

A treatment protocol in a mouse model as previously described (e.g.Perez et al, Antimicrobial Agents Chemotherapy, 2011) is used toevaluate the bacterial composition (test article) for treatingcarbapenem resistant Klebsiella and reducing carriage in the GI tract.Female CF1 mice (Harlan Sprague-Dawley, Indianapolis, Ind.) are used andare individually housed and weighed between 25 and 30 g.

The thoroughly characterized strain of K. pneumoniae, VA-367 (8, 9, 25)is used in this study. This clinical isolate is genetically related tothe KPC-Kp strain circulating in the Eastern United States.Characterization of the resistance mechanisms in K. pneumoniae VA-367with PCR and DNA sequence analysis revealed the presence of bla_(KPC-3),bla_(TEM-1), bla_(SHV-11), and bla_(SHV-12) as well as qnrB19 andaac(6′)-lb. Additionally, PCR and DNA sequencing revealed disruptions inthe coding sequences of the following outer membrane protein genes:ompK35, ompK36, and ompK37. Antibiotic susceptibility testing (AST) wasperformed with the agar dilution method and interpreted according tocurrent recommendations from the Clinical and Laboratory StandardsInstitute (CLSI). A modified Hodge test were performed, according to amethod described previously (e.g. see Anderson et al, Journal ofClinical Microbiology, 2007) with ertapenem, meropenem, and imipenem.Tigecycline and polymyxin E were evaluated by Etest susceptibilityassays (AB bioM'erieux, Solna, Sweden). Results for tigecycline wereinterpreted as suggested by the U.S. Food and Drug Administration (FDA)and according to CLSI recommendations (criteria for Pseudomonas) forpolymyxin E.

Mice (10 per group) are assigned to either a bacterial composition (testarticle), ethanol treated, spore preparation (e.g. see example 7),antibiotic clindamycin, piperacillin-tazobactam, tigecycline, ertapenem,cefepime, ciprofloxacin, or combination thereof or control groupreceiving only the vehicle. They are administered the test article dailyfrom day −10 to day 0, On day 0, 10³ CFU of KPC-Kp VA-367 diluted in 0.5ml phosphate-buffered saline (PBS) was administered by oral gavage usinga stainless-steel feeding tube (Perfektum; Popper & Sons, New Hyde Park,N.Y.). Stool samples were collected 1, 4, 6, and 11 days after theadministration of KPC-Kp in order to measure the concentration ofcarbapenem-resistant K. pneumoniae. Stool samples (100 mg diluted in 800ml of PBS) are plated onto MacConkey agar with and without 0.5 ug/ml ofimipenem, and the number of CFU per gram of stool was determined.Alternatively other methods may be used to measure the levels ofcarbapenem-resistant K. pneumoniae e.g. per, antigen testing, as onewho's skilled in the art could perform.

Stool samples were collected after 5 days of treatment to assess theeffects of the antibiotics on the stool microflora and to measureantibiotic levels in stool. To assess the effects on the microflora,fresh stool samples as previously described (e.g. see examples AAAB andAAAC). Additional experiments are performed to examine whether theadministration the bacterial composition (test article) resulted in theelimination or persistence of colonization with KPC-Kp VA-367.

Mice are treated with subcutaneous clindamycin to reduce the normalintestinal flora 1 day before receiving 104 CFU of KPC-Kp VA-367 by oralgavage, and the mice continued to receive subcutaneous clindamycin everyother day for 7 days. Concurrently, for 7 days after oral gavage withKPC-Kp, mice received oral gavage of normal saline (control group), orthe bacterial composition as specified. An additional dose ofsubcutaneous clindamycin was administered 20 days after theadministration of KPC-Kp VA-367 to assess whether low levels ofcarbapenem-resistant K. pneumoniae were present that could be augmentedby the elimination of the anaerobic microflora. Stool samples werecollected at baseline and at 3, 6, 8, 11, 16, and 21 days after KPC-KpVA-367 was given by gavage. The bacterial composition will be examinedby the reduction of CRKB in feces.

Example 20 Methods of Construction and Quantification

Construction of Binary Pairs in a High-Throughput 96-Well Format.

To allow high-throughput screening of binary pairs, vials of −80° C.glycerol stock banks were thawed and diluted to 1e8 CFU/mL. Each strainwas then diluted 10× (to a final concentration of 1e7 CFU/mL of eachstrain) into 200 uL of PBS+15% glycerol in the wells of a 96-well plate.Plates were then frozen at −80° C. When needed, plates were removed from−80° C. and thawed at room temperature under anaerobic conditions whentesting in an In vitro inhibition assay with Clostridium difficile.

Construction of Ternary Combinations in a High-Throughput 96-Well Format

To allow high-throughput screening of ternary combinations, vials of−80° C. glycerol stock banks were thawed and diluted to 1e8 CFU/mL. Eachstrain was then diluted 10× (to a final concentration of 1e7 CFU/mL ofeach strain) into 200 uL of PBS+15% glycerol in the wells of a 96-wellplate. Plates were then frozen at −80° C. When needed for the assay,plates were removed from −80° C. and thawed at room temperature underanaerobic conditions when testing in an In vitro inhibition assay withClostridium difficile.

Construction of an In Vitro Inhibition Assay to Screen for Ecobiotic™Compositions Inhibitory to the Growth of Clostridium Difficile

An overnight culture of Clostridium difficile was grown under anaerobicconditions in SweetB-FosIn or other suitable media for the growth of C.difficile. SweetB-FosIn is a complex media composed of brain heartinfusion, yeast extract, cysteine, cellobiose, maltose, soluble starch,and fructooligosaccharides/inulin, and hemin, and is buffered with MOPs.After 24 hr of growth the culture was diluted 100,000 fold into acomplex media such as SweetB-FosIn which is suitable for the growth of awide variety of anaerobic bacterial species. The diluted C. difficilemixture was then aliquoted to wells of a 96-well plate (180 uL to eachwell). 20 uL of a unique binary pair of potential inhibitory species wasthen added to each well at a final concentration of 1e6 CFU/mL of eachspecies. Alternatively the assay can be tested with binary pairs atdifferent initial concentrations (1e9 CFU/mL, 1e8 CFU/mL, 1e7 CFU/mL,1e5 CFU/mL, 1e4 CFU/mL, 1e3 CFU/mL, 1e2 CFU/mL). Control wells onlyinoculated with C. difficile were included for a comparison to thegrowth of C. difficile without inhibition. Additional wells were usedfor controls that either inhibit or do not inhibit the growth of C.difficile. One example of a positive control that inhibits growth was acombination of Blautia producta, Clostridium bifermentans andEscherichia coli. One example of a control that shows reduced inhibitionof C. difficile growth as a combination of Bacteroides thetaiotaomicron,Bacteroides ovatus and Bacteroides vulgatus. Plates were wrapped withparafilm and incubated for 24 hr at 37° C. under anaerobic conditions.After 24 hr the wells containing C. difficile alone were seriallydiluted and plated to determine titer. The 96-well plate was then frozenat −80 C before quantifying C. difficile by qPCR assay.

Construction of an In Vitro Inhibition Assay to Screen for BacterialCompositions that Produce Diffusible Products Inhibitory to the Growthof Clostridium difficile Using a Filter Insert.

The In vitro inhibition assay described above was modified by using a0.22 uM filter insert (Millipore™ MultiScreen™ 96-Well Assay Plates—ItemMAGVS2210) in 96-well format to physically separate C. difficile fromthe bacterial compositions. The C. difficile was aliquoted into the96-well plate while the bacterial compositions were aliquoted into mediaon the filter overlay. The nutrient media as in contact on both sides ofthe 0.22 uM filter, allowing exchange of nutrients, small molecules andmany macromolecules (e.g., bacteriocins, cell-surface proteins, orpolysaccharides) by diffusion. In this embodiment, after 24 hrincubation, the filter insert containing the bacterial compositions wasremoved. The plate containing C. difficile was then transferred to a96-well plate reader suitable for measuring optical density (OD) at 600nm. The growth of C. difficile in the presence of different bacterialcompositions was compared based on the OD measurement.

Construction of an In Vitro Inhibition Assay to Screen for BacterialCompositions Inhibitory to the Growth of Clostridium difficile UsingClostridium difficile Selective Media for Quantification

The In vitro inhibition assay described above can be modified todetermine final C. difficile titer by serially diluting and plating toC. difficile selective media (Bloedt et al 2009) such as CCFA(cycloserine cefoxitin fructose agar, Anaerobe Systems), CDSA(Clostridium difficile selective agar, which is cycloserine cefoxitinmannitol agar, Becton Dickinson).

Quantification of C. difficile Using Quantitative PCR (qPCR)

Standard Curve Preparation

The standard curve was generated from a well on each assay platecontaining only pathogenic C. difficile grown in SweetB+FosIn media asprovided herein and quantified by selective spot plating. Serialdilutions of the culture were performed in sterile phosphate-bufferedsaline. Genomic DNA was extracted from the standard curve samples alongwith the other wells.

Genomic DNA Extraction

Genomic DNA was extracted from 5 μl of each sample using a dilution,freeze/thaw, and heat lysis protocol. 5 μL of thawed samples were addedto 45 μL of UltraPure water (Life Technologies, Carlsbad, Calif.) andmixed by pipetting. The plates with diluted samples were frozen at −20°C. until use for qPCR which includes a heated lysis step prior toamplification. Alternatively the genomic DNA could be isolated using theMo Bio Powersoil®-htp 96 Well Soil DNA Isolation Kit (Mo BioLaboratories, Carlsbad, Calif.), Mo Bio Powersoil® DNA Isolation Kit (MoBio Laboratories, Carlsbad, Calif.), or the QIAamp DNA Stool Mini Kit(QIAGEN, Valencia, Calif.) according to the manufacturer's instructions.

qPCR Composition and Conditions

The qPCR reaction mixture contained 1× SsoAdvanced Universal ProbesSupermix, 900 nM of Wr-tcdB-F primer (AGCAGTTGAATATAGTGGTTTAGTTAGAGTTG(SEQ ID NO: 2040), IDT, Coralville, Iowa), 900 nM of Wr-tcdB-R primer(CATGCTTTTTTAGTTTCTGGATTGAA (SEQ ID NO: 2041), IDT, Coralville, Iowa),250 nM of Wr-tcdB-P probe (6FAM-CATCCAGTCTCAATTGTATATGTTTCTCCA-MGB (SEQID NO: 2042), Life Technologies, Grand Island, N.Y.), and MolecularBiology Grade Water (Mo Bio Laboratories, Carlsbad, Calif.) to 18 μl(Primers adapted from: Wroblewski, D. et al., Rapid MolecularCharacterization of Clostridium difficile and Assessment of Populationsof C. difficile in Stool Specimens, Journal of Clinical Microbiology47:2142-2148 (2009)). This reaction mixture was aliquoted to wells of aHard-shell Low-Profile Thin Wall 96-well Skirted PCR Plate (BioRad,Hercules, Calif.). To this reaction mixture, 2 μl of diluted, frozen,and thawed samples were added and the plate sealed with a Microseal ‘B’Adhesive Seal (BioRad, Hercules, Calif.). The qPCR was performed on aBioRad C1000™ Thermal Cycler equipped with a CFX96™ Real-Time System(BioRad, Hercules, Calif.). The thermocycling conditions were 95° C. for15 minutes followed by 45 cycles of 95° C. for 5 seconds, 60° C. for 30seconds, and fluorescent readings of the FAM channel. Alternatively, theqPCR could be performed with other standard methods known to thoseskilled in the art.

Data Analysis

The Cq value for each well on the FAM channel was determined by the CFXManager™ 3.0 software. The log₁₀ (cfu/mL) of C. difficile eachexperimental sample was calculated by inputting a given sample's Cqvalue into a linear regression model generated from the standard curvecomparing the Cq values of the standard curve wells to the known log₁₀(cfu/mL) of those samples. The log inhibition was calculated for eachsample by subtracting the log₁₀ (cfu/mL) of C. difficile in the samplefrom the log₁₀ (cfu/mL) of C. difficile in the sample on each assayplate used for the generation of the standard curve that has noadditional bacteria added. The mean log inhibition was calculated forall replicates for each composition.

A histogram of the range and standard deviation of each composition wasplotted. Ranges or standard deviations of the log inhibitions that weredistinct from the overall distribution were examined as possibleoutliers. If the removal of a single log inhibition datum from one ofthe binary pairs that were identified in the histograms would bring therange or standard deviation in line with those from the majority of thesamples, that datum was removed as an outlier, and the mean loginhibition was recalculated.

The pooled variance of all samples evaluated in the assay was estimatedas the average of the sample variances weighted by the sample's degreesof freedom. The pooled standard error was then calculated as the squareroot of the pooled variance divided by the square root of the number ofsamples. Confidence intervals for the null hypothesis were determined bymultiplying the pooled standard error to the z score corresponding to agiven percentage threshold. Mean log inhibitions outside the confidenceinterval were considered to be inhibitory if positive or stimulatory ifnegative with the percent confidence corresponding to the interval used.Samples with mean log inhibition greater than the 99% confidenceinterval (C.I) of the null hypothesis are reported as ++++, those with a95%<C.I.<99% as +++, those with a 90%<C.I.<95% as ++, those with a80%<C.I.<90% as + while samples with mean log inhibition less than thanthe 99% confidence interval (C.I) of the null hypothesis are reported as−−−−, those with a 95%<C.I.<99% as −−−, those with a 90%<C.I.<95% as −−,those with a 80%<C.I.<90% as −.

Many binary pairs inhibit C. difficile Table 8. 622 of 989 combinationsshow inhibition with a confidence interval >80%; 545 of 989 with aC.I.>90%; 507 of 989 with a C.I.>95%; 430 of 989 with a C.I. of >99%.Non-limiting but exemplary binary pairs include those with mean logreduction greater than 0.366, e.g. Alistipes shahii paired with Blautiaproducta, Clostridium hathaweyi, or Colinsella aerofaciens, orClostridium mayombei paired with C. innocuum, C. tertium, Colinsellaaerofaciens, or any of the other 424 combinations shown in Table 8.Equally important, the In vitro inhibition assay describes binary pairsthat do not effectively inhibit C. difficile. 188 of 989 combinationspromote growth with >80% confidence; 52 of 989 show a lack of inhibitionwith >90% confidence; 22 of 989 show a lack of inhibition with >95%confidence; 3 of 989, including B. producta combined with Coprococcuscatus, Alistipes shahii combined with Dorea formicigenerans, andEubacterium rectale combined with Roseburia intestinalis, show a lack ofinhibition with >99% confidence. 249 of 989 combinations are neutral inthe assay, meaning they neither promote nor inhibit C. difficile growthto the limit of measurement.

Ternary combinations with mean log inhibition greater than 0.312 arereported as ++++ (≥99% confidence interval (C.I.) of the nullhypothesis), those with mean log inhibition between 0.221 and 0.312 as+++ (95%<C.I.<99%), those with mean log inhibition between 0.171 and0.221 as ++ (90%<C.I.<95%), those with mean log inhibition between 0.113and 0.171 as + (80%<C.I.<90%), those with mean log inhibition between−0.113 and −0.171 as − (80%<C.I.<90%), those with mean log inhibitionbetween −0.171 and −0.221 as −− (90%<C.I.<95%), those with mean loginhibition between −0.221 and −0.312 as −−− (95%<C.I.<99%), and thosewith mean log inhibition less than −0.312 as −−−− (99%<C.I.).

The In vitro inhibition assay shows that many ternary combinationsinhibit C. difficile. 39 of 56 combinations show inhibition with aconfidence interval >80%; 36 of 56 with a C.I.>90%; 36 of 56 with aC.I.>95%; 29 of 56 with a C.I. of >99%. Non-limiting but exemplaryternary combinations include those with mean log reduction greater than0.171, e.g. any combination shown in Table 9 with a score of ++++, suchas Colinsella aerofaciens, Coprococcus comes, and Blautia producta.Equally important, the In vitro inhibition assay describes ternarycombinations that do not effectively inhibit C. difficile. 5 of 56combinations promote growth with >80% confidence; 2 of 56 promote growthwith >90% confidence; 1 of 56, Coprococcus comes, Clostridium symbiosumand Eubacterium rectale, promote growth with >95% confidence. 12 of 56combinations are neutral in the assay, meaning they neither promote norinhibit C. difficile growth to the limit of measurement.

Unless otherwise indicated, all numbers expressing quantities ofingredients, reaction conditions, and so forth used in thespecification, including claims, are to be understood as being modifiedin all instances by the term “about.” Accordingly, unless otherwiseindicated to the contrary, the numerical parameters are approximationsand may vary depending upon the desired properties sought to beobtained. At the very least, and not as an attempt to limit theapplication of the doctrine of equivalents to the scope of the claims,each numerical parameter should be construed in light of the number ofsignificant digits and ordinary rounding approaches.

Unless otherwise indicated, the term “at least” preceding a series ofelements is to be understood to refer to every element in the series.

While the invention has been particularly shown and described withreference to a preferred embodiment and various alternate embodiments,it will be understood by persons skilled in the relevant art thatvarious changes in form and details can be made therein withoutdeparting from the spirit and scope of the invention.

All references, issued patents and patent applications cited within thebody of the instant specification are hereby incorporated by referencein their entirety, for all purposes.

Tables

TABLE 1 List of Operational Taxonomic Units (OTU) with taxonomicassignments made to Genus, Species, and Phylogenetic Clade. Clademembership of bacterial OTUs is based on 16S sequence data. Clades aredefined based on the topology of a phylogenetic tree that is constructedfrom full-length 16S sequences using maximum likelihood methods familiarto individuals with ordinary skill in the art of phylogenetics. Cladesare constructed to ensure that all OTUs in a given clade are: (i) withina specified number of bootstrap supported nodes from one another, and(ii) within 5% genetic similarity. OTUs that are within the same cladecan be distinguished as genetically and phylogenetically distinct fromOTUs in a different clade based on 16S- V4 sequence data, while OTUsfalling within the same clade are closely related. OTUs falling withinthe same clade are evolutionarily closely related and may or may not bedistinguishable from one another using 16S-V4 sequence data. Members ofthe same clade, due to their evolutionary relatedness, play similarfunctional roles in a microbial ecology such as that found in the humangut. Compositions substituting one species with another from the sameclade are likely to have conserved ecological function and therefore areuseful in the present invention. All OTUs are denoted as to theirputative capacity to form spores and whether they are a Pathogen orPathobiont (see Definitions for description of “Pathobiont”). NIAIDPriority Pathogens are denoted as ‘Category-A’, ‘Category-B’, or‘Category-C’, and Opportunistic Pathogens are denoted as ‘OP’. OTUs thatare not pathogenic or for which their ability to exist as a pathogen isunknown are denoted as ‘N’. The ‘SEQ ID Number’ denotes the identifierof the OTU in the Sequence Listing File and ‘Public DB Accession’denotes the identifier of the OTU in a public sequence repository. SEQID Public DB Spore Pathogen OTU Number Accession Clade Former StatusEubacterium saburreum 858 AB525414 clade_178 Y N Eubacterium sp. oralclone IR009 866 AY349376 clade_178 Y N Lachnospiraceae bacterium ICM621061 HQ616401 clade_178 Y N Lachnospiraceae bacterium 1062 HQ616384clade_178 Y N MSX33 Lachnospiraceae bacterium oral 1063 ADDS01000069clade_178 Y N taxon 107 Alicyclobacillus acidocaldarius 122 NR_074721clade_179 Y N Clostridium baratii 555 NR_029229 clade_223 Y NClostridium colicanis 576 FJ957863 clade_223 Y N Clostridiumparaputrificum 611 AB536771 clade_223 Y N Clostridium sardiniense 621NR_041006 clade_223 Y N Eubacterium budayi 837 NR_024682 clade_223 Y NEubacterium moniliforme 851 HF558373 clade_223 Y N Eubacteriummultiforme 852 NR_024683 clade_223 Y N Eubacterium nitritogenes 853NR_024684 clade_223 Y N Anoxybacillus flavithermus 173 NR_074667clade_238 Y N Bacillus aerophilus 196 NR_042339 clade_238 Y N Bacillusaestuarii 197 GQ980243 clade_238 Y N Bacillus amyloliquefaciens 199NR_075005 clade_238 Y N Bacillus anthracis 200 AAEN01000020 clade_238 YCategory- A Bacillus atrophaeus 201 NR_075016 clade_238 Y OP Bacillusbadius 202 NR_036893 clade_238 Y OP Bacillus cereus 203 ABDJ01000015clade_238 Y OP Bacillus circulans 204 AB271747 clade_238 Y OP Bacillusfirmus 207 NR_025842 clade_238 Y OP Bacillus flexus 208 NR_024691clade_238 Y OP Bacillus fordii 209 NR_025786 clade_238 Y OP Bacillushalmapalus 211 NR_026144 clade_238 Y OP Bacillus herbersteinensis 213NR_042286 clade_238 Y OP Bacillus idriensis 215 NR_043268 clade_238 Y OPBacillus lentus 216 NR_040792 clade_238 Y OP Bacillus licheniformis 217NC_006270 clade_238 Y OP Bacillus megaterium 218 GU252124 clade_238 Y OPBacillus nealsonii 219 NR_044546 clade_238 Y OP Bacillus niabensis 220NR_043334 clade_238 Y OP Bacillus niacini 221 NR_024695 clade_238 Y OPBacillus pocheonensis 222 NR_041377 clade_238 Y OP Bacillus pumilus 223NR_074977 clade_238 Y OP Bacillus safensis 224 JQ624766 clade_238 Y OPBacillus simplex 225 NR_042136 clade_238 Y OP Bacillus sonorensis 226NR_025130 clade_238 Y OP Bacillus sp. 10403023 227 CAET01000089clade_238 Y OP MM10403188 Bacillus sp. 2_A_57_CT2 230 ACWD01000095clade_238 Y OP Bacillus sp. 2008724126 228 GU252108 clade_238 Y OPBacillus sp. 2008724139 229 GU252111 clade_238 Y OP Bacillus sp. 7_16AIA231 FN397518 clade_238 Y OP Bacillus sp. AP8 233 JX101689 clade_238 Y OPBacillus sp. B27(2008) 234 EU362173 clade_238 Y OP Bacillus sp. BT1B_CT2235 ACWC01000034 clade_238 Y OP Bacillus sp. GB1.1 236 FJ897765clade_238 Y OP Bacillus sp. GB9 237 FJ897766 clade_238 Y OP Bacillus sp.HU19.1 238 FJ897769 clade_238 Y OP Bacillus sp. HU29 239 FJ897771clade_238 Y OP Bacillus sp. HU33.1 240 FJ897772 clade_238 Y OP Bacillussp. JC6 241 JF824800 clade_238 Y OP Bacillus sp. oral taxon F79 248HM099654 clade_238 Y OP Bacillus sp. SRC_DSF1 243 GU797283 clade_238 YOP Bacillus sp. SRC_DSF10 242 GU797292 clade_238 Y OP Bacillus sp.SRC_DSF2 244 GU797284 clade_238 Y OP Bacillus sp. SRC_DSF6 245 GU797288clade_238 Y OP Bacillus sp. tc09 249 HQ844242 clade_238 Y OP Bacillussp. zh168 250 FJ851424 clade_238 Y OP Bacillus sphaericus 251 DQ286318clade_238 Y OP Bacillus sporothermodurans 252 NR_026010 clade_238 Y OPBacillus subtilis 253 EU627588 clade_238 Y OP Bacillus thermoamylovorans254 NR_029151 clade_238 Y OP Bacillus thuringiensis 255 NC_008600clade_238 Y OP Bacillus weihenstephanensis 256 NR_074926 clade_238 Y OPGeobacillus kaustophilus 933 NR_074989 clade_238 Y N Geobacillusstearothermophilus 936 NR_040794 clade_238 Y N Geobacillusthermodenitrificans 938 NR_074976 clade_238 Y N Geobacillusthermoglucosidasius 939 NR_043022 clade_238 Y N Lysinibacillussphaericus 1193 NR_074883 clade_238 Y N Clostridiales sp. SS3_4 543AY305316 clade_246 Y N Clostridium beijerinckii 557 NR_074434 clade_252Y N Clostridium botulinum 560 NC_010723 clade_252 Y Category- AClostridium butyricum 561 ABDT01000017 clade_252 Y N Clostridiumchauvoei 568 EU106372 clade_252 Y N Clostridium favososporum 582 X76749clade_252 Y N Clostridium histolyticum 592 HF558362 clade_252 Y NClostridium isatidis 597 NR_026347 clade_252 Y N Clostridium limosum 602FR870444 clade_252 Y N Clostridium sartagoforme 622 NR_026490 clade_252Y N Clostridium septicum 624 NR_026020 clade_252 Y N Clostridium sp.7_2_43FAA 626 ACDK01000101 clade_252 Y N Clostridium sporogenes 645ABKW02000003 clade_252 Y N Clostridium tertium 653 Y18174 clade_252 Y NClostridium carnis 564 NR_044716 clade_253 Y N Clostridium celatum 565X77844 clade_253 Y N Clostridium disporicum 579 NR_026491 clade_253 Y NClostridium gasigenes 585 NR_024945 clade_253 Y N Clostridium quinii 616NR_026149 clade_253 Y N Clostridium hylemonae 593 AB023973 clade_260 Y NClostridium scindens 623 AF262238 clade_260 Y N Lachnospiraceaebacterium 1054 ACTR01000020 clade_260 Y N 5_1_57FAA Clostridiumglycyrrhizinilyticum 588 AB233029 clade_262 Y N Clostridium nexile 607X73443 clade_262 Y N Coprococcus comes 674 ABVR01000038 clade_262 Y NLachnospiraceae bacterium 1048 ACTM01000065 clade_262 Y N 1_1_57FAALachnospiraceae bacterium 1049 ACTN01000028 clade_262 Y N 1_4_56FAALachnospiraceae bacterium 1057 ACWQ01000079 clade_262 Y N 8_1_57FAARuminococcus lactaris 1663 ABOU02000049 clade_262 Y N Ruminococcustorques 1670 AAVP02000002 clade_262 Y N Paenibacillus lautus 1397NR_040882 clade_270 Y N Paenibacillus polymyxa 1399 NR_037006 clade_270Y N Paenibacillus sp. HGF5 1402 AEXS01000095 clade_270 Y N Paenibacillussp. HGF7 1403 AFDH01000147 clade_270 Y N Eubacterium sp. oral cloneJI012 868 AY349379 clade_298 Y N Alicyclobacillus contaminans 124NR_041475 clade_301 Y N Alicyclobacillus herbarius 126 NR_024753clade_301 Y N Alicyclobacillus pomorum 127 NR_024801 clade_301 Y NBlautia coccoides 373 AB571656 clade_309 Y N Blautia glucerasea 374AB588023 clade_309 Y N Blautia glucerasei 375 AB439724 clade_309 Y NBlautia hansenii 376 ABYU02000037 clade_309 Y N Blautia luti 378AB691576 clade_309 Y N Blautia producta 379 AB600998 clade_309 Y NBlautia schinkii 380 NR_026312 clade_309 Y N Blautia sp. M25 381HM626178 clade_309 Y N Blautia stercoris 382 HM626177 clade_309 Y NBlautia wexlerae 383 EF036467 clade_309 Y N Bryantella formatexigens 439ACCL02000018 clade_309 Y N Clostridium coccoides 573 EF025906 clade_309Y N Eubacterium cellulosolvens 839 AY178842 clade_309 Y NLachnospiraceae bacterium 1056 ACTV01000014 clade_309 Y N 6_1_63FAARuminococcus hansenii 1662 M59114 clade_309 Y N Ruminococcus obeum 1664AY169419 clade_309 Y N Ruminococcus sp. 5_1_39BFAA 1666 ACII01000172clade_309 Y N Ruminococcus sp. K_1 1669 AB222208 clade_309 Y NSyntrophococcus sucromutans 1911 NR_036869 clade_309 Y N Bacillusalcalophilus 198 X76436 clade_327 Y N Bacillus clausii 205 FN397477clade_327 Y OP Bacillus gelatini 210 NR_025595 clade_327 Y OP Bacillushalodurans 212 AY144582 clade_327 Y OP Bacillus sp. oral taxon F26 246HM099642 clade_327 Y OP Clostridium innocuum 595 M23732 clade_351 Y NClostridium sp. HGF2 628 AENW01000022 clade_351 Y N Clostridiumperfringens 612 ABDW01000023 clade_353 Y Category- B Sarcina ventriculi1687 NR_026146 clade_353 Y N Clostridium bartlettii 556 ABEZ02000012clade_354 Y N Clostridium bifermentans 558 X73437 clade_354 Y NClostridium ghonii 586 AB542933 clade_354 Y N Clostridium glycolicum 587FJ384385 clade_354 Y N Clostridium mayombei 605 FR733682 clade_354 Y NClostridium sordellii 625 AB448946 clade_354 Y N Clostridium sp. MT4 E635 FJ159523 clade_354 Y N Eubacterium tenue 872 M59118 clade_354 Y NClostridium argentinense 553 NR_029232 clade_355 Y N Clostridium sp.JC122 630 CAEV01000127 clade_355 Y N Clostridium sp. NMBHI_1 636JN093130 clade_355 Y N Clostridium subterminale 650 NR_041795 clade_355Y N Clostridium sulfidigenes 651 NR_044161 clade_355 Y N Doreaformicigenerans 773 AAXA02000006 clade_360 Y N Dorea longicatena 774AJ132842 clade_360 Y N Lachnospiraceae bacterium 1050 ADLB01000035clade_360 Y N 2_1_46FAA Lachnospiraceae bacterium 1051 ACTO01000052clade_360 Y N 2_1_58FAA Lachnospiraceae bacterium 1053 ADCR01000030clade_360 Y N 4_1_37FAA Lachnospiraceae bacterium 1058 ACTX01000023clade_360 Y N 9_1_43BFAA Ruminococcus gnavus 1661 X94967 clade_360 Y NRuminococcus sp. ID8 1668 AY960564 clade_360 Y N Blautiahydrogenotrophica 377 ACBZ01000217 clade_368 Y N Lactonifactorlongoviformis 1147 DQ100449 clade_368 Y N Robinsoniella peoriensis 1633AF445258 clade_368 Y N Eubacterium infirmum 849 U13039 clade_384 Y NEubacterium sp. WAL 14571 864 FJ687606 clade_384 Y N Erysipelotrichaceaebacterium 823 ACZW01000054 clade_385 Y N 5_2_54FAA Eubacterium biforme835 ABYT01000002 clade_385 Y N Eubacterium cylindroides 842 FP929041clade_385 Y N Eubacterium dolichum 844 L34682 clade_385 Y N Eubacteriumsp. 3_1_31 861 ACTL01000045 clade_385 Y N Eubacterium tortuosum 873NR_044648 clade_385 Y N Bulleidia extructa 441 ADFR01000011 clade_388 YN Solobacterium moorei 1739 AECQ01000039 clade_388 Y N Coprococcus catus673 EU266552 clade_393 Y N Lachnospiraceae bacterium oral 1064 HM099641clade_393 Y N taxon F15 Clostridium cochlearium 574 NR_044717 clade_395Y N Clostridium malenominatum 604 FR749893 clade_395 Y N Clostridiumtetani 654 NC_004557 clade_395 Y N Acetivibrio ethanolgignens 6 FR749897clade_396 Y N Anaerosporobacter mobilis 161 NR_042953 clade_396 Y NBacteroides pectinophilus 288 ABVQ01000036 clade_396 Y N Clostridiumaminovalericum 551 NR_029245 clade_396 Y N Clostridium phytofermentans613 NR_074652 clade_396 Y N Eubacterium hallii 848 L34621 clade_396 Y NEubacterium xylanophilum 875 L34628 clade_396 Y N Ruminococcus callidus1658 NR_029160 clade_406 Y N Ruminococcus champanellensis 1659 FP929052clade_406 Y N Ruminococcus sp. 18P13 1665 AJ515913 clade_406 Y NRuminococcus sp. 9SE51 1667 FM954974 clade_406 Y N Anaerostipes caccae162 ABAX03000023 clade_408 Y N Anaerostipes sp. 3_2_56FAA 163ACWB01000002 clade_408 Y N Clostridiales bacterium 541 ABQR01000074clade_408 Y N 1_7_47FAA Clostridiales sp. SM4_1 542 FP929060 clade_408 YN Clostridiales sp. SSC_2 544 FP929061 clade_408 Y N Clostridiumaerotolerans 546 X76163 clade_408 Y N Clostridium aldenense 547NR_043680 clade_408 Y N Clostridium algidixylanolyticum 550 NR_028726clade_408 Y N Clostridium amygdalinum 552 AY353957 clade_408 Y NClostridium asparagiforme 554 ACCJ01000522 clade_408 Y N Clostridiumbolteae 559 ABCCO2000039 clade_408 Y N Clostridium celerecrescens 566JQ246092 clade_408 Y N Clostridium citroniae 569 ADLJ01000059 clade_408Y N Clostridium clostridiiformes 571 M59089 clade_408 Y N Clostridiumclostridioforme 572 NR_044715 clade_408 Y N Clostridium hathewayi 590AY552788 clade_408 Y N Clostridium indolis 594 AF028351 clade_408 Y NClostridium lavalense 600 EF564277 clade_408 Y N Clostridiumsaccharolyticum 620 CP002109 clade_408 Y N Clostridium sp. M62_1 633ACFX02000046 clade_408 Y N Clostridium sp. SS2_1 638 ABGC03000041clade_408 Y N Clostridium sphenoides 643 X73449 clade_408 Y NClostridium symbiosum 652 ADLQ01000114 clade_408 Y N Clostridiumxylanolyticum 658 NR_037068 clade_408 Y N Eubacterium hadrum 847FR749933 clade_408 Y N Lachnospiraceae bacterium 1052 ACTP01000124clade_408 Y N 3_1_57FAA_CT1 Lachnospiraceae bacterium 1055 ACTS01000081clade_408 Y N 5_1_63FAA Lachnospiraceae bacterium A4 1059 DQ789118clade_408 Y N Lachnospiraceae bacterium DJF 1060 EU728771 clade_408 Y NVP30 Lachnospiraceae genomosp. C1 1065 AY278618 clade_408 Y NClostridium difficile 578 NC_013315 clade_409 Y OP Eubacterium sp. AS15b862 HQ616364 clade_428 Y N Eubacterium sp. OBRC9 863 HQ616354 clade_428Y N Eubacterium sp. oral clone OH3A 871 AY947497 clade_428 Y NEubacterium yurii 876 AEES01000073 clade_428 Y N Clostridiumacetobutylicum 545 NR_074511 clade_430 Y N Clostridium algidicarnis 549NR_041746 clade_430 Y N Clostridium cadaveris 562 AB542932 clade_430 Y NClostridium carboxidivorans 563 FR733710 clade_430 Y N Clostridiumestertheticum 580 NR_042153 clade_430 Y N Clostridium fallax 581NR_044714 clade_430 Y N Clostridium felsineum 583 AF270502 clade_430 Y NClostridium frigidicarnis 584 NR_024919 clade_430 Y N Clostridiumkluyveri 598 NR_074165 clade_430 Y N Clostridium magnum 603 X77835clade_430 Y N Clostridium putrefaciens 615 NR_024995 clade_430 Y NClostridium sp. HPB_46 629 AY862516 clade_430 Y N Clostridiumtyrobutyricum 656 NR_044718 clade_430 Y N Sutterella parvirubra 1899AB300989 clade_432 Y N Acetanaerobacterium elongatum 4 NR_042930clade_439 Y N Clostridium cellulosi 567 NR_044624 clade_439 Y NEthanoligenens harbinense 832 AY675965 clade_439 Y N Eubacterium rectale856 FP929042 clade_444 Y N Eubacterium sp. oral clone GI038 865 AY349374clade_444 Y N Lachnobacterium bovis 1045 GU324407 clade_444 Y NRoseburia cecicola 1634 GU233441 clade_444 Y N Roseburia faecalis 1635AY804149 clade_444 Y N Roseburia faecis 1636 AY305310 clade_444 Y NRoseburia hominis 1637 AJ270482 clade_444 Y N Roseburia intestinalis1638 FP929050 clade_444 Y N Roseburia inulinivorans 1639 AJ270473clade_444 Y N Brevibacillus brevis 410 NR_041524 clade_448 Y NBrevibacillus laterosporus 414 NR_037005 clade_448 Y N Bacilluscoagulans 206 DQ297928 clade_451 Y OP Sporolactobacillus inulinus 1752NR_040962 clade_451 Y N Kocuria palustris 1041 EU333884 clade_453 Y NNocardia farcinica 1353 NC_006361 clade_455 Y N Bacillus sp. oral taxonF28 247 HM099650 clade_456 Y OP Catenibacterium mitsuokai 495 AB030224clade_469 Y N Clostridium sp. TM_40 640 AB249652 clade_469 Y NCoprobacillus cateniformis 670 AB030218 clade_469 Y N Coprobacillus sp.29_1 671 ADKX01000057 clade_469 Y N Clostridium rectum 618 NR_029271clade_470 Y N Eubacterium nodatum 854 U13041 clade_476 Y N Eubacteriumsaphenum 859 NR_026031 clade_476 Y N Eubacterium sp. oral clone JH012867 AY349373 clade_476 Y N Eubacterium sp. oral clone JS001 870 AY349378clade_476 Y N Faecalibacterium prausnitzii 880 ACOP02000011 clade_478 YN Gemmiger formicilis 932 GU562446 clade_478 Y N Subdoligranulumvariabile 1896 AJ518869 clade_478 Y N Clostridiaceae bacterium JC13 532JF824807 clade_479 Y N Clostridium sp. MLG055 634 AF304435 clade_479 Y NErysipelotrichaceae bacterium 822 ACTJ01000113 clade_479 Y N 3_1_53Clostridium cocleatum 575 NR_026495 clade_481 Y N Clostridium ramosum617 M23731 clade_481 Y N Clostridium saccharogumia 619 DQ100445clade_481 Y N Clostridium spiroforme 644 X73441 clade_481 Y NCoprobacillus sp. D7 672 ACDT01000199 clade_481 Y N Clostridialesbacterium SY8519 535 AB477431 clade_482 Y N Clostridium sp. SY8519 639AP012212 clade_482 Y N Eubacterium ramulus 855 AJ011522 clade_482 Y NErysipelothrix inopinata 819 NR_025594 clade_485 Y N Erysipelothrixrhusiopathiae 820 ACLK01000021 clade_485 Y N Erysipelothrix tonsillarum821 NR_040871 clade_485 Y N Holdemania filiformis 1004 Y11466 clade_485Y N Mollicutes bacterium pACH93 1258 AY297808 clade_485 Y N Coxiellaburnetii 736 CP000890 clade_486 Y Category- B Clostridium hiranonis 591AB023970 clade_487 Y N Clostridium irregulare 596 NR_029249 clade_487 YN Clostridium orbiscindens 609 Y18187 clade_494 Y N Clostridium sp. NML04A032 637 EU815224 clade_494 Y N Flavonifractor plautii 886 AY724678clade_494 Y N Pseudoflavonifractor capillosus 1591 AY136666 clade_494 YN Ruminococcaceae bacterium D16 1655 ADDX01000083 clade_494 Y NAcetivibrio cellulolyticus 5 NR_025917 clade_495 Y N Clostridiumaldrichii 548 NR_026099 clade_495 Y N Clostridium clariflavum 570NR_041235 clade_495 Y N Clostridium stercorarium 647 NR_025100 clade_495Y N Clostridium straminisolvens 649 NR_024829 clade_495 Y N Clostridiumthermocellum 655 NR_074629 clade_495 Y N Fusobacterium nucleatum 901ADVK01000034 clade_497 Y N Eubacterium barkeri 834 NR_044661 clade_512 YN Eubacterium callanderi 838 NR_026330 clade_512 Y N Eubacterium limosum850 CP002273 clade_512 Y N Anaerotruncus colihominis 164 ABGD02000021clade_516 Y N Clostridium methylpentosum 606 ACEC01000059 clade_516 Y NClostridium sp. YIT 12070 642 AB491208 clade_516 Y NHydrogenoanaerobacterium 1005 NR_044425 clade_516 Y N saccharovoransRuminococcus albus 1656 AY445600 clade_516 Y N Ruminococcus flavefaciens1660 NR_025931 clade_516 Y N Clostridium haemolyticum 589 NR_024749clade_517 Y N Clostridium novyi 608 NR_074343 clade_517 Y N Clostridiumsp. LMG 16094 632 X95274 clade_517 Y N Eubacterium ventriosum 874 L34421clade_519 Y N Bacteroides galacturonicus 280 DQ497994 clade_522 Y NEubacterium eligens 845 CP001104 clade_522 Y N Lachnospira multipara1046 FR733699 clade_522 Y N Lachnospira pectinoschiza 1047 L14675clade_522 Y N Lactobacillus rogosae 1114 GU269544 clade_522 Y N Bacillushorti 214 NR_036860 clade_527 Y OP Bacillus sp. 9_3AIA 232 FN397519clade_527 Y OP Eubacterium brachy 836 U13038 clade_533 Y N Filifactoralocis 881 CP002390 clade_533 Y N Filifactor villosus 882 NR_041928clade_533 Y N Clostridium leptum 601 AJ305238 clade_537 Y N Clostridiumsp. YIT 12069 641 AB491207 clade_537 Y N Clostridium sporosphaeroides646 NR_044835 clade_537 Y N Eubacterium coprostanoligenes 841 HM037995clade_537 Y N Ruminococcus bromii 1657 EU266549 clade_537 Y NEubacterium siraeum 860 ABCA03000054 clade_538 Y N Clostridium viride657 NR_026204 clade_540 Y N Oscillibacter sp. G2 1386 HM626173 clade_540Y N Oscillibacter valericigenes 1387 NR_074793 clade_540 Y NOscillospira guilliermondii 1388 AB040495 clade_540 Y N Butyrivibriocrossotus 455 ABWN01000012 clade_543 Y N Clostridium sp. L2_50 631AAYW02000018 clade_543 Y N Coprococcus eutactus 675 EF031543 clade_543 YN Coprococcus sp. ART55_1 676 AY350746 clade_543 Y N Eubacteriumruminantium 857 NR_024661 clade_543 Y N Collinsella aerofaciens 659AAVN02000007 clade_553 Y N Alkaliphilus metalliredigenes 137 AY137848clade_554 Y N Alkaliphilus oremlandii 138 NR_043674 clade_554 Y NClostridium sticklandii 648 L04167 clade_554 Y N Turicibacter sanguinis1965 AF349724 clade_555 Y N Fulvimonas sp. NML 060897 892 EF589680clade_557 Y N Desulfitobacterium frappieri 753 AJ276701 clade_560 Y NDesulfitobacterium hafniense 754 NR_074996 clade_560 Y NDesulfotomaculum nigrificans 756 NR_044832 clade_560 Y N Lutisporathermophila 1191 NR_041236 clade_564 Y N Brachyspira pilosicoli 405NR_075069 clade_565 Y N Eggerthella lenta 778 AF292375 clade_566 Y NStreptomyces albus 1888 AJ697941 clade_566 Y N Chlamydiales bacteriumNS11 505 JN606074 clade_567 Y N Anaerofustis stercorihominis 159ABIL02000005 clade_570 Y N Butyricicoccus pullicaecorum 453 HH793440clade_572 Y N Eubacterium desmolans 843 NR_044644 clade_572 Y NPapillibacter cinnamivorans 1415 NR_025025 clade_572 Y N Sporobactertermitidis 1751 NR_044972 clade_572 Y N Deferribacteres sp. oral clone744 AY349371 clade_575 Y N JV006 Clostridium colinum 577 NR_026151clade_576 Y N Clostridium lactatifermentans 599 NR_025651 clade_576 Y NClostridium piliforme 614 D14639 clade_576 Y N Saccharomonospora viridis1671 X54286 clade_579 Y N Thermobifida fusca 1921 NC_007333 clade_579 YN Leptospira licerasiae 1164 EF612284 clade_585 Y OP Moorellathermoacetica 1259 NR_075001 clade_590 Y N Thermoanaerobacter 1920CP000924 clade_590 Y N pseudethanolicus Flexistipes sinusarabici 888NR_074881 clade_591 Y N Gloeobacter violaceus 942 NR_074282 clade_596 YN Eubacterium sp. oral clone JN088 869 AY349377 clade_90 Y N Clostridiumoroticum 610 FR749922 clade_96 Y N Clostridium sp. D5 627 ADBG01000142clade_96 Y N Eubacterium contortum 840 FR749946 clade_96 Y N Eubacteriumfissicatena 846 FR749935 clade_96 Y N Corynebacterium coyleae 692 X96497clade_100 N N Corynebacterium mucifaciens 711 NR_026396 clade_100 N NCorynebacterium ureicelerivorans 733 AM397636 clade_100 N NCorynebacterium appendicis 684 NR_028951 clade_102 N N Corynebacteriumgenitalium 698 ACLJ01000031 clade_102 N N Corynebacterium glaucum 699NR_028971 clade_102 N N Corynebacterium imitans 703 AF537597 clade_102 NN Corynebacterium riegelii 719 EU848548 clade_102 N N Corynebacteriumsp. L_2012475 723 HE575405 clade_102 N N Corynebacterium sp. NML 724GU238409 clade_102 N N 93_0481 Corynebacterium sundsvallense 728 Y09655clade_102 N N Corynebacterium tuscaniae 730 AY677186 clade_102 N NPrevotella maculosa 1504 AGEK01000035 clade_104 N N Prevotella oris 1513ADDV01000091 clade_104 N N Prevotella salivae 1517 AB108826 clade_104 NN Prevotella sp. ICM55 1521 HQ616399 clade_104 N N Prevotella sp. oralclone AA020 1528 AY005057 clade_104 N N Prevotella sp. oral clone GI0321538 AY349396 clade_104 N N Prevotella sp. oral taxon G70 1558 GU432179clade_104 N N Prevotella corporis 1491 L16465 clade_105 N N Bacteroidessp. 4_1_36 312 ACTC01000133 clade_110 N N Bacteroides sp. AR20 315AF139524 clade_110 N N Bacteroides sp. D20 319 ACPT01000052 clade_110 NN Bacteroides sp. F_4 322 AB470322 clade_110 N N Bacteroides uniformis329 AB050110 clade_110 N N Prevotella nanceiensis 1510 JN867228clade_127 N N Prevotella sp. oral taxon 299 1548 ACWZ01000026 clade_127N N Prevotella bergensis 1485 ACKS01000100 clade_128 N N Prevotellabuccalis 1489 JN867261 clade_129 N N Prevotella timonensis 1564ADEF01000012 clade_129 N N Prevotella oralis 1512 AEPE01000021 clade_130N N Prevotella sp. SEQ072 1525 JN867238 clade_130 N N Leuconostoccarnosum 1177 NR_040811 clade_135 N N Leuconostoc gasicomitatum 1179FN822744 clade_135 N N Leuconostoc inhae 1180 NR_025204 clade_135 N NLeuconostoc kimchii 1181 NR_075014 clade_135 N N Edwardsiella tarda 777CP002154 clade_139 N N Photorhabdus asymbiotica 1466 Z76752 clade_139 NN Psychrobacter arcticus 1607 CP000082 clade_141 N N Psychrobactercibarius 1608 HQ698586 clade_141 N N Psychrobacter cryohalolentis 1609CP000323 clade_141 N N Psychrobacter faecalis 1610 HQ698566 clade_141 NN Psychrobacter nivimaris 1611 HQ698587 clade_141 N N Psychrobacterpulmonis 1612 HQ698582 clade_141 N N Pseudomonas aeruginosa 1592AABQ07000001 clade_154 N N Pseudomonas sp. 2_1_26 1600 ACWU01000257clade_154 N N Corynebacterium confusum 691 Y15886 clade_158 N NCorynebacterium propinquum 712 NR_037038 clade_158 N N Corynebacterium713 X84258 clade_158 N N pseudodiphtheriticum Bartonella bacilliformis338 NC_008783 clade_159 N N Bartonella grahamii 339 CP001562 clade_159 NN Bartonella henselae 340 NC_005956 clade_159 N N Bartonella quintana341 BX897700 clade_159 N N Bartonella tamiae 342 EF672728 clade_159 N NBartonella washoensis 343 FJ719017 clade_159 N N Brucella abortus 430ACBJ01000075 clade_159 N Category- B Brucella canis 431 NR_044652clade_159 N Category- B Brucella ceti 432 ACJD01000006 clade_159 NCategory- B Brucella melitensis 433 AE009462 clade_159 N Category- BBrucella microti 434 NR_042549 clade_159 N Category- B Brucella ovis 435NC_009504 clade_159 N Category- B Brucella sp. 83_13 436 ACBQ01000040clade_159 N Category- B Brucella sp. BO1 437 EU053207 clade_159 NCategory- B Brucella suis 438 ACBK01000034 clade_159 N Category- BOchrobactrum anthropi 1360 NC_009667 clade_159 N N Ochrobactrumintermedium 1361 ACQA01000001 clade_159 N N Ochrobactrumpseudintermedium 1362 DQ365921 clade_159 N N Prevotella genomosp. C21496 AY278625 clade_164 N N Prevotella multisaccharivorax 1509AFJE01000016 clade_164 N N Prevotella sp. oral clone 1543 AY550997clade_164 N N IDR_CEC_0055 Prevotella sp. oral taxon 292 1547 GQ422735clade_164 N N Prevotella sp. oral taxon 300 1549 GU409549 clade_164 N NPrevotella marshii 1505 AEEI01000070 clade_166 N N Prevotella sp. oralclone IK053 1544 AY349401 clade_166 N N Prevotella sp. oral taxon 7811554 GQ422744 clade_166 N N Prevotella stercorea 1562 AB244774 clade_166N N Prevotella brevis 1487 NR_041954 clade_167 N N Prevotella ruminicola1516 CP002006 clade_167 N N Prevotella sp. sp24 1560 AB003384 clade_167N N Prevotella sp. sp34 1561 AB003385 clade_167 N N Prevotella albensis1483 NR_025300 clade_168 N N Prevotella copri 1490 ACBX02000014clade_168 N N Prevotella oulorum 1514 L16472 clade_168 N N Prevotellasp. BI_42 1518 AJ581354 clade_168 N N Prevotella sp. oral clone P4PB_831546 AY207050 clade_168 N N P2 Prevotella sp. oral taxon G60 1557GU432133 clade_168 N N Prevotella amnii 1484 AB547670 clade_169 N NBacteroides caccae 268 EU136686 clade_170 N N Bacteroides finegoldii 277AB222699 clade_170 N N Bacteroides intestinalis 283 ABJL02000006clade_171 N N Bacteroides sp. XB44A 326 AM230649 clade_171 N NBifidobacteriaceae genomosp. C1 345 AY278612 clade_172 N NBifidobacterium adolescentis 346 AAXD02000018 clade_172 N NBifidobacterium angulatum 347 ABYS02000004 clade_172 N N Bifidobacteriumanimalis 348 CP001606 clade_172 N N Bifidobacterium breve 350 CP002743clade_172 N N Bifidobacterium catenulatum 351 ABXY01000019 clade_172 N NBifidobacterium dentium 352 CP001750 clade_172 N OP Bifidobacteriumgallicum 353 ABXB03000004 clade_172 N N Bifidobacterium infantis 354AY151398 clade_172 N N Bifidobacterium kashiwanohense 355 AB491757clade_172 N N Bifidobacterium longum 356 ABQQ01000041 clade_172 N NBifidobacterium 357 ABXX02000002 clade_172 N N pseudocatenulatumBifidobacterium pseudolongum 358 NR_043442 clade_172 N N Bifidobacteriumscardovii 359 AJ307005 clade_172 N N Bifidobacterium sp. HM2 360AB425276 clade_172 N N Bifidobacterium sp. HMLN12 361 JF519685 clade_172N N Bifidobacterium sp. M45 362 HM626176 clade_172 N N Bifidobacteriumsp. MSX5B 363 HQ616382 clade_172 N N Bifidobacterium sp. TM_7 364AB218972 clade_172 N N Bifidobacterium thermophilum 365 DQ340557clade_172 N N Leuconostoc citreum 1178 AM157444 clade_175 N NLeuconostoc lactis 1182 NR_040823 clade_175 N N Alicyclobacillusacidoterrestris 123 NR_040844 clade_179 N N Alicyclobacilluscycloheptanicus 125 NR_024754 clade_179 N N Acinetobacter baumannii 27ACYQ01000014 clade_181 N N Acinetobacter calcoaceticus 28 AM157426clade_181 N N Acinetobacter genomosp. C1 29 AY278636 clade_181 N NAcinetobacter haemolyticus 30 ADMT01000017 clade_181 N N Acinetobacterjohnsonii 31 ACPL01000162 clade_181 N N Acinetobacter junii 32ACPM01000135 clade_181 N N Acinetobacter lwoffii 33 ACPN01000204clade_181 N N Acinetobacter parvus 34 AIEB01000124 clade_181 N NAcinetobacter schindleri 36 NR_025412 clade_181 N N Acinetobacter sp.56A1 37 GQ178049 clade_181 N N Acinetobacter sp. CIP 101934 38 JQ638573clade_181 N N Acinetobacter sp. CIP 102143 39 JQ638578 clade_181 N NAcinetobacter sp. M16_22 41 HM366447 clade_181 N N Acinetobacter sp.RUH2624 42 ACQF01000094 clade_181 N N Acinetobacter sp. SH024 43ADCH01000068 clade_181 N N Lactobacillus jensenii 1092 ACQD01000066clade_182 N N Alcaligenes faecalis 119 AB680368 clade_183 N NAlcaligenes sp. CO14 120 DQ643040 clade_183 N N Alcaligenes sp. S3 121HQ262549 clade_183 N N Oligella ureolytica 1366 NR_041998 clade_183 N NOligella urethralis 1367 NR_041753 clade_183 N N Eikenella corrodens 784ACEA01000028 clade_185 N N Kingella denitrificans 1019 AEWV01000047clade_185 N N Kingella genomosp. P1 oral cone 1020 DQ003616 clade_185 NN MB2_C20 Kingella kingae 1021 AFHS01000073 clade_185 N N Kingellaoralis 1022 ACJW02000005 clade_185 N N Kingella sp. oral clone ID0591023 AY349381 clade_185 N N Neisseria elongata 1330 ADBF01000003clade_185 N N Neisseria genomosp. P2 oral clone 1332 DQ003630 clade_185N N MB5_P15 Neisseria sp. oral clone JC012 1345 AY349388 clade_185 N NNeisseria sp. SMC_A9199 1342 FJ763637 clade_185 N N Simonsiella muelleri1731 ADCY01000105 clade_185 N N Corynebacterium glucuronolyticum 700ABYP01000081 clade_193 N N Corynebacterium 716 FJ185225 clade_193 N Npyruviciproducens Rothia aeria 1649 DQ673320 clade_194 N N Rothiadentocariosa 1650 ADDW01000024 clade_194 N N Rothia sp. oral taxon 1881653 GU470892 clade_194 N N Corynebacterium accolens 681 ACGD01000048clade_195 N N Corynebacterium macginleyi 707 AB359393 clade_195 N NCorynebacterium 714 ABYQ01000237 clade_195 N N pseudogenitaliumCorynebacterium 729 ACVP01000009 clade_195 N N tuberculostearicumLactobacillus casei 1074 CP000423 clade_198 N N Lactobacillus paracasei1106 ABQV01000067 clade_198 N N Lactobacillus zeae 1143 NR_037122clade_198 N N Prevotella dentalis 1492 AB547678 clade_205 N N Prevotellasp. oral clone ASCG10 1529 AY923148 clade_206 N N Prevotella sp. oralclone HF050 1541 AY349399 clade_206 N N Prevotella sp. oral clone ID0191542 AY349400 clade_206 N N Prevotella sp. oral clone IK062 1545AY349402 clade_206 N N Prevotella genomosp. P9 oral 1499 DQ003633clade_207 N N clone MB7_G16 Prevotella sp. oral clone AU069 1531AY005062 clade_207 N N Prevotella sp. oral clone CY006 1532 AY005063clade_207 N N Prevotella sp. oral clone FL019 1534 AY349392 clade_207 NN Actinomyces genomosp. C1 56 AY278610 clade_212 N N Actinomycesgenomosp. C2 57 AY278611 clade_212 N N Actinomyces genomosp. P1 oral 58DQ003632 clade_212 N N clone MB6_C03 Actinomyces georgiae 59 GU561319clade_212 N N Actinomyces israelii 60 AF479270 clade_212 N N Actinomycesmassiliensis 61 AB545934 clade_212 N N Actinomyces meyeri 62 GU561321clade_212 N N Actinomyces odontolyticus 66 ACYT01000123 clade_212 N NActinomyces orihominis 68 AJ575186 clade_212 N N Actinomyces sp. CCUG37290 71 AJ234058 clade_212 N N Actinomyces sp. ICM34 75 HQ616391clade_212 N N Actinomyces sp. ICM41 76 HQ616392 clade_212 N NActinomyces sp. ICM47 77 HQ616395 clade_212 N N Actinomyces sp. ICM54 78HQ616398 clade_212 N N Actinomyces sp. oral clone IP081 87 AY349366clade_212 N N Actinomyces sp. oral taxon 178 91 AEUH01000060 clade_212 NN Actinomyces sp. oral taxon 180 92 AEPP01000041 clade_212 N NActinomyces sp. TeJ5 80 GU561315 clade_212 N N Haematobacter sp. BC14248968 GU396991 clade_213 N N Paracoccus denitrificans 1424 CP000490clade_213 N N Paracoccus marcusii 1425 NR_044922 clade_213 N N Grimontiahollisae 967 ADAQ01000013 clade_216 N N Shewanella putrefaciens 1723CP002457 clade_216 N N Afipia genomosp. 4 111 EU117385 clade_217 N NRhodopseudomonas palustris 1626 CP000301 clade_217 N N Methylobacteriumextorguens 1223 NC_010172 clade_218 N N Methylobacterium podarium 1224AY468363 clade_218 N N Methylobacterium radiotolerans 1225 GU294320clade_218 N N Methylobacterium sp. 1sub 1226 AY468371 clade_218 N NMethylobacterium sp. MM4 1227 AY468370 clade_218 N N Achromobacterdenitrificans 18 NR_042021 clade_224 N N Achromobacter piechaudii 19ADMS01000149 clade_224 N N Achromobacter xylosoxidans 20 ACRC01000072clade_224 N N Bordetella bronchiseptica 384 NR_025949 clade_224 N OPBordetella holmesii 385 AB683187 clade_224 N OP Bordetella parapertussis386 NR_025950 clade_224 N OP Bordetella pertussis 387 BX640418 clade_224N OP Microbacterium chocolatum 1230 NR_037045 clade_225 N NMicrobacterium flavescens 1231 EU714363 clade_225 N N Microbacteriumlacticum 1233 EU714351 clade_225 N N Microbacterium oleivorans 1234EU714381 clade_225 N N Microbacterium oxydans 1235 EU714348 clade_225 NN Microbacterium paraoxydans 1236 AJ491806 clade_225 N N Microbacteriumphyllosphaerae 1237 EU714359 clade_225 N N Microbacterium schleiferi1238 NR_044936 clade_225 N N Microbacterium sp. 768 1239 EU714378clade_225 N N Microbacterium sp. oral strain 1240 AF287752 clade_225 N NC24KA Microbacterium testaceum 1241 EU714365 clade_225 N NCorynebacterium atypicum 686 NR_025540 clade_229 N N Corynebacteriummastitidis 708 AB359395 clade_229 N N Corynebacterium sp. NML 725GU238411 clade_229 N N 97_0186 Mycobacterium elephantis 1275 AF385898clade_237 N OP Mycobacterium paraterrae 1288 EU919229 clade_237 N OPMycobacterium phlei 1289 GU142920 clade_237 N OP Mycobacterium sp. 17761293 EU703152 clade_237 N N Mycobacterium sp. 1781 1294 EU703147clade_237 N N Mycobacterium sp. AQ1GA4 1297 HM210417 clade_237 N NMycobacterium sp. GN_10546 1299 FJ497243 clade_237 N N Mycobacterium sp.GN_10827 1300 FJ497247 clade_237 N N Mycobacterium sp. GN_11124 1301FJ652846 clade_237 N N Mycobacterium sp. GN_9188 1302 FJ497240 clade_237N N Mycobacterium sp. GR_2007_210 1303 FJ555538 clade_237 N NAnoxybacillus contaminans 172 NR_029006 clade_238 N N Bacillus aeolius195 NR_025557 clade_238 N N Brevibacterium frigoritolerans 422 NR_042639clade_238 N N Geobacillus sp. E263 934 DQ647387 clade_238 N NGeobacillus sp. WCH70 935 CP001638 clade_238 N N Geobacillusthermocatenulatus 937 NR_043020 clade_238 N N Geobacillusthermoleovorans 940 NR_074931 clade_238 N N Lysinibacillus fusiformis1192 FN397522 clade_238 N N Planomicrobium koreense 1468 NR_025011clade_238 N N Sporosarcina newyorkensis 1754 AFPZ01000142 clade_238 N NSporosarcina sp. 2681 1755 GU994081 clade_238 N N Ureibacillus composti1968 NR_043746 clade_238 N N Ureibacillus suwonensis 1969 NR_043232clade_238 N N Ureibacillus terrenus 1970 NR_025394 clade_238 N NUreibacillus thermophilus 1971 NR_043747 clade_238 N N Ureibacillusthermosphaericus 1972 NR_040961 clade_238 N N Prevotella micans 1507AGWK01000061 clade_239 N N Prevotella sp. oral clone DA058 1533 AY005065clade_239 N N Prevotella sp. SEQ053 1523 JN867222 clade_239 N NTreponema socranskii 1937 NR_024868 clade_240 N OP Treponema sp.6:H:D15A_4 1938 AY005083 clade_240 N N Treponema sp. oral taxon 265 1953GU408850 clade_240 N N Treponema sp. oral taxon G85 1958 GU432215clade_240 N N Porphyromonas endodontalis 1472 ACNN01000021 clade_241 N NPorphyromonas sp. oral clone 1478 AY005068 clade_241 N N BB134Porphyromonas sp. oral clone 1479 AY005069 clade_241 N N F016Porphyromonas sp. oral clone 1480 AY207054 clade_241 N N P2PB_52 P1Porphyromonas sp. oral clone 1481 AY207057 clade_241 N N P4GB_100 P2Acidovorax sp. 98_63833 26 AY258065 clade_245 N N Comamonadaceaebacterium 663 JN585335 clade_245 N N NML000135 Comamonadaceae bacterium664 JN585331 clade_245 N N NML790751 Comamonadaceae bacterium 665JN585332 clade_245 N N NML910035 Comamonadaceae bacterium 666 JN585333clade_245 N N NML910036 Comamonas sp. NSP5 668 AB076850 clade_245 N NDelftia acidovorans 748 CP000884 clade_245 N N Xenophilus aerolatus 2018JN585329 clade_245 N N Oribacterium sp. oral taxon 078 1380 ACIQ02000009clade_246 N N Oribacterium sp. oral taxon 102 1381 GQ422713 clade_246 NN Weissella cibaria 2007 NR_036924 clade_247 N N Weissella confusa 2008NR_040816 clade_247 N N Weissella hellenica 2009 AB680902 clade_247 N NWeissella kandleri 2010 NR_044659 clade_247 N N Weissella koreensis 2011NR_075058 clade_247 N N Weissella paramesenteroides 2012 ACKU01000017clade_247 N N Weissella sp. KLDS 7.0701 2013 EU600924 clade_247 N NMobiluncus curtisii 1251 AEPZ01000013 clade_249 N N Enhydrobacteraerosaccus 785 ACYI01000081 clade_256 N N Moraxella osloensis 1262JN175341 clade_256 N N Moraxella sp. GM2 1264 JF837191 clade_256 N NBrevibacterium casei 420 JF951998 clade_257 N N Brevibacteriumepidermidis 421 NR_029262 clade_257 N N Brevibacterium sanguinis 426NR_028016 clade_257 N N Brevibacterium sp. H15 427 AB177640 clade_257 NN Acinetobacter radioresistens 35 ACVR01000010 clade_261 N NLactobacillus alimentarius 1068 NR_044701 clade_263 N N Lactobacillusfarciminis 1082 NR_044707 clade_263 N N Lactobacillus kimchii 1097NR_025045 clade_263 N N Lactobacillus nodensis 1101 NR_041629 clade_263N N Lactobacillus tucceti 1138 NR_042194 clade_263 N N Pseudomonasmendocina 1595 AAUL01000021 clade_265 N N Pseudomonas pseudoalcaligenes1598 NR_037000 clade_265 N N Pseudomonas sp. NP522b 1602 EU723211clade_265 N N Pseudomonas stutzeri 1603 AM905854 clade_265 N NPaenibacillus barcinonensis 1390 NR_042272 clade_270 N N Paenibacillusbarengoltzii 1391 NR_042756 clade_270 N N Paenibacillus chibensis 1392NR_040885 clade_270 N N Paenibacillus cookii 1393 NR_025372 clade_270 NN Paenibacillus durus 1394 NR_037017 clade_270 N N Paenibacillusglucanolyticus 1395 D78470 clade_270 N N Paenibacillus lactis 1396NR_025739 clade_270 N N Paenibacillus pabuli 1398 NR_040853 clade_270 NN Paenibacillus popilliae 1400 NR_040888 clade_270 N N Paenibacillus sp.CIP 101062 1401 HM212646 clade_270 N N Paenibacillus sp. JC66 1404JF824808 clade_270 N N Paenibacillus sp. R_27413 1405 HE586333 clade_270N N Paenibacillus sp. R_27422 1406 HE586338 clade_270 N N Paenibacillustimonensis 1408 NR_042844 clade_270 N N Rothia mucilaginosa 1651ACVO01000020 clade_271 N N Rothia nasimurium 1652 NR_025310 clade_271 NN Prevotella sp. oral taxon 302 1550 ACZK01000043 clade_280 N NPrevotella sp. oral taxon F68 1556 HM099652 clade_280 N N Prevotellatannerae 1563 ACIJ02000018 clade_280 N N Prevotellaceae bacterium P4P_621566 AY207061 clade_280 N N P1 Porphyromonas asaccharolytica 1471AENO01000048 clade_281 N N Porphyromonas gingivalis 1473 AE015924clade_281 N N Porphyromonas macacae 1475 NR_025908 clade_281 N NPorphyromonas sp. UQD 301 1477 EU012301 clade_281 N N Porphyromonasuenonis 1482 ACLR01000152 clade_281 N N Leptotrichia buccalis 1165CP001685 clade_282 N N Leptotrichia hofstadii 1168 ACVB02000032clade_282 N N Leptotrichia sp. oral clone HE012 1173 AY349386 clade_282N N Leptotrichia sp. oral taxon 223 1176 GU408547 clade_282 N NBacteroides fluxus 278 AFBN01000029 clade_285 N N Bacteroides helcogenes281 CP002352 clade_285 N N Parabacteroides johnsonii 1419 ABYH01000014clade_286 N N Parabacteroides merdae 1420 EU136685 clade_286 N NTreponema denticola 1926 ADEC01000002 clade_288 N OP Treponema genomosp.P5 oral 1929 DQ003624 clade_288 N N clone MB3_P23 Treponema putidum 1935AJ543428 clade_288 N OP Treponema sp. oral clone 1942 AY207055 clade_288N N P2PB_53 P3 Treponema sp. oral taxon 247 1949 GU408748 clade_288 N NTreponema sp. oral taxon 250 1950 GU408776 clade_288 N N Treponema sp.oral taxon 251 1951 GU408781 clade_288 N N Anaerococcus hydrogenalis 144ABXA01000039 clade_289 N N Anaerococcus sp. 8404299 148 HM587318clade_289 N N Anaerococcus sp. gpac215 156 AM176540 clade_289 N NAnaerococcus vaginalis 158 ACXU01000016 clade_289 N N Propionibacteriumacidipropionici 1569 NC_019395 clade_290 N N Propionibacterium avidum1571 AJ003055 clade_290 N N Propionibacterium granulosum 1573 FJ785716clade_290 N N Propionibacterium jensenii 1574 NR_042269 clade_290 N NPropionibacterium propionicum 1575 NR_025277 clade_290 N NPropionibacterium sp. H456 1577 AB177643 clade_290 N N Propionibacteriumthoenii 1581 NR_042270 clade_290 N N Bifidobacterium bifidum 349ABQP01000027 clade_293 N N Leuconostoc mesenteroides 1183 ACKV01000113clade_295 N N Leuconostoc 1184 NR_040814 clade_295 N Npseudomesenteroides Johnsonella ignava 1016 X87152 clade_298 N NPropionibacterium acnes 1570 ADJM01000010 clade_299 N NPropionibacterium sp. 434_HC2 1576 AFIL01000035 clade_299 N NPropionibacterium sp. LG 1578 AY354921 clade_299 N N Propionibacteriumsp. S555a 1579 AB264622 clade_299 N N Alicyclobacillus sp. CCUG 53762128 HE613268 clade_301 N N Actinomyces cardiffensis 53 GU470888clade_303 N N Actinomyces funkei 55 HQ906497 clade_303 N N Actinomycessp. HKU31 74 HQ335393 clade_303 N N Actinomyces sp. oral taxon C55 94HM099646 clade_303 N N Kerstersia gyiorum 1018 NR_025669 clade_307 N NPigmentiphaga daeguensis 1467 JN585327 clade_307 N N Aeromonasallosaccharophila 104 S39232 clade_308 N N Aeromonas enteropelogenes 105X71121 clade_308 N N Aeromonas hydrophila 106 NC_008570 clade_308 N NAeromonas jandaei 107 X60413 clade_308 N N Aeromonas salmonicida 108NC_009348 clade_308 N N Aeromonas trota 109 X60415 clade_308 N NAeromonas veronii 110 NR_044845 clade_308 N N Marvinbryantiaformatexigens 1196 AJ505973 clade_309 N N Rhodobacter sp. oral taxon C301620 HM099648 clade_310 N N Rhodobacter sphaeroides 1621 CP000144clade_310 N N Lactobacillus antri 1071 ACLL01000037 clade_313 N NLactobacillus coleohominis 1076 ACOH01000030 clade_313 N N Lactobacillusfermentum 1083 CP002033 clade_313 N N Lactobacillus gastricus 1085AICN01000060 clade_313 N N Lactobacillus mucosae 1099 FR693800 clade_313N N Lactobacillus oris 1103 AEKL01000077 clade_313 N N Lactobacilluspontis 1111 HM218420 clade_313 N N Lactobacillus reuteri 1112ACGW02000012 clade_313 N N Lactobacillus sp. KLDS 1.0707 1127 EU600911clade_313 N N Lactobacillus sp. KLDS 1.0709 1128 EU600913 clade_313 N NLactobacillus sp. KLDS 1.0711 1129 EU600915 clade_313 N N Lactobacillussp. KLDS 1.0713 1131 EU600917 clade_313 N N Lactobacillus sp. KLDS1.0716 1132 EU600921 clade_313 N N Lactobacillus sp. KLDS 1.0718 1133EU600922 clade_313 N N Lactobacillus sp. oral taxon 052 1137 GQ422710clade_313 N N Lactobacillus vaginalis 1140 ACGV01000168 clade_313 N NBrevibacterium aurantiacum 419 NR_044854 clade_314 N N Brevibacteriumlinens 423 AJ315491 clade_314 N N Lactobacillus pentosus 1108 JN813103clade_315 N N Lactobacillus plantarum 1110 ACGZ02000033 clade_315 N NLactobacillus sp. KLDS 1.0702 1123 EU600906 clade_315 N N Lactobacillussp. KLDS 1.0703 1124 EU600907 clade_315 N N Lactobacillus sp. KLDS1.0704 1125 EU600908 clade_315 N N Lactobacillus sp. KLDS 1.0705 1126EU600909 clade_315 N N Agrobacterium radiobacter 115 CP000628 clade_316N N Agrobacterium tumefaciens 116 AJ389893 clade_316 N N Corynebacteriumargentoratense 685 EF463055 clade_317 N N Corynebacterium diphtheriae693 NC_002935 clade_317 N OP Corynebacterium 715 NR_037070 clade_317 N Npseudotuberculosis Corynebacterium renale 717 NR_037069 clade_317 N NCorynebacterium ulcerans 731 NR_074467 clade_317 N N Aurantimonascoralicida 191 AY065627 clade_318 N N Aureimonas altamirensis 192FN658986 clade_318 N N Lactobacillus acidipiscis 1066 NR_024718clade_320 N N Lactobacillus salivarius 1117 AEBA01000145 clade_320 N NLactobacillus sp. KLDS 1.0719 1134 EU600923 clade_320 N N Lactobacillusbuchneri 1073 ACGH01000101 clade_321 N N Lactobacillus genomosp. C1 1086AY278619 clade_321 N N Lactobacillus genomosp. C2 1087 AY278620clade_321 N N Lactobacillus hilgardii 1089 ACGP01000200 clade_321 N NLactobacillus kefiri 1096 NR_042230 clade_321 N N Lactobacillusparabuchneri 1105 NR_041294 clade_321 N N Lactobacillus parakefiri 1107NR_029039 clade_321 N N Lactobacillus curvatus 1079 NR_042437 clade_322N N Lactobacillus sakei 1116 DQ989236 clade_322 N N Aneurinibacillusaneurinilyticus 167 AB101592 clade_323 N N Aneurinibacillus danicus 168NR_028657 clade_323 N N Aneurinibacillus migulanus 169 NR_036799clade_323 N N Aneurinibacillus terranovensis 170 NR_042271 clade_323 N NStaphylococcus aureus 1757 CP002643 clade_325 N Category- BStaphylococcus auricularis 1758 JQ624774 clade_325 N N Staphylococcuscapitis 1759 ACFR01000029 clade_325 N N Staphylococcus caprae 1760ACRH01000033 clade_325 N N Staphylococcus carnosus 1761 NR_075003clade_325 N N Staphylococcus cohnii 1762 JN175375 clade_325 N NStaphylococcus condimenti 1763 NR_029345 clade_325 N N Staphylococcusepidermidis 1764 ACHE01000056 clade_325 N N Staphylococcus equorum 1765NR_027520 clade_325 N N Staphylococcus haemolyticus 1767 NC_007168clade_325 N N Staphylococcus hominis 1768 AM157418 clade_325 N NStaphylococcus lugdunensis 1769 AEQA01000024 clade_325 N NStaphylococcus pasteuri 1770 FJ189773 clade_325 N N Staphylococcuspseudintermedius 1771 CP002439 clade_325 N N Staphylococcussaccharolyticus 1772 NR_029158 clade_325 N N Staphylococcussaprophyticus 1773 NC_007350 clade_325 N N Staphylococcus sp. clonebottae7 1777 AF467424 clade_325 N N Staphylococcus sp. H292 1775AB177642 clade_325 N N Staphylococcus sp. H780 1776 AB177644 clade_325 NN Staphylococcus succinus 1778 NR_028667 clade_325 N N Staphylococcuswarneri 1780 ACPZ01000009 clade_325 N N Staphylococcus xylosus 1781AY395016 clade_325 N N Cardiobacterium hominis 490 ACKY01000036clade_326 N N Cardiobacterium valvarum 491 NR_028847 clade_326 N NPseudomonas fluorescens 1593 AY622220 clade_326 N N Pseudomonasgessardii 1594 FJ943496 clade_326 N N Pseudomonas monteilii 1596NR_024910 clade_326 N N Pseudomonas poae 1597 GU188951 clade_326 N NPseudomonas putida 1599 AF094741 clade_326 N N Pseudomonas sp. G12291601 DQ910482 clade_326 N N Pseudomonas tolaasii 1604 AF320988 clade_326N N Pseudomonas viridiflava 1605 NR_042764 clade_326 N N Listeria grayi1185 ACCR02000003 clade_328 N OP Listeria innocua 1186 JF967625clade_328 N N Listeria ivanovii 1187 X56151 clade_328 N N Listeriamonocytogenes 1188 CP002003 clade_328 N Category- B Listeria welshimeri1189 AM263198 clade_328 N OP Capnocytophaga sp. oral clone 484 AY923149clade_333 N N ASCH05 Capnocytophaga sputigena 489 ABZV01000054 clade_333N N Leptotrichia genomosp. C1 1166 AY278621 clade_334 N N Leptotrichiashahii 1169 AY029806 clade_334 N N Leptotrichia sp. neutropenicPatient1170 AF189244 clade_334 N N Leptotrichia sp. oral clone GT018 1171AY349384 clade_334 N N Leptotrichia sp. oral clone GT020 1172 AY349385clade_334 N N Bacteroides sp. 20_3 296 ACRQ01000064 clade_335 N NBacteroides sp. 3_1_19 307 ADCJ01000062 clade_335 N N Bacteroides sp.3_2_5 311 ACIB01000079 clade_335 N N Parabacteroides distasonis 1416CP000140 clade_335 N N Parabacteroides goldsteinii 1417 AY974070clade_335 N N Parabacteroides gordonii 1418 AB470344 clade_335 N NParabacteroides sp. D13 1421 ACPW01000017 clade_335 N N Capnocytophagagenomosp. C1 477 AY278613 clade_336 N N Capnocytophaga ochracea 480AEOH01000054 clade_336 N N Capnocytophaga sp. GEJ8 481 GU561335clade_336 N N Capnocytophaga sp. oral strain 486 AY005077 clade_336 N NA47ROY Capnocytophaga sp. S1b 482 U42009 clade_336 N N Paraprevotellaclara 1426 AFFY01000068 clade_336 N N Bacteroides heparinolyticus 282JN867284 clade_338 N N Prevotella heparinolytica 1500 GQ422742 clade_338N N Treponema genomosp. P4 oral 1928 DQ003618 clade_339 N N cloneMB2_G19 Treponema genomosp. P6 oral 1930 DQ003625 clade_339 N N cloneMB4_G11 Treponema sp. oral taxon 254 1952 GU408803 clade_339 N NTreponema sp. oral taxon 508 1956 GU413616 clade_339 N N Treponema sp.oral taxon 518 1957 GU413640 clade_339 N N Chlamydia muridarum 502AE002160 clade_341 N OP Chlamydia trachomatis 504 U68443 clade_341 N OPChlamydia psittaci 503 NR_036864 clade_342 N Category- B Chlamydophilapneumoniae 509 NC_002179 clade_342 N OP Chlamydophila psittaci 510D85712 clade_342 N OP Anaerococcus octavius 146 NR_026360 clade_343 N NAnaerococcus sp. 8405254 149 HM587319 clade_343 N N Anaerococcus sp.9401487 150 HM587322 clade_343 N N Anaerococcus sp. 9403502 151 HM587325clade_343 N N Gardnerella vaginalis 923 CP001849 clade_344 N NCampylobacter lari 466 CP000932 clade_346 N OP Anaerobiospirillum 142NR_026075 clade_347 N N succiniciproducens Anaerobiospirillum thomasii143 AJ420985 clade_347 N N Ruminobacter amylophilus 1654 NR_026450clade_347 N N Succinatimonas hippei 1897 AEV001000027 clade_347 N NActinomyces europaeus 54 NR_026363 clade_348 N N Actinomyces sp. oralclone GU009 82 AY349361 clade_348 N N Moraxella catarrhalis 1260CP002005 clade_349 N N Moraxella lincolnii 1261 FR822735 clade_349 N NMoraxella sp. 16285 1263 JF682466 clade_349 N N Psychrobacter sp. 139831613 HM212668 clade_349 N N Actinobaculum massiliae 49 AF487679clade_350 N N Actinobaculum schaalii 50 AY957507 clade_350 N NActinobaculum sp. BM#101342 51 AY282578 clade_350 N N Actinobaculum sp.P2P_19 P1 52 AY207066 clade_350 N N Actinomyces sp. oral clone 1O076 84AY349363 clade_350 N N Actinomyces sp. oral taxon 848 93 ACUY01000072clade_350 N N Actinomyces neuii 65 X71862 clade_352 N N Mobiluncusmulieris 1252 ACKW01000035 clade_352 N N Blastomonas natatoria 372NR_040824 clade_356 N N Novosphingobium aromaticivorans 1357AAAV03000008 clade_356 N N Sphingomonas sp. oral clone 1745 AY349411clade_356 N N FI012 Sphingopyxis alaskensis 1749 CP000356 clade_356 N NOxalobacter formigenes 1389 ACDQ01000020 clade_357 N N Veillonellaatypica 1974 AEDS01000059 clade_358 N N Veillonella dispar 1975ACIK02000021 clade_358 N N Veillonella genomosp. P1 oral 1976 DQ003631clade_358 N N clone MB5_P17 Veillonella parvula 1978 ADFU01000009clade_358 N N Veillonella sp. 3_1_44 1979 ADCV01000019 clade_358 N NVeillonella sp. 6_1_27 1980 ADCW01000016 clade_358 N N Veillonella sp.ACP1 1981 HQ616359 clade_358 N N Veillonella sp. AS16 1982 HQ616365clade_358 N N Veillonella sp. BS32b 1983 HQ616368 clade_358 N NVeillonella sp. ICM51a 1984 HQ616396 clade_358 N N Veillonella sp. MSA121985 HQ616381 clade_358 N N Veillonella sp. NVG 100cf 1986 EF108443clade_358 N N Veillonella sp. OK11 1987 JN695650 clade_358 N NVeillonella sp. oral clone ASCG01 1990 AY923144 clade_358 N NVeillonella sp. oral clone ASCG02 1991 AY953257 clade_358 N NVeillonella sp. oral clone OH1A 1992 AY947495 clade_358 N N Veillonellasp. oral taxon 158 1993 AENU01000007 clade_358 N N Kocuria marina 1040GQ260086 clade_365 N N Kocuria rhizophila 1042 AY030315 clade_365 N NKocuria rosea 1043 X87756 clade_365 N N Kocuria varians 1044 AF542074clade_365 N N Clostridiaceae bacterium END_2 531 EF451053 clade_368 N NMicrococcus antarcticus 1242 NR_025285 clade_371 N N Micrococcus luteus1243 NR_075062 clade_371 N N Micrococcus lylae 1244 NR_026200 clade_371N N Micrococcus sp. 185 1245 EU714334 clade_371 N N Lactobacillus brevis1072 EU194349 clade_372 N N Lactobacillus parabrevis 1104 NR_042456clade_372 N N Pediococcus acidilactici 1436 ACXB01000026 clade_372 N NPediococcus pentosaceus 1437 NR_075052 clade_372 N N Lactobacillusdextrinicus 1081 NR_036861 clade_373 N N Lactobacillus perolens 1109NR_029360 clade_373 N N Lactobacillus rhamnosus 1113 ABWJ01000068clade_373 N N Lactobacillus saniviri 1118 AB602569 clade_373 N NLactobacillus sp. BT6 1121 HQ616370 clade_373 N N Mycobacteriummageritense 1282 FR798914 clade_374 N OP Mycobacterium neoaurum 1286AF268445 clade_374 N OP Mycobacterium smegmatis 1291 CP000480 clade_374N OP Mycobacterium sp. HE5 1304 AJ012738 clade_374 N N Dysgonomonasgadei 775 ADLV01000001 clade_377 N N Dysgonomonas mossii 776ADLW01000023 clade_377 N N Porphyromonas levii 1474 NR_025907 clade_377N N Porphyromonas somerae 1476 AB547667 clade_377 N N Bacteroidesbarnesiae 267 NR_041446 clade_378 N N Bacteroides coprocola 272ABIY02000050 clade_378 N N Bacteroides coprophilus 273 ACBW01000012clade_378 N N Bacteroides dorei 274 ABWZ01000093 clade_378 N NBacteroides massiliensis 284 AB200226 clade_378 N N Bacteroides plebeius289 AB200218 clade_378 N N Bacteroides sp. 3_1_33FAA 309 ACPS01000085clade_378 N N Bacteroides sp. 3_1_40A 310 ACRT01000136 clade_378 N NBacteroides sp. 4_3_47FAA 313 ACDR02000029 clade_378 N N Bacteroides sp.9_1_42FAA 314 ACAA01000096 clade_378 N N Bacteroides sp. NB_8 323AB117565 clade_378 N N Bacteroides vulgatus 331 CP000139 clade_378 N NBacteroides ovatus 287 ACWH01000036 clade_38 N N Bacteroides sp. 1_1_30294 ADCL01000128 clade_38 N N Bacteroides sp. 2_1_22 297 ACPQ01000117clade_38 N N Bacteroides sp. 2_2_4 299 ABZZ01000168 clade_38 N NBacteroides sp. 3_1_23 308 ACRS01000081 clade_38 N N Bacteroides sp. D1318 ACAB02000030 clade_38 N N Bacteroides sp. D2 321 ACGA01000077clade_38 N N Bacteroides sp. D22 320 ADCK01000151 clade_38 N NBacteroides xylanisolvens 332 ADKP01000087 clade_38 N N Treponemalecithinolyticum 1931 NR_026247 clade_380 N OP Treponema parvum 1933AF302937 clade_380 N OP Treponema sp. oral clone JU025 1940 AY349417clade_380 N N Treponema sp. oral taxon 270 1954 GQ422733 clade_380 N NParascardovia denticolens 1428 ADEB01000020 clade_381 N N Scardoviainopinata 1688 AB029087 clade_381 N N Scardovia wiggsiae 1689 AY278626clade_381 N N Clostridiales bacterium 9400853 533 HM587320 clade_384 N NMogibacterium diversum 1254 NR_027191 clade_384 N N Mogibacteriumneglectum 1255 NR_027203 clade_384 N N Mogibacterium pumilum 1256NR_028608 clade_384 N N Mogibacterium timidum 1257 Z36296 clade_384 N NBorrelia burgdorferi 389 ABGI01000001 clade_386 N OP Borrelia garinii392 ABJV01000001 clade_386 N OP Borrelia sp. NE49 397 AJ224142 clade_386N OP Caldimonas manganoxidans 457 NR_040787 clade_387 N N Comamonadaceaebacterium oral 667 HM099651 clade_387 N N taxon F47 Lautropia mirabilis1149 AEQP01000026 clade_387 N N Lautropia sp. oral clone AP009 1150AY005030 clade_387 N N Peptoniphilus asaccharolyticus 1441 D14145clade_389 N N Peptoniphilus duerdenii 1442 EU526290 clade_389 N NPeptoniphilus harei 1443 NR_026358 clade_389 N N Peptoniphilus indolicus1444 AY153431 clade_389 N N Peptoniphilus lacrimalis 1446 ADDO01000050clade_389 N N Peptoniphilus sp. gpac077 1450 AM176527 clade_389 N NPeptoniphilus sp. JC140 1447 JF824803 clade_389 N N Peptoniphilus sp.oral taxon 386 1452 ADCS01000031 clade_389 N N Peptoniphilus sp. oraltaxon 836 1453 AEAA01000090 clade_389 N N Peptostreptococcaceaebacterium 1454 JN837495 clade_389 N N ph1 Dialister pneumosintes 765HM596297 clade_390 N N Dialister sp. oral taxon 502 767 GQ422739clade_390 N N Cupriavidus metallidurans 741 GU230889 clade_391 N NHerbaspirillum seropedicae 1001 CP002039 clade_391 N N Herbaspirillumsp. JC206 1002 JN657219 clade_391 N N Janthinobacterium sp. SY12 1015EF455530 clade_391 N N Massilia sp. CCUG 43427A 1197 FR773700 clade_391N N Ralstonia pickettii 1615 NC_010682 clade_391 N N Ralstonia sp.5_7_47FAA 1616 ACUF01000076 clade_391 N N Francisella novicida 889ABSS01000002 clade_392 N N Francisella philomiragia 890 AY928394clade_392 N N Francisella tularensis 891 ABAZ01000082 clade_392 NCategory- A Ignatzschineria indica 1009 HQ823562 clade_392 N NIgnatzschineria sp. NML 95_0260 1010 HQ823559 clade_392 N NStreptococcus mutans 1814 AP010655 clade_394 N N Lactobacillus gasseri1084 ACOZ01000018 clade_398 N N Lactobacillus hominis 1090 FR681902clade_398 N N Lactobacillus iners 1091 AEKJ01000002 clade_398 N NLactobacillus johnsonii 1093 AE017198 clade_398 N N Lactobacillussenioris 1119 AB602570 clade_398 N N Lactobacillus sp. oral clone HT0021135 AY349382 clade_398 N N Weissella beninensis 2006 EU439435 clade_398N N Sphingomonas echinoides 1744 NR_024700 clade_399 N N Sphingomonassp. oral taxon A09 1747 HM099639 clade_399 N N Sphingomonas sp. oraltaxon F71 1748 HM099645 clade_399 N N Zymomonas mobilis 2032 NR_074274clade_399 N N Arcanobacterium haemolyticum 174 NR_025347 clade_400 N NArcanobacterium pyogenes 175 GU585578 clade_400 N N Trueperella pyogenes1962 NR_044858 clade_400 N N Lactococcus garvieae 1144 AF061005clade_401 N N Lactococcus lactis 1145 CP002365 clade_401 N NBrevibacterium mcbrellneri 424 ADNU01000076 clade_402 N N Brevibacteriumpaucivorans 425 EU086796 clade_402 N N Brevibacterium sp. JC43 428JF824806 clade_402 N N Selenomonas artemidis 1692 HM596274 clade_403 N NSelenomonas sp. FOBRC9 1704 HQ616378 clade_403 N N Selenomonas sp. oraltaxon 137 1715 AENV01000007 clade_403 N N Desmospora activa 751 AM940019clade_404 N N Desmospora sp. 8437 752 AFHT01000143 clade_404 N NPaenibacillus sp. oral taxon F45 1407 HM099647 clade_404 N NCorynebacterium ammoniagenes 682 ADNS01000011 clade_405 N NCorynebacterium aurimucosum 687 ACLH01000041 clade_405 N NCorynebacterium bovis 688 AF537590 clade_405 N N Corynebacterium canis689 GQ871934 clade_405 N N Corynebacterium casei 690 NR_025101 clade_405N N Corynebacterium durum 694 Z97069 clade_405 N N Corynebacteriumefficiens 695 ACLI01000121 clade_405 N N Corynebacterium falsenii 696Y13024 clade_405 N N Corynebacterium flavescens 697 NR_037040 clade_405N N Corynebacterium glutamicum 701 BA000036 clade_405 N NCorynebacterium jeikeium 704 ACYW01000001 clade_405 N OP Corynebacteriumkroppenstedtii 705 NR_026380 clade_405 N N Corynebacteriumlipophiloflavum 706 ACHJ01000075 clade_405 N N Corynebacteriummatruchotii 709 ACSH02000003 clade_405 N N Corynebacterium minutissimum710 X82064 clade_405 N N Corynebacterium resistens 718 ADGN01000058clade_405 N N Corynebacterium simulans 720 AF537604 clade_405 N NCorynebacterium singulare 721 NR_026394 clade_405 N N Corynebacteriumsp. 1 ex sheep 722 Y13427 clade_405 N N Corynebacterium sp. NML 726GU238413 clade_405 N N 99_0018 Corynebacterium striatum 727 ACGE01000001clade_405 N OP Corynebacterium urealyticum 732 X81913 clade_405 N OPCorynebacterium variabile 734 NR_025314 clade_405 N N Aerococcussanguinicola 98 AY837833 clade_407 N N Aerococcus urinae 99 CP002512clade_407 N N Aerococcus urinaeequi 100 NR_043443 clade_407 N NAerococcus viridans 101 ADNT01000041 clade_407 N N Fusobacteriumnaviforme 898 HQ223106 clade_408 N N Moryella indoligenes 1268 AF527773clade_408 N N Selenomonas genomosp. P5 1697 AY341820 clade_410 N NSelenomonas sp. oral clone IQ048 1710 AY349408 clade_410 N N Selenomonassputigena 1717 ACKP02000033 clade_410 N N Hyphomicrobium sulfonivorans1007 AY468372 clade_411 N N Methylocella silvestris 1228 NR_074237clade_411 N N Legionella pneumophila 1153 NC_002942 clade_412 N OPLactobacillus coryniformis 1077 NR_044705 clade_413 N N Arthrobacteragilis 178 NR_026198 clade_414 N N Arthrobacter arilaitensis 179NR_074608 clade_414 N N Arthrobacter bergerei 180 NR_025612 clade_414 NN Arthrobacter globiformis 181 NR_026187 clade_414 N N Arthrobacternicotianae 182 NR_026190 clade_414 N N Mycobacterium abscessus 1269AGQU01000002 clade_418 N OP Mycobacterium chelonae 1273 AB548610clade_418 N OP Bacteroides salanitronis 291 CP002530 clade_419 N NParaprevotella xylaniphila 1427 AFBR01000011 clade_419 N N Barnesiellaintestinihominis 336 AB370251 clade_420 N N Barnesiella viscericola 337NR_041508 clade_420 N N Parabacteroides sp. NS31_3 1422 JN029805clade_420 N N Porphyromonadaceae bacterium 1470 EF184292 clade_420 N NNML 060648 Tannerella forsythia 1913 CP003191 clade_420 N N Tannerellasp. 6_1_58FAA_CT1 1914 ACWX01000068 clade_420 N N Mycoplasmaamphoriforme 1311 AY531656 clade_421 N N Mycoplasma genitalium 1317L43967 clade_421 N N Mycoplasma pneumoniae 1322 NC_000912 clade_421 N NMycoplasma penetrans 1321 NC_004432 clade_422 N N Ureaplasma parvum 1966AE002127 clade_422 N N Ureaplasma urealyticum 1967 AAYN01000002clade_422 N N Treponema genomosp. P1 1927 AY341822 clade_425 N NTreponema sp. oral taxon 228 1943 GU408580 clade_425 N N Treponema sp.oral taxon 230 1944 GU408603 clade_425 N N Treponema sp. oral taxon 2311945 GU408631 clade_425 N N Treponema sp. oral taxon 232 1946 GU408646clade_425 N N Treponema sp. oral taxon 235 1947 GU408673 clade_425 N NTreponema sp. ovine footrot 1959 AJ010951 clade_425 N N Treponemavincentii 1960 ACYH01000036 clade_425 N OP Burkholderiales bacterium1_1_47 452 ADCQ01000066 clade_432 N OP Parasutterella excrementihominis1429 AFBP01000029 clade_432 N N Parasutterella secunda 1430 AB491209clade_432 N N Sutterella morbirenis 1898 AJ832129 clade_432 N NSutterella sanguinus 1900 AJ748647 clade_432 N N Sutterella sp. YIT12072 1901 AB491210 clade_432 N N Sutterella stercoricanis 1902NR_025600 clade_432 N N Sutterella wadsworthensis 1903 ADMF01000048clade_432 N N Propionibacterium freudenreichii 1572 NR_036972 clade_433N N Propionibacterium sp. oral taxon 1580 GQ422728 clade_433 N N 192Tessaracoccus sp. oral taxon F04 1917 HM099640 clade_433 N NPeptoniphilus ivorii 1445 Y07840 clade_434 N N Peptoniphilus sp. gpac0071448 AM176517 clade_434 N N Peptoniphilus sp. gpac018A 1449 AM176519clade_434 N N Peptoniphilus sp. gpac148 1451 AM176535 clade_434 N NFlexispira rappini 887 AY126479 clade_436 N N Helicobacter bilis 993ACDN01000023 clade_436 N N Helicobacter cinaedi 995 ABQT01000054clade_436 N N Helicobacter sp. None 998 U44756 clade_436 N NBrevundimonas subvibrioides 429 CP002102 clade_438 N N Hyphomonasneptunium 1008 NR_074092 clade_438 N N Phenylobacterium zucineum 1465AY628697 clade_438 N N Streptococcus downei 1793 AEKN01000002 clade_441N N Streptococcus sp. SHV515 1848 Y07601 clade_441 N N Acinetobacter sp.CIP 53.82 40 JQ638584 clade_443 N N Halomonas elongata 990 NR_074782clade_443 N N Halomonas johnsoniae 991 FR775979 clade_443 N NButyrivibrio fibrisolvens 456 U41172 clade_444 N N Roseburia sp. 11SE371640 FM954975 clade_444 N N Roseburia sp. 11SE38 1641 FM954976 clade_444N N Shuttleworthia satelles 1728 ACIP02000004 clade_444 N NShuttleworthia sp. MSX8B 1729 HQ616383 clade_444 N N Shuttleworthia sp.oral taxon G69 1730 GU432167 clade_444 N N Bdellovibrio sp. MPA 344AY294215 clade_445 N N Desulfobulbus sp. oral clone 755 AY005036clade_445 N N CH031 Desulfovibrio desulfuricans 757 DQ092636 clade_445 NN Desulfovibrio fairfieldensis 758 U42221 clade_445 N N Desulfovibriopiger 759 AF192152 clade_445 N N Desulfovibrio sp. 3_1_syn3 760ADDR01000239 clade_445 N N Geobacter bemidjiensis 941 CP001124 clade_445N N Brachybacterium alimentarium 401 NR_026269 clade_446 N NBrachybacterium conglomeratum 402 AB537169 clade_446 N N Brachybacteriumtyrofermentans 403 NR_026272 clade_446 N N Dermabacter hominis 749FJ263375 clade_446 N N Aneurinibacillus thermoaerophilus 171 NR_029303clade_448 N N Brevibacillus agri 409 NR_040983 clade_448 N NBrevibacillus centrosporus 411 NR_043414 clade_448 N N Brevibacilluschoshinensis 412 NR_040980 clade_448 N N Brevibacillus invocatus 413NR_041836 clade_448 N N Brevibacillus parabrevis 415 NR_040981 clade_448N N Brevibacillus reuszeri 416 NR_040982 clade_448 N N Brevibacillus sp.phR 417 JN837488 clade_448 N N Brevibacillus thermoruber 418 NR_026514clade_448 N N Lactobacillus murinus 1100 NR_042231 clade_449 N NLactobacillus oeni 1102 NR_043095 clade_449 N N Lactobacillus ruminis1115 ACGS02000043 clade_449 N N Lactobacillus vini 1141 NR_042196clade_449 N N Gemella haemolysans 924 ACDZ02000012 clade_450 N N Gemellamorbillorum 925 NR_025904 clade_450 N N Gemella morbillorum 926ACRX01000010 clade_450 N N Gemella sanguinis 927 ACRY01000057 clade_450N N Gemella sp. oral clone ASCE02 929 AY923133 clade_450 N N Gemella sp.oral clone ASCF04 930 AY923139 clade_450 N N Gemella sp. oral cloneASCF12 931 AY923143 clade_450 N N Gemella sp. WAL 1945J 928 EU427463clade_450 N N Sporolactobacillus nakayamae 1753 NR_042247 clade_451 N NGluconacetobacter entanii 945 NR_028909 clade_452 N N Gluconacetobactereuropaeus 946 NR_026513 clade_452 N N Gluconacetobacter hansenii 947NR_026133 clade_452 N N Gluconacetobacter oboediens 949 NR_041295clade_452 N N Gluconacetobacter xylinus 950 NR_074338 clade_452 N NAuritibacter ignavus 193 FN554542 clade_453 N N Dermacoccus sp. Ellin185750 AEIQ01000090 clade_453 N N Janibacter limosus 1013 NR_026362clade_453 N N Janibacter melonis 1014 EF063716 clade_453 N N Acetobacteraceti 7 NR_026121 clade_454 N N Acetobacter fabarum 8 NR_042678clade_454 N N Acetobacter lovaniensis 9 NR_040832 clade_454 N NAcetobacter malorum 10 NR_025513 clade_454 N N Acetobacter orientalis 11NR_028625 clade_454 N N Acetobacter pasteurianus 12 NR_026107 clade_454N N Acetobacter pomorum 13 NR_042112 clade_454 N N Acetobacter syzygii14 NR_040868 clade_454 N N Acetobacter tropicalis 15 NR_036881 clade_454N N Gluconacetobacter azotocaptans 943 NR_028767 clade_454 N NGluconacetobacter diazotrophicus 944 NR_074292 clade_454 N NGluconacetobacter johannae 948 NR_024959 clade_454 N N Nocardiabrasiliensis 1351 AIHV01000038 clade_455 N N Nocardia cyriacigeorgica1352 HQ009486 clade_455 N N Nocardia purls 1354 NR_028994 clade_455 N NNocardia sp. 01_Je_025 1355 GU574059 clade_455 N N Rhodococcus equi 1623ADNW01000058 clade_455 N N Oceanobacillus caeni 1358 NR_041533 clade_456N N Oceanobacillus sp. Ndiop 1359 CAER01000083 clade_456 N NOrnithinibacillus bavariensis 1384 NR_044923 clade_456 N NOrnithinibacillus sp. 7_10AIA 1385 FN397526 clade_456 N N Virgibacillusproomii 2005 NR_025308 clade_456 N N Corynebacterium amycolatum 683ABZU01000033 clade_457 N OP Corynebacterium hansenii 702 AM946639clade_457 N N Corynebacterium xerosis 735 FN179330 clade_457 N OPStaphylococcaceae bacterium 1756 AY841362 clade_458 N N NML 92_0017Staphylococcus fleurettii 1766 NR_041326 clade_458 N N Staphylococcussciuri 1774 NR_025520 clade_458 N N Staphylococcus vitulinus 1779NR_024670 clade_458 N N Stenotrophomonas maltophilia 1782 AAVZ01000005clade_459 N N Stenotrophomonas sp. FG_6 1783 EF017810 clade_459 N NMycobacterium africanum 1270 AF480605 clade_46 N OP Mycobacteriumalsiensis 1271 AJ938169 clade_46 N OP Mycobacterium avium 1272 CP000479clade_46 N OP Mycobacterium colombiense 1274 AM062764 clade_46 N OPMycobacterium gordonae 1276 GU142930 clade_46 N OP Mycobacteriumintracellulare 1277 GQ153276 clade_46 N OP Mycobacterium kansasii 1278AF480601 clade_46 N OP Mycobacterium lacus 1279 NR_025175 clade_46 N OPMycobacterium leprae 1280 FM211192 clade_46 N OP Mycobacteriumlepromatosis 1281 EU203590 clade_46 N OP Mycobacterium mantenii 1283FJ042897 clade_46 N OP Mycobacterium marinum 1284 NC_010612 clade_46 NOP Mycobacterium microti 1285 NR_025234 clade_46 N OP Mycobacteriumparascrofulaceum 1287 ADNV01000350 clade_46 N OP Mycobacterium seoulense1290 DQ536403 clade_46 N OP Mycobacterium sp. 1761 1292 EU703150clade_46 N N Mycobacterium sp. 1791 1295 EU703148 clade_46 N NMycobacterium sp. 1797 1296 EU703149 clade_46 N N Mycobacterium sp. 1298HQ174245 clade_46 N N B10_07.09.0206 Mycobacterium sp. NLA001000736 1305HM627011 clade_46 N N Mycobacterium sp. W 1306 DQ437715 clade_46 N NMycobacterium tuberculosis 1307 CP001658 clade_46 N Category- CMycobacterium ulcerans 1308 AB548725 clade_46 N OP Mycobacteriumvulneris 1309 EU834055 clade_46 N OP Xanthomonas campestris 2016EF101975 clade_461 N N Xanthomonas sp. kmd_489 2017 EU723184 clade_461 NN Dietzia natronolimnaea 769 GQ870426 clade_462 N N Dietzia sp. BBDP51770 DQ337512 clade_462 N N Dietzia sp. CA149 771 GQ870422 clade_462 N NDietzia timorensis 772 GQ870424 clade_462 N N Gordonia bronchialis 951NR_027594 clade_463 N N Gordonia polyisoprenivorans 952 DQ385609clade_463 N N Gordonia sp. KTR9 953 DQ068383 clade_463 N N Gordoniasputi 954 FJ536304 clade_463 N N Gordonia terrae 955 GQ848239 clade_463N N Leptotrichia goodfellowii 1167 ADAD01000110 clade_465 N NLeptotrichia sp. oral clone IK040 1174 AY349387 clade_465 N NLeptotrichia sp. oral clone 1175 AY207053 clade_465 N N P2PB_51 P1Bacteroidales genomosp. P7 oral 264 DQ003623 clade_466 N N clone MB3_P19Butyricimonas virosa 454 AB443949 clade_466 N N Odoribacter laneus 1363AB490805 clade_466 N N Odoribacter splanchnicus 1364 CP002544 clade_466N N Capnocytophaga gingivalis 478 ACLQ01000011 clade_467 N NCapnocytophaga granulosa 479 X97248 clade_467 N N Capnocytophaga sp.oral clone 483 AY005074 clade_467 N N AH015 Capnocytophaga sp. oralstrain S3 487 AY005073 clade_467 N N Capnocytophaga sp. oral taxon 488AEXX01000050 clade_467 N N 338 Capnocytophaga canimorsus 476 CP002113clade_468 N N Capnocytophaga sp. oral clone 485 AY349368 clade_468 N NID062 Lactobacillus catenaformis 1075 M23729 clade_469 N N Lactobacillusvitulinus 1142 NR_041305 clade_469 N N Cetobacterium somerae 501AJ438155 clade_470 N N Fusobacterium gonidiaformans 896 ACET01000043clade_470 N N Fusobacterium mortiferum 897 ACDB02000034 clade_470 N NFusobacterium necrogenes 899 X55408 clade_470 N N Fusobacteriumnecrophorum 900 AM905356 clade_470 N N Fusobacterium sp. 12_1B 905AGWJ01000070 clade_470 N N Fusobacterium sp. 3_1_5R 911 ACDD01000078clade_470 N N Fusobacterium sp. D12 918 ACDG02000036 clade_470 N NFusobacterium ulcerans 921 ACDH01000090 clade_470 N N Fusobacteriumvarium 922 ACIE01000009 clade_470 N N Mycoplasma arthritidis 1312NC_011025 clade_473 N N Mycoplasma faucium 1314 NR_024983 clade_473 N NMycoplasma hominis 1318 AF443616 clade_473 N N Mycoplasma orale 1319AY796060 clade_473 N N Mycoplasma salivarium 1324 M24661 clade_473 N NMitsuokella jalaludinii 1247 NR_028840 clade_474 N N Mitsuokellamultacida 1248 ABWK02000005 clade_474 N N Mitsuokella sp. oral taxon 5211249 GU413658 clade_474 N N Mitsuokella sp. oral taxon G68 1250 GU432166clade_474 N N Selenomonas genomosp. C1 1695 AY278627 clade_474 N NSelenomonas genomosp. P8 oral 1700 DQ003628 clade_474 N N clone MB5_P06Selenomonas ruminantium 1703 NR_075026 clade_474 N N Veillonellaceaebacterium oral 1994 GU402916 clade_474 N N taxon 131 Alloscardoviaomnicolens 139 NR_042583 clade_475 N N Alloscardovia sp. OB7196 140AB425070 clade_475 N N Bifidobacterium urinalis 366 AJ278695 clade_475 NN Prevotella loescheii 1503 JN867231 clade_48 N N Prevotella sp. oralclone ASCG12 1530 DQ272511 clade_48 N N Prevotella sp. oral clone GU0271540 AY349398 clade_48 N N Prevotella sp. oral taxon 472 1553ACZS01000106 clade_48 N N Selenomonas dianae 1693 GQ422719 clade_480 N NSelenomonas flueggei 1694 AF287803 clade_480 N N Selenomonas genomosp.C2 1696 AY278628 clade_480 N N Selenomonas genomosp. P6 oral 1698DQ003636 clade_480 N N clone MB3_C41 Selenomonas genomosp. P7 oral 1699DQ003627 clade_480 N N clone MB5_C08 Selenomonas infelix 1701 AF287802clade_480 N N Selenomonas noxia 1702 GU470909 clade_480 N N Selenomonassp. oral clone FT050 1705 AY349403 clade_480 N N Selenomonas sp. oralclone GI064 1706 AY349404 clade_480 N N Selenomonas sp. oral clone 1707AY349405 clade_480 N N GT010 Selenomonas sp. oral clone 1708 AY349406clade_480 N N HU051 Selenomonas sp. oral clone IK004 1709 AY349407clade_480 N N Selenomonas sp. oral clone JI021 1711 AY349409 clade_480 NN Selenomonas sp. oral clone JS031 1712 AY349410 clade_480 N NSelenomonas sp. oral clone OH4A 1713 AY947498 clade_480 N N Selenomonassp. oral clone 1714 AY207052 clade_480 N N P2PA_80 P4 Selenomonas sp.oral taxon 149 1716 AEEJ01000007 clade_480 N N Veillonellaceae bacteriumoral 1995 GU470897 clade_480 N N taxon 155 Agrococcus jenensis 117NR_026275 clade_484 N N Microbacterium gubbeenense 1232 NR_025098clade_484 N N Pseudoclavibacter sp. Timone 1590 FJ375951 clade_484 N NTropheryma whipplei 1961 BX251412 clade_484 N N Zimmermannella bifida2031 AB012592 clade_484 N N Legionella hackeliae 1151 M36028 clade_486 NOP Legionella longbeachae 1152 M36029 clade_486 N OP Legionella sp.D3923 1154 JN380999 clade_486 N OP Legionella sp. D4088 1155 JN381012clade_486 N OP Legionella sp. H63 1156 JF831047 clade_486 N OPLegionella sp. NML 93L054 1157 GU062706 clade_486 N OP Legionellasteelei 1158 HQ398202 clade_486 N OP Tatlockia micdadei 1915 M36032clade_486 N N Helicobacter pullorum 996 ABQU01000097 clade_489 N NAcetobacteraceae bacterium 16 AGEZ01000040 clade_490 N N AT_5844Roseomonas cervicalis 1643 ADVL01000363 clade_490 N N Roseomonas mucosa1644 NR_028857 clade_490 N N Roseomonas sp. NML94_0193 1645 AF533357clade_490 N N Roseomonas sp. NML97_0121 1646 AF533359 clade_490 N NRoseomonas sp. NML98_0009 1647 AF533358 clade_490 N N Roseomonas sp.NML98_0157 1648 AF533360 clade_490 N N Rickettsia akari 1627 CP000847clade_492 N OP Rickettsia conorii 1628 AE008647 clade_492 N OPRickettsia prowazekii 1629 M21789 clade_492 N Category- B Rickettsiarickettsii 1630 NC_010263 clade_492 N OP Rickettsia slovaca 1631 L36224clade_492 N OP Rickettsia typhi 1632 AE017197 clade_492 N OPAnaeroglobus geminatus 160 AGCJ01000054 clade_493 N N Megasphaeragenomosp. C1 1201 AY278622 clade_493 N N Megasphaera micronuciformis1203 AECS01000020 clade_493 N N Clostridiales genomosp. BVAB3 540CP001850 clade_495 N N Tsukamurella paurometabola 1963 X80628 clade_496N N Tsukamurella tyrosinosolvens 1964 AB478958 clade_496 N N Abiotrophiapara_adiacens 2 AB022027 clade_497 N N Carnobacterium divergens 492NR_044706 clade_497 N N Carnobacterium maltaromaticum 493 NC_019425clade_497 N N Enterococcus avium 800 AF133535 clade_497 N N Enterococcuscaccae 801 AY943820 clade_497 N N Enterococcus casseliflavus 802AEWT01000047 clade_497 N N Enterococcus durans 803 AJ276354 clade_497 NN Enterococcus faecalis 804 AE016830 clade_497 N N Enterococcus faecium805 AM157434 clade_497 N N Enterococcus gallinarum 806 AB269767clade_497 N N Enterococcus gilvus 807 AY033814 clade_497 N NEnterococcus hawaiiensis 808 AY321377 clade_497 N N Enterococcus hirae809 AF061011 clade_497 N N Enterococcus italicus 810 AEPV01000109clade_497 N N Enterococcus mundtii 811 NR_024906 clade_497 N NEnterococcus raffinosus 812 FN600541 clade_497 N N Enterococcus sp.BV2CASA2 813 JN809766 clade_497 N N Enterococcus sp. CCRI_16620 814GU457263 clade_497 N N Enterococcus sp. F95 815 FJ463817 clade_497 N NEnterococcus sp. RfL6 816 AJ133478 clade_497 N N Enterococcusthailandicus 817 AY321376 clade_497 N N Fusobacterium canifelinum 893AY162222 clade_497 N N Fusobacterium genomosp. C1 894 AY278616 clade_497N N Fusobacterium genomosp. C2 895 AY278617 clade_497 N N Fusobacteriumperiodonticum 902 ACJY01000002 clade_497 N N Fusobacterium sp. 1_1_41FAA906 ADGG01000053 clade_497 N N Fusobacterium sp. 11_3_2 904 ACUO01000052clade_497 N N Fusobacterium sp. 2_1_31 907 ACDC02000018 clade_497 N NFusobacterium sp. 3_1_27 908 ADGF01000045 clade_497 N N Fusobacteriumsp. 3_1_33 909 ACQE01000178 clade_497 N N Fusobacterium sp. 3_1_36A2 910ACPU01000044 clade_497 N N Fusobacterium sp. AC18 912 HQ616357 clade_497N N Fusobacterium sp. ACB2 913 HQ616358 clade_497 N N Fusobacterium sp.AS2 914 HQ616361 clade_497 N N Fusobacterium sp. CM1 915 HQ616371clade_497 N N Fusobacterium sp. CM21 916 HQ616375 clade_497 N NFusobacterium sp. CM22 917 HQ616376 clade_497 N N Fusobacterium sp. oralclone 919 AY923141 clade_497 N N ASCF06 Fusobacterium sp. oral clone 920AY953256 clade_497 N N ASCF11 Granulicatella adiacens 959 ACKZ01000002clade_497 N N Granulicatella elegans 960 AB252689 clade_497 N NGranulicatella paradiacens 961 AY879298 clade_497 N N Granulicatella sp.oral clone 963 AY923126 clade_497 N N ASC02 Granulicatella sp. oralclone 964 DQ341469 clade_497 N N ASCA05 Granulicatella sp. oral clone965 AY953251 clade_497 N N ASCB09 Granulicatella sp. oral clone 966AY923146 clade_497 N N ASCG05 Tetragenococcus halophilus 1918 NR_075020clade_497 N N Tetragenococcus koreensis 1919 NR_043113 clade_497 N NVagococcus fluvialis 1973 NR_026489 clade_497 N N Chryseobacteriumanthropi 514 AM982793 clade_498 N N Chryseobacterium gleum 515ACKQ02000003 clade_498 N N Chryseobacterium hominis 516 NR_042517clade_498 N N Treponema refringens 1936 AF426101 clade_499 N OPTreponema sp. oral clone JU031 1941 AY349416 clade_499 N N Treponema sp.oral taxon 239 1948 GU408738 clade_499 N N Treponema sp. oral taxon 2711955 GU408871 clade_499 N N Alistipes finegoldii 129 NR_043064 clade_500N N Alistipes onderdonkii 131 NR_043318 clade_500 N N Alistipesputredinis 132 ABFK02000017 clade_500 N N Alistipes shahii 133 FP929032clade_500 N N Alistipes sp. HGB5 134 AENZ01000082 clade_500 N NAlistipes sp. JC50 135 JF824804 clade_500 N N Alistipes sp. RMA 9912 136GQ140629 clade_500 N N Mycoplasma agalactiae 1310 AF010477 clade_501 N NMycoplasma bovoculi 1313 NR_025987 clade_501 N N Mycoplasma fermentans1315 CP002458 clade_501 N N Mycoplasma flocculare 1316 X62699 clade_501N N Mycoplasma ovipneumoniae 1320 NR_025989 clade_501 N N Arcobacterbutzleri 176 AEPT01000071 clade_502 N N Arcobacter cryaerophilus 177NR_025905 clade_502 N N Campylobacter curvus 461 NC_009715 clade_502 NOP Campylobacter rectus 467 ACFU01000050 clade_502 N OP Campylobactershowae 468 ACVQ01000030 clade_502 N OP Campylobacter sp. FOBRC14 469HQ616379 clade_502 N OP Campylobacter sp. FOBRC15 470 HQ616380 clade_502N OP Campylobacter sp. oral clone 471 AY005038 clade_502 N OP BB120Campylobacter sputorum 472 NR_044839 clade_502 N OP Bacteroidesureolyticus 330 GQ167666 clade_504 N N Campylobacter gracilis 463ACYG01000026 clade_504 N OP Campylobacter hominis 464 NC_009714clade_504 N OP Dialister invisus 762 ACIM02000001 clade_506 N NDialister micraerophilus 763 AFBB01000028 clade_506 N N Dialistermicroaerophilus 764 AENT01000008 clade_506 N N Dialisterpropionicifaciens 766 NR_043231 clade_506 N N Dialister succinatiphilus768 AB370249 clade_506 N N Megasphaera elsdenii 1200 AY038996 clade_506N N Megasphaera genomosp. type_1 1202 ADGP01000010 clade_506 N NMegasphaera sp. BLPYG_07 1204 HM990964 clade_506 N N Megasphaera sp.UPII 199_6 1205 AFIJ01000040 clade_506 N N Chromobacterium violaceum 513NC_005085 clade_507 N N Laribacter hongkongensis 1148 CP001154 clade_507N N Methylophilus sp. ECd5 1229 AY436794 clade_507 N N Finegoldia magna883 ACHM02000001 clade_509 N N Parvimonas micra 1431 AB729072 clade_509N N Parvimonas sp. oral taxon 110 1432 AFII01000002 clade_509 N NPeptostreptococcus micros 1456 AM176538 clade_509 N N Peptostreptococcussp. oral clone 1460 AY349390 clade_509 N N FJ023 Peptostreptococcus sp.P4P_31 1458 AY207059 clade_509 N N P3 Helicobacter pylori 997 CP000012clade_510 N OP Anaplasma marginale 165 ABOR01000019 clade_511 N NAnaplasma phagocytophilum 166 NC_007797 clade_511 N N Ehrlichiachaffeensis 783 AAIF01000035 clade_511 N OP Neorickettsia risticii 1349CP001431 clade_511 N N Neorickettsia sennetsu 1350 NC_007798 clade_511 NN Pseudoramibacter alactolyticus 1606 AB036759 clade_512 N N Veillonellamontpellierensis 1977 AF473836 clade_513 N N Veillonella sp. oral cloneASCA08 1988 AY923118 clade_513 N N Veillonella sp. oral clone ASCB031989 AY923122 clade_513 N N Inquilinus limosus 1012 NR_029046 clade_514N N Sphingomonas sp. oral clone 1746 AY349412 clade_514 N N FZ016Anaerococcus lactolyticus 145 ABYO01000217 clade_515 N N Anaerococcusprevotii 147 CP001708 clade_515 N N Anaerococcus sp. gpac104 152AM176528 clade_515 N N Anaerococcus sp. gpac126 153 AM176530 clade_515 NN Anaerococcus sp. gpac155 154 AM176536 clade_515 N N Anaerococcus sp.gpac199 155 AM176539 clade_515 N N Anaerococcus tetradius 157ACGC01000107 clade_515 N N Bacteroides coagulans 271 AB547639 clade_515N N Clostridiales bacterium 9403326 534 HM587324 clade_515 N NClostridiales bacterium ph2 539 JN837487 clade_515 N NPeptostreptococcus sp. 9succ1 1457 X90471 clade_515 N NPeptostreptococcus sp. oral clone 1459 AB175072 clade_515 N N AP24Tissierella praeacuta 1924 NR_044860 clade_515 N N Helicobactercanadensis 994 ABQS01000108 clade_518 N N Peptostreptococcus anaerobius1455 AY326462 clade_520 N N Peptostreptococcus stomatis 1461ADGQ01000048 clade_520 N N Bilophila wadsworthia 367 ADCP01000166clade_521 N N Desulfovibrio vulgaris 761 NR_074897 clade_521 N NActinomyces nasicola 64 AJ508455 clade_523 N N Cellulosimicrobium funkei500 AY501364 clade_523 N N Lactococcus raffinolactis 1146 NR_044359clade_524 N N Bacteroidales genomosp. P1 258 AY341819 clade_529 N NBacteroidales genomosp. P2 oral 259 DQ003613 clade_529 N N clone MB1_G13Bacteroidales genomosp. P3 oral 260 DQ003615 clade_529 N N clone MB1_G34Bacteroidales genomosp. P4 oral 261 DQ003617 clade_529 N N clone MB2_G17Bacteroidales genomosp. P5 oral 262 DQ003619 clade_529 N N clone MB2_P04Bacteroidales genomosp. P6 oral 263 DQ003634 clade_529 N N clone MB3_C19Bacteroidales genomosp. P8 oral 265 DQ003626 clade_529 N N clone MB4_G15Bacteroidetes bacterium oral taxon 333 HM099638 clade_530 N N D27Bacteroidetes bacterium oral taxon 334 HM099643 clade_530 N N F31Bacteroidetes bacterium oral taxon 335 HM099649 clade_530 N N F44Flavobacterium sp. NF2_1 885 FJ195988 clade_530 N N Myroidesodoratimimus 1326 NR_042354 clade_530 N N Myroides sp. MY15 1327GU253339 clade_530 N N Chlamydiales bacterium NS16 507 JN606076clade_531 N N Chlamydophila pecorum 508 D88317 clade_531 N OPParachlamydia sp. UWE25 1423 BX908798 clade_531 N N Fusobacterium russii903 NR_044687 clade_532 N N Streptobacillus moniliformis 1784 NR_027615clade_532 N N Eubacteriaceae bacterium P4P_50 833 AY207060 clade_533 N NP4 Abiotrophia defectiva 1 ACIN02000016 clade_534 N N Abiotrophia sp.oral clone 3 AY207063 clade_534 N N P4PA_155 P1 Catonella genomosp. P1oral clone 496 DQ003629 clade_534 N N MB5_P12 Catonella morbi 497ACIL02000016 clade_534 N N Catonella sp. oral clone FL037 498 AY349369clade_534 N N Eremococcus coleocola 818 AENN01000008 clade_534 N NFacklamia hominis 879 Y10772 clade_534 N N Granulicatella sp. M658_99_3962 AJ271861 clade_534 N N Campylobacter coli 459 AAFL01000004 clade_535N OP Campylobacter concisus 460 CP000792 clade_535 N OP Campylobacterfetus 462 ACLG01001177 clade_535 N OP Campylobacter jejuni 465 AL139074clade_535 N Category- B Campylobacter upsaliensis 473 AEPU01000040clade_535 N OP Atopobium minutum 183 HM007583 clade_539 N N Atopobiumparvulum 184 CP001721 clade_539 N N Atopobium rimae 185 ACFE01000007clade_539 N N Atopobium sp. BS2 186 HQ616367 clade_539 N N Atopobium sp.F0209 187 EU592966 clade_539 N N Atopobium sp. ICM42b10 188 HQ616393clade_539 N N Atopobium sp. ICM57 189 HQ616400 clade_539 N N Atopobiumvaginae 190 AEDQ01000024 clade_539 N N Coriobacteriaceae bacterium 677JN809768 clade_539 N N BV3Ac1 Actinomyces naeslundii 63 X81062 clade_54N N Actinomyces oricola 67 NR_025559 clade_54 N N Actinomyces oris 69BABV01000070 clade_54 N N Actinomyces sp. 7400942 70 EU484334 clade_54 NN Actinomyces sp. ChDC B197 72 AF543275 clade_54 N N Actinomyces sp.GEJ15 73 GU561313 clade_54 N N Actinomyces sp. M2231_94_1 79 AJ234063clade_54 N N Actinomyces sp. oral clone GU067 83 AY349362 clade_54 N NActinomyces sp. oral clone IO077 85 AY349364 clade_54 N N Actinomycessp. oral clone IP073 86 AY349365 clade_54 N N Actinomyces sp. oral cloneJA063 88 AY349367 clade_54 N N Actinomyces sp. oral taxon 170 89AFBL01000010 clade_54 N N Actinomyces sp. oral taxon 171 90 AECW01000034clade_54 N N Actinomyces urogenitalis 95 ACFH01000038 clade_54 N NActinomyces viscosus 96 ACRE01000096 clade_54 N N Orientia tsutsugamushi1383 AP008981 clade_541 N OP Megamonas funiformis 1198 AB300988clade_542 N N Megamonas hypermegale 1199 AJ420107 clade_542 N NAeromicrobium marinum 102 NR_025681 clade_544 N N Aeromicrobium sp. JC14103 JF824798 clade_544 N N Luteococcus sanguinis 1190 NR_025507clade_544 N N Propionibacteriaceae bacterium 1568 EF599122 clade_544 N NNML 02_0265 Rhodococcus corynebacterioides 1622 X80615 clade_546 N NRhodococcus erythropolis 1624 ACNO01000030 clade_546 N N Rhodococcusfascians 1625 NR_037021 clade_546 N N Segniliparus rotundus 1690CP001958 clade_546 N N Segniliparus rugosus 1691 ACZI01000025 clade_546N N Exiguobacterium acetylicum 878 FJ970034 clade_547 N N Macrococcuscaseolyticus 1194 NR_074941 clade_547 N N Streptomyces sp. 1 AIP_20091890 FJ176782 clade_548 N N Streptomyces sp. SD 524 1892 EU544234clade_548 N N Streptomyces sp. SD 528 1893 EU544233 clade_548 N NStreptomyces thermoviolaceus 1895 NR_027616 clade_548 N N Borreliaafzelii 388 ABCU01000001 clade_549 N OP Borrelia crocidurae 390 DQ057990clade_549 N OP Borrelia duttonii 391 NC_011229 clade_549 N OP Borreliahermsii 393 AY597657 clade_549 N OP Borrelia hispanica 394 DQ057988clade_549 N OP Borrelia persica 395 HM161645 clade_549 N OP Borreliarecurrentis 396 AF107367 clade_549 N OP Borrelia spielmanii 398ABKB01000002 clade_549 N OP Borrelia turicatae 399 NC_008710 clade_549 NOP Borrelia valaisiana 400 ABCY01000002 clade_549 N OP Providenciaalcalifaciens 1586 ABXW01000071 clade_55 N N Providencia rettgeri 1587AM040492 clade_55 N N Providencia rustigianii 1588 AM040489 clade_55 N NProvidencia stuartii 1589 AF008581 clade_55 N N Treponema pallidum 1932CP001752 clade_550 N OP Treponema phagedenis 1934 AEFH01000172 clade_550N N Treponema sp. clone DDKL_4 1939 Y08894 clade_550 N N Acholeplasmalaidlawii 17 NR_074448 clade_551 N N Mycoplasma putrefaciens 1323 U26055clade_551 N N Mycoplasmataceae genomosp. P1 1325 DQ003614 clade_551 N Noral clone MB1_G23 Spiroplasma insolitum 1750 NR_025705 clade_551 N NCollinsella intestinalis 660 ABXH02000037 clade_553 N N Collinsellastercoris 661 ABXJ01000150 clade_553 N N Collinsella tanakaei 662AB490807 clade_553 N N Caminicella sporogenes 458 NR_025485 clade_554 NN Acidaminococcus fermentans 21 CP001859 clade_556 N N Acidaminococcusintestini 22 CP003058 clade_556 N N Acidaminococcus sp. D21 23ACGB01000071 clade_556 N N Phascolarctobacterium faecium 1462 NR_026111clade_556 N N Phascolarctobacterium sp. YIT 1463 AB490812 clade_556 N N12068 Phascolarctobacterium 1464 AB490811 clade_556 N N succinatutensAcidithiobacillus ferrivorans 25 NR_074660 clade_557 N NXanthomonadaceae bacterium 2015 EU313791 clade_557 N N NML 03_0222Catabacter hongkongensis 494 AB671763 clade_558 N N Christensenellaminuta 512 AB490809 clade_558 N N Clostridiales bacterium oral clone 536AY207065 clade_558 N N P4PA_66 P1 Clostridiales bacterium oral taxon 537GQ422712 clade_558 N N 093 Heliobacterium modesticaldum 1000 NR_074517clade_560 N N Alistipes indistinctus 130 AB490804 clade_561 N NBacteroidales bacterium ph8 257 JN837494 clade_561 N N Candidatus Sulciamuelleri 475 CP002163 clade_561 N N Cytophaga xylanolytica 742 FR733683clade_561 N N Flavobacteriaceae genomosp. C1 884 AY278614 clade_561 N NGramella forsetii 958 NR_074707 clade_561 N N Sphingobacterium faecium1740 NR_025537 clade_562 N N Sphingobacterium mizutaii 1741 JF708889clade_562 N N Sphingobacterium multivorum 1742 NR_040953 clade_562 N NSphingobacterium spiritivorum 1743 ACHA02000013 clade_562 N NJonquetella anthropi 1017 ACOO02000004 clade_563 N N Pyramidobacterpiscolens 1614 AY207056 clade_563 N N Synergistes genomosp. C1 1904AY278615 clade_563 N N Synergistes sp. RMA 14551 1905 DQ412722 clade_563N N Synergistetes bacterium ADV897 1906 GQ258968 clade_563 N NCandidatus Arthromitus sp. 474 NR_074460 clade_564 N N SFB_mouse_YitGracilibacter thermotolerans 957 NR_043559 clade_564 N N Brachyspiraaalborgi 404 FM178386 clade_565 N N Brachyspira sp. HIS3 406 FM178387clade_565 N N Brachyspira sp. HIS4 407 FM178388 clade_565 N NBrachyspira sp. HIS5 408 FM178389 clade_565 N N Adlercreutziaequolifaciens 97 AB306661 clade_566 N N Coriobacteriaceae bacterium 678CAEM01000062 clade_566 N N JC110 Coriobacteriaceae bacterium phl 679JN837493 clade_566 N N Cryptobacterium curtum 740 GQ422741 clade_566 N NEggerthella sinensis 779 AY321958 clade_566 N N Eggerthella sp.1_3_56FAA 780 ACWN01000099 clade_566 N N Eggerthella sp. HGA1 781AEXR01000021 clade_566 N N Eggerthella sp. YY7918 782 AP012211 clade_566N N Gordonibacter pamelaeae 680 AM886059 clade_566 N N Gordonibacterpamelaeae 956 FP929047 clade_566 N N Slackia equolifaciens 1732 EU377663clade_566 N N Slackia exigua 1733 ACUX01000029 clade_566 N N Slackiafaecicanis 1734 NR_042220 clade_566 N N Slackia heliotrinireducens 1735NR_074439 clade_566 N N Slackia isoflavoniconvertens 1736 AB566418clade_566 N N Slackia piriformis 1737 AB490806 clade_566 N N Slackia sp.NATTS 1738 AB505075 clade_566 N N Chlamydiales bacterium NS13 506JN606075 clade_567 N N Victivallaceae bacterium NML 2003 FJ394915clade_567 N N 080035 Victivallis vadensis 2004 ABDE02000010 clade_567 NN Streptomyces griseus 1889 NR_074787 clade_573 N N Streptomyces sp. SD511 1891 EU544231 clade_573 N N Streptomyces sp. SD 534 1894 EU544232clade_573 N N Cloacibacillus evryensis 530 GQ258966 clade_575 N NDeferribacteres sp. oral clone 743 AY349370 clade_575 N N JV001Deferribacteres sp. oral clone 745 AY349372 clade_575 N N JV023Synergistetes bacterium 1907 GQ258969 clade_575 N N LBVCM1157Synergistetes bacterium oral taxon 1909 GU410752 clade_575 N N 362Synergistetes bacterium oral taxon 1910 GU430992 clade_575 N N D48Peptococcus sp. oral clone JM048 1439 AY349389 clade_576 N NHelicobacter winghamensis 999 ACDO01000013 clade_577 N N Wolinellasuccinogenes 2014 BX571657 clade_577 N N Olsenella genomosp. C1 1368AY278623 clade_578 N N Olsenella profusa 1369 FN178466 clade_578 N NOlsenella sp. F0004 1370 EU592964 clade_578 N N Olsenella sp. oral taxon809 1371 ACVE01000002 clade_578 N N Olsenella uli 1372 CP002106clade_578 N N Nocardiopsis dassonvillei 1356 CP002041 clade_579 N NPeptococcus niger 1438 NR_029221 clade_580 N N Peptococcus sp. oraltaxon 167 1440 GQ422727 clade_580 N N Akkermansia muciniphila 118CP001071 clade_583 N N Opitutus terrae 1373 NR_074978 clade_583 N NClostridiales bacterium oral taxon 538 HM099644 clade_584 N N F32Leptospira borgpetersenii 1161 NC_008508 clade_585 N OP Leptospirabroomii 1162 NR_043200 clade_585 N OP Leptospira interrogans 1163NC_005823 clade_585 N OP Methanobrevibacter gottschalkii 1213 NR_044789clade_587 N N Methanobrevibacter millerae 1214 NR_042785 clade_587 N NMethanobrevibacter oralis 1216 HE654003 clade_587 N N Methanobrevibacterthaueri 1219 NR_044787 clade_587 N N Methanobrevibacter smithii 1218ABYV02000002 clade_588 N N Deinococcus radiodurans 746 AE000513clade_589 N N Deinococcus sp. R_43890 747 FR682752 clade_589 N N Thermusaquaticus 1923 NR_025900 clade_589 N N Actinomyces sp. c109 81 AB167239clade_590 N N Syntrophomonadaceae genomosp. 1912 AY341821 clade_590 N NP1 Anaerobaculum hydrogeniformans 141 ACJX02000009 clade_591 N NMicrocystis aeruginosa 1246 NC_010296 clade_592 N N Prochlorococcusmarinus 1567 CP000551 clade_592 N N Methanobrevibacter acididurans 1208NR_028779 clade_593 N N Methanobrevibacter arboriphilus 1209 NR_042783clade_593 N N Methanobrevibacter curvatus 1210 NR_044796 clade_593 N NMethanobrevibacter cuticularis 1211 NR_044776 clade_593 N NMethanobrevibacter filiformis 1212 NR_044801 clade_593 N NMethanobrevibacter woesei 1220 NR_044788 clade_593 N N Roseiflexuscastenholzii 1642 CP000804 clade_594 N N Methanobrevibacter olleyae 1215NR_043024 clade_595 N N Methanobrevibacter ruminantium 1217 NR_042784clade_595 N N Methanobrevibacter wolinii 1221 NR_044790 clade_595 N NMethanosphaera stadtmanae 1222 AY196684 clade_595 N N Chloroflexigenomosp. P1 511 AY331414 clade_596 N N Halorubrum lipolyticum 992AB477978 clade_597 N N Methanobacterium formicicum 1207 NR_025028clade_597 N N Acidilobus saccharovorans 24 AY350586 clade_598 N NHyperthermus butylicus 1006 CP000493 clade_598 N N Ignicoccus islandicus1011 X99562 clade_598 N N Metallosphaera sedula 1206 D26491 clade_598 NN Thermofilum pendens 1922 X14835 clade_598 N N Prevotellamelaninogenica 1506 CP002122 clade_6 N N Prevotella sp. ICM1 1520HQ616385 clade_6 N N Prevotella sp. oral clone FU048 1535 AY349393clade_6 N N Prevotella sp. oral clone GI030 1537 AY349395 clade_6 N NPrevotella sp. SEQ116 1526 JN867246 clade_6 N N Streptococcus anginosus1787 AECT01000011 clade_60 N N Streptococcus milleri 1812 X81023clade_60 N N Streptococcus sp. 16362 1829 JN590019 clade_60 N NStreptococcus sp. 69130 1832 X78825 clade_60 N N Streptococcus sp. AC151833 HQ616356 clade_60 N N Streptococcus sp. CM7 1839 HQ616373 clade_60N N Streptococcus sp. OBRC6 1847 HQ616352 clade_60 N N Burkholderiaambifaria 442 AAUZ01000009 clade_61 N OP Burkholderia cenocepacia 443AAHI01000060 clade_61 N OP Burkholderia cepacia 444 NR_041719 clade_61 NOP Burkholderia mallei 445 CP000547 clade_61 N Category- B Burkholderiamultivorans 446 NC_010086 clade_61 N OP Burkholderia oklahomensis 447DQ108388 clade_61 N OP Burkholderia pseudomallei 448 CP001408 clade_61 NCategory- B Burkholderia rhizoxinica 449 HQ005410 clade_61 N OPBurkholderia sp. 383 450 CP000151 clade_61 N OP Burkholderia xenovorans451 U86373 clade_61 N OP Prevotella buccae 1488 ACRB01000001 clade_62 NN Prevotella genomosp. P8 oral 1498 DQ003622 clade_62 N N clone MB3_P13Prevotella sp. oral clone FW035 1536 AY349394 clade_62 N N Prevotellabivia 1486 ADFO01000096 clade_63 N N Prevotella disiens 1494AEDO01000026 clade_64 N N Bacteroides faecis 276 GQ496624 clade_65 N NBacteroides fragilis 279 AP006841 clade_65 N N Bacteroides nordii 285NR_043017 clade_65 N N Bacteroides salyersiae 292 EU136690 clade_65 N NBacteroides sp. 1_1_14 293 ACRP01000155 clade_65 N N Bacteroides sp.1_1_6 295 ACIC01000215 clade_65 N N Bacteroides sp. 2_1_56FAA 298ACWI01000065 clade_65 N N Bacteroides sp. AR29 316 AF139525 clade_65 N NBacteroides sp. B2 317 EU722733 clade_65 N N Bacteroidesthetaiotaomicron 328 NR_074277 clade_65 N N Actinobacillus minor 45ACFT01000025 clade_69 N N Haemophilus parasuis 978 GU226366 clade_69 N NVibrio cholerae 1996 AAUR01000095 clade_71 N Category- B Vibriofluvialis 1997 X76335 clade_71 N Category- B Vibrio furnissii 1998CP002377 clade_71 N Category- B Vibrio mimicus 1999 ADAF01000001clade_71 N Category- B Vibrio parahaemolyticus 2000 AAWQ01000116clade_71 N Category- B Vibrio sp. RC341 2001 ACZT01000024 clade_71 NCategory- B Vibrio vulnificus 2002 AE016796 clade_71 N Category- BLactobacillus acidophilus 1067 CP000033 clade_72 N N Lactobacillusamylolyticus 1069 ADNY01000006 clade_72 N N Lactobacillus amylovorus1070 CP002338 clade_72 N N Lactobacillus crispatus 1078 ACOG01000151clade_72 N N Lactobacillus delbrueckii 1080 CP002341 clade_72 N NLactobacillus helveticus 1088 ACLM01000202 clade_72 N N Lactobacilluskalixensis 1094 NR_029083 clade_72 N N Lactobacillus kefiranofaciens1095 NR_042440 clade_72 N N Lactobacillus leichmannii 1098 JX986966clade_72 N N Lactobacillus sp. 66c 1120 FR681900 clade_72 N NLactobacillus sp. KLDS 1.0701 1122 EU600905 clade_72 N N Lactobacillussp. KLDS 1.0712 1130 EU600916 clade_72 N N Lactobacillus sp. oral cloneHT070 1136 AY349383 clade_72 N N Lactobacillus ultunensis 1139ACGU01000081 clade_72 N N Prevotella intermedia 1502 AF414829 clade_81 NN Prevotella nigrescens 1511 AFPX01000069 clade_81 N N Prevotellapallens 1515 AFPY01000135 clade_81 N N Prevotella sp. oral taxon 3101551 GQ422737 clade_81 N N Prevotella genomosp. C1 1495 AY278624clade_82 N N Prevotella sp. CM38 1519 HQ610181 clade_82 N N Prevotellasp. oral taxon 317 1552 ACQH01000158 clade_82 N N Prevotella sp. SG121527 GU561343 clade_82 N N Prevotella denticola 1493 CP002589 clade_83 NN Prevotella genomosp. P7 oral 1497 DQ003620 clade_83 N N clone MB2_P31Prevotella histicola 1501 JN867315 clade_83 N N Prevotella multiformis1508 AEWX01000054 clade_83 N N Prevotella sp. JCM 6330 1522 AB547699clade_83 N N Prevotella sp. oral clone GI059 1539 AY349397 clade_83 N NPrevotella sp. oral taxon 782 1555 GQ422745 clade_83 N N Prevotella sp.oral taxon G71 1559 GU432180 clade_83 N N Prevotella sp. SEQ065 1524JN867234 clade_83 N N Prevotella veroralis 1565 ACVA01000027 clade_83 NN Bacteroides acidifaciens 266 NR_028607 clade_85 N N Bacteroidescellulosilyticus 269 ACCH01000108 clade_85 N N Bacteroides clarus 270AFBM01000011 clade_85 N N Bacteroides eggerthii 275 ACWG01000065clade_85 N N Bacteroides oleiciplenus 286 AB547644 clade_85 N NBacteroides pyogenes 290 NR_041280 clade_85 N N Bacteroides sp. 315_5300 FJ848547 clade_85 N N Bacteroides sp. 31SF15 301 AJ583248 clade_85 NN Bacteroides sp. 31SF18 302 AJ583249 clade_85 N N Bacteroides sp.35AE31 303 AJ583244 clade_85 N N Bacteroides sp. 35AE37 304 AJ583245clade_85 N N Bacteroides sp. 35BE34 305 AJ583246 clade_85 N NBacteroides sp. 35BE35 306 AJ583247 clade_85 N N Bacteroides sp. WH2 324AY895180 clade_85 N N Bacteroides sp. XB12B 325 AM230648 clade_85 N NBacteroides stercoris 327 ABFZ02000022 clade_85 N N Actinobacilluspleuropneumoniae 46 NR_074857 clade_88 N N Actinobacillus ureae 48AEVG01000167 clade_88 N N Haemophilus aegyptius 969 AFBC01000053clade_88 N N Haemophilus ducreyi 970 AE017143 clade_88 N OP Haemophilushaemolyticus 973 JN175335 clade_88 N N Haemophilus influenzae 974AADP01000001 clade_88 N OP Haemophilus parahaemolyticus 975 GU561425clade_88 N N Haemophilus parainfluenzae 976 AEWU01000024 clade_88 N NHaemophilus 977 M75076 clade_88 N N paraphrophaemolyticus Haemophilussomnus 979 NC_008309 clade_88 N N Haemophilus sp. 70334 980 HQ680854clade_88 N N Haemophilus sp. HK445 981 FJ685624 clade_88 N N Haemophilussp. oral clone 982 AY923117 clade_88 N N ASCA07 Haemophilus sp. oralclone 983 AY923147 clade_88 N N ASCG06 Haemophilus sp. oral clone BJ021984 AY005034 clade_88 N N Haemophilus sp. oral clone BJ095 985 AY005033clade_88 N N Haemophilus sp. oral taxon 851 987 AGRK01000004 clade_88 NN Haemophilus sputorum 988 AFNK01000005 clade_88 N N Histophilus somni1003 AF549387 clade_88 N N Mannheimia haemolytica 1195 ACZX01000102clade_88 N N Pasteurella bettyae 1433 L06088 clade_88 N N Moellerellawisconsensis 1253 JN175344 clade_89 N N Morganella morganii 1265AJ301681 clade_89 N N Morganella sp. JB_T16 1266 AJ781005 clade_89 N NProteus mirabilis 1582 ACLE01000013 clade_89 N N Proteus penneri 1583ABVP01000020 clade_89 N N Proteus sp. HS7514 1584 DQ512963 clade_89 N NProteus vulgaris 1585 AJ233425 clade_89 N N Oribacterium sinus 1374ACKX01000142 clade_90 N N Oribacterium sp. ACB1 1375 HM120210 clade_90 NN Oribacterium sp. ACB7 1376 HM120211 clade_90 N N Oribacterium sp. CM121377 HQ616374 clade_90 N N Oribacterium sp. ICM51 1378 HQ616397 clade_90N N Oribacterium sp. OBRC12 1379 HQ616355 clade_90 N N Oribacterium sp.oral taxon 108 1382 AFIH01000001 clade_90 N N Actinobacillus 44 AY362885clade_92 N N actinomycetemcomitans Actinobacillus succinogenes 47CP000746 clade_92 N N Aggregatibacter 112 CP001733 clade_92 N Nactinomycetemcomitans Aggregatibacter aphrophilus 113 CP001607 clade_92N N Aggregatibacter segnis 114 AEPS01000017 clade_92 N N Averyelladalhousiensis 194 DQ481464 clade_92 N N Bisgaard Taxon 368 AY683487clade_92 N N Bisgaard Taxon 369 AY683489 clade_92 N N Bisgaard Taxon 370AY683491 clade_92 N N Bisgaard Taxon 371 AY683492 clade_92 N N Buchneraaphidicola 440 NR_074609 clade_92 N N Cedecea davisae 499 AF493976clade_92 N N Citrobacter amalonaticus 517 FR870441 clade_92 N NCitrobacter braakii 518 NR_028687 clade_92 N N Citrobacter farmeri 519AF025371 clade_92 N N Citrobacter freundii 520 NR_028894 clade_92 N NCitrobacter gillenii 521 AF025367 clade_92 N N Citrobacter koseri 522NC_009792 clade_92 N N Citrobacter murliniae 523 AF025369 clade_92 N NCitrobacter rodentium 524 NR_074903 clade_92 N N Citrobacter sedlakii525 AF025364 clade_92 N N Citrobacter sp. 30_2 526 ACDJ01000053 clade_92N N Citrobacter sp. KMSI_3 527 GQ468398 clade_92 N N Citrobacterwerkmanii 528 AF025373 clade_92 N N Citrobacter youngae 529 ABWL02000011clade_92 N N Cronobacter malonaticus 737 GU122174 clade_92 N NCronobacter sakazakii 738 NC_009778 clade_92 N N Cronobacter turicensis739 FN543093 clade_92 N N Enterobacter aerogenes 786 AJ251468 clade_92 NN Enterobacter asburiae 787 NR_024640 clade_92 N N Enterobactercancerogenus 788 Z96078 clade_92 N N Enterobacter cloacae 789 FP929040clade_92 N N Enterobacter cowanii 790 NR_025566 clade_92 N NEnterobacter hormaechei 791 AFHR01000079 clade_92 N N Enterobacter sp.247BMC 792 HQ122932 clade_92 N N Enterobacter sp. 638 793 NR_074777clade_92 N N Enterobacter sp. JC163 794 JN657217 clade_92 N NEnterobacter sp. SCSS 795 HM007811 clade_92 N N Enterobacter sp. TSE38796 HM156134 clade_92 N N Enterobacteriaceae bacterium 797 ADCU01000033clade_92 N N 9_2_54FAA Enterobacteriaceae bacterium 798 AJ489826clade_92 N N CF01Ent_1 Enterobacteriaceae bacterium 799 AY538694clade_92 N N Smarlab 3302238 Escherichia albertii 824 ABKX01000012clade_92 N N Escherichia coli 825 NC_008563 clade_92 N Category- BEscherichia fergusonii 826 CU928158 clade_92 N N Escherichia hermannii827 HQ407266 clade_92 N N Escherichia sp. 1_1_43 828 ACID01000033clade_92 N N Escherichia sp. 4_1_40B 829 ACDM02000056 clade_92 N NEscherichia sp. B4 830 EU722735 clade_92 N N Escherichia vulneris 831NR_041927 clade_92 N N Ewingella americana 877 JN175329 clade_92 N NHaemophilus genomosp. P2 oral 971 DQ003621 clade_92 N N clone MB3_C24Haemophilus genomosp. P3 oral 972 DQ003635 clade_92 N N clone MB3_C38Haemophilus sp. oral clone JM053 986 AY349380 clade_92 N N Hafnia alvei989 DQ412565 clade_92 N N Klebsiella oxytoca 1024 AY292871 clade_92 N OPKlebsiella pneumoniae 1025 CP000647 clade_92 N OP Klebsiella sp. AS101026 HQ616362 clade_92 N N Klebsiella sp. Co9935 1027 DQ068764 clade_92N N Klebsiella sp. enrichment culture 1036 HM195210 clade_92 N N cloneSRC_DSD25 Klebsiella sp. OBRC7 1028 HQ616353 clade_92 N N Klebsiella sp.SP_BA 1029 FJ999767 clade_92 N N Klebsiella sp. SRC_DSD1 1033 GU797254clade_92 N N Klebsiella sp. SRC_DSD11 1030 GU797263 clade_92 N NKlebsiella sp. SRC_DSD12 1031 GU797264 clade_92 N N Klebsiella sp.SRC_DSD15 1032 GU797267 clade_92 N N Klebsiella sp. SRC_DSD2 1034GU797253 clade_92 N N Klebsiella sp. SRC_DSD6 1035 GU797258 clade_92 N NKlebsiella variicola 1037 CP001891 clade_92 N N Kluyvera ascorbata 1038NR_028677 clade_92 N N Kluyvera cryocrescens 1039 NR_028803 clade_92 N NLeminorella grimontii 1159 AJ233421 clade_92 N N Leminorella richardii1160 HF558368 clade_92 N N Pantoea agglomerans 1409 AY335552 clade_92 NN Pantoea ananatis 1410 CP001875 clade_92 N N Pantoea brenneri 1411EU216735 clade_92 N N Pantoea citrea 1412 EF688008 clade_92 N N Pantoeaconspicua 1413 EU216737 clade_92 N N Pantoea septica 1414 EU216734clade_92 N N Pasteurella dagmatis 1434 ACZR01000003 clade_92 N NPasteurella multocida 1435 NC_002663 clade_92 N N Plesiomonasshigelloides 1469 X60418 clade_92 N N Raoultella ornithinolytica 1617AB364958 clade_92 N N Raoultella planticola 1618 AF129443 clade_92 N NRaoultella terrigena 1619 NR_037085 clade_92 N N Salmonella bongori 1683NR_041699 clade_92 N Category- B Salmonella enterica 1672 NC_011149clade_92 N Category- B Salmonella enterica 1673 NC_011205 clade_92 NCategory- B Salmonella enterica 1674 DQ344532 clade_92 N Category- BSalmonella enterica 1675 ABEH02000004 clade_92 N Category- B Salmonellaenterica 1676 ABAK02000001 clade_92 N Category- B Salmonella enterica1677 NC_011080 clade_92 N Category- B Salmonella enterica 1678 EU118094clade_92 N Category- B Salmonella enterica 1679 NC_011094 clade_92 NCategory- B Salmonella enterica 1680 AE014613 clade_92 N Category- BSalmonella enterica 1682 ABFH02000001 clade_92 N Category- B Salmonellaenterica 1684 ABEM01000001 clade_92 N Category- B Salmonella enterica1685 ABAM02000001 clade_92 N Category- B Salmonella typhimurium 1681DQ344533 clade_92 N Category- B Salmonella typhimurium 1686 AF170176clade_92 N Category- B Serratia fonticola 1718 NR_025339 clade_92 N NSerratia liquefaciens 1719 NR_042062 clade_92 N N Serratia marcescens1720 GU826157 clade_92 N N Serratia odorifera 1721 ADBY01000001 clade_92N N Serratia proteamaculans 1722 AAUN01000015 clade_92 N N Shigellaboydii 1724 AAKA01000007 clade_92 N Category- B Shigella dysenteriae1725 NC_007606 clade_92 N Category- B Shigella flexneri 1726 AE005674clade_92 N Category- B Shigella sonnei 1727 NC_007384 clade_92 NCategory- B Tatumella ptyseos 1916 NR_025342 clade_92 N N Trabulsiellaguamensis 1925 AY373830 clade_92 N N Yersinia aldovae 2019 AJ871363clade_92 N OP Yersinia aleksiciae 2020 AJ627597 clade_92 N OP Yersiniabercovieri 2021 AF366377 clade_92 N OP Yersinia enterocolitica 2022FR729477 clade_92 N Category- B Yersinia frederiksenii 2023 AF366379clade_92 N OP Yersinia intermedia 2024 AF366380 clade_92 N OP Yersiniakristensenii 2025 ACCA01000078 clade_92 N OP Yersinia mollaretii 2026NR_027546 clade_92 N OP Yersinia pestis 2027 AE013632 clade_92 NCategory- A Yersinia pseudotuberculosis 2028 NC_009708 clade_92 N OPYersinia rohdei 2029 ACCD01000071 clade_92 N OP Yokenella regensburgei2030 AB273739 clade_92 N N Conchiformibius kuhniae 669 NR_041821clade_94 N N Morococcus cerebrosus 1267 JN175352 clade_94 N N Neisseriabacilliformis 1328 AFAY01000058 clade_94 N N Neisseria cinerea 1329ACDY01000037 clade_94 N N Neisseria flavescens 1331 ACQV01000025clade_94 N N Neisseria gonorrhoeae 1333 CP002440 clade_94 N OP Neisserialactamica 1334 ACEQ01000095 clade_94 N N Neisseria macacae 1335AFQE01000146 clade_94 N N Neisseria meningitidis 1336 NC_003112 clade_94N OP Neisseria mucosa 1337 ACDX01000110 clade_94 N N Neisseria pharyngis1338 AJ239281 clade_94 N N Neisseria polysaccharea 1339 ADBE01000137clade_94 N N Neisseria sicca 1340 ACKO02000016 clade_94 N N Neisseriasp. KEM232 1341 GQ203291 clade_94 N N Neisseria sp. oral clone AP1321344 AY005027 clade_94 N N Neisseria sp. oral strain B33KA 1346 AY005028clade_94 N N Neisseria sp. oral taxon 014 1347 ADEA01000039 clade_94 N NNeisseria sp. TM10_1 1343 DQ279352 clade_94 N N Neisseria subflava 1348ACEO01000067 clade_94 N N Okadaella gastrococcus 1365 HQ699465 clade_98N N Streptococcus agalactiae 1785 AAJO01000130 clade_98 N NStreptococcus alactolyticus 1786 NR_041781 clade_98 N N Streptococcusaustralis 1788 AEQR01000024 clade_98 N N Streptococcus bovis 1789AEEL01000030 clade_98 N N Streptococcus canis 1790 AJ413203 clade_98 N NStreptococcus constellatus 1791 AY277942 clade_98 N N Streptococcuscristatus 1792 AEVC01000028 clade_98 N N Streptococcus dysgalactiae 1794AP010935 clade_98 N N Streptococcus equi 1795 CP001129 clade_98 N NStreptococcus equinus 1796 AEVB01000043 clade_98 N N Streptococcusgallolyticus 1797 FR824043 clade_98 N N Streptococcus genomosp. C1 1798AY278629 clade_98 N N Streptococcus genomosp. C2 1799 AY278630 clade_98N N Streptococcus genomosp. C3 1800 AY278631 clade_98 N N Streptococcusgenomosp. C4 1801 AY278632 clade_98 N N Streptococcus genomosp. C5 1802AY278633 clade_98 N N Streptococcus genomosp. C6 1803 AY278634 clade_98N N Streptococcus genomosp. C7 1804 AY278635 clade_98 N N Streptococcusgenomosp. C8 1805 AY278609 clade_98 N N Streptococcus gordonii 1806NC_009785 clade_98 N N Streptococcus infantarius 1807 ABJK02000017clade_98 N N Streptococcus infantis 1808 AFNN01000024 clade_98 N NStreptococcus intermedius 1809 NR_028736 clade_98 N N Streptococcuslutetiensis 1810 NR_037096 clade_98 N N Streptococcus massiliensis 1811AY769997 clade_98 N N Streptococcus mitis 1813 AM157420 clade_98 N NStreptococcus oligofermentans 1815 AY099095 clade_98 N N Streptococcusoralis 1816 ADMV01000001 clade_98 N N Streptococcus parasanguinis 1817AEKM01000012 clade_98 N N Streptococcus pasteurianus 1818 AP012054clade_98 N N Streptococcus peroris 1819 AEVF01000016 clade_98 N NStreptococcus pneumoniae 1820 AE008537 clade_98 N N Streptococcusporcinus 1821 EF121439 clade_98 N N Streptococcus pseudopneumoniae 1822FJ827123 clade_98 N N Streptococcus pseudoporcinus 1823 AENS01000003clade_98 N N Streptococcus pyogenes 1824 AE006496 clade_98 N OPStreptococcus ratti 1825 X58304 clade_98 N N Streptococcus sanguinis1827 NR_074974 clade_98 N N Streptococcus sinensis 1828 AF432857clade_98 N N Streptococcus sp. 2_1_36FAA 1831 ACOI01000028 clade_98 N NStreptococcus sp. 2285_97 1830 AJ131965 clade_98 N N Streptococcus sp.ACS2 1834 HQ616360 clade_98 N N Streptococcus sp. AS20 1835 HQ616366clade_98 N N Streptococcus sp. BS35a 1836 HQ616369 clade_98 N NStreptococcus sp. C150 1837 ACRI01000045 clade_98 N N Streptococcus sp.CM6 1838 HQ616372 clade_98 N N Streptococcus sp. ICM10 1840 HQ616389clade_98 N N Streptococcus sp. ICM12 1841 HQ616390 clade_98 N NStreptococcus sp. ICM2 1842 HQ616386 clade_98 N N Streptococcus sp. ICM41844 HQ616387 clade_98 N N Streptococcus sp. ICM45 1843 HQ616394clade_98 N N Streptococcus sp. M143 1845 ACRK01000025 clade_98 N NStreptococcus sp. M334 1846 ACRL01000052 clade_98 N N Streptococcus sp.oral clone 1849 AY923121 clade_98 N N ASB02 Streptococcus sp. oral clone1850 DQ272504 clade_98 N N ASCA03 Streptococcus sp. oral clone 1851AY923116 clade_98 N N ASCA04 Streptococcus sp. oral clone 1852 AY923119clade_98 N N ASCA09 Streptococcus sp. oral clone 1853 AY923123 clade_98N N ASCB04 Streptococcus sp. oral clone 1854 AY923124 clade_98 N NASCB06 Streptococcus sp. oral clone 1855 AY923127 clade_98 N N ASCC04Streptococcus sp. oral clone 1856 AY923128 clade_98 N N ASCC05Streptococcus sp. oral clone 1857 DQ272507 clade_98 N N ASCC12Streptococcus sp. oral clone 1858 AY923129 clade_98 N N ASCD01Streptococcus sp. oral clone 1859 AY923130 clade_98 N N ASCD09Streptococcus sp. oral clone 1860 DQ272509 clade_98 N N ASCD10Streptococcus sp. oral clone 1861 AY923134 clade_98 N N ASCE03Streptococcus sp. oral clone 1862 AY953253 clade_98 N N ASCE04Streptococcus sp. oral clone 1863 DQ272510 clade_98 N N ASCE05Streptococcus sp. oral clone 1864 AY923135 clade_98 N N ASCE06Streptococcus sp. oral clone 1865 AY923136 clade_98 N N ASCE09Streptococcus sp. oral clone 1866 AY923137 clade_98 N N ASCE10Streptococcus sp. oral clone 1867 AY923138 clade_98 N N ASCE12Streptococcus sp. oral clone 1868 AY923140 clade_98 N N ASCF05Streptococcus sp. oral clone 1869 AY953255 clade_98 N N ASCF07Streptococcus sp. oral clone 1870 AY923142 clade_98 N N ASCF09Streptococcus sp. oral clone 1871 AY923145 clade_98 N N ASCG04Streptococcus sp. oral clone 1872 AY005042 clade_98 N N BW009Streptococcus sp. oral clone 1873 AY005044 clade_98 N N CH016Streptococcus sp. oral clone 1874 AY349413 clade_98 N N GK051Streptococcus sp. oral clone 1875 AY349414 clade_98 N N GM006Streptococcus sp. oral clone 1876 AY207051 clade_98 N N P2PA_41 P2Streptococcus sp. oral clone 1877 AY207064 clade_98 N N P4PA_30 P4Streptococcus sp. oral taxon 071 1878 AEEP01000019 clade_98 N NStreptococcus sp. oral taxon G59 1879 GU432132 clade_98 N NStreptococcus sp. oral taxon G62 1880 GU432146 clade_98 N NStreptococcus sp. oral taxon G63 1881 GU432150 clade_98 N NStreptococcus suis 1882 FM252032 clade_98 N N Streptococcus thermophilus1883 CP000419 clade_98 N N Streptococcus salivarius 1826 AGBV01000001clade_98 N N Streptococcus uberis 1884 HQ391900 clade_98 N NStreptococcus urinalis 1885 DQ303194 clade_98 N N Streptococcusvestibularis 1886 AEK001000008 clade_98 N N Streptococcus viridans 1887AF076036 clade_98 N N Synergistetes bacterium oral clone 1908 GU227192clade_98 N N 03 5 D05

TABLE 2 Mouse studies with bacterial compositions Mortality D3 WeightMorbidity Summary Score Score >3 Score Score Treatment 1 3 3.0 3.0 9Treatment 2 0 0.6 0.0 1 Treatment 3 0 −0.5 0.0 −1 Treatment 4 0.5 2.40.6 3 Treatment 5 0 0.5 0.0 0 Treatment 6 1 2.0 0.6 4 Treatment 7 0.50.7 0.4 2 Treatment 8 0 0.6 0.0 1 Treatment 9 0.5 1.3 0.6 2 Treatment 100.5 1.5 0.6 3 Treatment 11 0.5 1.0 0.6 2 Treatment 12 0 1.3 0.0 1Treatment 13 0.5 1.3 0.4 2 Treatment 14 0.5 1.2 0.6 2

TABLE 3A Table 3A Mouse studies with bacterial compositions Mortality D3Weight Morbidity Summary Score Score >3 Score Score Treatment 1 3 3.03.0 9 Treatment 2 0 0.0 0.0 0 Treatment 3 3 2.1 2.7 8 Treatment 4 1.51.1 1.1 4 Treatment 5 0 0.7 0.2 1 Treatment 6 0 1.2 0.0 1 Treatment 7 32.4 2.1 8 Treatment 8 0 0.8 0.6 1 Treatment 9 0 0.9 0.3 1 Treatment 101.5 2.5 2.7 7 Treatment 11 0 1.3 0.8 2 Treatment 12 0 0.1 0.0 0Treatment 13 3 1.6 0.3 5 Treatment 14 0 0.4 2.3 3 Treatment 15 1.5 3.42.6 7

TABLE 3B Table 3B Mouse studies with bacterial compositions Mortality D3Weight Morbidity Summary Score Score >3 Score Score Treatment 1 3 3.03.0 9 Treatment 2 1.8 0.7 2.1 5 Treatment 3 0 0.0 0.0 0 Treatment 4 00.5 0.0 0 Treatment 5 0 0.7 0.0 1 Treatment 6 0.6 2.3 0.7 4 Treatment 70.6 1.7 0.6 3 Treatment 8 2.4 3.0 2.0 7 Treatment 9 0.6 1.4 0.6 3Treatment 10 0 1.1 0.0 1 Treatment 11 0 1.7 0.6 2 Treatment 12 3 3.1 3.29

TABLE 4 Table 4 Species isolated from ethanol treated spore preparationpreparation before (left) and after (right) CsCl gradient step ethanoltreated, ethanol treated gradient purified Isolates spore preparationspore preparation Bacillus coagulans 7 2 Blautia luti 1 1 Blautia sp 1413 Blautia wexlerae 3 1 Ruminococcus obeum 4 2 Clostridiales sp 1 2Clostridium aerotolerans 1 2 Clostridium disporicum 0 1 Clostridium sp 11 Clostridium symbiosum 0 1 Dorea longicatena 8 6 Eubacteriumcellulosolvens 1 0 Eubacterium ventriosum 2 2 Gemmiger formicilis 0 1Robinsoniella peoriensis 0 1 Roseburia hominis 3 6 Roseburiaintestinalis 9 7 Ruminococcus sp 5 2 Syntrophococcus 1 1 sucromutansTuricibacter sanguinis 3 4 Clostridiales sp 7 9 Clostridium bartlettii 811 Clostridium irregulare 0 1 Clostridium sordellii 4 6 Lachnospiraceaesp 1 0

TABLE 5 Mortality and weight change in mice challenged with C. difficilewith or without ethanol treated, spore preparation treatment. mortality% weight Test article (n = 10) change on Day 3 vehicle (negativecontrol) 20% −10.5%     Donor feces (positive control) 0 −0.1%    EtOH-treated spore 0 2.3%   preparation 1x EtOH-treated spore 0 2.4%  preparation 0.1x EtOH-treated spore 0 −3%   preparation 0.01xheat-treated spore 0 0.1%   preparation

Table 6 shows spore quantitation for ethanol treated spore preparationsusing spore CFU (SCFU) assay and DPA assay.

TABLE 6 SCFU/30 DPA SEq/30 Ratio SCFU/ Preparation capsules capsules DPAPreparation 1 4.0 × 10⁵ 6.8 × 10⁷ 5.9 × 10⁻³ Preparation 2 2.1 × 10⁷ 9.2× 10⁸ 0.023 Preparation 3 6.9 × 10⁹ 9.6 × 10⁹ 0.72 

TABLE 7 DPA doses in Table 7 when normalized to 4 × 10⁵ SCFU per doseFraction of SCFU/30 DPA SEq/30 Preparation 1 Preparation capsulescapsules Dose Preparation 1 4.0 × 10⁵ 6.8 × 10⁷ 1.0   Preparation 2 4.0× 10⁵ 1.8 × 10⁷ 0.26  Preparation 3 4.0 × 10⁵ 5.6 × 10⁵ 0.0082

TABLE 8 SPC1 SPC2 SPC3 OTU1 OTU2 OTU3 Results SPC10325 SPC10415 SPC10567Clostridium_bolteae Blautia producta Eubacterium_rectale ++++ SPC10325SPC10355 SPC10415 Clostridium_bolteae Clostridium_symbiosum Blautiaproducta ++++ SPC10325 SPC10355 SPC10567 Clostridium_bolteaeClostridium_symbiosum Eubacterium_rectale − SPC10325 SPC10355 SPC10386Clostridium_bolteae Clostridium_symbiosum Faecalibacterium_prausnitzii −SPC10325 SPC10355 SPC10390 Clostridium_bolteae Clostridium_symbiosumLachnospiraceae_bacterium_5_1_57FAA SPC10325 SPC10386 SPC10415Clostridium_bolteae Faecalibacterium_prausnitzii Blautia producta ++++SPC10325 SPC10386 SPC10567 Clostridium_bolteaeFaecalibacterium_prausnitzii Eubacterium_rectale SPC10325 SPC10386SPC10390 Clostridium_bolteae Faecalibacterium_prausnitziiLachnospiraceae_bacterium_5_1_57FAA ++++ SPC10325 SPC10390 SPC10415Clostridium_bolteae Lachnospiraceae_bacter- Blautia producta ++++ium_5_1_57FAA SPC10325 SPC10390 SPC10567 Clostridium_bolteaeLachnospiraceae_bacter- Eubacterium_rectale + ium_5_1_57FAA SPC10355SPC10415 SPC10567 Clostridium_symbiosum Blautia productaEubacterium_rectale ++++ SPC10355 SPC10386 SPC10415Clostridium_symbiosum Faecalibacterium_prausnitzii Blautia producta ++++SPC10355 SPC10386 SPC10567 Clostridium_symbiosumFaecalibacterium_prausnitzii Eubacterium_rectale SPC10355 SPC10386SPC10390 Clostridium_symbiosum Faecalibacterium_prausnitziiLachnospiraceae_bacterium_5_1_57FAA + SPC10355 SPC10390 SPC10415Clostridium_symbiosum Lachnospiraceae_bacter- Blautia producta ++++ium_5_1_57FAA SPC10355 SPC10390 SPC10567 Clostridium_symbiosumLachnospiraceae_bacter- Eubacterium_rectale ium_5_1_57FAA SPC10097SPC10415 SPC10567 Collinsella_aerofaciens Blautia productaEubacterium_rectale ++++ SPC10097 SPC10325 SPC10415Collinsella_aerofaciens Clostridium_bolteae Blautia producta ++++SPC10097 SPC10325 SPC10355 Collinsella_aerofaciens Clostridium_bolteaeClostridium_symbiosum ++++ SPC10097 SPC10325 SPC10567Collinsella_aerofaciens Clostridium_bolteae Eubacterium_rectale ++++SPC10097 SPC10325 SPC10386 Collinsella_aerofaciens Clostridium_bolteaeFaecalibacterium_prausnitzii ++++ SPC10097 SPC10325 SPC10390Collinsella_aerofaciens Clostridium_bolteaeLachnospiraceae_bacterium_5_1_57FAA ++++ SPC10097 SPC10355 SPC10415Collinsella_aerofaciens Clostridium_symbiosum Blautia producta ++++SPC10097 SPC10355 SPC10567 Collinsella_aerofaciens Clostridium_symbiosumEubacterium_rectale SPC10097 SPC10355 SPC10386 Collinsella_aerofaciensClostridium_symbiosum Faecalibacterium_prausnitzii SPC10097 SPC10355SPC10390 Collinsella_aerofaciens Clostridium_symbiosumLachnospiraceae_bacterium_5_1_57FAA + SPC10097 SPC10304 SPC10415Collinsella_aerofaciens Coprococcus_comes Blautia producta ++++ SPC10097SPC10304 SPC10325 Collinsella_aerofaciens Coprococcus_comesClostridium_bolteae ++++ SPC10097 SPC10304 SPC10355Collinsella_aerofaciens Coprococcus_comes Clostridium_symbiosum +++SPC10097 SPC10304 SPC10567 Collinsella_aerofaciens Coprococcus_comesEubacterium_rectale +++ SPC10097 SPC10304 SPC10386Collinsella_aerofaciens Coprococcus_comes Faecalibacterium_prausnitzii++++ SPC10097 SPC10304 SPC10390 Collinsella_aerofaciensCoprococcus_comes Lachnospiraceae_bacterium_5_1_57FAA +++ SPC10097SPC10386 SPC10415 Collinsella_aerofaciens Faecalibacterium_prausnitziiBlautia producta ++++ SPC10097 SPC10386 SPC10567 Collinsella_aerofaciensFaecalibacterium_prausnitzii Eubacterium_rectale +++ SPC10097 SPC10386SPC10390 Collinsella_aerofaciens Faecalibacterium_prausnitziiLachnospiraceae_bacterium_5_1_57FAA +++ SPC10097 SPC10390 SPC10415Collinsella_aerofaciens Lachnospiraceae_bacter- Blautia producta ++++ium_5_1_57FAA SPC10097 SPC10390 SPC10567 Collinsella_aerofaciensLachnospiraceae_bacter- Eubacterium_rectale ++++ ium_5_1_57FAA SPC10304SPC10415 SPC10567 Coprococcus_comes Blautia producta Eubacterium_rectale++++ SPC10304 SPC10325 SPC10415 Coprococcus_comes Clostridium_bolteaeBlautia producta ++++ SPC10304 SPC10325 SPC10355 Coprococcus_comesClostridium_bolteae Clostridium_symbiosum SPC10304 SPC10325 SPC10567Coprococcus_comes Clostridium_bolteae Eubacterium_rectale −− SPC10304SPC10325 SPC10386 Coprococcus_comes Clostridium_bolteaeFaecalibacterium_prausnitzii +++ SPC10304 SPC10325 SPC10390Coprococcus_comes Clostridium_bolteaeLachnospiraceae_bacterium_5_1_57FAA +++ SPC10304 SPC10355 SPC10415Coprococcus_comes Clostridium_symbiosum Blautia producta ++++ SPC10304SPC10355 SPC10567 Coprococcus_comes Clostridium_symbiosumEubacterium_rectale −−− SPC10304 SPC10355 SPC10386 Coprococcus_comesClostridium_symbiosum Faecalibacterium_prausnitzii SPC10304 SPC10355SPC10390 Coprococcus_comes Clostridium_symbiosumLachnospiraceae_bacterium_5_1_57FAA SPC10304 SPC10386 SPC10415Coprococcus_comes Faecalibacterium_prausnitzii Blautia producta ++++SPC10304 SPC10386 SPC10567 Coprococcus_comesFaecalibacterium_prausnitzii Eubacterium_rectale − SPC10304 SPC10386SPC10390 Coprococcus_comes Faecalibacterium_prausnitziiLachnospiraceae_bacterium_5_1_57FAA SPC10304 SPC10390 SPC10415Coprococcus_comes Lachnospiraceae_bacter- Blautia producta ++++ium_5_1_57FAA SPC10304 SPC10390 SPC10567 Coprococcus_comesLachnospiraceae_bacter- Eubacterium_rectale ium_5_1_57FAA SPC10386SPC10415 SPC10567 Faecalibacter- Blautia producta Eubacterium_rectale++++ ium_prausnitzii SPC10386 SPC10390 SPC10415 Faecalibacter-Lachnospiraceae_bacter- Blautia producta ++++ ium_prausnitziiium_5_1_57FAA SPC10386 SPC10390 SPC10567 Faecalibacter-Lachnospiraceae_bacter- Eubacterium_rectale ium_prausnitziiium_5_1_57FAA SPC10390 SPC10415 SPC10567 Lachnospiraceae_bacter- Blautiaproducta Eubacterium_rectale ++++ ium_5_1_57FAA

TABLE 9 SPC1 SPC2 OTU1 OTU2 Result SPC10414 SPC10414 Alistipes_shahiiAlistipes_shahii SPC10211 SPC10414 Bacteroides_caccae Alistipes_shahiiSPC10213 SPC10414 Bacteroides_eggerthii Alistipes_shahii −− SPC10030SPC10414 Bacteroides_ovatus Alistipes_shahii SPC00006 SPC10414Bacteroides_sp_1_1_6 Alistipes_shahii ++++ SPC00007 SPC10414Bacteroides_sp_3_1_23 Alistipes_shahii + SPC10019 SPC10414Bacteroides_sp_D20 Alistipes_shahii − SPC00005 SPC10414Bacteroides_vulgatus Alistipes_shahii +++ SPC10081 SPC10414Bacteroides_vulgatus Alistipes_shahii + SPC10301 SPC10414Bifidobacterium_adolescentis Alistipes_shahii ++++ SPC10298 SPC10414Bifidobacterium_pseudocatenulatum Alistipes_shahii SPC00021 SPC10414Blautia_producta Alistipes_shahii ++++ SPC10403 SPC10414Blautia_schinkii Alistipes_shahii SPC10243 SPC10414Clostridium_hathewayi Alistipes_shahii ++++ SPC00026 SPC10414Clostridium_nexile Alistipes_shahii SPC00027 SPC10414Clostridium_sp_HGF2 Alistipes_shahii SPC10355 SPC10414Clostridium_symbiosum Alistipes_shahii SPC10097 SPC10414Collinsella_aerofaciens Alistipes_shahii ++++ SPC00009 SPC10414Coprobacillus_sp_D7 Alistipes_shahii ++++ SPC00080 SPC10414Coprococcus_catus Alistipes_shahii − SPC10304 SPC10414 Coprococcus_comesAlistipes_shahii SPC00018 SPC10414 Dorea_formicigeneransAlistipes_shahii −−−− SPC00057 SPC10414 Dorea_longicatenaAlistipes_shahii ++++ SPC00008 SPC10414 Enterococcus_faecalisAlistipes_shahii ++++ SPC10001 SPC10414 Erysipelotrichaceae_bacteriumAlistipes_shahii −−− SPC00001 SPC10414 Escherichia_coli Alistipes_shahii++++ SPC10110 SPC10414 Escherichia_coli Alistipes_shahii ++++ SPC00022SPC10414 Eubacterium_eligens Alistipes_shahii −− SPC10363 SPC10414Eubacterium_rectale Alistipes_shahii SPC00054 SPC10414Faecalibacterium_prausnitzii Alistipes_shahii SPC10386 SPC10414Faecalibacterium_prausnitzii Alistipes_shahii + SPC10390 SPC10414Lachnospiraceae_bacterium_5_1_57FAA Alistipes_shahii SPC00056 SPC10414Odoribacter_splanchnicus Alistipes_shahii SPC10388 SPC10414Odoribacter_splanchnicus Alistipes_shahii SPC10048 SPC10414Parabacteroides_merdae Alistipes_shahii SPC00061 SPC10414Roseburia_intestinalis Alistipes_shahii − SPC10197 SPC10414Ruminococcus_obeum Alistipes_shahii SPC10233 SPC10414Ruminococcus_torques Alistipes_shahii SPC00015 SPC10414Streptococcus_thermophilus Alistipes_shahii SPC10211 SPC10211Bacteroides_caccae Bacteroides_caccae ++++ SPC10030 SPC10211Bacteroides_ovatus Bacteroides_caccae SPC00006 SPC10211Bacteroides_sp_1_1_6 Bacteroides_caccae ++++ SPC00007 SPC10211Bacteroides_sp_3_1_23 Bacteroides_caccae +++ SPC10019 SPC10211Bacteroides_sp_D20 Bacteroides_caccae +++ SPC00005 SPC10211Bacteroides_vulgatus Bacteroides_caccae ++++ SPC10081 SPC10211Bacteroides_vulgatus Bacteroides_caccae + SPC00021 SPC10211Blautia_producta Bacteroides_caccae ++++ SPC00026 SPC10211Clostridium_nexile Bacteroides_caccae SPC00027 SPC10211Clostridium_sp_HGF2 Bacteroides_caccae SPC10097 SPC10211Collinsella_aerofaciens Bacteroides_caccae ++++ SPC00009 SPC10211Coprobacillus_sp_D7 Bacteroides_caccae +++ SPC00080 SPC10211Coprococcus_catus Bacteroides_caccae ++++ SPC00018 SPC10211Dorea_formicigenerans Bacteroides_caccae +++ SPC00057 SPC10211Dorea_longicatena Bacteroides_caccae SPC00008 SPC10211Enterococcus_faecalis Bacteroides_caccae ++++ SPC10001 SPC10211Erysipelotrichaceae_bacterium Bacteroides_caccae ++ SPC00001 SPC10211Escherichia_coli Bacteroides_caccae ++++ SPC10110 SPC10211Escherichia_coli Bacteroides_caccae ++++ SPC00022 SPC10211Eubacterium_eligens Bacteroides_caccae ++ SPC00054 SPC10211Faecalibacterium_prausnitzii Bacteroides_caccae − SPC00056 SPC10211Odoribacter_splanchnicus Bacteroides_caccae SPC10048 SPC10211Parabacteroides_merdae Bacteroides_caccae + SPC00061 SPC10211Roseburia_intestinalis Bacteroides_caccae + SPC10197 SPC10211Ruminococcus_obeum Bacteroides_caccae ++++ SPC00015 SPC10211Streptococcus_thermophilus Bacteroides_caccae ++ SPC10211 SPC10213Bacteroides_caccae Bacteroides_eggerthii ++++ SPC10213 SPC10213Bacteroides_eggerthii Bacteroides_eggerthii ++++ SPC10030 SPC10213Bacteroides_ovatus Bacteroides_eggerthii SPC00006 SPC10213Bacteroides_sp_1_1_6 Bacteroides_eggerthii +++ SPC00007 SPC10213Bacteroides_sp_3_1_23 Bacteroides_eggerthii ++ SPC10019 SPC10213Bacteroides_sp_D20 Bacteroides_eggerthii SPC00005 SPC10213Bacteroides_vulgatus Bacteroides_eggerthii ++++ SPC10081 SPC10213Bacteroides_vulgatus Bacteroides_eggerthii + SPC00021 SPC10213Blautia_producta Bacteroides_eggerthii ++++ SPC00026 SPC10213Clostridium_nexile Bacteroides_eggerthii SPC00027 SPC10213Clostridium_sp_HGF2 Bacteroides_eggerthii − SPC10097 SPC10213Collinsella_aerofaciens Bacteroides_eggerthii ++++ SPC00009 SPC10213Coprobacillus_sp_D7 Bacteroides_eggerthii SPC00080 SPC10213Coprococcus_catus Bacteroides_eggerthii + SPC00018 SPC10213Dorea_formicigenerans Bacteroides_eggerthii SPC00057 SPC10213Dorea_longicatena Bacteroides_eggerthii − SPC00008 SPC10213Enterococcus_faecalis Bacteroides_eggerthii ++++ SPC10001 SPC10213Erysipelotrichaceae_bacterium Bacteroides_eggerthii SPC00001 SPC10213Escherichia_coli Bacteroides_eggerthii ++++ SPC10110 SPC10213Escherichia_coli Bacteroides_eggerthii ++++ SPC00022 SPC10213Eubacterium_eligens Bacteroides_eggerthii SPC00054 SPC10213Faecalibacterium_prausnitzii Bacteroides_eggerthii SPC00056 SPC10213Odoribacter_splanchnicus Bacteroides_eggerthii SPC10048 SPC10213Parabacteroides_merdae Bacteroides_eggerthii SPC00061 SPC10213Roseburia_intestinalis Bacteroides_eggerthii SPC10197 SPC10213Ruminococcus_obeum Bacteroides_eggerthii ++++ SPC00015 SPC10213Streptococcus_thermophilus Bacteroides_eggerthii SPC10030 SPC10030Bacteroides_ovatus Bacteroides_ovatus +++ SPC00006 SPC10030Bacteroides_sp_1_1_6 Bacteroides_ovatus ++++ SPC00007 SPC10030Bacteroides_sp_3_1_23 Bacteroides_ovatus SPC10019 SPC10030Bacteroides_sp_D20 Bacteroides_ovatus − SPC00005 SPC10030Bacteroides_vulgatus Bacteroides_ovatus + SPC00021 SPC10030Blautia_producta Bacteroides_ovatus ++++ SPC00026 SPC10030Clostridium_nexile Bacteroides_ovatus SPC00027 SPC10030Clostridium_sp_HGF2 Bacteroides_ovatus SPC00009 SPC10030Coprobacillus_sp_D7 Bacteroides_ovatus SPC00080 SPC10030Coprococcus_catus Bacteroides_ovatus SPC00018 SPC10030Dorea_formicigenerans Bacteroides_ovatus SPC00057 SPC10030Dorea_longicatena Bacteroides_ovatus − SPC00008 SPC10030Enterococcus_faecalis Bacteroides_ovatus ++++ SPC10001 SPC10030Erysipelotrichaceae_bacterium Bacteroides_ovatus SPC00001 SPC10030Escherichia_coli Bacteroides_ovatus ++++ SPC00022 SPC10030Eubacterium_eligens Bacteroides_ovatus − SPC00054 SPC10030Faecalibacterium_prausnitzii Bacteroides_ovatus SPC00056 SPC10030Odoribacter_splanchnicus Bacteroides_ovatus SPC00061 SPC10030Roseburia_intestinalis Bacteroides_ovatus SPC00015 SPC10030Streptococcus_thermophilus Bacteroides_ovatus ++ SPC00006 SPC00006Bacteroides_sp_1_1_6 Bacteroides_sp_1_1_6 ++++ SPC00005 SPC00006Bacteroides_vulgatus Bacteroides_sp_1_1_6 ++++ SPC00001 SPC00006Escherichia_coli Bacteroides_sp_1_1_6 ++++ SPC00006 SPC00007Bacteroides_sp_1_1_6 Bacteroides_sp_3_1_23 ++++ SPC00007 SPC00007Bacteroides_sp_3_1_23 Bacteroides_sp_3_1_23 SPC00005 SPC00007Bacteroides_vulgatus Bacteroides_sp_3_1_23 +++ SPC00001 SPC00007Escherichia_coli Bacteroides_sp_3_1_23 ++++ SPC00006 SPC10019Bacteroides_sp_1_1_6 Bacteroides_sp_D20 ++++ SPC00007 SPC10019Bacteroides_sp_3_1_23 Bacteroides_sp_D20 ++++ SPC10019 SPC10019Bacteroides_sp_D20 Bacteroides_sp_D20 SPC00005 SPC10019Bacteroides_vulgatus Bacteroides_sp_D20 + SPC00021 SPC10019Blautia_producta Bacteroides_sp_D20 ++++ SPC00026 SPC10019Clostridium_nexile Bacteroides_sp_D20 − SPC00027 SPC10019Clostridium_sp_HGF2 Bacteroides_sp_D20 SPC00009 SPC10019Coprobacillus_sp_D7 Bacteroides_sp_D20 SPC00080 SPC10019Coprococcus_catus Bacteroides_sp_D20 SPC00018 SPC10019Dorea_formicigenerans Bacteroides_sp_D20 − SPC00057 SPC10019Dorea_longicatena Bacteroides_sp_D20 SPC00008 SPC10019Enterococcus_faecalis Bacteroides_sp_D20 ++++ SPC10001 SPC10019Erysipelotrichaceae_bacterium Bacteroides_sp_D20 SPC00001 SPC10019Escherichia_coli Bacteroides_sp_D20 ++++ SPC00022 SPC10019Eubacterium_eligens Bacteroides_sp_D20 − SPC00054 SPC10019Faecalibacterium_prausnitzii Bacteroides_sp_D20 SPC00056 SPC10019Odoribacter_splanchnicus Bacteroides_sp_D20 SPC00061 SPC10019Roseburia_intestinalis Bacteroides_sp_D20 − SPC00015 SPC10019Streptococcus_thermophilus Bacteroides_sp_D20 + SPC10030 SPC10081Bacteroides_ovatus Bacteroides_vulgatus SPC00006 SPC10081Bacteroides_sp_1_1_6 Bacteroides_vulgatus SPC00007 SPC10081Bacteroides_sp_3_1_23 Bacteroides_vulgatus − SPC10019 SPC10081Bacteroides_sp_D20 Bacteroides_vulgatus SPC00005 SPC00005Bacteroides_vulgatus Bacteroides_vulgatus + SPC00005 SPC10081Bacteroides_vulgatus Bacteroides_vulgatus ++ SPC10081 SPC10081Bacteroides_vulgatus Bacteroides_vulgatus SPC00021 SPC10081Blautia_producta Bacteroides_vulgatus ++++ SPC00026 SPC10081Clostridium_nexile Bacteroides_vulgatus SPC00027 SPC10081Clostridium_sp_HGF2 Bacteroides_vulgatus +++ SPC00009 SPC10081Coprobacillus_sp_D7 Bacteroides_vulgatus − SPC00080 SPC10081Coprococcus_catus Bacteroides_vulgatus ++ SPC00018 SPC10081Dorea_formicigenerans Bacteroides_vulgatus SPC00057 SPC10081Dorea_longicatena Bacteroides_vulgatus SPC00008 SPC10081Enterococcus_faecalis Bacteroides_vulgatus ++++ SPC10001 SPC10081Erysipelotrichaceae_bacterium Bacteroides_vulgatus SPC00001 SPC00005Escherichia_coli Bacteroides_vulgatus ++++ SPC00001 SPC10081Escherichia_coli Bacteroides_vulgatus ++++ SPC00022 SPC10081Eubacterium_eligens Bacteroides_vulgatus SPC00054 SPC10081Faecalibacterium_prausnitzii Bacteroides_vulgatus SPC00056 SPC10081Odoribacter_splanchnicus Bacteroides_vulgatus SPC10048 SPC10081Parabacteroides_merdae Bacteroides_vulgatus + SPC00061 SPC10081Roseburia_intestinalis Bacteroides_vulgatus SPC00015 SPC10081Streptococcus_thermophilus Bacteroides_vulgatus −− SPC10211 SPC10301Bacteroides_caccae Bifidobacterium_adolescentis ++++ SPC10213 SPC10301Bacteroides_eggerthii Bifidobacterium_adolescentis ++++ SPC10030SPC10301 Bacteroides_ovatus Bifidobacterium_adolescentis ++++ SPC00006SPC10301 Bacteroides_sp_1_1_6 Bifidobacterium_adolescentis ++++ SPC00007SPC10301 Bacteroides_sp_3_1_23 Bifidobacterium_adolescentis ++++SPC10019 SPC10301 Bacteroides_sp_D20 Bifidobacterium_adolescentis ++++SPC00005 SPC10301 Bacteroides_vulgatus Bifidobacterium_adolescentis ++++SPC10081 SPC10301 Bacteroides_vulgatus Bifidobacterium_adolescentis ++++SPC10301 SPC10301 Bifidobacterium_adolescentisBifidobacterium_adolescentis ++++ SPC10298 SPC10301Bifidobacterium_pseudocatenulatum Bifidobacterium_adolescentis ++++SPC00021 SPC10301 Blautia_producta Bifidobacterium_adolescentis ++++SPC10243 SPC10301 Clostridium_hathewayi Bifidobacterium_adolescentis++++ SPC00026 SPC10301 Clostridium_nexile Bifidobacterium_adolescentis++++ SPC00027 SPC10301 Clostridium_sp_HGF2 Bifidobacterium_adolescentis++++ SPC10097 SPC10301 Collinsella_aerofaciensBifidobacterium_adolescentis ++++ SPC00009 SPC10301 Coprobacillus_sp_D7Bifidobacterium_adolescentis ++++ SPC00080 SPC10301 Coprococcus_catusBifidobacterium_adolescentis SPC00018 SPC10301 Dorea_formicigeneransBifidobacterium_adolescentis ++++ SPC00057 SPC10301 Dorea_longicatenaBifidobacterium_adolescentis ++++ SPC00008 SPC10301Enterococcus_faecalis Bifidobacterium_adolescentis ++++ SPC10001SPC10301 Erysipelotrichaceae_bacterium Bifidobacterium_adolescentis ++++SPC00001 SPC10301 Escherichia_coli Bifidobacterium_adolescentis ++++SPC10110 SPC10301 Escherichia_coli Bifidobacterium_adolescentis ++++SPC00022 SPC10301 Eubacterium_eligens Bifidobacterium_adolescentis ++++SPC00054 SPC10301 Faecalibacterium_prausnitziiBifidobacterium_adolescentis + SPC00056 SPC10301Odoribacter_splanchnicus Bifidobacterium_adolescentis +++ SPC10048SPC10301 Parabacteroides_merdae Bifidobacterium_adolescentis ++++SPC00061 SPC10301 Roseburia_intestinalis Bifidobacterium_adolescentis+++ SPC10197 SPC10301 Ruminococcus_obeum Bifidobacterium_adolescentis++++ SPC10233 SPC10301 Ruminococcus_torques Bifidobacterium_adolescentis++++ SPC00015 SPC10301 Streptococcus_thermophilusBifidobacterium_adolescentis ++++ SPC10211 SPC10298 Bacteroides_caccaeBifidobacterium_pseudocatenulatum ++++ SPC10213 SPC10298Bacteroides_eggerthii Bifidobacterium_pseudocatenulatum ++++ SPC10030SPC10298 Bacteroides_ovatus Bifidobacterium_pseudocatenulatum ++++SPC00006 SPC10298 Bacteroides_sp_1_1_6 Bifidobacterium_pseudocatenulatum++++ SPC00007 SPC10298 Bacteroides_sp_3_1_23Bifidobacterium_pseudocatenulatum ++++ SPC10019 SPC10298Bacteroides_sp_D20 Bifidobacterium_pseudocatenulatum −− SPC00005SPC10298 Bacteroides_vulgatus Bifidobacterium_pseudocatenulatum ++++SPC10081 SPC10298 Bacteroides_vulgatus Bifidobacterium_pseudocatenulatum++++ SPC10298 SPC10298 Bifidobacterium_pseudocatenulatumBifidobacterium_pseudocatenulatum ++++ SPC00021 SPC10298Blautia_producta Bifidobacterium_pseudocatenulatum + SPC10243 SPC10298Clostridium_hathewayi Bifidobacterium_pseudocatenulatum ++++ SPC00026SPC10298 Clostridium_nexile Bifidobacterium_pseudocatenulatum ++++SPC00027 SPC10298 Clostridium_sp_HGF2 Bifidobacterium_pseudocatenulatum+++ SPC10097 SPC10298 Collinsella_aerofaciensBifidobacterium_pseudocatenulatum ++++ SPC00009 SPC10298Coprobacillus_sp_D7 Bifidobacterium_pseudocatenulatum +++ SPC00080SPC10298 Coprococcus_catus Bifidobacterium_pseudocatenulatum SPC00018SPC10298 Dorea_formicigenerans Bifidobacterium_pseudocatenulatum +++SPC00057 SPC10298 Dorea_longicatena Bifidobacterium_pseudocatenulatum++++ SPC00008 SPC10298 Enterococcus_faecalisBifidobacterium_pseudocatenulatum ++++ SPC10001 SPC10298Erysipelotrichaceae_bacterium Bifidobacterium_pseudocatenulatum SPC00001SPC10298 Escherichia_coli Bifidobacterium_pseudocatenulatum ++++SPC10110 SPC10298 Escherichia_coli Bifidobacterium_pseudocatenulatum++++ SPC00022 SPC10298 Eubacterium_eligensBifidobacterium_pseudocatenulatum ++++ SPC00054 SPC10298Faecalibacterium_prausnitzii Bifidobacterium_pseudocatenulatum ++SPC00056 SPC10298 Odoribacter_splanchnicusBifidobacterium_pseudocatenulatum + SPC10048 SPC10298Parabacteroides_merdae Bifidobacterium_pseudocatenulatum ++++ SPC00061SPC10298 Roseburia_intestinalis Bifidobacterium_pseudocatenulatum +++SPC10197 SPC10298 Ruminococcus_obeum Bifidobacterium_pseudocatenulatum++++ SPC10233 SPC10298 Ruminococcus_torquesBifidobacterium_pseudocatenulatum ++++ SPC00015 SPC10298Streptococcus_thermophilus Bifidobacterium_pseudocatenulatum ++++SPC10414 SPC10415 Alistipes_shahii Blautia_producta SPC10211 SPC10415Bacteroides_caccae Blautia_producta + SPC10213 SPC10415Bacteroides_eggerthii Blautia_producta SPC10030 SPC10415Bacteroides_ovatus Blautia_producta − SPC00006 SPC00021Bacteroides_sp_1_1_6 Blautia_producta ++++ SPC00006 SPC10415Bacteroides_sp_1_1_6 Blautia_producta ++++ SPC00007 SPC00021Bacteroides_sp_3_1_23 Blautia_producta ++++ SPC00007 SPC10415Bacteroides_sp_3_1_23 Blautia_producta ++ SPC10019 SPC10415Bacteroides_sp_D20 Blautia_producta SPC00005 SPC00021Bacteroides_vulgatus Blautia_producta ++++ SPC00005 SPC10415Bacteroides_vulgatus Blautia_producta ++++ SPC10081 SPC10415Bacteroides_vulgatus Blautia_producta ++++ SPC10301 SPC10415Bifidobacterium_adolescentis Blautia_producta ++++ SPC10298 SPC10415Bifidobacterium_pseudocatenulatum Blautia_producta SPC00021 SPC00021Blautia_producta Blautia_producta ++++ SPC00021 SPC10415Blautia_producta Blautia_producta ++++ SPC10415 SPC10415Blautia_producta Blautia_producta + SPC10415 SPC10415 Blautia_productaBlautia_producta ++++ SPC10403 SPC10415 Blautia_schinkiiBlautia_producta SPC10256 SPC10415 Clostridium butyricumBlautia_producta ++++ SPC10358 SPC10415 Clostridium orbiscindensBlautia_producta ++++ SPC10325 SPC10415 Clostridium_bolteaeBlautia_producta ++++ SPC10167 SPC10415 Clostridium_disporicumBlautia_producta ++++ SPC10243 SPC10415 Clostridium_hathewayiBlautia_producta +++ SPC10313 SPC10415 Clostridium_hylemonaeBlautia_producta ++++ SPC10202 SPC10415 Clostridium_innocuumBlautia_producta ++++ SPC10238 SPC10415 Clostridium_mayombeiBlautia_producta ++++ SPC00026 SPC10415 Clostridium_nexileBlautia_producta − SPC00027 SPC10415 Clostridium_sp_HGF2Blautia_producta SPC10355 SPC10415 Clostridium_symbiosumBlautia_producta SPC10355 SPC10415 Clostridium_symbiosumBlautia_producta ++++ SPC10155 SPC10415 Clostridium_tertiumBlautia_producta ++++ SPC10097 SPC10415 Collinsella_aerofaciensBlautia_producta ++++ SPC10097 SPC10415 Collinsella_aerofaciensBlautia_producta ++++ SPC00009 SPC00021 Coprobacillus_sp_D7Blautia_producta ++++ SPC00009 SPC10415 Coprobacillus_sp_D7Blautia_producta ++++ SPC00080 SPC10415 Coprococcus_catusBlautia_producta −−−− SPC10304 SPC10415 Coprococcus_comesBlautia_producta SPC10304 SPC10415 Coprococcus_comes Blautia_producta++++ SPC00018 SPC00021 Dorea_formicigenerans Blautia_producta ++++SPC00018 SPC10415 Dorea_formicigenerans Blautia_producta −− SPC00057SPC10415 Dorea_longicatena Blautia_producta +++ SPC00008 SPC00021Enterococcus_faecalis Blautia_producta ++++ SPC00008 SPC10415Enterococcus_faecalis Blautia_producta ++++ SPC10001 SPC10415Erysipelotrichaceae_bacterium Blautia_producta −−− SPC00001 SPC00021Escherichia_coli Blautia_producta ++++ SPC00001 SPC10415Escherichia_coli Blautia_producta ++++ SPC10110 SPC10415Escherichia_coli Blautia_producta ++++ SPC00022 SPC10415Eubacterium_eligens Blautia_producta −−− SPC10363 SPC10415Eubacterium_rectale Blautia_producta + SPC00054 SPC10415Faecalibacterium_prausnitzii Blautia_producta SPC10386 SPC10415Faecalibacterium_prausnitzii Blautia_producta + SPC10386 SPC10415Faecalibacterium_prausnitzii Blautia_producta ++++ SPC10390 SPC10415Lachnospiraceae_bacterium_5_1_57FAA Blautia_producta + SPC10390 SPC10415Lachnospiraceae_bacterium_5_1_57FAA Blautia_producta ++++ SPC00056SPC10415 Odoribacter_splanchnicus Blautia_producta − SPC10388 SPC10415Odoribacter_splanchnicus Blautia_producta + SPC10048 SPC10415Parabacteroides_merdae Blautia_producta +++ SPC00061 SPC10415Roseburia_intestinalis Blautia_producta −− SPC10468 SPC10415Ruminococcus_gnavus Blautia_producta ++++ SPC10197 SPC10415Ruminococcus_obeum Blautia_producta SPC10233 SPC10415Ruminococcus_torques Blautia_producta SPC00015 SPC00021Streptococcus_thermophilus Blautia_producta ++++ SPC00015 SPC10415Streptococcus_thermophilus Blautia_producta SPC10211 SPC10403Bacteroides_caccae Blautia_schinkii SPC10213 SPC10403Bacteroides_eggerthii Blautia_schinkii −− SPC10030 SPC10403Bacteroides_ovatus Blautia_schinkii − SPC00006 SPC10403Bacteroides_sp_1_1_6 Blautia_schinkii +++ SPC00007 SPC10403Bacteroides_sp_3_1_23 Blautia_schinkii + SPC10019 SPC10403Bacteroides_sp_D20 Blautia_schinkii −− SPC00005 SPC10403Bacteroides_vulgatus Blautia_schinkii ++ SPC10081 SPC10403Bacteroides_vulgatus Blautia_schinkii SPC10301 SPC10403Bifidobacterium_adolescentis Blautia_schinkii ++ SPC10298 SPC10403Bifidobacterium_pseudocatenulatum Blautia_schinkii − SPC00021 SPC10403Blautia_producta Blautia_schinkii ++++ SPC10403 SPC10403Blautia_schinkii Blautia_schinkii SPC10243 SPC10403Clostridium_hathewayi Blautia_schinkii ++++ SPC00026 SPC10403Clostridium_nexile Blautia_schinkii −− SPC00027 SPC10403Clostridium_sp_HGF2 Blautia_schinkii SPC10355 SPC10403Clostridium_symbiosum Blautia_schinkii SPC10097 SPC10403Collinsella_aerofaciens Blautia_schinkii ++++ SPC00009 SPC10403Coprobacillus_sp_D7 Blautia_schinkii ++++ SPC00080 SPC10403Coprococcus_catus Blautia_schinkii −−− SPC10304 SPC10403Coprococcus_comes Blautia_schinkii + SPC00018 SPC10403Dorea_formicigenerans Blautia_schinkii SPC00057 SPC10403Dorea_longicatena Blautia_schinkii +++ SPC00008 SPC10403Enterococcus_faecalis Blautia_schinkii ++++ SPC10001 SPC10403Erysipelotrichaceae_bacterium Blautia_schinkii −−− SPC00001 SPC10403Escherichia_coli Blautia_schinkii ++++ SPC10110 SPC10403Escherichia_coli Blautia_schinkii ++++ SPC00022 SPC10403Eubacterium_eligens Blautia_schinkii − SPC10363 SPC10403Eubacterium_rectale Blautia_schinkii + SPC00054 SPC10403Faecalibacterium_prausnitzii Blautia_schinkii SPC10386 SPC10403Faecalibacterium_prausnitzii Blautia_schinkii SPC10390 SPC10403Lachnospiraceae_bacterium_5_1_57FAA Blautia_schinkii SPC00056 SPC10403Odoribacter_splanchnicus Blautia_schinkii − SPC10388 SPC10403Odoribacter_splanchnicus Blautia_schinkii SPC10048 SPC10403Parabacteroides_merdae Blautia_schinkii SPC00061 SPC10403Roseburia_intestinalis Blautia_schinkii − SPC10197 SPC10403Ruminococcus_obeum Blautia_schinkii SPC10233 SPC10403Ruminococcus_torques Blautia_schinkii SPC00015 SPC10403Streptococcus_thermophilus Blautia_schinkii SPC10256 SPC10256Clostridium_butyricum Clostridium butyricum ++++ SPC10167 SPC10256Clostridium_disporicum Clostridium butyricum ++++ SPC10202 SPC10256Clostridium_innocuum Clostridium butyricum ++++ SPC10238 SPC10256Clostridium_mayombei Clostridium butyricum ++++ SPC10155 SPC10256Clostridium_tertium Clostridium butyricum ++++ SPC10097 SPC10256Collinsella_aerofaciens Clostridium butyricum ++++ SPC10304 SPC10256Coprococcus_comes Clostridium butyricum ++++ SPC10256 SPC10358Clostridium butyricum Clostridium orbiscindens ++++ SPC10358 SPC10358Clostridium orbiscindens Clostridium orbiscindens + SPC10325 SPC10358Clostridium_bolteae Clostridium orbiscindens ++++ SPC10167 SPC10358Clostridium_disporicum Clostridium orbiscindens ++++ SPC10313 SPC10358Clostridium_hylemonae Clostridium orbiscindens SPC10202 SPC10358Clostridium_innocuum Clostridium orbiscindens ++++ SPC10238 SPC10358Clostridium_mayombei Clostridium orbiscindens ++++ SPC10355 SPC10358Clostridium_symbiosum Clostridium orbiscindens ++++ SPC10155 SPC10358Clostridium_tertium Clostridium orbiscindens ++++ SPC10097 SPC10358Collinsella_aerofaciens Clostridium orbiscindens ++++ SPC10304 SPC10358Coprococcus_comes Clostridium orbiscindens ++++ SPC10386 SPC10358Faecalibacterium_prausnitzii Clostridium orbiscindens SPC10256 SPC10325Clostridium butyricum Clostridium_bolteae ++++ SPC10325 SPC10325Clostridium_bolteae Clostridium_bolteae ++++ SPC10167 SPC10325Clostridium_disporicum Clostridium_bolteae ++++ SPC10313 SPC10325Clostridium_hylemonae Clostridium_bolteae SPC10202 SPC10325Clostridium_innocuum Clostridium_bolteae ++++ SPC10238 SPC10325Clostridium_mayombei Clostridium_bolteae ++++ SPC10355 SPC10325Clostridium_symbiosum Clostridium_bolteae ++++ SPC10155 SPC10325Clostridium_tertium Clostridium_bolteae ++++ SPC10097 SPC10325Collinsella_aerofaciens Clostridium_bolteae ++++ SPC10304 SPC10325Coprococcus_comes Clostridium_bolteae ++++ SPC10167 SPC10167Clostridium_disporicum Clostridium_disporicum +++ SPC10202 SPC10167Clostridium_innocuum Clostridium_disporicum +++ SPC10155 SPC10167Clostridium_tertium Clostridium_disporicum ++++ SPC10097 SPC10167Collinsella_aerofaciens Clostridium_disporicum − SPC10211 SPC10243Bacteroides_caccae Clostridium_hathewayi ++++ SPC10213 SPC10243Bacteroides_eggerthii Clostridium_hathewayi ++++ SPC10030 SPC10243Bacteroides_ovatus Clostridium_hathewayi ++++ SPC00006 SPC10243Bacteroides_sp_1_1_6 Clostridium_hathewayi ++++ SPC00007 SPC10243Bacteroides_sp_3_1_23 Clostridium_hathewayi ++++ SPC10019 SPC10243Bacteroides_sp_D20 Clostridium_hathewayi ++++ SPC00005 SPC10243Bacteroides_vulgatus Clostridium_hathewayi ++++ SPC10081 SPC10243Bacteroides_vulgatus Clostridium_hathewayi ++++ SPC00021 SPC10243Blautia_producta Clostridium_hathewayi ++++ SPC10243 SPC10243Clostridium_hathewayi Clostridium_hathewayi ++++ SPC00026 SPC10243Clostridium_nexile Clostridium_hathewayi SPC00027 SPC10243Clostridium_sp_HGF2 Clostridium_hathewayi SPC10097 SPC10243Collinsella_aerofaciens Clostridium_hathewayi ++++ SPC00009 SPC10243Coprobacillus_sp_D7 Clostridium_hathewayi ++++ SPC00080 SPC10243Coprococcus_catus Clostridium_hathewayi +++ SPC00018 SPC10243Dorea_formicigenerans Clostridium_hathewayi ++++ SPC00057 SPC10243Dorea_longicatena Clostridium_hathewayi + SPC00008 SPC10243Enterococcus_faecalis Clostridium_hathewayi ++++ SPC10001 SPC10243Erysipelotrichaceae_bacterium Clostridium_hathewayi ++++ SPC00001SPC10243 Escherichia_coli Clostridium_hathewayi ++++ SPC10110 SPC10243Escherichia_coli Clostridium_hathewayi ++++ SPC00022 SPC10243Eubacterium_eligens Clostridium_hathewayi + SPC00054 SPC10243Faecalibacterium_prausnitzii Clostridium_hathewayi SPC00056 SPC10243Odoribacter_splanchnicus Clostridium_hathewayi SPC10048 SPC10243Parabacteroides_merdae Clostridium_hathewayi + SPC00061 SPC10243Roseburia_intestinalis Clostridium_hathewayi +++ SPC10197 SPC10243Ruminococcus_obeum Clostridium_hathewayi ++++ SPC10233 SPC10243Ruminococcus_torques Clostridium_hathewayi ++++ SPC00015 SPC10243Streptococcus_thermophilus Clostridium_hathewayi ++ SPC10256 SPC10313Clostridium butyricum Clostridium_hylemonae ++++ SPC10325 SPC10313Clostridium_bolteae Clostridium_hylemonae SPC10167 SPC10313Clostridium_disporicum Clostridium_hylemonae SPC10313 SPC10313Clostridium_hylemonae Clostridium_hylemonae SPC10202 SPC10313Clostridium_innocuum Clostridium_hylemonae ++++ SPC10238 SPC10313Clostridium_mayombei Clostridium_hylemonae ++++ SPC10155 SPC10313Clostridium_tertium Clostridium_hylemonae ++++ SPC10097 SPC10313Collinsella_aerofaciens Clostridium_hylemonae +++ SPC10304 SPC10313Coprococcus_comes Clostridium_hylemonae + SPC10167 SPC10202Clostridium_disporicum Clostridium_innocuum +++ SPC10202 SPC10202Clostridium_innocuum Clostridium_innocuum ++++ SPC10238 SPC10202Clostridium_mayombei Clostridium_innocuum ++++ SPC10155 SPC10202Clostridium_tertium Clostridium_innocuum ++++ SPC10097 SPC10202Collinsella_aerofaciens Clostridium_innocuum +++ SPC10256 SPC10238Clostridium butyricum Clostridium_mayombei ++++ SPC10167 SPC10238Clostridium_disporicum Clostridium_mayombei ++++ SPC10202 SPC10238Clostridium_innocuum Clostridium_mayombei ++++ SPC10238 SPC10238Clostridium_mayombei Clostridium_mayombei ++++ SPC10155 SPC10238Clostridium_tertium Clostridium_mayombei ++++ SPC10097 SPC10238Collinsella_aerofaciens Clostridium_mayombei ++++ SPC00006 SPC00026Bacteroides_sp_1_1_6 Clostridium_nexile ++++ SPC00007 SPC00026Bacteroides_sp_3_1_23 Clostridium_nexile ++++ SPC00005 SPC00026Bacteroides_vulgatus Clostridium_nexile ++++ SPC00021 SPC00026Blautia_producta Clostridium_nexile ++++ SPC00026 SPC00026Clostridium_nexile Clostridium_nexile ++ SPC00009 SPC00026Coprobacillus_sp_D7 Clostridium_nexile SPC00018 SPC00026Dorea_formicigenerans Clostridium_nexile SPC00008 SPC00026Enterococcus_faecalis Clostridium_nexile ++++ SPC00001 SPC00026Escherichia_coli Clostridium_nexile ++++ SPC00022 SPC00026Eubacterium_eligens Clostridium_nexile + SPC00015 SPC00026Streptococcus_thermophilus Clostridium_nexile + SPC00006 SPC00027Bacteroides_sp_1_1_6 Clostridium_sp_HGF2 ++++ SPC00007 SPC00027Bacteroides_sp_3_1_23 Clostridium_sp_HGF2 ++++ SPC00005 SPC00027Bacteroides_vulgatus Clostridium_sp_HGF2 ++ SPC00021 SPC00027Blautia_producta Clostridium_sp_HGF2 ++++ SPC00026 SPC00027Clostridium_nexile Clostridium_sp_HGF2 ++++ SPC00027 SPC00027Clostridium_sp_HGF2 Clostridium_sp_HGF2 ++++ SPC00009 SPC00027Coprobacillus_sp_D7 Clostridium_sp_HGF2 − SPC00018 SPC00027Dorea_formicigenerans Clostridium_sp_HGF2 SPC00008 SPC00027Enterococcus_faecalis Clostridium_sp_HGF2 ++++ SPC00001 SPC00027Escherichia_coli Clostridium_sp_HGF2 ++++ SPC00022 SPC00027Eubacterium_eligens Clostridium_sp_HGF2 SPC00015 SPC00027Streptococcus_thermophilus Clostridium_sp_HGF2 + SPC10211 SPC10355Bacteroides_caccae Clostridium_symbiosum +++ SPC10213 SPC10355Bacteroides_eggerthii Clostridium_symbiosum ++++ SPC10030 SPC10355Bacteroides_ovatus Clostridium_symbiosum SPC00006 SPC10355Bacteroides_sp_1_1_6 Clostridium_symbiosum ++++ SPC00007 SPC10355Bacteroides_sp_3_1_23 Clostridium_symbiosum ++++ SPC10019 SPC10355Bacteroides_sp_D20 Clostridium_symbiosum SPC00005 SPC10355Bacteroides_vulgatus Clostridium_symbiosum +++ SPC10081 SPC10355Bacteroides_vulgatus Clostridium_symbiosum SPC10301 SPC10355Bifidobacterium_adolescentis Clostridium_symbiosum ++++ SPC10298SPC10355 Bifidobacterium_pseudocatenulatum Clostridium_symbiosum +SPC00021 SPC10355 Blautia_producta Clostridium_symbiosum ++++ SPC10256SPC10355 Clostridium butyricum Clostridium_symbiosum ++++ SPC10358SPC10355 Clostridium orbiscindens Clostridium_symbiosum ++++ SPC10325SPC10355 Clostridium_bolteae Clostridium_symbiosum ++++ SPC10167SPC10355 Clostridium_disporicum Clostridium_symbiosum ++++ SPC10243SPC10355 Clostridium_hathewayi Clostridium_symbiosum ++++ SPC10313SPC10355 Clostridium_hylemonae Clostridium_symbiosum +++ SPC10202SPC10355 Clostridium_innocuum Clostridium_symbiosum ++++ SPC10238SPC10355 Clostridium_mayombei Clostridium_symbiosum ++++ SPC00026SPC10355 Clostridium_nexile Clostridium_symbiosum + SPC00027 SPC10355Clostridium_sp_HGF2 Clostridium_symbiosum SPC10355 SPC10355Clostridium_symbiosum Clostridium_symbiosum + SPC10355 SPC10355Clostridium_symbiosum Clostridium_symbiosum ++++ SPC10155 SPC10355Clostridium_tertium Clostridium_symbiosum + SPC10097 SPC10355Collinsella_aerofaciens Clostridium_symbiosum +++ SPC10097 SPC10355Collinsella_aerofaciens Clostridium_symbiosum ++++ SPC00009 SPC10355Coprobacillus_sp_D7 Clostridium_symbiosum SPC00080 SPC10355Coprococcus_catus Clostridium_symbiosum − SPC10304 SPC10355Coprococcus_comes Clostridium_symbiosum SPC10304 SPC10355Coprococcus_comes Clostridium_symbiosum ++++ SPC00018 SPC10355Dorea_formicigenerans Clostridium_symbiosum SPC00057 SPC10355Dorea_longicatena Clostridium_symbiosum ++++ SPC00008 SPC10355Enterococcus_faecalis Clostridium_symbiosum ++++ SPC10001 SPC10355Erysipelotrichaceae_bacterium Clostridium_symbiosum SPC00001 SPC10355Escherichia_coli Clostridium_symbiosum ++++ SPC10110 SPC10355Escherichia_coli Clostridium_symbiosum ++++ SPC00022 SPC10355Eubacterium_eligens Clostridium_symbiosum + SPC00054 SPC10355Faecalibacterium_prausnitzii Clostridium_symbiosum SPC00056 SPC10355Odoribacter_splanchnicus Clostridium_symbiosum SPC10048 SPC10355Parabacteroides_merdae Clostridium_symbiosum − SPC00061 SPC10355Roseburia_intestinalis Clostridium_symbiosum −− SPC10197 SPC10355Ruminococcus_obeum Clostridium_symbiosum ++++ SPC10233 SPC10355Ruminococcus_torques Clostridium_symbiosum ++ SPC00015 SPC10355Streptococcus_thermophilus Clostridium_symbiosum SPC10167 SPC10155Clostridium_disporicum Clostridium_tertium ++++ SPC10155 SPC10155Clostridium_tertium Clostridium_tertium ++++ SPC10097 SPC10155Collinsella_aerofaciens Clostridium_tertium SPC10030 SPC10097Bacteroides_ovatus Collinsella_aerofaciens ++++ SPC00006 SPC10097Bacteroides_sp_1_1_6 Collinsella_aerofaciens ++++ SPC00007 SPC10097Bacteroides_sp_3_1_23 Collinsella_aerofaciens ++++ SPC10019 SPC10097Bacteroides_sp_D20 Collinsella_aerofaciens ++++ SPC00005 SPC10097Bacteroides_vulgatus Collinsella_aerofaciens ++++ SPC10081 SPC10097Bacteroides_vulgatus Collinsella_aerofaciens ++++ SPC00021 SPC10097Blautia_producta Collinsella_aerofaciens ++++ SPC00026 SPC10097Clostridium_nexile Collinsella_aerofaciens + SPC00027 SPC10097Clostridium_sp_HGF2 Collinsella_aerofaciens ++++ SPC10155 SPC10097Clostridium_tertium Collinsella_aerofaciens SPC10097 SPC10097Collinsella_aerofaciens Collinsella_aerofaciens ++++ SPC10097 SPC10097Collinsella_aerofaciens Collinsella_aerofaciens SPC00009 SPC10097Coprobacillus_sp_D7 Collinsella_aerofaciens +++ SPC00080 SPC10097Coprococcus_catus Collinsella_aerofaciens ++++ SPC00018 SPC10097Dorea_formicigenerans Collinsella_aerofaciens ++ SPC00057 SPC10097Dorea_longicatena Collinsella_aerofaciens ++++ SPC00008 SPC10097Enterococcus_faecalis Collinsella_aerofaciens ++++ SPC10001 SPC10097Erysipelotrichaceae_bacterium Collinsella_aerofaciens ++++ SPC00001SPC10097 Escherichia_coli Collinsella_aerofaciens ++++ SPC00022 SPC10097Eubacterium_eligens Collinsella_aerofaciens +++ SPC00054 SPC10097Faecalibacterium_prausnitzii Collinsella_aerofaciens +++ SPC00056SPC10097 Odoribacter_splanchnicus Collinsella_aerofaciens +++ SPC10048SPC10097 Parabacteroides_merdae Collinsella_aerofaciens ++++ SPC00061SPC10097 Roseburia_intestinalis Collinsella_aerofaciens ++ SPC00015SPC10097 Streptococcus_thermophilus Collinsella_aerofaciens + SPC00006SPC00009 Bacteroides_sp_1_1_6 Coprobacillus_sp_D7 +++ SPC00007 SPC00009Bacteroides_sp_3_1_23 Coprobacillus_sp_D7 SPC00005 SPC00009Bacteroides_vulgatus Coprobacillus_sp_D7 + SPC00009 SPC00009Coprobacillus_sp_D7 Coprobacillus_sp_D7 − SPC00008 SPC00009Enterococcus_faecalis Coprobacillus_sp_D7 ++++ SPC00001 SPC00009Escherichia_coli Coprobacillus_sp_D7 ++ SPC00006 SPC00080Bacteroides_sp_1_1_6 Coprococcus_catus ++++ SPC00007 SPC00080Bacteroides_sp_3_1_23 Coprococcus_catus SPC00005 SPC00080Bacteroides_vulgatus Coprococcus_catus + SPC00021 SPC00080Blautia_producta Coprococcus_catus ++++ SPC00026 SPC00080Clostridium_nexile Coprococcus_catus SPC00027 SPC00080Clostridium_sp_HGF2 Coprococcus_catus −−− SPC00009 SPC00080Coprobacillus_sp_D7 Coprococcus_catus −−− SPC00080 SPC00080Coprococcus_catus Coprococcus_catus SPC00018 SPC00080Dorea_formicigenerans Coprococcus_catus SPC00057 SPC00080Dorea_longicatena Coprococcus_catus SPC00008 SPC00080Enterococcus_faecalis Coprococcus_catus ++++ SPC00001 SPC00080Escherichia_coli Coprococcus_catus ++++ SPC00022 SPC00080Eubacterium_eligens Coprococcus_catus SPC00054 SPC00080Faecalibacterium_prausnitzii Coprococcus_catus SPC00056 SPC00080Odoribacter_splanchnicus Coprococcus_catus SPC00061 SPC00080Roseburia_intestinalis Coprococcus_catus SPC00015 SPC00080Streptococcus_thermophilus Coprococcus_catus SPC10211 SPC10304Bacteroides_caccae Coprococcus_comes +++ SPC10213 SPC10304Bacteroides_eggerthii Coprococcus_comes +++ SPC10030 SPC10304Bacteroides_ovatus Coprococcus_comes SPC00006 SPC10304Bacteroides_sp_1_1_6 Coprococcus_comes +++ SPC00007 SPC10304Bacteroides_sp_3_1_23 Coprococcus_comes ++++ SPC10019 SPC10304Bacteroides_sp_D20 Coprococcus_comes SPC00005 SPC10304Bacteroides_vulgatus Coprococcus_comes ++++ SPC10081 SPC10304Bacteroides_vulgatus Coprococcus_comes SPC10301 SPC10304Bifidobacterium_adolescentis Coprococcus_comes ++++ SPC10298 SPC10304Bifidobacterium_pseudocatenulatum Coprococcus_comes ++++ SPC00021SPC10304 Blautia_producta Coprococcus_comes ++++ SPC10256 SPC10304Clostridium butyricum Coprococcus_comes ++++ SPC10167 SPC10304Clostridium_disporicum Coprococcus_comes ++++ SPC10243 SPC10304Clostridium_hathewayi Coprococcus_comes ++++ SPC10313 SPC10304Clostridium_hylemonae Coprococcus_comes + SPC10202 SPC10304Clostridium_innocuum Coprococcus_comes ++++ SPC10238 SPC10304Clostridium_mayombei Coprococcus_comes ++++ SPC00026 SPC10304Clostridium_nexile Coprococcus_comes SPC00027 SPC10304Clostridium_sp_HGF2 Coprococcus_comes SPC10155 SPC10304Clostridium_tertium Coprococcus_comes ++++ SPC10097 SPC10304Collinsella_aerofaciens Coprococcus_comes ++++ SPC10097 SPC10304Collinsella_aerofaciens Coprococcus_comes +++ SPC00009 SPC10304Coprobacillus_sp_D7 Coprococcus_comes +++ SPC00080 SPC10304Coprococcus_catus Coprococcus_comes −− SPC10304 SPC10304Coprococcus_comes Coprococcus_comes SPC10304 SPC10304 Coprococcus_comesCoprococcus_comes ++ SPC00018 SPC10304 Dorea_formicigeneransCoprococcus_comes SPC00057 SPC10304 Dorea_longicatena Coprococcus_comesSPC00008 SPC10304 Enterococcus_faecalis Coprococcus_comes ++++ SPC10001SPC10304 Erysipelotrichaceae_bacterium Coprococcus_comes − SPC00001SPC10304 Escherichia_coli Coprococcus_comes ++++ SPC10110 SPC10304Escherichia_coli Coprococcus_comes ++++ SPC00022 SPC10304Eubacterium_eligens Coprococcus_comes ++ SPC00054 SPC10304Faecalibacterium_prausnitzii Coprococcus_comes SPC00056 SPC10304Odoribacter_splanchnicus Coprococcus_comes SPC10048 SPC10304Parabacteroides_merdae Coprococcus_comes − SPC00061 SPC10304Roseburia_intestinalis Coprococcus_comes − SPC10197 SPC10304Ruminococcus_obeum Coprococcus_comes ++++ SPC10233 SPC10304Ruminococcus_torques Coprococcus_comes ++++ SPC00015 SPC10304Streptococcus_thermophilus Coprococcus_comes ++ SPC00006 SPC00018Bacteroides_sp_1_1_6 Dorea_formicigenerans +++ SPC00007 SPC00018Bacteroides_sp_3_1_23 Dorea_formicigenerans SPC00005 SPC00018Bacteroides_vulgatus Dorea_formicigenerans ++ SPC00009 SPC00018Coprobacillus_sp_D7 Dorea_formicigenerans − SPC00018 SPC00018Dorea_formicigenerans Dorea_formicigenerans −− SPC00008 SPC00018Enterococcus_faecalis Dorea_formicigenerans ++++ SPC00001 SPC00018Escherichia_coli Dorea_formicigenerans ++ SPC00015 SPC00018Streptococcus_thermophilus Dorea_formicigenerans SPC00006 SPC00057Bacteroides_sp_1_1_6 Dorea_longicatena ++++ SPC00007 SPC00057Bacteroides_sp_3_1_23 Dorea_longicatena +++ SPC00005 SPC00057Bacteroides_vulgatus Dorea_longicatena ++++ SPC00021 SPC00057Blautia_producta Dorea_longicatena ++++ SPC00026 SPC00057Clostridium_nexile Dorea_longicatena SPC00027 SPC00057Clostridium_sp_HGF2 Dorea_longicatena −− SPC00009 SPC00057Coprobacillus_sp_D7 Dorea_longicatena SPC00018 SPC00057Dorea_formicigenerans Dorea_longicatena ++ SPC00057 SPC00057Dorea_longicatena Dorea_longicatena − SPC00008 SPC00057Enterococcus_faecalis Dorea_longicatena ++++ SPC00001 SPC00057Escherichia_coli Dorea_longicatena ++++ SPC00022 SPC00057Eubacterium_eligens Dorea_longicatena ++ SPC00054 SPC00057Faecalibacterium_prausnitzii Dorea_longicatena − SPC00056 SPC00057Odoribacter_splanchnicus Dorea_longicatena SPC00015 SPC00057Streptococcus_thermophilus Dorea_longicatena + SPC00006 SPC00008Bacteroides_sp_1_1_6 Enterococcus_faecalis ++++ SPC00007 SPC00008Bacteroides_sp_3_1_23 Enterococcus_faecalis ++++ SPC00005 SPC00008Bacteroides_vulgatus Enterococcus_faecalis ++++ SPC00008 SPC00008Enterococcus_faecalis Enterococcus_faecalis ++++ SPC00001 SPC00008Escherichia_coli Enterococcus_faecalis ++++ SPC00006 SPC10001Bacteroides_sp_1_1_6 Erysipelotrichaceae_bacterium ++++ SPC00007SPC10001 Bacteroides_sp_3_1_23 Erysipelotrichaceae_bacterium SPC00005SPC10001 Bacteroides_vulgatus Erysipelotrichaceae_bacterium + SPC00021SPC10001 Blautia_producta Erysipelotrichaceae_bacterium ++++ SPC00026SPC10001 Clostridium_nexile Erysipelotrichaceae_bacterium SPC00027SPC10001 Clostridium_sp_HGF2 Erysipelotrichaceae_bacterium −− SPC00009SPC10001 Coprobacillus_sp_D7 Erysipelotrichaceae_bacterium − SPC00080SPC10001 Coprococcus_catus Erysipelotrichaceae_bacterium SPC00018SPC10001 Dorea_formicigenerans Erysipelotrichaceae_bacterium −− SPC00057SPC10001 Dorea_longicatena Erysipelotrichaceae_bacterium SPC00008SPC10001 Enterococcus_faecalis Erysipelotrichaceae_bacterium ++++SPC10001 SPC10001 Erysipelotrichaceae_bacteriumErysipelotrichaceae_bacterium − SPC00001 SPC10001 Escherichia_coliErysipelotrichaceae_bacterium ++++ SPC00022 SPC10001 Eubacterium_eligensErysipelotrichaceae_bacterium − SPC00054 SPC10001Faecalibacterium_prausnitzii Erysipelotrichaceae_bacterium − SPC00056SPC10001 Odoribacter_splanchnicus Erysipelotrichaceae_bacterium SPC00061SPC10001 Roseburia_intestinalis Erysipelotrichaceae_bacterium − SPC00015SPC10001 Streptococcus_thermophilus Erysipelotrichaceae_bacteriumSPC10030 SPC10110 Bacteroides_ovatus Escherichia_coli ++++ SPC00006SPC10110 Bacteroides_sp_1_1_6 Escherichia_coli ++++ SPC00007 SPC10110Bacteroides_sp_3_1_23 Escherichia_coli ++++ SPC10019 SPC10110Bacteroides_sp_D20 Escherichia_coli ++++ SPC00005 SPC10110Bacteroides_vulgatus Escherichia_coli ++++ SPC10081 SPC10110Bacteroides_vulgatus Escherichia_coli ++++ SPC00021 SPC10110Blautia_producta Escherichia_coli ++++ SPC00026 SPC10110Clostridium_nexile Escherichia_coli ++++ SPC00027 SPC10110Clostridium_sp_HGF2 Escherichia_coli ++++ SPC10097 SPC10110Collinsella_aerofaciens Escherichia_coli ++++ SPC00009 SPC10110Coprobacillus_sp_D7 Escherichia_coli ++ SPC00080 SPC10110Coprococcus_catus Escherichia_coli ++++ SPC00018 SPC10110Dorea_formicigenerans Escherichia_coli ++++ SPC00057 SPC10110Dorea_longicatena Escherichia_coli ++++ SPC00008 SPC10110Enterococcus_faecalis Escherichia_coli ++++ SPC10001 SPC10110Erysipelotrichaceae_bacterium Escherichia_coli ++++ SPC00001 SPC00001Escherichia_coli Escherichia_coli ++++ SPC00001 SPC10110Escherichia_coli Escherichia_coli ++++ SPC10110 SPC10110Escherichia_coli Escherichia_coli ++++ SPC00022 SPC10110Eubacterium_eligens Escherichia_coli ++++ SPC00054 SPC10110Faecalibacterium_prausnitzii Escherichia_coli +++ SPC00056 SPC10110Odoribacter_splanchnicus Escherichia_coli +++ SPC10048 SPC10110Parabacteroides_merdae Escherichia_coli ++++ SPC00061 SPC10110Roseburia_intestinalis Escherichia_coli +++ SPC00015 SPC10110Streptococcus_thermophilus Escherichia_coli +++ SPC00006 SPC00022Bacteroides_sp_1_1_6 Eubacterium_eligens ++++ SPC00007 SPC00022Bacteroides_sp_3_1_23 Eubacterium_eligens SPC00005 SPC00022Bacteroides_vulgatus Eubacterium_eligens +++ SPC00021 SPC00022Blautia_producta Eubacterium_eligens ++++ SPC00009 SPC00022Coprobacillus_sp_D7 Eubacterium_eligens SPC00018 SPC00022Dorea_formicigenerans Eubacterium_eligens −− SPC00008 SPC00022Enterococcus_faecalis Eubacterium_eligens ++++ SPC00001 SPC00022Escherichia_coli Eubacterium_eligens ++ SPC00022 SPC00022Eubacterium_eligens Eubacterium_eligens SPC00015 SPC00022Streptococcus_thermophilus Eubacterium_eligens SPC10211 SPC10363Bacteroides_caccae Eubacterium_rectale SPC10213 SPC10363Bacteroides_eggerthii Eubacterium_rectale SPC10030 SPC10363Bacteroides_ovatus Eubacterium_rectale SPC00006 SPC10363Bacteroides_sp_1_1_6 Eubacterium_rectale ++++ SPC00007 SPC10363Bacteroides_sp_3_1_23 Eubacterium_rectale +++ SPC10019 SPC10363Bacteroides_sp_D20 Eubacterium_rectale −− SPC00005 SPC10363Bacteroides_vulgatus Eubacterium_rectale ++++ SPC10081 SPC10363Bacteroides_vulgatus Eubacterium_rectale SPC10301 SPC10363Bifidobacterium_adolescentis Eubacterium_rectale ++++ SPC10298 SPC10363Bifidobacterium_pseudocatenulatum Eubacterium_rectale SPC00021 SPC10363Blautia_producta Eubacterium_rectale ++++ SPC10415 SPC10567Blautia_producta Eubacterium_rectale ++++ SPC10256 SPC10567 Clostridiumbutyricum Eubacterium_rectale ++++ SPC10358 SPC10567 Clostridiumorbiscindens Eubacterium_rectale + SPC10325 SPC10567 Clostridium_bolteaeEubacterium_rectale ++ SPC10167 SPC10567 Clostridium_disporicumEubacterium_rectale ++++ SPC10243 SPC10363 Clostridium_hathewayiEubacterium_rectale ++++ SPC10313 SPC10567 Clostridium_hylemonaeEubacterium_rectale SPC10202 SPC10567 Clostridium_innocuumEubacterium_rectale ++++ SPC10238 SPC10567 Clostridium_mayombeiEubacterium_rectale ++++ SPC00026 SPC10363 Clostridium_nexileEubacterium_rectale − SPC00027 SPC10363 Clostridium_sp_HGF2Eubacterium_rectale −− SPC10355 SPC10363 Clostridium_symbiosumEubacterium_rectale ++ SPC10355 SPC10567 Clostridium_symbiosumEubacterium_rectale + SPC10155 SPC10567 Clostridium_tertiumEubacterium_rectale ++++ SPC10097 SPC10363 Collinsella_aerofaciensEubacterium_rectale ++++ SPC10097 SPC10567 Collinsella_aerofaciensEubacterium_rectale ++++ SPC00009 SPC10363 Coprobacillus_sp_D7Eubacterium_rectale +++ SPC00080 SPC10363 Coprococcus_catusEubacterium_rectale −−− SPC10304 SPC10363 Coprococcus_comesEubacterium_rectale + SPC10304 SPC10567 Coprococcus_comesEubacterium_rectale ++++ SPC00018 SPC10363 Dorea_formicigeneransEubacterium_rectale − SPC00057 SPC10363 Dorea_longicatenaEubacterium_rectale ++++ SPC00008 SPC10363 Enterococcus_faecalisEubacterium_rectale ++++ SPC10001 SPC10363 Erysipelotrichaceae_bacteriumEubacterium_rectale − SPC00001 SPC10363 Escherichia_coliEubacterium_rectale ++++ SPC10110 SPC10363 Escherichia_coliEubacterium_rectale ++++ SPC00022 SPC10363 Eubacterium_eligensEubacterium_rectale SPC10363 SPC10363 Eubacterium_rectaleEubacterium_rectale +++ SPC10567 SPC10567 Eubacterium_rectaleEubacterium_rectale SPC00054 SPC10363 Faecalibacterium_prausnitziiEubacterium_rectale −− SPC10386 SPC10567 Faecalibacterium_prausnitziiEubacterium_rectale SPC10390 SPC10567Lachnospiraceae_bacterium_5_1_57FAA Eubacterium_rectale +++ SPC00056SPC10363 Odoribacter_splanchnicus Eubacterium_rectale − SPC10048SPC10363 Parabacteroides_merdae Eubacterium_rectale − SPC00061 SPC10363Roseburia_intestinalis Eubacterium_rectale −−−− SPC10470 SPC10567Ruminococcus_bromii Eubacterium_rectale + SPC10468 SPC10567Ruminococcus_gnavus Eubacterium_rectale ++++ SPC10197 SPC10363Ruminococcus_obeum Eubacterium_rectale ++ SPC10233 SPC10363Ruminococcus_torques Eubacterium_rectale + SPC00015 SPC10363Streptococcus_thermophilus Eubacterium_rectale SPC10211 SPC10386Bacteroides_caccae Faecalibacterium_prausnitzii SPC10213 SPC10386Bacteroides_eggerthii Faecalibacterium_prausnitzii − SPC10030 SPC10386Bacteroides_ovatus Faecalibacterium_prausnitzii − SPC00006 SPC00054Bacteroides_sp_1_1_6 Faecalibacterium_prausnitzii ++++ SPC00006 SPC10386Bacteroides_sp_1_1_6 Faecalibacterium_prausnitzii +++ SPC00007 SPC00054Bacteroides_sp_3_1_23 Faecalibacterium_prausnitzii ++ SPC00007 SPC10386Bacteroides_sp_3_1_23 Faecalibacterium_prausnitzii SPC10019 SPC10386Bacteroides_sp_D20 Faecalibacterium_prausnitzii −− SPC00005 SPC00054Bacteroides_vulgatus Faecalibacterium_prausnitzii ++++ SPC00005 SPC10386Bacteroides_vulgatus Faecalibacterium_prausnitzii +++ SPC10081 SPC10386Bacteroides_vulgatus Faecalibacterium_prausnitzii −−− SPC10301 SPC10386Bifidobacterium_adolescentis Faecalibacterium_prausnitzii + SPC10298SPC10386 Bifidobacterium_pseudocatenulatum Faecalibacterium_prausnitziiSPC00021 SPC00054 Blautia_producta Faecalibacterium_prausnitzii ++++SPC00021 SPC10386 Blautia_producta Faecalibacterium_prausnitzii ++++SPC10256 SPC10386 Clostridium butyricum Faecalibacterium_prausnitzii++++ SPC10358 SPC10386 Clostridium orbiscindensFaecalibacterium_prausnitzii SPC10325 SPC10386 Clostridium_bolteaeFaecalibacterium_prausnitzii ++ SPC10167 SPC10386 Clostridium_disporicumFaecalibacterium_prausnitzii SPC10243 SPC10386 Clostridium_hathewayiFaecalibacterium_prausnitzii +++ SPC10313 SPC10386 Clostridium_hylemonaeFaecalibacterium_prausnitzii SPC10202 SPC10386 Clostridium_innocuumFaecalibacterium_prausnitzii ++++ SPC10238 SPC10386 Clostridium_mayombeiFaecalibacterium_prausnitzii ++++ SPC00026 SPC00054 Clostridium_nexileFaecalibacterium_prausnitzii SPC00026 SPC10386 Clostridium_nexileFaecalibacterium_prausnitzii − SPC00027 SPC00054 Clostridium_sp_HGF2Faecalibacterium_prausnitzii ++ SPC00027 SPC10386 Clostridium_sp_HGF2Faecalibacterium_prausnitzii −− SPC10355 SPC10386 Clostridium_symbiosumFaecalibacterium_prausnitzii +++ SPC10355 SPC10386 Clostridium_symbiosumFaecalibacterium_prausnitzii ++++ SPC10155 SPC10386 Clostridium_tertiumFaecalibacterium_prausnitzii ++++ SPC10097 SPC10386Collinsella_aerofaciens Faecalibacterium_prausnitzii ++++ SPC10097SPC10386 Collinsella_aerofaciens Faecalibacterium_prausnitzii ++++SPC00009 SPC00054 Coprobacillus_sp_D7 Faecalibacterium_prausnitzii −−−SPC00009 SPC10386 Coprobacillus_sp_D7 Faecalibacterium_prausnitziiSPC00080 SPC10386 Coprococcus_catus Faecalibacterium_prausnitzii −−−SPC10304 SPC10386 Coprococcus_comes Faecalibacterium_prausnitziiSPC10304 SPC10386 Coprococcus_comes Faecalibacterium_prausnitzii +++SPC00018 SPC00054 Dorea_formicigenerans Faecalibacterium_prausnitziiSPC00018 SPC10386 Dorea_formicigenerans Faecalibacterium_prausnitzii −−−SPC00057 SPC10386 Dorea_longicatena Faecalibacterium_prausnitzii +++SPC00008 SPC00054 Enterococcus_faecalis Faecalibacterium_prausnitzii++++ SPC00008 SPC10386 Enterococcus_faecalisFaecalibacterium_prausnitzii ++++ SPC10001 SPC10386Erysipelotrichaceae_bacterium Faecalibacterium_prausnitzii −− SPC00001SPC00054 Escherichia_coli Faecalibacterium_prausnitzii ++++ SPC00001SPC10386 Escherichia_coli Faecalibacterium_prausnitzii ++++ SPC10110SPC10386 Escherichia_coli Faecalibacterium_prausnitzii ++ SPC00022SPC00054 Eubacterium_eligens Faecalibacterium_prausnitzii SPC00022SPC10386 Eubacterium_eligens Faecalibacterium_prausnitzii SPC10363SPC10386 Eubacterium_rectale Faecalibacterium_prausnitzii + SPC00054SPC00054 Faecalibacterium_prausnitzii Faecalibacterium_prausnitzii +SPC00054 SPC10386 Faecalibacterium_prausnitziiFaecalibacterium_prausnitzii SPC10386 SPC10386Faecalibacterium_prausnitzii Faecalibacterium_prausnitzii + SPC10386SPC10386 Faecalibacterium_prausnitzii Faecalibacterium_prausnitziiSPC10390 SPC10386 Lachnospiraceae_bacterium_5_1_57FAAFaecalibacterium_prausnitzii ++++ SPC00056 SPC10386Odoribacter_splanchnicus Faecalibacterium_prausnitzii −− SPC10048SPC10386 Parabacteroides_merdae Faecalibacterium_prausnitzii − SPC00061SPC10386 Roseburia_intestinalis Faecalibacterium_prausnitzii SPC10197SPC10386 Ruminococcus_obeum Faecalibacterium_prausnitzii SPC10233SPC10386 Ruminococcus_torques Faecalibacterium_prausnitzii SPC00015SPC00054 Streptococcus_thermophilus Faecalibacterium_prausnitziiSPC00015 SPC10386 Streptococcus_thermophilusFaecalibacterium_prausnitzii SPC10211 SPC10390 Bacteroides_caccaeLachnospiraceae_bacterium_5_1_57FAA SPC10213 SPC10390Bacteroides_eggerthii Lachnospiraceae_bacterium_5_1_57FAA SPC10030SPC10390 Bacteroides_ovatus Lachnospiraceae_bacterium_5_1_57FAA −SPC00006 SPC10390 Bacteroides_sp_1_1_6Lachnospiraceae_bacterium_5_1_57FAA +++ SPC00007 SPC10390Bacteroides_sp_3_1_23 Lachnospiraceae_bacterium_5_1_57FAA SPC10019SPC10390 Bacteroides_sp_D20 Lachnospiraceae_bacterium_5_1_57FAA −−−SPC00005 SPC10390 Bacteroides_vulgatusLachnospiraceae_bacterium_5_1_57FAA +++ SPC10081 SPC10390Bacteroides_vulgatus Lachnospiraceae_bacterium_5_1_57FAA −− SPC10301SPC10390 Bifidobacterium_adolescentisLachnospiraceae_bacterium_5_1_57FAA ++++ SPC10298 SPC10390Bifidobacterium_pseudocatenulatum Lachnospiraceae_bacterium_5_1_57FAASPC00021 SPC10390 Blautia_producta Lachnospiraceae_bacterium_5_1_57FAA++++ SPC10415 SPC10390 Blautia_productaLachnospiraceae_bacterium_5_1_57FAA ++++ SPC10256 SPC10390 Clostridiumbutyricum Lachnospiraceae_bacterium_5_1_57FAA ++++ SPC10358 SPC10390Clostridium orbiscindens Lachnospiraceae_bacterium_5_1_57FAA ++++SPC10325 SPC10390 Clostridium_bolteaeLachnospiraceae_bacterium_5_1_57FAA ++++ SPC10167 SPC10390Clostridium_disporicum Lachnospiraceae_bacterium_5_1_57FAA ++++ SPC10243SPC10390 Clostridium_hathewayi Lachnospiraceae_bacterium_5_1_57FAA ++++SPC10313 SPC10390 Clostridium_hylemonaeLachnospiraceae_bacterium_5_1_57FAA ++++ SPC10202 SPC10390Clostridium_innocuum Lachnospiraceae_bacterium_5_1_57FAA ++++ SPC10238SPC10390 Clostridium_mayombei Lachnospiraceae_bacterium_5_1_57FAA ++++SPC00026 SPC10390 Clostridium_nexile Lachnospiraceae_bacterium_5_1_57FAA− SPC00027 SPC10390 Clostridium_sp_HGF2Lachnospiraceae_bacterium_5_1_57FAA − SPC10355 SPC10390Clostridium_symbiosum Lachnospiraceae_bacterium_5_1_57FAA + SPC10355SPC10390 Clostridium_symbiosum Lachnospiraceae_bacterium_5_1_57FAA ++++SPC10155 SPC10390 Clostridium_tertiumLachnospiraceae_bacterium_5_1_57FAA ++++ SPC10097 SPC10390Collinsella_aerofaciens Lachnospiraceae_bacterium_5_1_57FAA ++++SPC10097 SPC10390 Collinsella_aerofaciensLachnospiraceae_bacterium_5_1_57FAA ++++ SPC00009 SPC10390Coprobacillus_sp_D7 Lachnospiraceae_bacterium_5_1_57FAA ++++ SPC00080SPC10390 Coprococcus_catus Lachnospiraceae_bacterium_5_1_57FAA SPC10304SPC10390 Coprococcus_comes Lachnospiraceae_bacterium_5_1_57FAA SPC10304SPC10390 Coprococcus_comes Lachnospiraceae_bacterium_5_1_57FAA ++++SPC00018 SPC10390 Dorea_formicigeneransLachnospiraceae_bacterium_5_1_57FAA −− SPC00057 SPC10390Dorea_longicatena Lachnospiraceae_bacterium_5_1_57FAA ++++ SPC00008SPC10390 Enterococcus_faecalis Lachnospiraceae_bacterium_5_1_57FAA ++++SPC10001 SPC10390 Erysipelotrichaceae_bacteriumLachnospiraceae_bacterium_5_1_57FAA −−− SPC00001 SPC10390Escherichia_coli Lachnospiraceae_bacterium_5_1_57FAA ++++ SPC10110SPC10390 Escherichia_coli Lachnospiraceae_bacterium_5_1_57FAA ++++SPC00022 SPC10390 Eubacterium_eligensLachnospiraceae_bacterium_5_1_57FAA SPC10363 SPC10390Eubacterium_rectale Lachnospiraceae_bacterium_5_1_57FAA SPC00054SPC10390 Faecalibacterium_prausnitziiLachnospiraceae_bacterium_5_1_57FAA SPC10386 SPC10390Faecalibacterium_prausnitzii Lachnospiraceae_bacterium_5_1_57FAASPC10386 SPC10390 Faecalibacterium_prausnitziiLachnospiraceae_bacterium_5_1_57FAA ++++ SPC10390 SPC10390Lachnospiraceae_bacterium_5_1_57FAA Lachnospiraceae_bacterium_5_1_57FAASPC10390 SPC10390 Lachnospiraceae_bacterium_5_1_57FAALachnospiraceae_bacterium_5_1_57FAA ++++ SPC00056 SPC10390Odoribacter_splanchnicus Lachnospiraceae_bacterium_5_1_57FAA −− SPC10388SPC10390 Odoribacter_splanchnicus Lachnospiraceae_bacterium_5_1_57FAASPC10048 SPC10390 Parabacteroides_merdaeLachnospiraceae_bacterium_5_1_57FAA − SPC00061 SPC10390Roseburia_intestinalis Lachnospiraceae_bacterium_5_1_57FAA SPC10197SPC10390 Ruminococcus_obeum Lachnospiraceae_bacterium_5_1_57FAA SPC10233SPC10390 Ruminococcus_torques Lachnospiraceae_bacterium_5_1_57FAASPC00015 SPC10390 Streptococcus_thermophilusLachnospiraceae_bacterium_5_1_57FAA SPC10211 SPC10388 Bacteroides_caccaeOdoribacter_splanchnicus SPC10213 SPC10388 Bacteroides_eggerthiiOdoribacter_splanchnicus − SPC10030 SPC10388 Bacteroides_ovatusOdoribacter_splanchnicus −− SPC00006 SPC00056 Bacteroides_sp_1_1_6Odoribacter_splanchnicus ++++ SPC00006 SPC10388 Bacteroides_sp_1_1_6Odoribacter_splanchnicus + SPC00007 SPC00056 Bacteroides_sp_3_1_23Odoribacter_splanchnicus + SPC00007 SPC10388 Bacteroides_sp_3_1_23Odoribacter_splanchnicus SPC10019 SPC10388 Bacteroides_sp_D20Odoribacter_splanchnicus −−− SPC00005 SPC00056 Bacteroides_vulgatusOdoribacter_splanchnicus +++ SPC00005 SPC10388 Bacteroides_vulgatusOdoribacter_splanchnicus +++ SPC10081 SPC10388 Bacteroides_vulgatusOdoribacter_splanchnicus − SPC10301 SPC10388Bifidobacterium_adolescentis Odoribacter_splanchnicus ++++ SPC10298SPC10388 Bifidobacterium_pseudocatenulatum Odoribacter_splanchnicus +++SPC00021 SPC00056 Blautia_producta Odoribacter_splanchnicus ++++SPC00021 SPC10388 Blautia_producta Odoribacter_splanchnicus ++++SPC10243 SPC10388 Clostridium_hathewayi Odoribacter_splanchnicus ++++SPC00026 SPC00056 Clostridium_nexile Odoribacter_splanchnicus SPC00026SPC10388 Clostridium_nexile Odoribacter_splanchnicus −−− SPC00027SPC00056 Clostridium_sp_HGF2 Odoribacter_splanchnicus SPC00027 SPC10388Clostridium_sp_HGF2 Odoribacter_splanchnicus −−− SPC10355 SPC10388Clostridium_symbiosum Odoribacter_splanchnicus ++ SPC10097 SPC10388Collinsella_aerofaciens Odoribacter_splanchnicus ++++ SPC00009 SPC00056Coprobacillus_sp_D7 Odoribacter_splanchnicus − SPC00009 SPC10388Coprobacillus_sp_D7 Odoribacter_splanchnicus +++ SPC00080 SPC10388Coprococcus_catus Odoribacter_splanchnicus −− SPC10304 SPC10388Coprococcus_comes Odoribacter_splanchnicus SPC00018 SPC00056Dorea_formicigenerans Odoribacter_splanchnicus SPC00018 SPC10388Dorea_formicigenerans Odoribacter_splanchnicus − SPC00057 SPC10388Dorea_longicatena Odoribacter_splanchnicus ++++ SPC00008 SPC00056Enterococcus_faecalis Odoribacter_splanchnicus ++++ SPC00008 SPC10388Enterococcus_faecalis Odoribacter_splanchnicus ++++ SPC10001 SPC10388Erysipelotrichaceae_bacterium Odoribacter_splanchnicus −− SPC00001SPC00056 Escherichia_coli Odoribacter_splanchnicus ++++ SPC00001SPC10388 Escherichia_coli Odoribacter_splanchnicus ++++ SPC10110SPC10388 Escherichia_coli Odoribacter_splanchnicus ++++ SPC00022SPC00056 Eubacterium_eligens Odoribacter_splanchnicus SPC00022 SPC10388Eubacterium_eligens Odoribacter_splanchnicus SPC10363 SPC10388Eubacterium_rectale Odoribacter_splanchnicus + SPC00054 SPC00056Faecalibacterium_prausnitzii Odoribacter_splanchnicus SPC00054 SPC10388Faecalibacterium_prausnitzii Odoribacter_splanchnicus − SPC10386SPC10388 Faecalibacterium_prausnitzii Odoribacter_splanchnicus +SPC00056 SPC00056 Odoribacter_splanchnicus Odoribacter_splanchnicusSPC00056 SPC10388 Odoribacter_splanchnicus Odoribacter_splanchnicus −−−SPC10388 SPC10388 Odoribacter_splanchnicus Odoribacter_splanchnicus +SPC10048 SPC10388 Parabacteroides_merdae Odoribacter_splanchnicusSPC00061 SPC10388 Roseburia_intestinalis Odoribacter_splanchnicusSPC10197 SPC10388 Ruminococcus_obeum Odoribacter_splanchnicus + SPC10233SPC10388 Ruminococcus_torques Odoribacter_splanchnicus SPC00015 SPC00056Streptococcus_thermophilus Odoribacter_splanchnicus SPC00015 SPC10388Streptococcus_thermophilus Odoribacter_splanchnicus + SPC10030 SPC10048Bacteroides_ovatus Parabacteroides_merdae SPC00006 SPC10048Bacteroides_sp_1_1_6 Parabacteroides_merdae ++++ SPC00007 SPC10048Bacteroides_sp_3_1_23 Parabacteroides_merdae +++ SPC10019 SPC10048Bacteroides_sp_D20 Parabacteroides_merdae SPC00005 SPC10048Bacteroides_vulgatus Parabacteroides_merdae ++++ SPC00021 SPC10048Blautia_producta Parabacteroides_merdae ++++ SPC00026 SPC10048Clostridium_nexile Parabacteroides_merdae ++ SPC00027 SPC10048Clostridium_sp_HGF2 Parabacteroides_merdae +++ SPC00009 SPC10048Coprobacillus_sp_D7 Parabacteroides_merdae − SPC00080 SPC10048Coprococcus_catus Parabacteroides_merdae +++ SPC00018 SPC10048Dorea_formicigenerans Parabacteroides_merdae SPC00057 SPC10048Dorea_longicatena Parabacteroides_merdae SPC00008 SPC10048Enterococcus_faecalis Parabacteroides_merdae ++++ SPC10001 SPC10048Erysipelotrichaceae_bacterium Parabacteroides_merdae SPC00001 SPC10048Escherichia_coli Parabacteroides_merdae ++++ SPC00022 SPC10048Eubacterium_eligens Parabacteroides_merdae SPC00054 SPC10048Faecalibacterium_prausnitzii Parabacteroides_merdae + SPC00056 SPC10048Odoribacter_splanchnicus Parabacteroides_merdae SPC10048 SPC10048Parabacteroides_merdae Parabacteroides_merdae +++ SPC00061 SPC10048Roseburia_intestinalis Parabacteroides_merdae SPC00015 SPC10048Streptococcus_thermophilus Parabacteroides_merdae SPC00006 SPC00061Bacteroides_sp_1_1_6 Roseburia_intestinalis ++++ SPC00007 SPC00061Bacteroides_sp_3_1_23 Roseburia_intestinalis + SPC00005 SPC00061Bacteroides_vulgatus Roseburia_intestinalis + SPC00021 SPC00061Blautia_producta Roseburia_intestinalis ++++ SPC00026 SPC00061Clostridium_nexile Roseburia_intestinalis − SPC00027 SPC00061Clostridium_sp_HGF2 Roseburia_intestinalis −−− SPC00009 SPC00061Coprobacillus_sp_D7 Roseburia_intestinalis − SPC00018 SPC00061Dorea_formicigenerans Roseburia_intestinalis SPC00057 SPC00061Dorea_longicatena Roseburia_intestinalis − SPC00008 SPC00061Enterococcus_faecalis Roseburia_intestinalis ++++ SPC00001 SPC00061Escherichia_coli Roseburia_intestinalis ++++ SPC00022 SPC00061Eubacterium_eligens Roseburia_intestinalis SPC00054 SPC00061Faecalibacterium_prausnitzii Roseburia_intestinalis SPC00056 SPC00061Odoribacter_splanchnicus Roseburia_intestinalis − SPC00061 SPC00061Roseburia_intestinalis Roseburia_intestinalis SPC00015 SPC00061Streptococcus_thermophilus Roseburia_intestinalis SPC10415 SPC10470Blautia_producta Ruminococcus_bromii ++++ SPC10256 SPC10470 Clostridiumbutyricum Ruminococcus_bromii ++++ SPC10358 SPC10470 Clostridiumorbiscindens Ruminococcus_bromii SPC10325 SPC10470 Clostridium_bolteaeRuminococcus_bromii +++ SPC10167 SPC10470 Clostridium_disporicumRuminococcus_bromii SPC10313 SPC10470 Clostridium_hylemonaeRuminococcus_bromii SPC10202 SPC10470 Clostridium_innocuumRuminococcus_bromii ++++ SPC10238 SPC10470 Clostridium_mayombeiRuminococcus_bromii ++++ SPC10355 SPC10470 Clostridium_symbiosumRuminococcus_bromii ++++ SPC10155 SPC10470 Clostridium_tertiumRuminococcus_bromii ++++ SPC10097 SPC10470 Collinsella_aerofaciensRuminococcus_bromii ++++ SPC10304 SPC10470 Coprococcus_comesRuminococcus_bromii ++++ SPC10567 SPC10470 Eubacterium_rectaleRuminococcus_bromii + SPC10386 SPC10470 Faecalibacterium_prausnitziiRuminococcus_bromii SPC10390 SPC10470Lachnospiraceae_bacterium_5_1_57FAA Ruminococcus_bromii ++++ SPC10470SPC10470 Ruminococcus_bromii Ruminococcus_bromii − SPC10468 SPC10470Ruminococcus_gnavus Ruminococcus_bromii ++++ SPC10415 SPC10468Blautia_producta Ruminococcus_gnavus ++++ SPC10256 SPC10468 Clostridiumbutyricum Ruminococcus_gnavus ++++ SPC10358 SPC10468 Clostridiumorbiscindens Ruminococcus_gnavus ++++ SPC10325 SPC10468Clostridium_bolteae Ruminococcus_gnavus ++++ SPC10167 SPC10468Clostridium_disporicum Ruminococcus_gnavus ++++ SPC10313 SPC10468Clostridium_hylemonae Ruminococcus_gnavus +++ SPC10202 SPC10468Clostridium_innocuum Ruminococcus_gnavus ++++ SPC10238 SPC10468Clostridium_mayombei Ruminococcus_gnavus ++++ SPC10355 SPC10468Clostridium_symbiosum Ruminococcus_gnavus ++++ SPC10155 SPC10468Clostridium_tertium Ruminococcus_gnavus ++++ SPC10097 SPC10468Collinsella_aerofaciens Ruminococcus_gnavus ++++ SPC10304 SPC10468Coprococcus_comes Ruminococcus_gnavus ++++ SPC10386 SPC10468Faecalibacterium_prausnitzii Ruminococcus_gnavus ++++ SPC10390 SPC10468Lachnospiraceae_bacterium_5_1_57FAA Ruminococcus_gnavus ++++ SPC10470SPC10468 Ruminococcus_bromii Ruminococcus_gnavus ++++ SPC10468 SPC10468Ruminococcus_gnavus Ruminococcus_gnavus +++ SPC10030 SPC10197Bacteroides_ovatus Ruminococcus_obeum SPC00006 SPC10197Bacteroides_sp_1_1_6 Ruminococcus_obeum +++ SPC00007 SPC10197Bacteroides_sp_3_1_23 Ruminococcus_obeum +++ SPC10019 SPC10197Bacteroides_sp_D20 Ruminococcus_obeum SPC00005 SPC10197Bacteroides_vulgatus Ruminococcus_obeum ++++ SPC10081 SPC10197Bacteroides_vulgatus Ruminococcus_obeum SPC00021 SPC10197Blautia_producta Ruminococcus_obeum ++++ SPC00026 SPC10197Clostridium_nexile Ruminococcus_obeum − SPC00027 SPC10197Clostridium_sp_HGF2 Ruminococcus_obeum −− SPC10097 SPC10197Collinsella_aerofaciens Ruminococcus_obeum ++++ SPC00009 SPC10197Coprobacillus_sp_D7 Ruminococcus_obeum + SPC00080 SPC10197Coprococcus_catus Ruminococcus_obeum SPC00018 SPC10197Dorea_formicigenerans Ruminococcus_obeum ++++ SPC00057 SPC10197Dorea_longicatena Ruminococcus_obeum − SPC00008 SPC10197Enterococcus_faecalis Ruminococcus_obeum ++++ SPC10001 SPC10197Erysipelotrichaceae_bacterium Ruminococcus_obeum SPC00001 SPC10197Escherichia_coli Ruminococcus_obeum +++ SPC10110 SPC10197Escherichia_coli Ruminococcus_obeum ++++ SPC00022 SPC10197Eubacterium_eligens Ruminococcus_obeum + SPC00054 SPC10197Faecalibacterium_prausnitzii Ruminococcus_obeum SPC00056 SPC10197Odoribacter_splanchnicus Ruminococcus_obeum − SPC10048 SPC10197Parabacteroides_merdae Ruminococcus_obeum SPC00061 SPC10197Roseburia_intestinalis Ruminococcus_obeum SPC10197 SPC10197Ruminococcus_obeum Ruminococcus_obeum ++++ SPC00015 SPC10197Streptococcus_thermophilus Ruminococcus_obeum +++ SPC10211 SPC10233Bacteroides_caccae Ruminococcus_torques ++++ SPC10213 SPC10233Bacteroides_eggerthii Ruminococcus_torques ++++ SPC10030 SPC10233Bacteroides_ovatus Ruminococcus_torques ++++ SPC00006 SPC10233Bacteroides_sp_1_1_6 Ruminococcus_torques ++++ SPC00007 SPC10233Bacteroides_sp_3_1_23 Ruminococcus_torques ++++ SPC10019 SPC10233Bacteroides_sp_D20 Ruminococcus_torques ++ SPC00005 SPC10233Bacteroides_vulgatus Ruminococcus_torques ++++ SPC10081 SPC10233Bacteroides_vulgatus Ruminococcus_torques ++++ SPC00021 SPC10233Blautia_producta Ruminococcus_torques ++++ SPC00026 SPC10233Clostridium_nexile Ruminococcus_torques + SPC00027 SPC10233Clostridium_sp_HGF2 Ruminococcus_torques SPC10097 SPC10233Collinsella_aerofaciens Ruminococcus_torques ++++ SPC00009 SPC10233Coprobacillus_sp_D7 Ruminococcus_torques ++++ SPC00080 SPC10233Coprococcus_catus Ruminococcus_torques + SPC00018 SPC10233Dorea_formicigenerans Ruminococcus_torques ++++ SPC00057 SPC10233Dorea_longicatena Ruminococcus_torques SPC00008 SPC10233Enterococcus_faecalis Ruminococcus_torques ++++ SPC10001 SPC10233Erysipelotrichaceae_bacterium Ruminococcus_torques + SPC00001 SPC10233Escherichia_coli Ruminococcus_torques ++++ SPC10110 SPC10233Escherichia_coli Ruminococcus_torques ++++ SPC00022 SPC10233Eubacterium_eligens Ruminococcus_torques ++ SPC00054 SPC10233Faecalibacterium_prausnitzii Ruminococcus_torques SPC00056 SPC10233Odoribacter_splanchnicus Ruminococcus_torques SPC10048 SPC10233Parabacteroides_merdae Ruminococcus_torques + SPC00061 SPC10233Roseburia_intestinalis Ruminococcus_torques + SPC10197 SPC10233Ruminococcus_obeum Ruminococcus_torques ++++ SPC10233 SPC10233Ruminococcus_torques Ruminococcus_torques ++++ SPC00015 SPC10233Streptococcus_thermophilus Ruminococcus_torques + SPC00006 SPC00015Bacteroides_sp_1_1_6 Streptococcus_thermophilus +++ SPC00007 SPC00015Bacteroides_sp_3_1_23 Streptococcus_thermophilus +++ SPC00005 SPC00015Bacteroides_vulgatus Streptococcus_thermophilus + SPC00009 SPC00015Coprobacillus_sp_D7 Streptococcus_thermophilus + SPC00008 SPC00015Enterococcus_faecalis Streptococcus_thermophilus ++++ SPC00001 SPC00015Escherichia_coli Streptococcus_thermophilus + SPC00015 SPC00015Streptococcus_thermophilus Streptococcus_thermophilus

1-43. (canceled)
 44. A method of treating a mammalian subject sufferingfrom or at risk of developing a gastrointestinal disease, disorder orcondition, comprising administering to the mammalian subject in needthereof a composition comprising a bacterial population consisting offrom seven to nine isolated bacterial strains, wherein two of thebacterial strains are Clostridium innocuum and Blautia producta; and acapsule substantially encapsulating the bacterial population.
 45. Themethod of claim 44, wherein the gastrointestinal disease, disorder orcondition is relapsing diarrhea caused by Clostridium difficile,ulcerative colitis, colitis, Crohn's disease, or irritable boweldisease.
 46. The method of claim 44, wherein the gastrointestinaldisease, disorder or condition is recurrent Clostridium difficileinfection.
 47. The method of claim 44, wherein the gastrointestinaldisease, disorder or condition is Clostridium difficile infection. 48.The method of claim 44, wherein the composition is administered once aday for several days or more than once a day on the day ofadministration.
 49. The method of claim 44, wherein the composition isadministered once prior to improvement of the disease, disorder orcondition.
 50. The method of claim 44, wherein the composition isadministered at intervals greater than two days.
 51. The method of claim44, wherein the mammalian subject has not received at least two doses ofa vancomycin, a metronidazole, or an antibiotic compound within one weekprior to administration of the composition.
 52. The method of claim 44,wherein the mammalian subject is not suffering from relapsing diarrheacaused by C. difficile.
 53. The method of claim 44, wherein themammalian subject has received an antibiotic prior to administration ofthe composition.
 54. The method of claim 53, wherein the antibiotic isan aminoglycoside antibiotic, amoxicillin, ampicillin, Augmentin, acephalosporin, clavulanate potassium, clindamycin, colistin gentamycin,kanamycin, metronidazole, vancomycin, or a combination thereof.
 55. Themethod of claim 44, wherein the mammalian subject has not previouslyreceived an antibiotic compound in the one month prior to administrationof the composition.
 56. The method of claim 44, wherein the compositionis formulated for oral or gastric administration.
 57. The method ofclaim 44, wherein the bacterial strains are present at a concentrationof at least 1×10⁴ viable bacteria.
 58. The method of claim 44, whereinat least one of the bacterial strains is provided in a concentration ofgreater than 1×10⁹ viable bacteria.
 59. The method of claim 44, whereinthe bacterial population consists of seven bacterial strains.
 60. Themethod of claim 44, wherein the bacterial population consists of eightbacterial strains.
 61. The method of claim 44, wherein the bacterialpopulation consists of nine bacterial strains.
 62. The method of claim44, wherein the composition further comprises an excipient.
 63. Themethod of claim 44, wherein the bacterial strains are lyophilized. 64.The method of claim 44, wherein the bacterial strains are in vegetativeform.
 65. The method of claim 44, wherein the bacterial strains are inspore form.
 66. A method of treating recurrent Clostridium difficileinfection in a subject in need thereof, comprising administering to thesubject a composition comprising a bacterial population consisting offrom seven to nine isolated bacterial strains, wherein two of thebacterial strains are Clostridium innocuum and Blautia producta; and acapsule substantially encapsulating the bacterial population.